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Abstract
Recent work linked the RNA-binding protein UNR to a number of human pathologies although little is
currently known about how UNR functions in human cells. This thesis aims to elucidate how UNR functions
by, among other things, discovering novel UNR-interacting proteins and transcripts and proteins that are
differentially expressed in the presence or absence of UNR.
It is shown that UNR levels decrease with increasing cell confluency in cultured HeLa cells but that they
increase with increasing confluency in the wild type TP53-containing U2OS cell line. UNR is shown to co-
localise to stress granules with TP53 in arsenite-stressed HeLa cells.
A number of novel UNR-interacting proteins were discovered in three cell lines (HeLa, U2OS and SaOS-2),
including HUWE1, NARR, SQSTM1 and LDB1. GO-term overrepresentation analysis confirmed that UNR is
an RNA-binding protein as ‘RNA binding’ and ‘poly(A) RNA binding’ were the top two overrepresented
molecular function GO terms by p-value across each of the cell types. Less expected overrepresented GO
terms pertained to selenium metabolism and the extracellular exosome.
There was no evidence for conservation of UNR-interacting transcripts across the cell types but there
were some similar significantly overrepresented GO terms among the respective UNR-interacting
transcripts. These included terms pertaining to RNA and the nucleus. The most significant UNR-interacting
transcript in HeLa cells was PABPC1 and that the PABP protein was also significantly upregulated following
UNR knockdown in HeLa cells.
‘Poly (A) RNA binding’ was a significantly overrepresented GO term among proteins differentially
regulated following UNR knockdown in HeLa and U2OS cells. ‘Adherens junction’ was another significantly
overrepresented GO term using proteins that were higher in abundance in siUNR-treated HeLa cells and
either higher or lower in abundance in either arsenite-stressed or unstressed U2OS cells. UNR was
observed at cell-cell junctions in HeLa and U2OS cells by immunofluorescence microscopy.
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1 Introduction
The flow of genetic information from DNA to RNA to protein has been referred to as the Central
Dogma of Molecular Biology although the author of this term later qualified this simplistic
concept of unidirectional flow (Crick, 1970) following the discovery of reverse transcription in
RNA viruses (Baltimore, 1970; Temin & Mizutani, 1970). Although the idea of unidirectional flow
from DNA to RNA and ultimately to protein is not a universal truth, it is nevertheless true that
the processes of transcription and translation can generate protein from DNA through an mRNA
intermediate. RNA occupies a central role in this process and is a key point of control in protein
synthesis. As well as messenger RNA (mRNA), transfer RNAs and ribosomal RNAs are
fundamental to protein synthesis. Other non-coding RNAs can play a role in various processes
relating to protein synthesis, including RNA degradation (considered in Cech & Bass 1986; He &
Hannon 2004), repression of translation (He & Hannon, 2004), and splicing (Lerner, Boyle,
Mount, Wolin, & Steitz, 1980; Waring & Davies, 1984). RNA-binding proteins have a variety of
functions in the cell, including splicing (Gubitz, Feng, & Dreyfuss, 2004), RNA export from the
nucleus (Erkmann & Kutay, 2004), RNA localisation within the cell (Holt & Bullock, 2009) and
translation initiation (Sonenberg & Hinnebusch, 2009). Various groups of RNA-binding domains
exist within RNA-binding proteins that allow them to bind to RNAs to carry out their roles. These
include RNA-recognition motifs (Cléry, Blatter, & Allain, 2008), cold shock domains (Mihailovich,
Militti, Gabaldón, & Gebauer, 2010) and zinc finger domains (Hall, 2005).
This thesis was undertaken in order to expand upon both the current knowledge of the cold
shock domain-containing RNA-binding protein ‘upstream of NRAS’ (UNR)-interacting proteins
and transcripts and upon the current knowledge of proteins that have their expression levels
modulated by UNR. It is laid out in seven chapters.
This first introductory chapter considers the current state of the literature concerning UNR/UNR.
It first considers the UNR gene, then its transcripts and finally the UNR protein. The second
chapter lists materials and methods used in the thesis. The third chapter is an introductory
experimental chapter in which the distribution of UNR within cells under different conditions is
explored together with the expression levels of UNR at different cell confluencies. It is shown
that UNR levels are inversely related to cell confluency in HeLa cells although the relationship is
reversed in U2OS cells. The fourth chapter explores novel UNR-interacting proteins and suggests
some that appear to be consistent across three different cell lines (HeLa, U2OS and SaOS-2). The
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fifth chapter explores novel UNR-interacting transcripts with particular reference to groups of
transcripts that are involved in a biological process, molecular function or that are located within
a given cellular component. The sixth chapter explores the effect of knocking down UNR upon
the proteome. A conclusion then follows that draws together salient findings from the earlier
chapters.
1.1 The UNR gene
1.1.1 Nomenclature
When Northern blot analysis of guinea pig NRAS led Doniger & DiPaolo to suggest that another
gene was located immediately upstream of NRAS, they conferred the locative name ‘upstream
of NRAS’ (UNR) upon it (Doniger & DiPaolo, 1988). Indeed, the intimate proximity of these two
genes is unrivalled within many genomes; their coding sequences are separated by a mere 130
bases in mice (Jeffers, Paciucci, & Pellicer, 1990). The UNR gene is also known by a variety of
other names, such as the synteny mapping-based ‘D1S155E’. Such names point to the genomic
location of UNR but gave no information about its function. The term ‘Cold Shock Domain-
containing protein E1’ (CSDE1) is the preferred name for the UNR protein in the
www.uniprot.org database. This name refers to the structure of the protein and, by inference,
suggests that it may function in a way akin to other cold shock domain containing proteins
documented in the literature. This chapter will address the current literature on UNR/UNR,
mainly focussing on the protein, and will allude to some exciting research being undertaken in
the Anderson lab that lies beyond the scope of this thesis.
1.1.2 Conservation of UNR
The UNR gene is widely conserved among the metazoan linage (Mihailovich et al., 2010).
Interestingly, the nematode worm, Caenorhabditis elegans, appears to have secondarily lost its
UNR homologue over evolutionary time (Mihailovich et al., 2010). Such observations as these
imply both an early origin and an essential function for UNR. The observed intimacy between
the coding regions of NRAS and UNR in the guinea pig genome was later shown to be widely
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conserved within mammalian genomes (Jacquemin-Sablon et al., 1994). For example, there are
around 150 bases between the human genes (Jacquemin-Sablon & Dautry, 1992).
1.1.3 Transcriptional interference on expression of murine Nras
The spatial proximity between the genes may result in UNR exerting transcriptional interference
on NRAS (Boussadia et al., 1997). To test this hypothesis, mice were bred that were
heterozygous for deletion of the Unr promoter. These rodents expressed a significantly reduced
amount of Unr transcript across a number of different tissues. As expected, the reduction in Unr
mRNA levels were accompanied with concomitant increases in Nras transcript levels.
Interestingly, however, the absolute amount the UNR transcript in given tissues, taken to be
proportional to the rate of UNR transcription, did not appear to be related to the level of NRAS
mRNA in those same tissues. This is considered further in section 1.5.4.
1.1.4 Unr is an essential gene in mice
It was noted that no Unr -/- homozygotes were born of heterozygote parents, leading the
investigators to surmise that Unr is essential in mice (Boussadia et al., 1997). As discussed below,
recent work has helped to explain this observation on a functional level although much remains
to be elucidated in relation to the molecular mechanism by which Unr affects embryonic viability
in the mouse (Elatmani et al., 2011).
1.1.5 UNR copy number
It was suggested that there is only one murine Unr gene and that it is located in close proximity
to murine Nras. The human genome, however, was predicted to possess two UNR sequences,
of which one was believed to be situated immediately upstream of NRAS and the other at an
unknown location elsewhere in the genome (Jeffers et al., 1990). It should be pointed out that
there is currently little evidence in the literature to support the existence of a second, non-NRAS-
related, UNR in the human genome.
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In their attempt to ascertain the murine and human Unr/UNR genetic copy numbers, Jeffers et
al. (1990) used the following cDNA sequence as a probe:
GATCCTTGGTGCAGCTTCTGTTCAACTTTGTATCACGGGAACGGATTGGCCTGATTTCTTGGCC
TTCCTCTTGAATTGGCCCCAAACAGGGTCCCTGGCAAGTGGAGTGAAGGCTTTTTGTCTAAAGA
TGACAAGGGTCAGCTCAGGGGTTGTGGGGGAGGGCGTTTTCATCTTCCCCGTTGTCACTTGAGG
TTTTGAACTCTGGGTAAAGAGGCCGTTTATCTTTGTAAACACAAAACATTTTTGCTTTCTCCGG
TTTCATGTTAATGGCGAAAGAATGGAAGCgaataaaGTTTTACTGATTTTTGAAAAAAAAAGGA
ATTC
It equates to part of the 3’UTR of the rat Unr transcript. The sequence is 97.1% identical to the
mouse equivalent and 90.5% identical to the human equivalent, according to a Basic Local
Alignment Search Tool [BLAST]-Like Alignment Tool (BLAT) search using an online tool at
https://genome.ucsc.edu/ (data not shown). Default settings were used.
Jeffers et al. (1990) initially cleaved murine and human genomic DNA with a restriction
endonuclease and the digested samples were separated electrophoretically and transferred to
a membrane. The Southern blot was then hybridised with the rat Unr probe (v.s.). The blot was
then stripped and re-probed with a probe against the 5’ region of murine Nras.
They found that there was one band for murine Unr that coincided with a band for Nras and
inferred that the mouse haploid genome contains one Unr gene. For humans, they found two
UNR bands, of which only one coincided with a band for NRAS. They inferred from this that the
human genome has two UNR genes although they stated that they were unaware as to whether
or not both genes could be translated.
Given that the method they used to probe for human UNR was indirect (i.e. they used part of
the rat Unr gene), it was decided to investigate some seemingly unresolved issues surrounding
their claims using public database searches.
Whilst there is little support for there being a second UNR gene in the human genome, the online
BLAT tool at www.ensembl.org was used to carry out a search for sequences similar to the Jeffers
probe using the GRCh38 version of the human genome. Default settings were used and results
with E values above 10-10 were rejected. This provided support for there being a sequence
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approximately as similar to that of Jeffers’ probe on human chromosome 10 as the equivalent
UNR sequence on chromosome 1 (Table 1.1).
Table 1.1: Regions of high similarity between regions of the human genome and Jeffers’
probe containing part of the 3’ untranslated region of the rat Unr transcript
Genomic
Location
Orientation
Query
Start
Query
End
Length Score E-value
Identity
(%)
1:
114716923-
114717228
Reverse 1 309 310 485 2.60E-137 91.29
10:
58918950-
58919064
Forward 1 115 115 168 6.40E-42 85.22
10:
58919073-
58919117
Forward 127 171 45 77 1.90E-14 93.33
10:
58919130-
58919193
Forward 187 250 64 104 1.80E-22 89.06
10:
58919201-
58919252
Forward 257 309 53 84 1.50E-16 94.34
N.B. The sequence in yellow overlaps the UNR gene. The pink shading shows an almost
continuous region of chromosome 10. It is not known why the method of calculating lengths in
the first two rows appear to differ.
This observation suggests that Jeffers had mistaken the region on Chromosome 10 for a second
UNR gene. It is worth noting that Jeffers was working before the age of the human genome
project and readily available bioinformatics tools based upon it.
Database searches carried out within the Anderson lab drew attention to another interesting
observation concerning UNR copy number (Ó Catnaigh, unpublished observations). The UNR
transcript ‘Homo sapiens cold shock domain containing E1 (CSDE1), transcript variant 4, mRNA’
has 4330 nucleotides of which 18 were terminal adenines. The adenines were removed and the
remaining nucleotides were BLATed against GRCh38 (Genomic sequence) using the tool at
www.ensembl.org with default settings and an E-value cut off of 10-100. This yielded 6 hits; four
from the UNR genomic region and one region each from chromosome 7 and chromosome 5
(Table 1.2).
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Table 1.2: Regions of high similarity between the mRNA sequence for human ‘CSDE1,
transcript variant 4’ and human genomic DNA.
Genomic
Location
Orientation
Query
Start
Query
End
Length Score E-value
Identity
(%)
1:
114716914-
114718217
Reverse 3009 4312 1304 2521
0.00E+00
(sic)
100.00
1:
114732603-
114732819
Reverse 1495 1711 217 422 3.20E-118 100.00
1:
114739692-
114739890
Reverse 661 859 199 386 1.50E-107 100.00
1:
114749821-
114750208
Reverse 126 513 388 752 1.20E-217 100.00
5:
179082484-
179083091
Reverse 2637 3249 614 1078
0.00E+00
(sic)
95.28
7:
88802635-
88802955
Reverse 3272 3584 321 472 1.80E-133 88.16
N.B. The sequences in yellow overlap the UNR gene. The pink shading shows a 614 nucleotide
sequence on chromosome 5 and the blue shading shows a 321 nucleotide stretch on
chromosome 7.
The region on chromosome 7 overlapped the ZNF804B gene and the UNR transcript nucleotides
that aligned to it lay within the same UNR exon highlighted in row 1 of Table 1.2 (i.e.
Chromosome 1, 114716914-114718217). The region on chromosome 5 covered at least three
UNR exons (Chromosome 1, 114718612-114718746, 114719579-114719746 and 114720539-
114720718). This implied that it may have been a processed pseudogene of UNR. The BLAT tool
stated that the region on chromosome 5 overlapped a gene, ZNF354C, and a known
pseudogene, RP11-281O15.7. The pseudogene was found to be recorded as a:
“pseudogene similat (sic) to part of cold shock domain containing E1, RNA-binding CSDE1”
http://vega.sanger.ac.uk/Homo_sapiens/Gene/Summary?g=OTTHUMG00000163598;r=5:1790
82680-179083194;t=OTTHUMT00000374452
7Chapter 1
Therefore, as well as there being a genomic sequence similar to part of the UNR gene on
chromosome 10, there also appears to be a processed pseudogene of UNR on chromosome 5.
1.1.6 Regulation of UNR transcription
The human UNR gene is transcriptionally repressed by the protooncoprotein MYC in conjunction
with MAX (Mao et al., 2003). This is interesting when considered alongside the finding that UNR
has a positive effect on the translation of the MYC transcript (Evans et al., 2003; v.i.).
1.2 The UNR transcript
1.2.1 The Unr transcript has a polarised distribution in rat muscle
The Unr transcript was shown to have a polarised distribution in rat muscle, where only around
a fifth to a third as much Unr mRNA was found in the neuromuscular junction (NMJ) synaptic
region in comparison to other regions of the cell. Interestingly, more than two times more was
found in the NMJ synaptic region of denervated rat muscle cells when compared to innervated
muscle cells. The underrepresentation of Unr transcript in the synaptic region was shown by
both real time polymerase chain reaction (PCR) and microarray analysis (McGeachie, Koishi,
Andrews, & McLennan, 2005).
1.2.2 UNR mRNA levels vary with cell type
The absolute amount of transcript found in mammalian cells varies greatly throughout the body.
By means of example, it has been reported that there is approximately 7 times more Unr
transcript present in the testes as compared to the liver (Boussadia et al., 1997). The transcript
has been reported to be highly expressed in human MCF-7 cells (Sun et al., 2005).
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1.2.3 The UNR transcript contains at least three different polyadenylation sites
It was claimed that cDNA formed from mouse, rat and human Unr/UNR transcripts each came
in three different sizes – an observation that was explained as being a result of multiple 3’
polyadenylation sites (Jeffers et al., 1990). Whilst this observation may have been valid, it is now
known that different splice variants also exist (see below).
1.2.4 Major splice variants differ by presence or absence of exon 5
A 798-amino acid encoding open reading frame within UNR cDNA was suggested by Jeffers et
al. (1990). The 798 amino acid protein has since been taken as the canonical UNR protein
(www.uniprot.org).
It was later shown that UNR/Unr has a shorter splice variant that differs by the absence of exon
5 (Boussadia, Jacquemin-Sablon, & Dautry, 1993). Two serine residues within exon 5 were
shown to be sites of phosphorylation within the UNR protein (Figure 1.2). There is also a lysine
residue present within exon 5 that is predicted to have a 77% chance of being a site of
ubiquitylation (Figure 1.3). This exon is responsible for encoding a series of 31 residues that lie
between the first cold shock domain (see section 1.3.1) and the first pseudo cold shock domain
(see section 1.3.1). It is reported that transcripts in which exon 5 is spliced out are generally
more abundant than full-length transcripts except in brain tissue, where the two are equivalent
in concentration (Boussadia et al., 1993).
The 798 and 767 amino acid-encoding transcripts are not the only transcript variants of UNR,
however. A database search flagged up a variety of other transcripts, many of which being
protein coding (Table 1.3). The exon structures, and protein lengths, of selected UNR transcripts
are further presented in (Anderson & Ó Catnaigh, 2015).
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Table 1.3: Reported/predicted UNR transcripts, with Ensembl IDs, and UNR protein
lengths
N.B. Downloaded on 24/08/16 from:
http://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000009307;r=1:1
14716916-114750190;t=ENST00000438362
1.2.5 Regulation of the UNR transcript
One mechanism by which the UNR transcript level can be regulated has been mentioned above
(see section 1.1.6). As MYC is a transcriptional repressor of UNR (Mao et al., 2003) and UNR is a
translational enhancer of the MYC transcript (Evans et al., 2003), this allows UNR to limit its own
transcription and, thereby, the number of UNR transcripts in the cell indirectly through
modulation of the MYC protein level.
It has also been shown that Unr represses its own translation; the translational output of the
Unr transcript increases around 3.6 fold when it has its UTR regions removed (Dormoy-Raclet,
Markovits, Jacquemin-Sablon, & Jacquemin-Sablon, 2005). The authors demonstrated that the
3’-UTR destabilises the Unr transcript and also showed that the repressive effect of having its 5’-
Name Transcript ID bp Protein Biotype
CSDE1-201 ENST00000610726.4 4312 844aa Protein coding
CSDE1-008 ENST00000438362.6 4167 844aa Protein coding
CSDE1-002 ENST00000358528.8 4076 798aa Protein coding
CSDE1-001 ENST00000339438.10 4006 767aa Protein coding
CSDE1-004 ENST00000369530.5 3774 813aa Protein coding
CSDE1-003 ENST00000261443.9 3228 767aa Protein coding
CSDE1-009 ENST00000534699.5 2667 798aa Protein coding
CSDE1-007 ENST00000530886.5 3459 668aa Protein coding
CSDE1-010 ENST00000525878.5 626 46aa Protein coding
CSDE1-016 ENST00000534389.2 601 94aa Protein coding
CSDE1-014 ENST00000529046.5 571 136aa Protein coding
CSDE1-015 ENST00000525132.1 521 36aa Protein coding
CSDE1-013 ENST00000525970.5 503 7aa Protein coding
CSDE1-005 ENST00000483407.1 741 No protein Processed transcript
CSDE1-011 ENST00000524652.1 562 No protein Processed transcript
CSDE1-012 ENST00000533818.5 552 No protein Processed transcript
CSDE1-006 ENST00000483030.1 873 No protein Retained intron
CSDE1-017 ENST00000530784.1 545 No protein Retained intron
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UTR is reduced in Unr -/- cells. They provided evidence for their contention that Unr exerts an
autoregulatory negative influence on its own translation through an interaction with an internal
ribosome entry site (IRES) in its 5’-UTR. This shows that Unr can reduce its own translation by
acting directly on its transcript as well as indirectly reducing its own transcription via increased
translation of Myc. The polypyrimidine tract binding protein (PTB) also binds to and represses
the capacity of the UNR IRES to undergo translational initiation events (Cornelis, Tinton,
Schepens, Bruynooghe, & Beyaert, 2005).
1.2.6 Cell cycle dependent spike in cytoplasmic UNR
UNR and PTB stabilise an inactive conformation of the UNR IRES (Schepens et al., 2007). During
early mitosis, the nuclear envelope breaks down and nuclear proteins become more free to
interact with cytoplasmic proteins and mature mRNAs. The predominantly nuclear
HNRNPC1/HNRNPC2 (hereafter termed hnRNP C1/C2), having been liberated from the nucleus,
can bind to the UNR IRES. By doing so, they cause the dissociation of UNR and PTB and contort
the transcript into a conformation conducive to translation initiation events occurring (Schepens
et al., 2007). This does two things; it frees up UNR (and PTB) and it results in nascent UNR being
translated. The increase in free UNR and PTB concentration then increases the probability of
APAF1 being translated, potentially priming the cell for apoptosis during mitosis (Mitchell,
Brown, Coldwell, Jackson, & Willis, 2001).
To add another level of complexity, both hnRNP C1/C2 and HDM2 also increase the translation
rate of the X-linked inhibitor of apoptosis protein (XIAP) in a TP53-independent manner. This
can then inhibit the activity of caspases such as caspase 3 (Figure 1.1; Holcik et al. 2003;
Deveraux et al. 1997; Gu et al. 2009).
In relation to section 1.2.5, as well as UNR having a positive effect at the MYC IRES (Evans et al.,
2003), hnRNP C1/C2 also have a positive influence on the MYC IRES, leading to increased
translation at G2/M (Figure 1.1; Kim et al., 2003). PTB has also been shown to increase MYC
translation through its IRES, at least in multiple myeloma (Figure 1.1; Cobbold et al. 2010).
11Chapter 1
IRES trans-acting factor (ITAF)
Transcript
IRES
UNR PTB
hnRNP
C1/C2
HDM2 Key
UNR positive effect
APAF1 negative effect
XIAP
MYC
Figure 1.1: Effect of selected IRES trans-acting factors (ITAFs) upon selected transcript IRES
structures, see text for discussion.
1.3 The UNR protein
1.3.1 UNR contains 5 canonical cold shock domains
The UNR protein has five single-stranded nucleic acid-binding cold shock domains (Jacquemin-
Sablon et al., 1994). The cold shock domain (CSD) is one of the most ancestral nucleic acid
binding domains, being present in proteins across archaea (Giaquinto et al., 2007), eubacteria
(Graumann & Marahiel, 1998) and eukaryotes (Mihailovich et al., 2010). The domain was noted
to be present in bacterial proteins involved in the response to cold shock (reviewed in Schindelin,
Marahiel, & Heinemann, 1993). There is no evidence that UNR is in any way related to
responding to cold shock in mammalian cells, however. That said, whilst no functional
explanation for the overrepresentation of UNR transcripts in testicular cells is currently
available, it is interesting to consider the relative ‘cold shock’ experienced by all testicular cells
in comparison to those within the internal organs.
The nucleic acid-binding domains of CSD-containing proteins allow them to function as RNA-
chaperone proteins (Graumann & Marahiel, 1998). The five CSD architecture of UNR is unique
(Brown & Jackson, 2004). UNR also possesses four regions that are closely related to cold shock
domains but with mutations at critical residues that are predicted to render them non-
functional. The location of these ‘pseudo cold shock domains’ (ψCSD), interspersed between 
adjacent CSDs (Figure 1.2), suggests that a series of duplication events led to the modern
structure of the UNR protein.
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1.3.2 UNR is well conserved among mammalian species and beyond
In general, the UNR protein is well conserved among metazoans. The protein alignment tool
available at www.uniprot.org (accessed 28/07/14) was used with default settings to align the
following 798 amino acid UNR homologs:
. H2N6A0 (Sumatran orang-utan),
. K7E2B4 (Gray short-tailed opossum),
. H9EMW2 (Rhesus macaque),
. P18395 (rat),
. Q91W50 (mouse),
. O75534 (human).
The alignment showed that all six proteins were identical at 756 of the 798 amino acids, equating
to 95% identity (rounded to 2 significant figures). Reducing the number of species compared to
human, macaque and orang-utan increased the identity to 797/798, rounding up to 100%
(human and macaque UNR proteins were identical with Q713P in orang-utan). Even when a 799
residue homolog in the zebrafish was compared to the 798 residue human UNR, 622 residues
were identical (78%).
1.3.3 UNR sequence is less well conserved in non-mammalian animal species
As stated previously, no homolog of UNR is believed to be present in C. elegans. Also, as of
24/08/2016, no D. melanogaster protein was termed CSDE1 in the Uniprot database
(www.uniprot.org). There is, however, a wealth of literature on dUnr, published in large part by
the Gebauer lab in Barcelona, Catalonia. Weighing against the general conservation apparent
within the primary structure of UNR, D. melanogaster Unr, isoform A has some striking
differences with respect to the human protein. The most salient difference is the presence of an
N-terminal glutamine-rich region in dUnr across 63 residues, 49 are glutamine and 11 of the
remaining 14 residues are histidine. The differences between documented UNR proteins in
mammals and those in D. melanogaster imply a possible divergence in function. There is some
evidence for this in the literature. For example, one function of dUnr that is not believed to be
shared by human UNR concerns dosage compensation (reviewed briefly in Ray, Ó Catnaigh, &
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Anderson, 2015). It is worth considering that the problem of gene dosage is different in different
animal species and must, therefore, be addressed by different mechanisms (Payer & Lee, 2008).
One piece of earlier work that was potentially related to this work was an exploration that was
carried out to identify dUnr-binding transcripts by both RIP-Seq and RIP-Chip (Mihailovich et al.,
2012). That work identified transcripts encoding a wide variety of proteins including metabolic
enzymes, transcription factors, signalling proteins and members of the ubiquitin-proteasome
pathway. A number of housekeeping gene transcripts were also pulled down, including those
encoding a variety of ribosomal proteins, and various isoforms of actin and tubulin subunits
(Mihailovich et al., 2012).
Due to the known differences between mammalian and D. melanogaster UNR proteins, it was
uncertain as to whether or not anything should be extrapolated from work on dUnr.
1.3.4 D. melanogaster Unr is an ortholog to human UNR
The database at www.uniprot.org contains information that shows human UNR and dUnr to be
true orthologs.
To extract this information, the ‘canonical’ sequence for the human UNR protein (Uniprot
identifier = O75534) was BLASTed against all arthropod proteins using the BLAST tool at
www.uniprot.org with default settings on 24/08/2016. When only D. melanogaster proteins
were considered, five sequences had E values less than 10-10. Four were annotated as Unr and
the other was not annotated to any gene. The E values for the proteins ranged from 20E-99 to
66E-129 (sic, values given as per www.uniprot.org). The best hit by E value was M9ND61
(Upstream of N-ras, isoform C). This was then BLASTed against all proteins in the human
genome. The joint best hit by E value was O75534 (E value = 5.2E-129). The other joint top hit,
100% identical to O75534 at the protein level, was termed ‘CSDE1, RNA binding, isoform CRA_a’.
This means that human and D. melanogaster UNR proteins are reciprocal best hits and are
strongly expected to have common ancestor. Interestingly, however, some other proteins also
had highly significant alignments to M9ND61. These included the polyglutamine-containing
ataxins, Ataxin 3 (best E value = 44E-24) and Ataxin 8 (best E value = 1.5E-24), both of which had
over 70% identity over the aligned regions. The polyglutamine-rich N terminal region in most
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versions of dUnr demonstrates a fundamental difference in primary sequence to that of human
UNR.
1.3.5 The cold shock domains of D. melanogaster Unr retain stronger similarity to
their human counterparts
Whereas dUnr has major differences in amino acid sequence from the protein found in humans,
it retains stronger sequence identity within its cold shock domains. The first CSD (CSD1) is the
most conserved; there is >70% identity between the human and D. melanogaster forms. It also
exhibits the greatest similarity to bacterial cold shock domain containing proteins (Mihailovich
et al., 2010). Different combinations of cold shock domains can be involved in mediating
protein/transcript binding by any given UNR and any knock-on functions. Whilst different cold
shock domains may function in unison to bind specific RNAs or proteins, a mere three residues
within CSD1 were shown to mediate the binding of dUnr to either the dSxl protein or
Dmel\msl-2 mRNA (Mihailovich et al., 2010). It should be noted, however, that the dUnr
interaction with the Dmel\msl-2 transcript did not involve a phenylalanine residue and that
deleterious effects on binding/function can be the result of other, unpredicted, effects of
mutations.
Whilst strong conservation may be expected within protein domains that require a specific
structure to retain their general function, it should nevertheless be noted that the reduced
degree of conservation in sequences expected to bind single stranded nucleic acids implies that
the D. melanogaster protein could have an entirely divergent set of mRNA binding partners. That
implies that, whilst retaining the nucleic acid-binding function of a cold shock domain containing
protein, dUnr may share little (if any) cellular functions with human UNR.
Due to the differences between dUnr and human UNR, both in sequence and function, it was
decided not to consider dUnr any further in relation to this work.
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1.3.6 RNA binding specificity of UNR
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) (Tuerk & Gold, 1990) was
used to predict consensus sequences of ribonucleotides for binding RNAs to human UNR
(Triqueneaux, Velten, Franzon, Dautry, & Jacquemin-Sablon, 1999). This sequence was found to
be AAGUA or AAC(G/A) located immediately downstream of 5-8 A/G nucleotides. UNR has been
shown or suggested to have a variety of mRNA binding partners in the literature. Some of these
originate from genes that exist throughout the metazoa. Others are more species-specific and
show some diversity in UNR’s mRNA binding partners has developed over evolutionary time.
At the point of writing (28th August 2016), the latest available update of the UTR database
(http://utrdb.ba.itb.cnr.it/home/statistics) shows 656 potential UNR binding sites within 625
human 5’-UTRs and 3951 potential UNR binding sites within 3522 human 3’-UTRs. This uses the
U0017 UNR binding site which is actually two sequences which closely resemble the reported
SELEX sequences (Table 1.4). Given that this does not consider the potential for UNR binding
within coding regions, it is clear that UNR could potentially directly interact with a substantial
subset of human transcripts. Keeping this in mind, the identity of UNR-associated transcripts is
an ongoing point of research for the Anderson lab.
Other reported Unr-binding RNA sequences include two closely apposed polypurine sequences
within the major protein coding region determinant of instability (mCRD) from the Fos transcript
(Chang et al., 2004; Table 1.4) and another purine rich sequence from the IRES within the coding
region of the CDK11 transcript that gives rise to the CDK11p58 form of the protein (Tinton,
Schepens, Bruynooghe, Beyaert, & Cornelis, 2005; Table 1.4). Two observations should be noted
concerning the Fos mCRD work. Firstly, whilst the reported regions believed to be involved in
Unr binding were polypurine stretches, the actual sequences tested included some flanking
pyrimidines. Secondly, the first sequence (termed ‘PuSI’) was tested directly for Unr binding
whereas the support provided for the second sequence (PuSII) was indirect. Purine to pyrimidine
mutations were placed into one of two polypurine sequences (PuSII and PuSIII) within a longer
purine rich sequence and the resultant RNA molecule was tested for Unr binding. Mutations in
PuSII caused the molecule to lose its affinity for Unr whereas mutations in PuSIII did not have
this effect. It was from this analysis that the group inferred that PuSII is involved in binding Unr
and that PuSIII is not (Chang et al., 2004).
16Chapter 1
Table 1.4: RNA sequences reported to bind UNR/Unr
Nucleotide Sequence Source Reference
*AAGUA SELEX Triqueneaux et al., 1999
*AAGUG SELEX Triqueneaux et al., 1999
*AACG SELEX Triqueneaux et al., 1999
**RRRRRAAGUAR UTRsite http://utrsite.ba.itb.cnr.it
**RRRRRRRRAACRRR UTRsite http://utrsite.ba.itb.cnr.it
AGAAGAAGAAGAGAAAAGGAGAA PuS I from FosmCRD region Chang et al., 2004
GAAGGGAAAGGAA PuS II from FosmCRD region Chang et al., 2004
GAAGAAGUAAA IRES from CDK11transcript Tinton et al., 2005
* This is found downstream of a purine stretch. ** R = A or G (i.e. a purine).
1.3.7 Post-translational modifications 1 - phosphorylation
Three serine residues have been shown to be phosphorylated in UNR (S116, S123 and S514)
(Figure 1.2; Dephoure et al., 2008; Olsen et al., 2010). Interestingly, S116 and S123 were found
to be phosphorylated during mitosis but not during G1 (Dephoure et al., 2008). This raises an
interesting question about a potential isoform-specific role for UNR in mitosis, given that most
UNR transcripts were shown to lack exon 5 (Boussadia et al., 1993).
1.3.8 Post-translational modifications 2 – acetylation
K81 is reported to be susceptible to acetylation (Figure 1.2; Choudhary et al., 2009).
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Figure 1.2: Schematic diagram of full length UNR protein showing the approximate location of
its five canonical cold shock domains (pink), its four pseudo-cold shock domains (turquoise),
exon 5 that is missing in the most common forms of the protein (green; see text for details). The
blue arrow points to lysine 81, reported to be a site of acetylation. The red arrows point to three
serines (serine 116, serine 123 and serine 514) noted to be phosphorylated under specific
conditions (see text for details). N.B. K81 lies within CSD1 and both S116 and S123 lie within
exon 5.
1.3.9 Post-translational modifications 3 – other potential modifications
There are multiple other potential sites of phosphorylation, ubiquitylation, SUMOylation, etc.
that are easily obtained from searching online databases (Figure 1.3; condensed and reproduced
in Anderson & Ó Catnaigh (2015).
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Figure 1.3: Schematic diagram of full length UNR protein showing the approximate location of
its five canonical cold shock domains (pink), its four pseudo-cold shock domains (turquoise),
exon 5 that is missing in the most common forms of the protein (green; see text for details). The
figure shows: A) the top three most probable sites of potential SUMOylation within full length
UNR with associated probabilities and, B) the top two most probable sites of potential
Ubiquitylation within full length UNR with associated probabilities. N.B. the K115 site of
potential ubiquitylation is within Exon 5.
1.4 UNR as a modulator of translational initiation
1.4.1 Cap-dependent initiation
The processes of transcription and post-transcriptional modification generate mRNA species
that are exported from the nucleus. Typical eukaryotic transcripts have a 5’ cap and a 3’ poly(A)
tail. A variety of canonical initiation factors contort mRNA into a circularised structure that is
conducive for efficient translation. Briefly, EIF3 binds to the small ribosomal subunit and then to
EIF2 that has bound an initiation methionyl-tRNA. Then EIF3 binds to EIF4G which is part of the
EIF4F complex, together with EIF4A (4A) and the cap-binding EIF4E, to which a capped transcript
is bound. The helicase 4A helps to smoothen out any complex RNA structures that could
otherwise prevent or impede translation. Multiple copies of poly(A) binding protein (PABP) are
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bound to the 3’ poly(A) tail of the transcript and PABP also binds 4G, thereby generating a
physical link between the 5’ and 3’ ends of the transcript. The 5’ end of the transcript is then
scanned for an initiation codon (usually AUG). Once this is found, inhibitors of large and small
ribosomal subunit binding are removed and a functional ribosome is formed on the transcript.
The next stage in translation, elongation, can then proceed. These steps are reviewed in more
detail in (Jackson, Hellen, & Pestova, 2010).
1.4.2 UNR as a global regulator of translation
Work within the lab has led to the suggestion that UNR may be a global regulator of translation
(Ray & Anderson, 2016). This work showed that recombinant wild type UNR stimulates the in
vitro translation of Renilla luciferase mRNA around 5 fold when the transcript is capped and
polyadenylated. The increase was about 4 fold when polyadenylation was lost, almost 40 fold
when the cap was lost and approaching 200 fold when both the cap and polyadenylation were
lost. The experiment also involved the use of recombinant mutant UNR proteins with an
essential phenylalanine from each cold shock domain being mutated. UNR with a mutation in
cold shock domains 1, 3 or 5 generally provided a similar or better increase in translation to wild
type UNR across all conditions. UNR with a mutation in cold shock domain 4 and, more so, cold
shock domain 2 showed a reduced increase in translation relative to wild type UNR. The paper
went on to show that UNR interacts with PABP in vitro but that the interaction is reduced by
71% with the CSD2 mutant UNR, by 76% with the CSD4 mutant UNR and by 21% when RNase A
is added to the rabbit reticulocyte lysate. This implied that UNR interacts with PABP, which was
already known (Chang et al., 2004), in large part via cold shock domains 2 and 4. It also implied
that the interaction was stabilised by the presence of RNA. Data from one of the cell types used
during the course of the present study (HeLa) then showed that knocking down UNR reduced
the amount of 4G pulled down by PABP by 80%. Interestingly, the amount of UNR and PABP
pulled down with 4G in the presence of RNase ONE both dropped by 40% following UNR
knockdown where the knockdown was much greater than 40%. This led to the suggestion that
UNR binds Pabp directly and EIF4G via PABP and that UNR stabilises the interaction between
PABP and EIF4G. Finally, it was shown in two cell lines used in the current study (HeLa and U2OS)
that knocking down UNR resulted in a reduction of 35S-methionine incorporation of around a
third (U2OS) or around a half (HeLa). This implied that the addition of UNR (i.e. not knocking it
down) increases global translation in human cell lines as well as in vitro (Ray & Anderson, 2016).
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1.4.3 Cap-independent initiation via IRES structures
Under certain pathological and non-pathological conditions, such as infection with certain
viruses or during mitosis, cap-dependent initiation events are prevented or reduced in
frequency. A widely held view states that a proportion of transcripts contain complex folded
structures termed internal ribosome entry sites (IRESes) within their 5’ untranslated region
(5’UTR) or within their coding sequences (reviewed in Jackson, 2013). These structures can bind
to IRES trans-acting factors (ITAFs) that can modulate their activity. These ITAFs, in conjunction
with other canonical and non-canonical initiation factors, can contort transcripts into
conformations that are conducive for translational initiation to occur, effectively side-stepping
the need for the cap and cap-binding proteins. The process is less rigidly choreographed in
comparison with cap-dependent initiation events as the identity of the ITAFs shows some
transcript selectivity. This is to be expected as, unlike 5’ caps and PABP proteins, IRES structures
are variable in topological structure (Jackson, 2013).
IRES structures are common in RNA viral genomes as they offer a mechanism by which the virus
can dispense with the need to obtain a cap to be able to undertake efficient translation initiation
events (Jackson, 2013). It should be noted that the concept of cellular IRESes, whilst currently
the prevailing consensus view within the field, is not universally accepted. One alternative,
though not necessarily contradictory, hypothesis states that cap independent scanning of
transcripts occurs with the aid of cap-independent translational enhancers (CITEs) that can bind
to either the 3’ or the 5’ regions of a transcript (for a review of this, see Shatsky, Dmitriev,
Terenin, & Andreev, 2010). The remainder of this thesis will make the assumption that cellular
IRESes do exist and that UNR is an ITAF for a selection of both cellular and viral IRES structures.
1.4.4 UNR as an ITAF
UNR has been reported to modulate initiation events through a number of IRES structures, as
described below. As an example, UNR was identified as being important for the translation of
the rhinovirus RNA through its IRES and was later shown to be used by poliovirus for the same
role (Boussadia et al., 2003; Hunt, Hsuan, Totty, & Jackson, 1999). All five CSDs are required for
the efficient translation of the human rhinovirus RNA, however. CSD1 and CSD2 were suggested
to be most important in that role, as UNR proteins in which conserved phenylalanine residues,
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thought to be important in RNA binding, were mutated to alanine in either of those CSDs totally
abrogated the stimulatory effect of UNR. Similar mutations in the other CSDs merely reduced
the effect (Brown & Jackson, 2004). It is worth considering this finding in conjunction with the
finding that CSD2 was important in the interaction between UNR and PABP (Ray & Anderson,
2016). The same authors later showed that UNR has two independent binding sites on the
rhinovirus IRES (Anderson, Hunt, & Jackson, 2007).
Like UNR, PTB can also be usurped by viruses for the purposes of enhancing their capacity for
translation initiation. For example, PTB was shown to enhance translation through the foot and
mouth virus IRES and multiple copies of PTB were shown to bind to the IRES of
encephalomyocarditis virus (Kafasla et al., 2009; Niepmann, 1996). It is also involved, with UNR,
in translation initiation at the poliovirus and human rhinovirus IRES (Boussadia et al., 2003).
Indeed, UNR was only discovered to be necessary for activation of the rhinovirus IRES after PTB
had previously been shown to be necessary but not sufficient (Hunt and Jackson, 1999).
There are a number of reported cases of UNR functioning as an enhancer ITAF at cellular IRESes.
Several of these, such as the transcripts encoding APAF1 and CDK11 will be discussed below
(v.i.). UNR has also been reported to bind to an IRES region within its own transcript, where it
acts to stabilise an inactive conformation and, thereby, reduce the probability of IRES-mediated
initiation events occurring (v.i.).
The main point here is that UNR binds to different transcripts in conjunction with different
protein partners (reviewed in Ray et al. 2015). This is important because it provides the cell with
a mechanism to carefully control UNR function by controlling the levels and localisation of a
variety of other proteins aside from UNR itself.
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1.4.5 Non-ITAF molecular functions of UNR in translational regulation
As well as stimulating or repressing translation through IRES structures, Unr has also been shown
to function in the co-translational regulation of the Fos transcript. As discussed in section 1.5.3,
Unr can stabilise the Fos transcript until it is translated, at which time Unr dissociates from the
transcript, leading to Ccr4-dependent deadenylation and transcript degradation (v.i.). This
shows Unr acting as both a transcript stabilising factor and a modulator of transcript degradation
(Chang et al., 2004; Grosset et al., 2000).
UNR has been shown to interact with an A-rich autoregulatory region within the 5’-UTR of the
mRNA for poly-A binding protein (PABP) and inhibit its translation (Patel, Ma, & Bag, 2005).
Drawing on an earlier finding that Unr is unable to bind poly(A)-RNA (Chang et al., 2004), the
assumption was made that UNR required PABP to associate with the region.
The negative feedback phenomenon by which parathyroid hormone (PTH) levels are controlled
by, and, in turn, control the systemic calcium level was observed several decades ago (Walton,
1977). PTH/Pth levels change in response to changes in the concentration of such factors as
vitamin D, calcium and phosphate in PTH/Pth-producing cells, the latter two exerting their effect
post-transcriptionally (Kumar & Thompson, 2011; Silver, Yalcindag, Sela-Brown, Kilav, & Naveh-
Many, 1999). It was reported that hypocalcaemia stabilised the Pth transcript whereas
hypophosphataemia was associated with its rapid degradation (Moallem, Kilav, Silver, & Naveh-
Many, 1998). PKA was later suggested to play a role in the control of PTH levels in relation to
low calcium and PKC was postulated to be involved in basal expression levels (Moallem, Silver,
& Naveh-Many, 1995).
UV cross-linking of the 3’UTR of Pth mRNA showed that three proteins interacted with its AU-
rich element in rat parathyroid tissue (Moallem et al., 1998). When the extracts came from
animals subjected to a low calcium diet immediately prior to being sacrificed, there was more
overall binding and the converse was true with low phosphate-fed animals (Moallem et al.,
1998). The same three proteins were observed when extracts from certain other tissues were
used but an increase in binding with low calcium and decrease with low phosphate was not
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apparent. More overall binding was noticed with brain tissue extract in comparison to other
tissue extracts examined (Moallem et al., 1998).
Further research by the same group showed that one of the three proteins that bound to the
extreme 3’UTR of the Pth mRNA was the AU-rich binding factor 1 (AUF1) (Sela-Brown, Silver,
Brewer, & Naveh-Many, 2000). Interestingly, the group went on to show that UNR was another
of the three proteins and that its cellular concentration was positively correlated with Pth
expression (Dinur, Kilav, Sela-Brown, Jacquemin-Sablon, & Naveh-Many, 2006). Possibly
coincidentally, it was noted elsewhere that the predominant UNR transcript in most adult rat
tissues lacked exon 5 except brain tissue where transcripts encoding full-length UNR were
almost as abundant (Boussadia et al., 1993). Bringing the developmental role of UNR into
consideration here, it is worth noting that the rate at which exon skipping occurs increases
through development and into adulthood in a range of murine tissues (López-Fernández, López-
Alañón, & del Mazo, 1995).
As research developed over time, the control of PTH/Pth mRNA stability and output came to be
thought to obey the following model (Nechama, Peng, et al., 2009; Nechama, Uchida, Mor Yosef-
Levi, Silver, & Naveh-Many, 2009):
UNR associates with an AU rich element (ARE) in the 3’-UTR of the PTH transcript under low
calcium levels. This stabilises the transcript and increases PTH expression. Under low phosphate
levels, UNR and AUF1 dissociate from the transcript and KH-type splicing regulatory protein
(KSRP, also known as FBP2) binds. This, in turn, recruits the exosome and the endonuclease,
polysome ribonuclease 1 (PMR1) and leads to the cleavage of the transcript and a subsequent
reduction in the PTH concentration. The stability is further mediated by the peptidyl prolyl
isomerase PIN1. Under basal conditions of calcium and phosphate, both KSRP and the
UNR/AUF1 complex can bind to the transcript. Under these conditions, active PIN1 causes KSRP1
to be active (dephosphorylated) and recruit the exosome. Inactive PIN1 or the absence of PIN1
results in KSRP1 also being inactive (phosphorylated), thereby resulting in it being unable to bind
to the transcript and this, in turn, results in transcript stability (Figure 1.4).
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Figure 1.4: Model to show effects of PIN1, UNR and PKC on osteoblast proliferation. Data is, of
necessity, from different cell types. Pink arrows show a positive influence on expression. Black
blunt arrow shows strong repression on expression. The green curly arrow shows that UNR
promotes both transcript stability and transcript degradation.
As an interesting aside, in its guise as FBP2, KSRP1 has a negative effect on the translation of the
Enterovirus 71 picornavirus RNA (Lin, Li, & Shih, 2009). As stated above, it is known that UNR
promotes the translation of the RNA of other picornaviruses. Indeed, UNR was shown to interact
with the 5’UTR of the Enterovirus 71 RNA (Lin et al., 2008). It was also recently demonstrated
that AUF1 associates with Enterovirus 71 IRES. Unlike with the PTH transcript, however, AUF1
has a negative effect on its translation (Lin, Li, & Brewer, 2014).
1.5 Suggested functional roles for UNR
1.5.1 Possible role in apoptosis
UNR has been implicated in modulating the translation of the apoptosome scaffold protein
Apoptotic protease activating factor 1 (APAF1) through an internal ribosome entry site (IRES) in
the 5’ untranslated region of its transcript (Mitchell et al., 2001). Translational activity is
stimulated in the presence of both UNR and the polypyrimidine tract binding protein (PTB). Later
work by the same group showed that the APAF1 IRES is contorted into a conformation conducive
25Chapter 1
to translational initiation upon binding to the both UNR and PTB (Mitchell, Spriggs, Coldwell,
Jackson, & Willis, 2003).
APAF1 is an essential component of the intrinsic pathway of apoptosis. Following upstream
signalling leading to mitochondrial outer membrane permeablisation (MOMP), cytochrome c is
free to enter the cytoplasm. The binding of cytochrome c causes a conformational change in
APAF1 that promotes its oligomerisation into the apoptosome backbone. APAF1 is not an inert
scaffold; the oligomer possesses an active proteolytic domain that can cleave procaspase 9 to
form active caspase 9. Caspase 9 is then free to activate the effector caspase, Caspase 3
(reviewed in Bratton & Salvesen, 2010). A reduction in the APAF1 transcript level and the APAF1
protein levels in melanoma is strongly correlated with metastasis, possibly due to promoter
methylation and/or excessive histone deacetylase activity (Soengas et al., 2001). In keeping with
the idea of histone acetylation, trichostatin A was shown to enhance transcription of the APAF1
gene. This also increased the transcription of E2f1 and Tp53, two transcription factors involved
in Apaf1 transcription (Wallace & Cotter, 2009). Interestingly, APAF1 translation is believed to
be exclusively initiated through the IRES ultimately discovered to be controlled by UNR
(Coldwell, Mitchell, Stoneley, MacFarlane, & Willis, 2000).
It is important here to consider that APAF1 is not exclusively involved in the control of apoptosis.
For example, the APAF1 promoter was found to be methylated in various testicular germ cell
cancers (TGCCs) but the protein was not linked to apoptosis in these cells (Behjati et al., 2011;
Christoph et al., 2006). The amount of APAF1 protein expressed in different TGCCs was,
however, found to correlate inversely with the degree of differentiation of the cells within the
cancer. (Behjati et al., 2011). It was further shown that APAF1 translocates to the nucleus
following treatment with cisplatin in A549 cells and the knocking down of APAF1 abrogates the
capacity of cisplatin to cause cell cycle arrest in the same cell line (Zermati et al., 2007). The
same study showed that APAF1 knock-down can also reduce the amount of CHK1
phosphorylation in response to γ-irradiation in the same TP53-deficient cells. To summarise, 
APAF1 is both up- and down-stream of TP53 and possibly plays a role in the DNA damage
response as well as apoptosis. Of interest to the work at hand, whatever multiple functions
APAF1 has in the cell, UNR is required for the efficient translation of its transcript.
As well as regulating the translation of the APAF1 transcript, further work implicates UNR as a
potential master regulator of apoptosis. For example, whilst Unr null murine embryonic stem
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(ES) cells were shown to exhibit no deleterious effects in terms of cellular proliferation, the
ability of such cells to undergo apoptosis in response to ionising radiation (IR) was reduced.
Furthermore, expression of transcripts for the apoptosis-mediating proteins Tp53, caspase-3
and Gadd45γ were all reduced (Dormoy-Raclet et al., 2007). The same work also found that 
siRNA-knockdown of UNR in HuH7 cells doubled the proportion of apoptotic cells in response to
IR and slightly increased the proportion in untreated cells. Barring the possibility that the
increase in apoptosis was caused by off-target effects of the siRNA or some other mutation
within the HuH7 cancer cell line, the implication is that UNR may have tissue-specific effects. A
larger list of differentially expressed transcripts between Unr-wild type and Unr-null ES cells,
with or without IR stress, had been reported previously by the same author (Dormoy-Raclet,
2005).
UNR is also known to modulate the translation of proteins involved in functions not directly
related to apoptosis, such as cytokinesis (see section 1.5.2) and cellular proliferation (see section
1.5.3). This raises the possibility that UNR may act as a more general master regulator of
translation. It should also be noted, however, that failure to undergo cytokinesis and/or
uncontrolled proliferation are likely to cause apoptosis and UNR may be acting as an apoptotic
switch that integrates and assesses information on cellular viability and becomes activated when
cellular homeostasis is compromised in some way.
1.5.2 Suggested role for UNR in mitosis
It has been suggested that UNR plays an important role in regulating the translation of proteins
during mitosis. In this model, UNR binds to, and represses translation of, its own transcript in
conjunction with polypyrimidine tract-binding protein (PTB). Following breakdown of the
nuclear envelope in early mitosis, hnRNP C1/C2 can come into contact with the cytoplasmic
translation machinery. These outcompete UNR for binding on the UNR transcript, leading to the
detachment of UNR and PTB. This drives the translation of UNR from its IRES (Schepens et al.,
2007). Logically, having a cell cycle dependent expression pattern greatly increases the
probability of a given protein being involved in some form of cell cycle dependent processes
itself. The liberated and nascent UNR proteins can then promote the translation of cell cycle
regulator CDK11p58 from an IRES in the coding region of its transcript during G2-M (Schepens et
al., 2007; Tinton et al., 2005).
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Transcription of Cdk11 results in a transcript that can be translated to form a constitutive 110kDa
kinase that functions within a multi-protein complex involved in transcriptional regulation and
the splicing of pre-mRNA species (Li, Inoue, Lahti, & Kidd, 2004). IRES-mediated translation
results in the generation of a smaller 58kDa product that functions in the regulation of
cytokinesis. Unr has been shown to stimulate IRES-mediated translation of Cdk11 between G2
and M phase. Whereas humans have two CDK11 genes, mice have a single copy; the loss of
which results in death of the blastocyst prior to E4. It was suggested that lethality is caused by
excessive apoptosis in response to mitotic arrest (Li et al., 2004). Interestingly, during the
progression of extrinsic pathway-instigated apoptosis, CDK11p110 is cleaved by caspase 3 and the
N-terminal non-kinase domain-containing fragment translocates from the nucleus to the
mitochondrion where it dissipates the potential across mitochondrial membrane and induces
the release of cytochrome c into the cytoplasm (Feng, Ariza, Goulet, Shi, & Nelson, 2005).
1.5.3 UNR and the proto-oncogenes MYC and Fos
UNR regulation of the translation of some common proto-oncogenes has been documented in
the literature. For example, it has been suggested that UNR can increase the translation of MYC
mRNA through an IRES in conjunction with UNR-interacting protein (UNRIP) and a variety of
other non-canonical initiation factors (Evans et al., 2003).
Similar proteins to those noted to enhance the translation of MYC through its IRES, including
UNR, were also noted to form a complex on the Major Protein Coding Region Determinant of
Instability (mCRD) of Fos mRNA (Grosset et al., 2000). As the complex also included Pabp, it was
able to link the mCRD to the poly(A)-tail. Interestingly, the regulation of the transcript by Ccr4-
mediated deadenylation was linked to the rate of translation; non-translating transcripts were
not degraded. Reducing cellular Unr with siRNA reduced the rate of degradation (Chang et al.,
2004).
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1.5.4 Suggested essential role in embryonic development
From coitus and subsequent conception, mouse concepti start to undergo a series of well-
choreographed cell divisions (reviewed in Kojima, Tam, & Tam, 2014). Briefly, the earliest cell
divisions give rise to a solid ball of around 20 cells, termed the morula. Within this ball of cells,
the first major cell fate decision is taken such that the outer cells differentiate into
trophectoderm and the inner cells develop into inner cell mass cell. From this point, the cells of
conceptus develop a clear morphological polarity as the blastocyst cavity starts to appear within
the ball. This pushes the inner cell mass to one end and the conceptus, still surrounded by the
zona pellucida, is termed the blastocyst and its cells become termed blastomeres. The
blastomeres of the inner cell mass then make a second major cell fate decision, with some
becoming primitive endoderm (predominantly extraembryonic) and the remainder becoming
pluripotent epiblast. As it is relevant to later discussion, a simplified model of this process shall
be discussed briefly at the molecular level.
Undifferentiated inner mass cells express both Gata6, a marker for primitive endoderm, and
Nanog, a pluripotency marker. These transcription factors exert a mutually repressive
downstream effect on each other (Bessonnard et al., 2014). Nanog is involved in promoting the
expression of the paracrine fibroblast growth factor receptor ligand, Fgf4 (Frankenberg et al.,
2011). This can diffuse to Fgfr2-expressing cells and instigate a MAPK cascade in cells destined
to differentiate into primitive endoderm, resulting in the activation of Erk by phosphorylation.
Phosphorylated Erk then reinforces the asymmetry in Gata6 level by promoting its further
expression (Frankenberg et al., 2011). Reinforcing this point, pharmacological inhibition of Erk
resulted in a reduction in Gata6 expression (Hamilton et al., 2014). Activation of the Fgfr2 was
further shown to downregulate Nanog at the transcriptional level (Santostefano, Hamazaki,
Pardo, Kladde, & Terada, 2012). Mouse embryonic stem cells lacking Nanog were shown to
express a high level of Gata6 and to differentiate into a primitive endoderm-like state that was
claimed to lack Oct4 and other markers of mature primitive endoderm (Mitsui et al., 2003).
Overexpression of Gata6/GATA6 was also shown to cause differentiation into primitive
endoderm independent of Fgf signalling (Wamaitha et al., 2015). Conversely, Gata6-null
embryos completely lack a primitive endoderm (Schrode, Saiz, Di Talia, & Hadjantonakis, 2014).
A simplified model of the cell fate decision of inner cell mass cells to become epiblast or primitive
endoderm is provided in Figure 1.5 (v.i.).
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Figure 1.5: Variations in the amount of NANOG and GATA6 in undifferentiated inner cell mass
cells (pink) are responsible for a cell fate decision. Excess NANOG represses GATA6 expression
and leads to the retention of stemness and differentiation into pluripotent epiblast (blue).
Conversely, excess GATA6 represses NANOG expression and results in cells differentiating into
primitive endoderm (red). The latter is accompanied by the activation of a mitogen activated
protein kinase (MAPK) cascade by the fibroblast growth factor receptor 2 (FGFR2), leading to
the phosphorylation and activation of an extracellular signal regulated kinase (ERK).
Phosphorylated ERK potentiates the expression of GATA6.
It was noted that Unr is associated with preventing epiblast cells from differentiating
inappropriately into a primitive endoderm-like lineage that expressed pluripotency markers
such as Nanog and Oct4 (Elatmani et al., 2011). Here, the authors used two techniques to obtain
murine embryonic stem cells (ESCs) that were deficient in Unr. One set came from selecting Unr
null early embryos formed by the crossing of two mice heterozygous for a deletion in the Unr
promoter, as discussed previously. A second method involved stably knocking down Unr by
means of shRNA. They found that cells deficient in Unr adopted a primitive endoderm-like
phenotype in which Gata6 was heavily expressed. When they reintroduced a tagged Unr via a
retroviral construct, they found that Unr was expressed although at a much lower level than in
wild type cells. A tagged retroviral insert alone had no effect on Unr levels. They noted that even
a very low level of Unr expression was sufficient to reduce primitive endoderm markers such as
Gata6 and Gata4 by more than half. Whilst showing that shRNA-mediated ablation of Unr could
cause differentiation into a primitive endoderm-like state, the authors also showed that both
wild type and Unr-null ESC retained the capacity to generate teratomas in immunodeficient
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mice. The removal of Unr, therefore, does not affect the differentiation potential of ESC per se.
Earlier work in the same lab had shown that the amount of Unr transcription in a given cell type
can affect the transcriptional output of the Nras gene (Boussadia et al., 1997). They therefore
explored the possibility of Nras having affected the differentiation pathway. This was of interest
as a signalling pathway had previously been elucidated between the activation of fibroblast
growth factor receptors and the activation of Erk via Ras (Kouhara et al., 1997). They did this by
looking at the absolute amounts of Nras transcripts in wild type cell, those with Unr knocked out
and those with Unr stably knocked down with or without the retroviral Unr insertion. They found
that the amount of Nras transcripts was 2-3 times greater in Unr knockouts compared to the
other three conditions (in which Nras transcripts levels were similar). This led them to conclude
that the differentiation or otherwise of Unr depleted cells into primitive endoderm was
independent of the Nras mRNA concentration. They then examined the protein and transcript
concentrations of Nanog/Nanog between Unr-wild type and Unr-null ESCs. They noted that
there was no significant difference and inferred that Unr must act downstream of Nanog. The
presence of Nanog highlighted two things; firstly, Nanog was partially located in the cytoplasm
contrary to the received wisdom as to its localisation in cells. Secondly, the joint expression of
Nanog and Gata6 implied that the cells were not true primitive endoderm. The authors claim
that the state is an early stage in the differentiation process. They show that the removal of Unr
expression results in the stabilisation of Gata6 mRNA as measured by transcript half-life. They
further provide evidence that suggests that Unr may act to destabilise the Gata6 transcript
through an interaction with its 3’-UTR.
Given the link between UNR, GATA6 and cell fate decisions, it is interesting to consider that
GATA6-FGFR2 over-expression is associated with the cancer phenotype, e.g. in oesophageal
adenocarcinoma (Lin et al., 2012). These authors showed a dependence of cancer cells on GATA6
expression such that, when GATA6 was depleted, the cells underwent apoptosis. Conversely, it
has been shown that Gata6 overexpression is associated with cellular quiescence (Nagata et al.,
2000). Therefore, whilst UNR may modulate the expression levels of GATA6, the functional
response could be context dependent.
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1.5.5 UNR and Diamond Blackfan Anaemia
A new line of investigation into the function of UNR involves a link to the ribosomopathy-related
blood disorder, Diamond Blackfan Anaemia (DBA) (Da Costa et al., 2010). The UNR protein level
is reduced in erythroblasts from patients with DBA and it was shown that knocking down Unr in
Tp53-null mouse erythroblasts reduced both proliferation and differentiation (Horos et al.,
2012).
1.5.6 UNR and the migration of precerebellar neurons
It has been suggested that Unr has a developmental role in the correct migration of
precerebellar neurons in the developing hindbrain (Kobayashi, Kawauchi, Hashimoto, Ogata, &
Murakami, 2013). They showed that the in utero knocking down of Unr in these cells resulted in
significant numbers failing to reach their target region in 19/19 brains tested, whereas this was
the case in none of eight brains containing control-transfected cells (Kobayashi et al., 2013).
They suggest that Unr may be involved in the post-transcriptional regulation of a group of
mRNAs involved in the migration process.
1.5.7 UNR and autism
It has been suggested that UNR may play a role in autism with a gene that lies in close proximity
to it in the human genome, TRIM33 (Xia et al., 2013). Links between UNR and TRIM33 are
discussed in more depth later (see section 4.3.6).
1.5.8 UNR and Alzheimer’s disease
Amyloid precursor protein (APP) is a transmembrane protein that has been implicated in the
pathogenesis of Alzheimer’s disease. Briefly, the protein is processed by one of two proteases
(α- or β-secretase) that differ in their site of cleavage. The processed protein is then acted on by 
another protease, γ-secretase. This results in a variety of cleavage products; one of those formed 
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by the action of β- and γ-secretase is the precursor of the amyloid plaques that are believed to 
be responsible for the development of Alzheimer’s disease (reviewed in Renner, 2014). It is
believed that the protein ADAM10 (a disintegrin and metalloproteinase 10) acts as an α-
secretase. UNR was shown to interact with the 5’UTR of the ADAM10 transcript. It was shown
to stabilise the transcript without repressing translation (Renner, 2014). Linked to this, UNR
knockdown resulted in reduced levels of ADAM10, thereby potentially increasing the risk of
more plaque precursor proteins being formed. Interestingly, that outcome was not observed
although it was suggested that this may have been due to the cell line being used (Renner, 2014).
Paradoxically, although UNR knockdown did not increase the amount of plaque precursor,
overexpression of UNR did increase it. It was postulated that UNR may increase the translation
of the BACE1 β-secretase through a hypothetical interaction with the 3’UTR of its transcript 
(Renner, 2014).
In other work, UNR expression was shown to be 50% lower in Alzheimer’s Disease-affected
hippocampi relative to control samples (Acquaah-Mensah, Agu, Khan, & Gardner, 2015). It is
interesting to consider this finding in light of the ADAM10 work. A reduction in UNR levels could
be expected to destabilise the ADAM10 transcript but, if Renner’s hypothesis about UNR
positively affecting BACE1 translation is correct, UNR would still be available to generate the
plaque precursor protein.
Interestingly, APP translation is driven by hnRNP C, like UNR, although it wasn’t apparent
whether or not this event involved the IRES in the APP transcript (Lee et al., 2010).
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1.6 UNR and cancer
Between their seminal review of 2000 and subsequent update of 2011, Hanahan and Weinberg
laid out a number of hallmarks of cancer (Hanahan & Weinberg, 2000, 2011). These included
their six original hallmarks:
. Self-sufficiency in growth signals
. Insensitivity to antigrowth signals
. Limitless replicative potential
. Sustained angiogenesis
. Evading apoptosis
. Tissue invasion and metastasis
In terms of these hallmarks, UNR could immediately be linked to cancer in a general way. As an
example, it could be postulated that a protein that controls the expression of a proto-oncogene
like FOS, if mutated, could result in self-sufficiency in growth signals. Likewise, as UNR modulates
the expression of the apoptosome scaffold protein, APAF1, a loss in that function could result in
a cell potentially evading apoptosis. There are many such theoretical considerations that could
link UNR to cancer but, in most cases, they are hypotheses based upon no experimental
evidence whatsoever. That said, there is some circumstantial evidence in the literature that links
UNR to cancer. For example, UNR has been shown to be differentially regulated or mutated in a
number of cancers or during the development of the cancer phenotype.
Another of Hanahan and Weinberg’s classic hallmarks is invasion and metastasis. The UNR
transcript was shown to be down-regulated in cases of metastatic gastric cancer (p value =
0.00228 by random permutation test) compared to non-metastatic tumours. Biopsies of
resected advanced gastric tumours were taken from 56 patients who were then followed up for
three years. The patients were noted to have shown peritoneal metastases or to be recurrence
free (as tested by peritoneal lavage). They were then assigned to one of two groups with 30 (13
with metastasis, 17 without) or 24 (13 with metastasis, 11 without) patients, respectively. The
first group was designated the ‘learning group’ and microarray analysis of data from those
patients was used to make predictions of which of 2304 genes could potentially be used as
diagnostic markers of metastatic potential. These predictions were then tested by examination
of the second ‘validation group’ samples (Motoori et al., 2006). Conversely, with advanced
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cervical cancer treated with radiotherapy, it was found that UNR was expressed approximately
two times higher in samples from patients who went on to die from cancer within 3-23 months
compared to those who showed no signs of cancer for at least 39 months, going up to over 102
months, depending on the individual patients within the course of the study (Harima et al.,
2004). The genomic region containing the UNR gene was found to be a common region to show
a gain of copy number in paediatric adrenocortical tumours, the authors considering UNR to be
important in adenomas but less so in carcinomas (Mateo et al., 2011). Interestingly, the region
showed more frequent increases in copy number in carcinoma samples although the consensus
length of amplification was slightly longer in carcinoma samples such that it included the NRAS
gene.
1.6.1 UNR and cancer – COSMIC database search
There are other examples in the literature of UNR being associated with various cancers, mainly
coming from high throughput experiments. The Catalogue Of Somatic Mutations In Cancer
(COSMIC) database (version 70) listed 177 mutations in UNR found in different cancers, this
equated to 95 changes in coding (Ray et al., 2015).
A more up to date version (v76) that used the GRCh38 version of the human genome was
accessed on 16/02/2016 in order to obtain information about the amino acid mutations in UNR
in cancer. It is worth pointing out that some observations from a given sample may have been
coincidental and not related to the cancer, per se.
The first observation was that there appeared to be more arginines mutated than any other
amino acid (Figure 1.6).
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Figure 1.6: A bar chart showing the number of observed amino acid changes within the UNR
protein recorded in the COSMIC database by affected amino acid residue. Changes include each
mutation where the same residue has been recorded as being mutated into multiple amino acids
and the introduction of stop codons but exclude silent mutations.
Taking the 844 amino acid version, there are 44 arginines in UNR, of which 20 were recorded as
having at least one non-silent mutation. 17.1% of all recorded non-silent mutations were in
arginine residues, more than both of the next most mutated amino acids (glutamine and
glutamate at 7.7% each). This skew towards UNR having mutated arginines in cancer has been
alluded to in the literature – e.g. it was noted that there are three recurrently mutated arginines
within endometrial cancers (Bell, 2014). The reason for this overrepresentation of arginines is
not known but it is easy to speculate that positively charged residues being mutated could alter,
reduce or remove the capacity for UNR to bind to negatively charged molecules like RNA. Whilst
pure speculation, it is considered unlikely that UNR-RNA binding would be rendered impossible
as a result of these mutations. That is because it is believed that UNR binds RNA via its cold shock
domains and these have particular highly conserved regions for binding nucleic acids (the RNP-
1 [Y/FGFI] and RNP-2 [FFH] motifs) and neither of these contain arginine. It is postulated here,
therefore, that the mutations in arginine residues are more about altering the thermodynamic
stability of specific UNR-RNA interactions and, thereby, possibly altering the set of RNAs involved
in UNR-RNA interactions.
Mutations recorded in the COSMIC database from within the five canonical cold shock domains
of UNR are shown below (Figure 1.7).
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Figure 1.7: Schematic representation of the five canonical cold shock domains (CSD), as stated,
within the UNR protein. Pink bands contain single letter amino acid code for the residues within
each cold shock domain. Turquoise bands contain the numbers of the residues within the 798
residue protein. The magenta band refers to the individual residues. White spaces within the
magenta bands refer to residues reported to have at least one non-silent mutation recorded in
the COSMIC data referred to in the text. Yellow blocks refer to residues that have at least one
silent mutation but no non-silent mutations recorded in the COSMIC data referred to in the text.
Blue boxes highlight the two ‘ribonucleoprotein domain’ RNA-binding motifs (RNP1/2) found in
each cold shock domain. Green boxes highlight arginines found within the cold shock domains.
Different cold shock domains appear to have different degrees of recorded mutations, an
observation that holds for both the RNA binding motifs and the domains more generally (Figure
1.7). Cold shock domain 1 has recorded mutations in both of its RNA binding motifs. One is a
conservative mutation I40V, whereas the other removes a conserved phenylalanine F51L. The
possibility of arginine mutations towards the end of the domain is also observed. Cold shock
domain 2 has some potentially catastrophic mutations in its RNA binding motifs. G198D takes
away a small neutral residue and replaces it with a larger negatively charged residue that could
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be expected to exert electrostatic repulsion on RNA molecules. Mutations have been observed
in all residues of its RNP-2 motif (F210L, F211Y, H212D/H212Y). This could imply that alteration
of the binding specificity of this CSD for RNA species is an important driver for cancers. It is worth
considering the finding that CSD2 was important in the UNR-PABP interaction, although the
mutated phenylalanine used in that work (equivalent to F199 here) did not have a mutation
recorded in the COSMIC database (Ray & Anderson, 2016). The residues within the RNA binding
motifs of cold shock domain 3 had no recorded mutations in the COSMIC database. It should
also be considered here, however, that charged residues either side of RNP-2 have been
reported to have been mutated which may affect the binding specificity of the domain for RNA
species. Furthermore, as more cancer samples are sequenced and uploaded to the COSMIC
database, new mutations in the RNA binding motif residues may be discovered. N529H,
immediately preceding the residues in RNP-1, was recorded as a possible mutation in cold shock
domain 4. The last conserved residue in RNP-2 (H545) has been recorded as being mutated to a
tyrosine. A phenylalanine located just to the C terminal end of RNP-2 was recorded more than
once as being mutated to a leucine (F549L). Cold shock domain 5 has a conservative mutation
reported just N terminal of RNP-1 (D683E), as well as a mutation in RNP-1 itself (F687L). An
N689S mutation has been found, abutting RNP-1 to the N terminal side. No mutations have
currently been reported within RNP-2.
Another known region of UNR is its UNRIP binding site (v.i.). Looking for mutations within that
site shows that some conserved UNRIP-binding residues are flagged up as potential sites of non-
synonymous mutation in different cancers (Figure 1.8). The effect of these mutations on the
UNR-UNRIP interaction, as well as any possible pathological changes in biological function,
remain unknown. Given the huge array of functions carried out by UNRIP within the cell (see
section 1.7), the potential effect of these mutations merits further consideration in future by
other researchers.
Figure 1.8: Schematic representation of the reported Unrip-binding site in the C terminal region
of UNR. The pink band contain single letter amino acid codes and the turquoise band contain
the residue numbers within the 798 residue protein. The magenta band refers to the individual
residues. White spaces within the magenta band refer to residues that have at least one non-
silent mutation recorded in the COSMIC data referred to in the text.
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It is unknown if any of the recorded mutations in the Unrip-binding site would prevent the
binding of Unrip to UNR.
1.6.2 UNR and cancer – CONAN database search
The COpy Number ANalysis (CONAN) database (accessible from the COSMIC website) shows
copy number changes recorded in cancer samples. It flagged up a number of copy number
changes in UNR. An alignment of these data with similar data for NRAS showed that the UNR
data was a subset of the NRAS data (data not shown). As NRAS is a known protooncogene and
UNR is not, it was considered likely that the changes in copy number for NRAS would outweigh
and confound any equivalent changes in UNR copy number. For this reason it was assumed to
be unworthy of further consideration.
In another investigation, the expression profile of 4 pancreatic cancer cell lines and two
pancreatic cancer primary cell lines were taken and compared with 11 libraries of non-neoplastic
tissue that included both primary and cultured cells. The comparison showed 15 UNR tags per
million in non-neoplastic samples and 144 UNR tags per million in the pancreatic cancer samples
(Hustinx et al., 2004). Confoundingly, the tag they used for UNR was shared with that for
lumican, a collagen binding protein reported to be upregulated in breast and colorectal cancer
(Lu et al., 2002). As the same sequences were present in each transcript, obviously, they shared
the statistics and it is impossible to infer anything about the proportion of relative upregulation
accounted for by each transcript.
1.7 UNRIP
UNRIP is a known UNR-interacting protein (Hunt et al., 1999). The Unrip gene is believed to be
expressed in all mouse tissues with high levels of expression observed in the liver and testicular
tissue (Datta, Chytil, Gorska, & Moses, 1998). In comparison, Unr transcript levels were reported
to be 7 times lower in liver compared to testis (Boussadia et al., 1997). The UNRIP gene is
universally conserved among the eukaryotae from yeast to mammals (Datta et al., 1998), is often
upregulated in cancer (e.g. in a variety of lung cancers, as compared with healthy lung tissue
from the same patients (Halder et al., 2006)), and has been shown to be essential in mice (Chen,
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Delrow, Corrin, Frazier, & Soriano, 2004). It is reported to be one of ten oncogenes responsible
for the phenotype of one of the cancer cell lines used in this study – the SaOS-2 osteosarcoma
cell line (Niforou et al. 2006).
Whilst UNRIP is not believed to possess a nuclear localization signal, it is observed in the nucleus
(Halder et al., 2006). One protein with which it can interact is GEMIN7, part of the survival motor
neuron (SMN) complex (Grimmler et al., 2005). The SMN complex is involved in splicing and
consists of a variety of proteins including the eponymously named SMN protein and GEMINs
2-7 (Gubitz et al., 2004). Unrip was later shown to interact with the SMN complex via GEMIN7,
although this relationship was only apparent in the cytoplasm. Knocking down UNRIP increased
the nuclear localisation of the SMN complex (Grimmler et al., 2005). Interestingly, the
interaction between Unrip and either GEMIN7 or UNR was noted to be mutually exclusive
(Grimmler et al., 2005). Later work showed that the binding of another Unrip binding partner,
La-related protein 6 (Larp6), was also mutually exclusive to both Gemin7 and Unr (Vukmirovic,
Manojlovic, & Stefanovic, 2013). Protein sequences for UNR (O75534), LARP6 (Q9BRS8) and
GEMIN7 (Q9H840) are freely available at www.uniprot.org. Manual comparison of these
sequences suggests a shared consensus Unrip binding motif VLRxPRGPD (Figure 1.9).
Importantly, a mutually exclusive relationship between UNRIP and either UNR or one of two
other proteins implies that UNR function through UNRIP could be competitively reduced by the
presence of LARP6 or GEMIN7. Also, UNR could competitively reduce the activity of UNRIP with
LARP6 and GEMIN7.
Figure 1.9: Conserved residues in mutually exclusive Unrip binding proteins imply a putative
Unrip binding consensus sequence. Alignments were carried out by hand based on the
www.uniprot.org human protein sequences O75534 (UNR), Q9BRS8 (LARP6) and Q9H840
(GEMIN7). Yellow shading signifies residue shared by all three proteins. Green shading signifies
a serine or a threonine. Black shading signifies that a gap was intentionally inserted into a protein
sequence to improve the alignment (subjectively) between the three proteins. N.B. This is similar
to a diagram in Vukmirovic et al. (2013) although the amino acid range considered here is greater
(their diagram runs from VRL to GF). They align the phenylalanine of GEMIN7 that lies
immediately before the green-shaded serine with asparagines from the other two proteins – i.e.
they shift the spaces from N-S/T to D-N).
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UNRIP was shown to interact with Transforming Growth Factor beta (TGFβ) Receptor 1 and 2 
(TGFβR1/2) homodimers in the presence or absence of receptor agonist (Datta & Moses, 2000). 
It was shown to interact with a variety of Sister of Mothers Against Decapentaplegic (SMAD)
proteins; including SMAD2, SMAD3 and SMAD7 (Datta & Moses, 2000). UNRIP binding to SMAD7
increases SMAD7 repression of TGFβ signalling (Datta & Moses, 2000). One protein 
downregulated by UNRIP activity at TGFβ receptors is p21Cip and knocking down UNRIP increases
p21Cip expression (Halder et al., 2006). Over-expression of UNRIP in cancer therefore leads to
the hyperphosphorylation of the retinoblastoma protein, reducing its capacity to sequester
proliferation-promoting E2F transcription factors, and driving cellular proliferation (Harbour &
Dean, 2000).
The 3-phosphoinositide dependent kinase PDK1 binds to protein kinase B (PKB/AKT) and recruits
it to the membrane where it can then act as one of the two PKB activating kinases. Other key
targets include the ribosomal protein S6 kinase 1 (S6K1) and the atypical protein kinase C zeta
(PKCζ) (Berridge, 2014). UNRIP/Unrip interacts with PDK1/Pdk1 and the interaction is enhanced 
by insulin signalling. The insulin effect is likely to be PI-3,4,5-P3-dependent as it was not observed
when cells were treated with wortmannin (Seong, Jung, Choi, Kim, & Ha, 2005). This indirect link
between insulin signalling and UNR via UNRIP is worth considering in light of work linking UNR
expression to control of diabetes. That work showed by qPCR that the UNR transcript level went
up over 6 fold after one week of treatment in patients who were admitted to hospital with
poorly controlled diabetes (Xavier et al., 2014). Interestingly, in light of current findings in this
work linking UNR to selenium compound metabolism (see section 4.11.6), there were two other
genes that were considered significant by the authors; one of which being Selenoprotein S,
which fell more than three-fold following treatment (Xavier et al., 2014).
UNRIP has been shown to interact with the pro-apoptotic apoptosis signal regulating kinase 1
(ASK1), an interaction promoted by ASK1 phosphorylating UNRIP at T175 and S179. The addition
of UNRIP was shown to decrease the amount of hydrogen peroxide-instigated apoptosis,
whereas knocking down UNRIP increased the proportion of cells undergoing apoptosis in
response to hydrogen peroxide (Jung, Seong, Manoharan, & Ha, 2010).
Drawing together the previous two sections, the pro-survival PDK1 was shown to interact with
the pro-apoptotic ASK1 and that mutual phosphorylation reduced their respective downstream
signalling activities (Seong, Jung, Ichijo, & Ha, 2010).
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Unrip interacts with the Ewing’s Sarcoma protein (EWS) in the nucleus, inhibiting an alternative
interaction with the transcriptional co-activator EP300/CBP and downregulating EWS target
genes such as c-fos (Anumanthan, Halder, Friedman, & Datta, 2006). As stated previously, UNR
interacts with other proteins on the mCRD of the c-fos transcript, both stabilising and promoting
degradation of the message following translation. EP300/CBP is required for EWS to activate
hepatocyte nuclear factor 4 (HNF4)-mediated transcription (Araya et al., 2003). HNF4-mediated
transcription is important in differentiation. For example, dedifferentiated hepatoma cells can
be forced to re-differentiate following the stable expression of Hnf4 (Späth & Weiss, 1998).
Gata6 is involved in transcribing the Hnf4 gene within primitive endoderm and this is required
for differentiation into visceral extraembryonic endoderm (Morrisey et al., 1998). As discussed
previously, the essential function of Unr in mice was linked to destabilisation of the Gata6
transcript (Elatmani et al., 2011).
UNRIP has been shown to interact with nuclear export factors and has also been suggested to
be part of neuronal transport granules that transfer mRNAs into the cytoplasm and around the
cell linked to microtubules (Tretyakova et al., 2005).
There are many other reported roles for UNRIP in the literature that shall be overlooked here
for the sake of brevity. Based upon the lines of investigation that have been considered here,
however, it appears that the functional roles of UNR and UNRIP overlap beyond any physical
interactions between the two.
1.8 Concept of ‘RNA operons’
When taken together, the current state of the literature pertaining to UNR implies that it is
involved in controlling the cellular concentrations of a variety of mammalian proteins at the level
of translation. The mRNA binding partners outlined here have included transcripts involved in
universal processes like mitosis (e.g. CDK11), translation (e.g. Unr itself) and cellular proliferation
(e.g. Fos). They also include mRNAs that encode proteins involved in essential metazoa-specific
functions such as apoptosis (e.g. APAF1) and development (e.g. Gata6). Unfortunately, the
literature concerning the role of UNR in the control of translation in human cells in incomplete.
The current project aims to help address that gap by obtaining high-throughput data using a
large-scale systems-based investigation.
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Multiple related transcripts regulated by specific proteins have been termed ‘RNA operons’
(reviewed in Keene, 2007). The idea that UNR may be involved in modulating groups of
transcripts that could be termed an RNA operon will be considered by GO-term analysis and
other methods.
1.9 Use of sodium arsenite as a stressor
Sodium arsenite is used as a stressor in subsequent chapters. Arsenite has also been shown to
modulate various signalling pathways at different concentrations across multiple cell lines
(discussed in Bode & Dong 2002). Arsenite can downregulate EIF4E and, thereby, reduce cap-
dependent translation (Othumpangat, Kashon, & Joseph, 2005).
Different effects of arsenite have been reported at different concentrations of the drug. Doses
up to 1 μM were shown to be protective against subsequent oxidative stress and DNA damage 
in cultured skin cells (Snow, Sykora, Durham, & Klein, 2005). As little as 2-5 μM of arsenite were 
sufficient to lead to significant production of reactive oxygen species after 2 hours and significant
depolarisation of the mitochondrial membrane after 30 minutes in MCF7 cells (Ruiz-Ramos,
Lopez-Carrillo, Rios-Perez, De Vizcaya-Ruíz, & Cebrian, 2009).
0.1-1 mM arsenite was shown to reduce the rate of activity of the succinoxidase complex (Potter
& Dubois, 1943), thereby showing it to be an inhibitor of cellular respiration. Later research
showed that arsenite can generally inhibit the tricarboxylic cycle, with 50 μM arsenite able to 
reduce citrate production from pyruvate by 57% over control and 100 μM arsenite able to 
reduce citrate production from pyruvate by 100% in a rat cardiac mitochondria preparation
(Reiss & Hellerman, 1958). Whilst not directly relevant to the cell lines used here, arsenite was
also shown to also inhibit β-oxidation and ketogenesis in rat liver mitochondria (Rein, Borrebaek, 
& Bremer, 1979), thereby inhibiting pathways of energy production distinct from
glycolysis->pyruvate->tricarboxylic acid cycle.
Several factors were taken into consideration when deciding on the concentration of the drug
that was to be used. Experiments to calculate the LC50 of arsenite showed that 50% of HeLa
cells died in 24 hours after treatment with around 200 μM arsenite, the lowest LC50 of the 4 cell 
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lines explored (Othumpangat et al., 2005). Other experiments had shown that UNR migrates to
stress granules in HeLa cells following stress with 500 μM arsenite for 30 minutes (White & Lloyd, 
2011) but that over 50% of keratinocytes die within 2 hours of exposure to 1 mM arsenite.
Partially due to the findings of White and Lloyd (2011), and partially due to a desire to explore
oxidative stress more than starvation, it was decided to use 500 μM arsenite for 30 minutes as 
a starting point in the experiments shown in this thesis. When immunofluorescence microscopy
showed clearer staining for UNR in stress granules with minimal loss of cells when 1 mM arsenite
was used for 1 hour, it was decided to use these conditions for the main experiments.
1.10 Aims and objectives
A brief glance over the literature pertaining to UNR shows a protein that is implicated in multiple
biological processes of great interest to mankind such as mammalian development. Beyond
academic interest, further research into UNR is potentially of economic benefit when it is viewed
in terms of potential links to various pathological conditions that cause human suffering,
decreased life expectancy and put strain on healthcare budgets around the world such as cancer,
diabetes and Alzheimer’s disease. In order to expand upon the current understanding of UNR
function in human cells, this work intends to identify novel UNR-interacting proteins and mRNAs.
It is hoped that the function of these currently unknown UNR-interactors may shed new light on
the function of UNR in human cells.
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2 Materials and methods
2.1 Materials
2.1.1 Antibodies
The antibodies used to generate Western blot images shown in this thesis* (Table 2.1), for
carrying out immunoprecipitations/ribonucleoprotein immunoprecipitations (Table 2.2) and for
carrying out immunofluorescence microscopy staining (Table 2.3) are presented below.
* For Figures 3.1 to 3.5 only, the antibodies used to detect UNRIP and/or UNR were the rabbit
polyclonal antibodies documented in (Hunt et al. 1999), provided as a kind gift from Richard
Jackson (University of Cambridge).
Table 2.1: Antibodies used for Western blotting
Target Source Dilution (v/v) Company Company ID Storage
UNR Rabbit pAb 1:1000 Novus Biologicals NBP1-71914 4°C
UNR Goat pAb 1:1000 Santa Cruz sc-79292 4°C
UNRIP Mouse mAb 1:1000 Santa Cruz sc-136083 4°C
TP53 Mouse mAb 1:1000 Santa Cruz sc-126 4°C
PABP Rabbit pAb 1:1000 Abcam ab21060 -20°C
SQSTM1 Goat pAb 1:1000 Santa Cruz Sc-10117 4°C
HUWE1 Rabbit pAb 1:1000 Bethyl Laboratories A300-486A 4°C
γ-tubulin Mouse mAb 1:10000 Sigma T6557 -20°C
α/β-tubulin Rabbit pAb 1:2000 Cell Signaling 2148S -20°C
Rabbit IgG Donkey 1:10000 Santa Cruz sc-2313 4°C
Goat IgG Donkey 1:10000 Santa Cruz sc-2056 4°C
Mouse IgG Donkey 1:10000 Santa Cruz sc-2318 4°C
N.B. Yellow shading denotes horseradish peroxidase (HRP)-conjugated secondary antibodies.
The UNR IP that showed dirty staining for HUWE1 (Figure 4.19) was carried out using the
antibody as stated in Table 2.2 with subsequent membrane probing with the anti-HUWE1
antibody listed in Table 2.1. There had previously been an anti-HUWE1 antibody raised in goat
in the lab but that did not generate any bands when used to probe the membrane (see section
2.2.7). The membrane was then stripped (see section 2.2.8) and re-probed with the rabbit anti-
HUWE1 antibody – thus the large amount of background staining.
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Table 2.2: Antibodies used for immunoprecipitations and ribonucleoprotein
immunoprecipitations
Target Source Amount used Company Company ID Storage
UNR Rabbit pAb* 5 or 6 μg per 25 μl Dynabeads** Novus Biologicals NBP1-71914 4°C
Control Rabbit 5 or 6 μg per 25 μl Dynabeads** Invitrogen 10500C 4°C
* The immunoprecipitation related to Figure 3.11 was carried out with Dr Swagat Ray using the
anti-UNR immunoglobulin raised in goat (Table 2.1; see section 3.2.3).The associated conspecific
IgG was obtained from Invitrogen (ID: 10200).
**IPs shown in chapter 3 used 5 μg per 25 μl but this ratio was calculated to be sub-saturating 
in terms of the amount of antibody being available to bind to the Protein A on the Dynabeads
(according to the manufacturer of the beads [Invitrogen]), so 6 μg per 25 μl was used for main 
RIPs (see section 2.2.9 for further information).
Table 2.3: Antibodies used for immunofluorescence microscopy staining
Target Source Dilution (v/v) Company Company ID Storage
UNR Rabbit pAb 1:250 NovusBiologicals NBP1-71914 4°C
UNR Goat pAb 1:250 Santa Cruz sc-79292 4°C
TIA1 Goat pAb 1:250 Santa Cruz sc-1751 4°C
TP53 Mouse mAb 1:250 Santa Cruz sc-126 4°C
HUWE1 Rabbit pAb 1:250 BethylLaboratories A300-486A 4°C
Anti-
Rabbit IgG Donkey 1:1000 Invitrogen A21207 4°C
Anti-
Mouse IgG Donkey 1:1000 Invitrogen A21202 4°C
Anti-
Rabbit IgG Donkey 1:1000 Santa Cruz sc-362261 4°C
Anti-
Mouse IgG Donkey 1:1000 Santa Cruz sc-362248 4°C
Anti-Goat
IgG Donkey 1:1000 Santa Cruz sc-362245 4°C
N.B. Coloured cells refers to the fluorophore conjugated to the highlighted secondary antibody
(red = Alexa-594, light green = Alexa-488, dark green = CruzFluor™-488, blue = CruzFluor™-405)
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2.1.2 siRNA
The siRNAs used in this thesis were:
1) siUNR (Life Technologies, ID = 122624, sequence from exon 8 of UNR)
2) control siRNA (Life Technologies, ID = Silencer negative control 2)
2.1.3 P A BP primers used for reverse transcriptase-polymerase chain reaction
amplification
The identity of these primers is currently unavailable to the author but should be available from
Dr Emma Anderson upon her return to the University of Warwick.
2.1.4 Source of chemicals
Sodium arsenite was obtained from Sigma (S7400). All other laboratory chemicals were
sourced from standard suppliers, including Sigma.
2.2 Methods
2.2.1 Tissue culture
HeLa, U2OS and SaOS-2 cells were all maintained in tissue culture dishes or flasks of various sizes
depending on their ultimate use. They were fed Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (v/v) foetal calf serum (FCS) (Biosera) and were incubated at 37°C
(unless stated otherwise) in a humidified environment containing 5% (v/v) carbon dioxide in air.
Cells were split when they reached 70-100% confluent. To do this, the cells were washed twice
with sterile phosphate buffered saline (PBS) at 37°C and treated with a trypsin/EDTA solution to
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cause the cells to detach from their substratum and each other. They were then split 1:10 (HeLa)
or 1:5 (U2OS and SaOS-2) into fresh medium.
2.2.2 Sodium arsenite treatment
Where cells were to be treated with sodium arsenite, they were fed fresh DMEM containing 10%
(v/v) FCS that had been made with 100 mM sodium arsenite to a final concentration of 500 μM 
or 1 mM, as stated in the text. Negative control cells were mock treated with fresh DMEM
containing 10% (v/v) FCS to which had been added the same volume of sterile PBS as 100 mM
sodium arsenite had been added to the arsenite-treatment medium. The cells were then
returned to the incubator for the amount of time stated in the text.
2.2.3 siRNA transfection
Both HeLa and U2OS cells were transfected with siRNA during the course of this thesis. They
were transfected according to the same protocol which is laid out here using volumes
appropriate for a single 10 cm plate.
1) Cells were split into 10 cm tissue culture plates and were allowed to grow to a
confluency of 50-70%.
2) 1ml of Opti-MEM was mixed with 20 μl of Lipofectamine 2000 and left for 5 minutes at 
room temperature. Meanwhile, 2 μl of a 200 μM stock solution of either siUNR or
control siRNA was added to another 1 ml of Opti-MEM.
3) After 5 minutes, the two solutions were mixed by inversion and left for 20 minutes at
room temperature. This generated 2 ml of a solution of 200 nM siRNA.
4) During this time, the plates were fed with 18 ml of fresh DMEM containing 10% (v/v)
FCS.
5) After the 20 minutes, the Opti-MEM mixture was added dropwise around the plates
which were then returned to the incubator for 42-48 hours, giving a final siRNA
concentration of 20 nM.
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2.2.4 Immunofluorescence microscopy
Coverslips were prepared in a tissue culture hood by being dropped into 70% (v/v) ethanol (in
sterile deionised water) before being removed and allowed to dry propped up on the side of a
six well plate lid. Once dry, the coverslips were placed into wells of six well plates (one per well).
Cells were then split (see section 2.2.1) and diluted 1:10 (v/v) (HeLa) or 1:5 (v/v) (U2OS and
SaOS-2) by surface area. Cells were then allowed to grow to a suitable confluency (generally 50-
70%) before being processed for visualisation. Arsenite treatment was then undertaken if
required. The cells were then washed twice with ice cold PBS and between 500 μl and 1 ml of
ice cold 10% (w/v) methanal solution (made up as 10 ml of 37% (w/v) aqueous methanal diluted
with 27 ml of phosphate buffered saline [PBS]) was then added to the wells to cover the
coverslips. This was left for 10 minutes, after which the cells were washed twice with ice cold
PBS. Between 500 μl and 1 ml of room temperature 0.5% (v/v) NP-40 solution (38 ml of PBS
added to 2 ml of 10% (v/v) NP-40 in deionised water) was then added and left for 10 minutes,
upon which time the coverslips were again washed twice with ice cold PBS.
300-500 μl of blocking reagent (serum from the species in which the secondary antibodies were
raised – donkey [Sigma, D9663] for all experiments in this thesis – diluted to 2% (v/v) with PBS)
was added directly to the coverslips and the plates were shaken gently for 60 minutes on an
orbital shaker. The blocking reagent was then removed and 500 μl of primary antibody
combinations, diluted in blocking reagent, were added to the appropriate coverslips without
washing. The plates were again allowed to rotate gently on an orbital shaker for 60 minutes. The
coverslips were then washed thrice with cold PBS and 300-500 μl of the required secondary
antibody combination was added gently to each coverslip. The secondary antibodies were
diluted in blocking reagent and were kept in the dark prior to application. The plates were then
placed in tupperware boxes covered with aluminium foil and allowed to shake gently for 60
minutes. When 60 minutes had elapsed, the secondary antibodies were removed and the
coverslips were washed thrice with cold PBS and placed cell side up against the edges of 6 well
plate tops to dry under foil-covered tupperware for 15 minutes. During the 15 minutes, the
necessary number of microscope slides were washed with 70% (v/v) ethanol in deionised water
and allowed to dry.
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When coverslips were dry, a drop of the Vectashield (Vector Laboratories), with or without DAPI
as appropriate, was added to the centre of a microscope slide and a coverslip was placed on top,
cell side down. The edges of the coverslip were then sealed with nail varnish and the slides were
labelled and placed coverslip side up under foil-covered tupperware until the nail varnish set.
When all slides were dry, they were placed in a slide holder, covered with aluminium foil and
stored at 4°C prior to visualisation using a Leica SP5 confocal microscope with a 60X oil
immersion objective. Images were then saved using the Leica confocal software associated with
the microscope for off-site processing using LAS AF Lite software (Leica Microsystems).
In most cases, multiple optical slices were imaged and images are presented as max projections.
Any changes in brightness or contrast were carried out equally on all channels in the images,
which were saved as tagged image file format files. The images were then altered in the same
way in Microsoft Office software (Powerpoint and Word) in order to enhance the visibility of the
printed images.
2.2.5 Cell lysate generation
All lysates used in this thesis were generated using polysome lysis buffer (PLB). The recipe was
taken from Keene et al. (2006). A pre-buffer was initially made and stored at 4°C prior to use. It
consisted of:
100mM KCl,
5mM MgCl2,
10mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) at pH = 7.0,
0.5% (v/v) NP-40.
Immediately prior to use, the following reagents were added to the stated end concentrations:
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1mM dithiothreitol (DTT),
100 units ml-1 RNase OUT (Invitrogen),
400 μM vanadyl ribonucleoside complex (VRC), 
1X protease inhibitor cocktail (Roche Diagnostics)
It should be noted that RNase OUT was used for the main experiments in chapters 4 and 5 but
was not always used elsewhere (see text for further information).
Cells were washed twice in cold PBS before being just covered with cold PBS and gently scraped
off the surface of the plates. The cell suspension was then centrifuged at 1000g and 4°C until the
cells became sedimented at the bottom of the tube. The supernatant was removed and the cells
resuspended in cold PBS and centrifuged as before and the supernatant was again discarded.
Following a second resuspension and supernatant removal the cells were suspended in a similar
volume of PLB and transferred to a suitably sized clean tube. This was incubated on ice for 5
minutes before being transferred to a freezer at -80°C for a period of no less than 8 hours. Finally,
the raw lysates were thawed on ice before being spun down at 15000g and 4°C for 15 minutes,
after which the supernatant was collected and the cell debris pellet discarded. The lysate was
purified by a subsequent round of spinning down at 15000g and 4°C in order to separate out the
aqueous portion of the lysate from unwanted lipids that were carried over from the raw lysate.
A portion of the lysate was then set aside for protein quantification and the rest stored at -80°C
until required.
2.2.6 Protein quantification
Protein quantification was carried out using Pierce BCA Protein Assay Kit (Thermo Scientific), as
per the manufacturer’s guidelines.
8Chapter 2
2.2.7 Western blot analysis
Cell lysates, if quantified, were diluted to the lowest protein concentration among them in pre-
PLB buffer (see above) to give equal sample loadings. These lysates, or immunoprecipitated
samples, were then heated to 95°C for 5 minutes in sodium dodecyl sulfate (SDS) loading buffer,
which contained the following components at the following end concentrations:
50mM 2-Amino-2-hydroxymethyl-propane-1,3-diol (Tris) adjusted to pH=8.8 with concentrated
hydrochloric acid.
10% (v/v) glycerol
2% (w/v) SDS
Bromophenol blue dye (used sparingly to generate a dark blue colour)
These samples were then subjected to polyacrylamide gel electrophoresis (Laemmli 1970). They
were loaded onto an SDS polyacrylamide gel with a suitable protein marker and had their
constituent proteins separated through a 5% stacking gel and a 10% resolving gel by
electrophoresis. The gels were made using the reagents and quantities in Table 2.4.
Table 2.4 Reagents used in the formation of protein gels (by percentage of end mixture)
Component Stacking Resolving
Protogel (National Diagnostics)* 17 33.3
1M Tris (pH=6.8) 12.5 0
1M Tris (pH=8.8) 0 25
10% (w/v) ammonium persulfate 1 1
10% (w/v) SDS 1 1
TEMED 0.1 0.04
water 68 39.7
* 30% (v/v) acrylamide : 0.8% (v/v) methylene bisacrylamide
The gels were run at 120 V for 10 minutes followed by 200 V until adequate separation had been
achieved. The proteins in the gel were then transferred onto nitrocellulose membrane using a
wet transfer tank with a current of 350 mA for two hours in a room at 4°C or, alternatively, at a
lower current overnight such that the end product of current and time was no less than 700 mA
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hours. The membrane was then stained with Ponceau S dye (0.1% [w/v] of dye in 5% [v/v]
ethanoic acid). The stained membrane was then photographed followed by being washed at
least three times in TBST until the red colouration had gone. It was then blocked in 5% (w/v)
reconstituted milk (Marvel, Premier Foods Group) in Tris-buffered saline-Tween20 (TBST) buffer
with gentle rocking for 30 minutes. The milk was removed and a primary antibody (or, on
occasion, two primary antibodies), diluted in 5% (w/v) Marvel in TBST, was then applied to cover
the membrane which was then either left for 1-2 hours at room temperature with gentle
rocking, or overnight at 4°C, again with gentle rocking. The primary antibody was then removed
and the membrane was subjected to three 15 minute washes in TBST. A suitable secondary
antibody, diluted in 5% (w/v) Marvel in TBST, was then applied to cover the membrane which
was left to rock gently for 60 minutes. After this, the secondary antibody was discarded and the
membrane was given five 15 minute washes in TBST with quick intervening swirl washes in TBST.
The membrane was then treated with an enhanced chemiluminescence (ECL) reagent made by
the author based on a helpful suggestion by Dr Andrew Turnell (University of Birmingham,
England) which was, in turn, based on (Haan & Behrmann 2007). The ECL solutions were made
as follows:
Solution 1:
1) Make 10.5 ml 250mM luminol in dimethyl sulfoxide (DMSO)
2) Make 5 ml 90mM p-Coumaric acid in DMSO
3) Add 885.6 ml deionised water to 100 ml 1M Tris-HCl at pH = 8.5
4) Then add 10 ml of the luminol solution and 4.4 ml of the p-Coumaric acid solution
5) Wrap in aluminium foil, as luminol is light sensitive, label and store at 4°C.
Solution 2:
1) Add 899.36 ml deionised water to 100 ml 1M Tris-HCl at pH = 8.5
2) Add 640 μl 30% (v/v) hydrogen peroxide 
3) Wrap in aluminium foil, label and store at 4°C.
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Equal volumes of these solutions were mixed together immediately prior to applying to the
membrane in a dark room and swirling for 60s. The ECL solution was then poured off and the
membrane was placed protein side down on cling film and wrapped. It was then placed protein
side up into a developing cassette. A photographic film was then placed on top of the membrane
and the cassette was closed for a set amount of time. The film was then removed from the
cassette and developed in an X-ray film processor. Depending on the appearance of the
developed film, additional films were developed for longer or shorter periods of time. The films
were then annotated, scanned and saved as .jpg files.
2.2.8 Stripping of membranes
Where a membrane was to be re-probed having been previously probed with a different primary
antibody, Restore PLUS Western Blot Stripping Buffer (Thermo Scientific) was used, as per the
manufacturer’s guidelines.
2.2.9 Immunoprecipitation and ribonucleoprotein immunoprecipitation
PLB was used to generate all lysates which were used in immunoprecipitation experiments for
which results are recorded in this thesis. As a result of this, the differences between standard
immunoprecipitations and ribonucleoprotein immunoprecipitations were minimal (where
stated, RNase OUT was not used in the lysis/immunoprecipitation buffer). The protocol was
optimised in the Anderson lab by Dr Swagat Ray, based on Keene et al. (2006).
In brief, Protein A-conjugated Dynabeads (Life Technologies) were incubated with either an
antibody against UNR or a control IgG (see section 2.1.1) in PBS containing 0.01% (v/v) Tween-
20 (PBST) in tubes attached to a rotating mixer for 60 minutes at room temperature. Following
this, the beads were blocked in 0.1% (w/v) bovine serum albumin (BSA) in PBS in tubes attached
to a rotating mixer in a cold room at 4°C. Whilst the blocking step was carried out with every
IP/RIP for which data is presented in this document, it was later discovered that the blocking
step was, at best, unnecessary due to poor binding between the beads and BSA (publicity from
the ThermoFisher website).
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The beads were then washed twice in ice cold PBST and then once in ice cold NT2 buffer (50 mM
Tris-HCl at pH=7.4, 150 mM NaCl, 1mM MgCl2, 0.05% [v/v] NP-40). After this, they were
resuspended in NT2 to which had been added: 5 μl of RNase OUT per ml, VRC to a final 
concentration of 400 μM and DTT to a final concentration of 1 mM. Cleared lysate was then 
added at 1 part to 9 parts bead suspension. The immunoprecipitation was then carried out in
tubes attached to a rotating mixer for 4 hours at 4°C. The beads were then washed five times in
ice cold NT2 using a magnetic stand to pellet the beads.
At this point, the beads were treated differently depending on the purpose of the IP experiment.
Where the IP had been carried out for analysis by Western blot, the beads were boiled in SDS
loading buffer. Likewise, where the IP was carried out to generate samples that were to be
separated by SDS-PAGE prior to analysis by mass spectrometry, the beads were also boiled in
SDS loading buffer (see section 2.2.10). Where the samples were to be used for the trial run
using the on-bead method of sample preparation for mass spectrometry, all beads were
immediately processed for that purpose (see section 2.2.11). Finally, in the case of the large
scale experiments discussed in Chapters 4 and 5, the beads were separated 4 parts for RNA
extraction and 1 part for analysis by mass spectrometry (on-bead sample preparation method).
2.2.10 Preparation of samples for mass spectrometry 1 – gel slice method
Immunoprecipitated samples were boiled in SDS loading buffer and their proteins were then
separated by SDS-PAGE. The gel was then covered in InstantBlue (Expedeon) and left for 1 hour.
Following this, the stained gel was processed for mass spectrometry. To do this, the lanes were
cut into gel slices that were then transferred to labelled plastic tubes and these were then
washed twice for 20 minutes in 50% (v/v) ethanol containing 50mM ammonium hydrogen
carbonate (NH4HCO3) with shaking at 50°C. The supernatant was discarded after each wash. The
gel was then dehydrated with 100% ethanol for five minutes at 55°C with shaking. Again, the
supernatant was discarded. Disulphide bridges were then reduced with 10 mM DTT in 50 mM
NH4HCO3 at 56°C for 45 minutes with shaking. The supernatant was discarded. Cysteine residues
were then alkylated with 55 mM iodoacetamide in 50 mM NH4HCO3 for 30 minutes at room
temperature in the dark. The supernatant was then discarded. Gel slices were then washed
twice for 10 minutes each with 50% (v/v) ethanol in 50 mM NH4HCO3 with the wash liquid
discarded on both occasions. The gel was then dehydrated with 100% ethanol for five minutes,
after which the excess ethanol was discarded. Mass spectrometry grade trypsin, dissolved in
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100 mM NH4HCO3, was then added to submerge the gel slices which were incubated overnight
at 37°C with shaking. The same volume of 5% (v/v) methanoic acid in 25% (v/v) acetonitrile as
that of the trypsin solution was then added and the samples were sonicated for 10 minutes in
an ultrasonic cleaning bath with sweep mode (model number USC100T, VWR, Radnor, USA) prior
to the supernatant being retained in a fresh labelled tube. This step was repeated twice with all
supernatants for a given gel slice being merged. The peptide solutions were then dried overnight
in a miVac DUO concentrator (Genevac Ltd., Ipswich, England) at 40°C. The pellets were then
resuspended in 50 μl of 2.5% (v/v) acetonitrile containing 0.05% (v/v) 2,2,2-trifluoroethanoic 
acid (TFA) and the solutions were sonicated for 30 minutes. The samples were then centrifuged
at 17000g for five minutes and the samples were transferred to labelled glass vials for further
processing by the mass spectrometry department.
2.2.11 Preparation of samples for mass spectrometry 2 – on-bead method
It was possible for NP-40-free NT2-washed beads to be processed directly for analysis by mass
spectrometry using the on-bead method.
In this, beads were re-suspended in 45 μl of 100mM NH4HCO3 and 5 μl of 100mM DTT was 
added. This mixture was incubated at 60°C for 15 minutes with shaking. 5 μl of 200 mM 
iodoacetamide was then added and the mixture was left in the dark at room temperature for 30
minutes. Mass spectrometry grade trypsin, dissolved in 100 mM NH4HCO3, was then added to
cover and the samples were shaken overnight at 37°C. They were then centrifuged at 5000g for
two minutes followed by the supernatants being transferred to Costar Spin-X columns (Corning)
and centrifuged at 13300g for 15 minutes. The sample liquids were then transferred to glass
vials for further processing by the mass spectrometry department.
2.2.12 Preparation of samples for mass spectrometry 3 – filter aided sample
preparation
The knockdown experiments generated whole cell lysate samples in PLB as opposed to
immunoprecipitated samples. These samples were processed directly for mass spectrometry as
follows:
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To around 80 μl of sample, DTT was added to an end concentration of 50 mM and the samples 
were heated with shaking at 55°C for 40 minutes. This was then added to 400 μl of buffer UA     
(8 M urea, 100 mM Tris-HCl at pH=8.8, made fresh) and mixed by vortexing. The solution was
then centrifuged in 3k molecular weight cut off spin columns (Thermo Scientific) at 14000g for
40 minutes at room temperature. The eluent was discarded and a further 400 μl of UA was 
added to the column and it was respun as before. The eluent was discarded and 400 μl of 
iodoacetamide solution (46.2 mg iodoacetamide in 5 ml UA, end concentration 0.05 M) was
added. This was mixed with shaking for one minute without heating and left to incubate for five
minutes without shaking under aluminium foil. The column was then spun at 14000g for 40
minutes and the eluent was discarded.
The following step was then carried out three times: 400 μl of UB buffer (8 M urea, 100 mM Tris-
HCl at pH=8.0, 10 ml ultrapure water, made fresh) was added to the columns which were
centrifuged at 14000g for 40 minutes with the eluent discarded.
The following step was then carried out three times: 400 μl of 100 mM NH4HCO3 was added to
the columns which were centrifuged at 14000g for 40 minutes with the eluent discarded.
Mass spectrometry grade trypsin, dissolved in 100 mM NH4HCO3, was then added to the
columns which were shaken for one minute before being transferred to a 37°C water bath
overnight. The columns were then transferred to new labelled tubes and spun down at 14000g
for 40 minutes. The eluent was not discarded. 50 μl of 0.5 M NaCl was then added to the columns 
and then were spun down again at 14000g for 20 minutes. The columns were then discarded
and TFA was added to the tubes to an end concentration of 0.5% (v/v). As discussed at the
relevant section in the text, the protocol was changed by the mass spectrometry department
during the course of this work due to an error in the concentration of acid added at this point.
Previously, the protocol had stated that 1 μl of 5% (v/v) TFA should be added here. As there was 
120 μl of trypsin solution and 50 μl of NaCl present, the end concentration would be less than 
0.03% - more than ten times lower than was suggested in their updated protocol.
Rows of tubes were then arranged that had 200 μl of acetonitrile in the first row, the samples in 
the second row, 200 μl of 0.1% (v/v) TFA to wash and desalt in the third row and 50 μl of 0.1% 
(v/v) TFA in 50% (v/v) acetonitrile for elution in the fourth row. A C18 ZipTip (Millipore) was then
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activated by pipetting up and down the acetonitrile 12 times. The activated tip was then inserted
into the sample below and peptides were collected by pipetting up and down 12 times. The
peptides were washed and desalted by pipetting the TFA in acetonitrile below up and down 12
times. Finally, the peptides were eluted by pipetting the elution buffer below up and down 12
times. This was repeated with a fresh tip for each sample.
The samples were then spun in the Speed-Vac for 150 minutes (-OH setting at 40°C) to evaporate
all the solvent. The samples were then resuspended in 50 μl of ultrapure water, to which was 
added 500 nl of 10% (v/v) methanoic acid. They were finally spun down at 17000g for three
minutes and transferred to labelled glass vials for further processing by the mass spectrometry
department.
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2.2.13 Extraction of RNA
RNA was extracted from whole cell lysate or immunoprecipitated material using Trizol reagent
(Life Technologies) as follows:
1) 1 ml of Trizol added to beads or 100 μl of cell lysate 
2) Vortex and leave at room temperature for five minutes
3) Add 200 μl of trichloromethane 
4) Vortex for 15 seconds and leave at room temperature for two minutes
5) Centrifuge at 12000g for 15 minutes at 4°C
6) Transfer aqueous layer to clean tube and add 500 μl of trichloromethane 
7) Vortex for 15 seconds and then centrifuge at 12000g for 15 minutes at 4°C
8) Transfer aqueous layer to clean tube
9) Add 1 μl of 20 mg/ml glycogen (Invitrogen, ID = 10814-010) and mix by finger tapping 
10) Add 500 μl of propan-2-ol and incubate for 10 minutes at room temperature 
11) Centrifuge at 12000g for 15 minutes at 4°C and then discard supernatant
12) Add 1 ml of 75% (v/v) aqueous ethanol and store for at least eight hours at -20°C
13) Dislodge pellet by inversion
14) Centrifuge at 7500g for five minutes at 4°C
15) Remove most of the supernatant and spin down at 7500g for five minutes at 4°C
16) Remove remaining supernatant with p20 pipette and leave pellet to dry under a hood
17) Re-suspend pellet in 15 μl of nuclease-free water by pipetting 
18) Incubate at 50°C for ten minutes
19) Transfer to a clean tube and store at -80°C until required
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2.2.14 Reverse transcriptase polymerase chain reaction amplification of cDNA
Reverse transcriptase polymerase chain reaction amplification of cDNA and subsequent
visualisation was carried out as follows:
1) 10 pmol each of forward and reverse PABP primers were mixed with with nuclease-free
water and Biomix Red (Bioline, to an end concentration of 1x).
2) To 18 μl of this mixture was added 2 μl of test solution (cDNA from a UNR IP, cDNA from 
an IgG IP, a total cell cDNA positive control or a nuclease-free water negative control).
3) The mixes were then subjected to amplification in a PCR machine with the following
conditions:
1) Heat lid to 105°C
2) 30s at 94°C
3) 30s at 57°C
4) 30s at 72°C
5) Repeat steps 2-4 a further 29 times
6) Hold at 4°C until samples are removed
4) Amplified cDNA samples subjected to electrophoresis on an agarose gel (2% in Tris-
Acetate-EDTA buffer [40 mM Tris, 20 mM ethanoic acid, and 1 mM EDTA at pH=8])
containing ethidium bromide with a DNA ladder. The gel was run at 100 V/60 mA for 90
minutes in the same buffer.
5) The gel was then imaged in a UV box attached to a printer.
The experiment presented in section 3.2.3 was carried out with assistance from Dr Swagat Ray
using cDNA he had generated previously. He had made the cDNA from RNA he obtained from:
a) HeLa cell lysate and,
b) UNR/IgG IPs using the same lysate as in (a).
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2.2.15 Preparation of samples for RNA-sequencing
The RNA obtained in section 2.2.13 was handed over to the Genomics Department within the
School of Life Sciences, University of Warwick. It was then processed according to their standard
operating procedures and passed on to a Wellcome Trust site in Oxford, England for sequencing.
Sequencing was carried out on an Illumina HiSeq4000 on a 75 base pair paired end run according
to their own standard operating procedures. The details of the processing carried out within
Warwick is detailed briefly in section 5.1.1.
2.2.16 Analysis of mass spectrometry results using Scaffold
The proteomics department in the School of Life Sciences of the University of Warwick provided
.sf3 Scaffold files with a semi-quantified summary of the data.
A free Scaffold file viewer offered for download from the Proteome Software website was used
to visualise the data contained in the .sf3 files. Some figures contained in this work were
generated by the viewer software. Decisions pertaining to statistical significance, in experiments
that included repeats, were taken in two parts (hits by t test p value and hits by fold enrichment)
as follows:
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a) Hits based on t test p values
1) Scaffold-generated abundances were exported to Microsoft Excel
2) Two tailed paired t tests were carried out at the level of the individual protein
3) Those proteins with p values below a stated cut off were taken to be significant
b) Hits based on fold enrichment (immunoprecipitations)
1) A ratio was generated of the average values for the UNR and IgG samples by
protein*
2) Those proteins with ratios >10 and <∞ were considered significant 
3) Those with ratios =∞ were considered significant if all UNR abundances were >0 
* UNR = immunoprecipitated samples using an anti-UNR immunoglobulin, IgG = negative control
immunoprecipitated samples using a conspecific nonspecific IgG.
c) Hits based on fold enrichment (knockdowns)
1) A ratio was generated of the average values for the siU and siC samples by protein*
2) Those proteins with ratios >10 and <∞ were considered significant 
3) Those with ratios =∞ were considered significant if all siU abundances were >0 
4) Those proteins with ratios <0.1 and >0 were considered significant
5) Those with ratios =0 were considered significant if all siC abundances were >0
* siU = cell lysates formed from siUNR-treated cells, siC = cell lysates formed from control siRNA-
treated cells
2.2.17 Analysis of mass spectrometry results using Progenesis
The proteomics department provided raw data files generated by their mass spectrometry
machine in .raw format. Due to licencing restrictions, these were loaded into the ‘Progenesis QI
for Proteomics’ software (Nonlinear Dynamics) within the mass spectrometry department.
Following the identification of putative peptide sequences, these were exported to the MASCOT
server (Matrix Science) for assignment to proteins. The MASCOT searches were then reimported
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into Progenesis which then quantified proteins based on the peptides assigned to them by
MASCOT.
As with Scaffold, some figures were exported directly from Progenesis for use in this thesis. The
methodology for detecting significant proteins was also the same (abundances exported to Excel
for analysis by t test, etc.).
2.2.18 Analysis of RNA sequencing data using DESeq2
The RNA sequencing data was pre-processed by Dr Nigel Dyer (University of Warwick, England)
and presented to the author as a Microsoft Excel file of abundances, as described in section
5.1.1. MATLAB was then used to carry out principal component analysis one the samples to
detect outliers and verify that the majority of the variation in the remaining samples was
associated with known sources such as cell type or treatment. This is discussed in section 5.2.
The samples that were not excluded as outliers (or as the siUNR-immunoprecipitation or control
siRNA-immunoprecipitation pairs of outliers – see section 5.3.2) were analysed using the R tool
DESeq2 (Love et al. 2014). DESeq2 was used to generate Benjamini-Hochberg-adjusted p values
for RNAs that had been detected by RNA sequencing. The precise ways in which DESeq2 was
used are described in more detail in the relevant chapter.
2.2.19 Gene Ontology term overrepresentation analysis
Gene Ontology (GO)-term overrepresentation analysis was carried out on significant proteins or
transcripts, detected as in the previous sections, from different comparisons. The
protein/transcript lists and/or the technical data for the analyses are provided at the relevant
sections.
The gene ontology (GO) tool chosen to analyse proteins (Chapter 4) or protein coding RNAs
(Chapter 5) that were pulled down in RIPs, or whole cell proteomes (Chapter 6) was the ‘AmiGO
2 Term Enrichment Service’. This tool records the total number of genes associated with a given
GO term in the reference genome (the background frequency). It predicts how many genes out
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of a sample of a certain size should be associated with a given GO term in a purely random
sample. It then notes the actual number of genes in the sample that do map to the given GO
term (the sample frequency) and calculates the probability of observing at least that number of
genes being observed by chance alone, assuming the sample was indeed randomly selected.
Associated gene names were fed into the tool and, where it failed to recognise certain genes,
those genes were removed. The GO tool contained multiple entries for some inputted gene
names that referred to different genes or proteins. Where that occurred, the alternative GO
tool-suggested gene identifiers or Uniprot protein identifiers were compared against additional
information provided by Scaffold, Progenesis or DESeq2. That allowed for a Uniprot identifier to
be located that referred to a protein encoded by the gene in question. The ambiguous gene
name was then replaced with the Uniprot identifier and the updated list was re-entered into the
GO tool.
The Bonferroni multiple testing correction was used in all tests and these were carried out for
each of the following three classes of GO term:
1) Biological Process
2) Molecular Function
3) Cellular Component
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3 Validation of techniques for investigating UNR expression and localisation
In order to proceed with the high-throughput experiments that form the main body of this work,
it was considered essential to demonstrate initially that the groundwork methods worked with
respect to the available reagents and equipment. For example, failure to demonstrate that UNR
could be immunoprecipitated from cell lysates with the available antibodies would call into
question any mass spectrometry work to identify UNR-interacting proteins from UNR co-
immunoprecipitated samples.
This initial experimental chapter therefore set out to confirm that UNR could be detected by
Western blotting and immunofluorescence microscopy. It furthermore set out to confirm that
UNR could be immunoprecipitated from HeLa whole cell lysate in combination with a known
UNR-interacting protein and mRNA (PABP and PABP, respectively). Finally, the effect of sodium
arsenite treatment on the distribution of UNR in three different cell lines was to be explored.
Re: section 3.2.3, the experiment was carried out with Dr Swagat Ray who made the original
image shown in Fig 3.11 and had prepared the cell lysate used for the immunoprecipitation. Re:
section 3.2.4, the experiment was carried out with Dr Swagat Ray using cDNA that he had
prepared previously.
3.1 UNR and UNRIP can be detected by Western blotting
3.1.1 Western blot analysis can detect recombinant UNR and UNRIP
As the lab possessed some legacy recombinant UNR protein and legacy antibodies, it was
considered useful to show that the antibodies could detect recombinant proteins. The
recombinant proteins were:
1) UNR
2) UNR/UNRIP mixture
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Samples were prepared by boiling 50 ng, 30 ng, 20 ng and 10 ng aliquots of each set in SDS
loading buffer and running these on a 10% polyacrylamide gel prior to transferring the proteins
to nitrocellulose membrane. The membrane was then blocked and probed with antibodies
against UNR (rabbit polyclonal, see section 2.1.1), UNRIP (rabbit polyclonal, see section 2.1.1) or
a combination of the two, as appropriate. Horseradish peroxidase (HRP)-conjugated anti-rabbit
IgG secondary antibodies were then applied and the membrane was ultimately developed using
an enhanced chemiluminescence-based approach.
This showed that the antibody was able to detect UNR but that the pure recombinant UNR
protein had become degraded over time (Figure 3.1).
Figure 3.1: Result of a Western blot probing for recombinant UNR protein boiled in loading
buffer. 10 ng, 20 ng, 30 ng or 50 ng (as stated) of the protein was loaded per lane of a 10%
polyacrylamide gel prior to being transferred onto nitrocellulose membrane which was blocked,
probed with a polyclonal anti-UNR immunoglobulin raised in rabbit, followed by a HRP-
conjugated anti-rabbit IgG secondary antibody and then developed using an enhanced
chemiluminescence-based approach. The numbers on the left hand side of the image are
approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained
Protein Ladder (ThermoFisher).
The recombinant UNRIP protein showed little degradation as part of the UNR/UNRIP mixture
(Figure 3.2). Interestingly, whilst the recombinant UNR in the UNR/UNRIP mixture was
degraded, it appeared to be much less so than the pure sample (Figure 3.2).
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Figure 3.2: Result of a Western blot probing for UNR and UNRIP. A mixture of recombinant UNR
and recombinant UNRIP proteins were boiled in loading buffer and the following amounts were
added to wells of a 10% polyacrylamide gel: left to right 50 ng, 30 ng (these two lanes ran into
each other), 20 ng and 10 ng (as stated). The mixtures were then separated by SDS-PAGE prior
to being transferred onto a nitrocellulose membrane which was blocked, probed with a mixture
of anti-UNR and anti-UNRIP immunoglobulins raised in rabbit (see section 2.1.1) followed by a
HRP-conjugated anti-rabbit IgG secondary antibody and then developed using an enhanced
chemiluminescence-based approach. The numbers on the left hand side of the image are
approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained
Protein Ladder (ThermoFisher).
3.1.2 Western blot analysis can detect endogenous UNR and UNRIP
Having demonstrated that UNR and UNRIP could be detected by Western blotting using
recombinant proteins, it was decided to show that these proteins could also be detected by
Western blotting from HeLa cell lysate.
50 μg of HeLa cell lysate that had been produced and quantified in the lab previously by Dr 
Swagat Ray was boiled in SDS loading buffer and run on a 10% polyacrylamide gel prior to the
proteins being transferred to a nitrocellulose membrane. The membrane was then blocked and
probed with antibodies against UNR and UNRIP (see section 2.1.1). A HRP-conjugated anti-
rabbit IgG secondary antibody was then applied and the membrane was ultimately developed
using an enhanced chemiluminescence-based approach (Figure 3.3).
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Figure 3.3: Result of a Western blot probing for endogenous UNR and UNRIP proteins using HeLa
cell lysate. 50 μg of lysate was boiled in SDS loading buffer and loaded in a lane of a 10% 
polyacrylamide gel prior to being transferred onto nitrocellulose membrane which was blocked,
probed with a mixture of anti-UNR and anti-UNRIP immunoglobulins raised in rabbit (see section
2.1.1) followed by a HRP-conjugated anti-rabbit IgG secondary antibody and then developed
using an enhanced chemiluminescence-based approach. The numbers on the left hand side of
the image are approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus
Prestained Protein Ladder (ThermoFisher). This is the last figure that was made using the UNRIP
antibody that was gifted to Emma Anderson by Richard Jackson (see section 2.1.1).
3.1.3 UNR levels decrease with increasing cell confluency in HeLa cells
It was stated in the literature that UNR levels vary in a cell cycle dependent manner and that this
observation can result in UNR having cell cycle-dependent functions (Tinton et al. 2005;
Schepens et al. 2007). In order to ascertain the strength of the cell cycle dependent expression
of UNR effect, it was decided to carry out a confluency course experiment looking at the amount
of UNR in lysates obtained from HeLa cells grown to different confluencies. It was assumed that
plates with a lower confluency of cells would be expected to have a larger proportion of cells
undergoing mitosis. This, in turn, could be expected to lead to a larger relative yield of UNR than
harvesting the same number of cells from confluent plates where very few, if any, cells would
be expected to be undergoing mitosis.
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It had been decided not to synchronise cells prior to harvesting in order to obtain a general
overview of UNR function that was, as much as possible, independent of cell cycle specific
functions. That was with a view to carrying out later mass spectrometry and RIP-sequencing
experiments with samples obtained from UNR immunoprecipitation. In order to confirm
whether or not any apparent change in the level of UNR was due to unequal loading, a
photograph was taken of the Ponceau S-stained membrane prior to developing the UNR images
and the membrane was later stripped and re-probed for γ-tubulin. 
Figure 3.4: Western blot detection of UNR (A) or γ-tubulin (B) and Ponceau S staining of the 
original membrane (C), by confluency at the point of harvesting HeLa cells, as stated. 200 μg of 
total protein was loaded per lane. The membrane was originally probed for UNR, then stripped
and re-probed for γ-tubulin.  The numbers on the left hand side of the image are approximate 
molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained Protein Ladder
(ThermoFisher).
It seemed clear that the γ-tubulin blot was not a fair loading control as, if it were, it would have 
to be assumed that there was no protein in the first lane even though there was a strong UNR
band and Ponceau S staining in that lane, and that there was γ-tubulin in the gel marker (Figure 
3.4). Comparing the γ-tubulin image with the Ponceau S staining showed clear differences. The 
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Ponceau S staining showed that there was a similar amount of protein in all the HeLa lanes, as
would be expected if protein quantification had been carried out correctly. A quick search of the
literature suggested that proteins encoded by housekeeping genes can fluctuate in
concentration with fluctuations in cell confluency (Greer et al. 2010). For this reason, it was
decided to use Ponceau S staining as a loading control for many subsequent Western blots,
especially those in which there could be differences in confluency between the samples
(Romero-Calvo et al. 2010).
In terms of the relative amounts of UNR in cells at different confluencies, it appeared that there
was more UNR in HeLa cells that were at lower confluency (Figure 3.4). This posed an issue for
subsequent experiments in which large amounts of lysate was to be obtained. It could be that
harvesting cells at lower confluency could generate more UNR even though fewer cells would
contain less protein overall. Cell type specific differences in this pattern (compare Figures 3.4
and 3.15) and concerns over the risk of not getting a fair sample of all potential UNR-containing
complexes, led to the decision to harvest cells when they were around 70% confluent. It was
hoped that that would give a better spread of mitotic and non-mitotic cells and, hopefully, a
more representative sample of UNR-containing complexes.
Another observation was that UNR levels appeared to increase in HeLa cells that were allowed
to become over-confluent (data not shown). It was decided not to include images of this as the
conditions were non-physiological and potentially difficult to replicate (i.e. localised cell density
would change the amount of oxygen and nutrients available to cells attached to the surface of
the plate meaning that lysate made from 110% confluent cells with one large clump could have
a different composition to lysate made from 110% confluent cells with the extra 10% spread out
more sparsely over the monolayer of cells attached to the plate).
3.1.4 Cold shock may reduce UNR levels in confluent HeLa cells
It was stated in section 1.3.1 that cold shock domains are associated with response to cold shock
in bacteria but that there was no evidence for UNR being involved in response to cold shock in
mammalian cells. It was decided to test the assumption that UNR is not involved in the cold
shock response in human cells by exploring whether or not cold shock had an effect on the UNR
protein level in confluent HeLa cells. To do this, four plates of HeLa cells were grown to near
confluence in a 37°C humidified incubator with 5% carbon dioxide. Half were then fed with fresh
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medium that had been heated to 33°C and were transferred to a 33°C humidified incubator with
5% carbon dioxide. The other two were fed with medium at 37°C and returned to the 37°C
incubator. They had been allowed to reach near confluence as previous experience had shown
that HeLa cells take a few days before becoming over-confluent. As the cells were expected to
slow their growth at 33°C, this was meant to ensure that the cells would be at similar confluency
at the end of the experiment and that there wouldn’t be a major change in the percentage of
cells that were in G0. One plate from each incubator was harvested at 4 hours and the others at
9 hours (Figure 3.5).
Figure 3.5: Western blot showing UNR. Four plates of almost confluent HeLas cells were grown
at 37°C before being separated at time=0 and fed with fresh DMEM (containing 10% FCS) that
had been heated to either 33°C or 37°C. The two plates fed with medium at 37°C were returned
to the incubator set at 37°C and the other two were moved to a separate incubator at 33°C.
Other conditions were kept the same. Cells from one plate from each set were harvested at the
specified times, the lysates were purified and quantified and 50 μg total protein per lane was 
run on a 10% polyacrylamide gel. The upper panel shows the result of the Western blot; the
lower panel shows a photograph of Ponceau S staining of the membrane over the same region
as shown in the upper panel. The numbers on the left hand side of the image are approximate
molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained Protein Ladder
(ThermoFisher). This is the last figure that was made using the UNR antibody that was gifted to
Emma Anderson by Richard Jackson (see section 2.1.1).
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In order to calculate the relative changes in the amount of UNR between the different
conditions, Image J was used to measure the intensity of the UNR bands. Comparing the cold
shock samples to the corresponding control samples, there was around 38.5% less UNR in the
cold shock sample at 4 hours and around 24.1% less at 9 hours. This implies that cold shock may
reduce UNR levels in confluent HeLa cells.
This experiment was repeated with cells split and grown at 33°C but they grew at a much slower
rate and it was not considered fair to compare them with cells that were grown at 37°C for a
different number of days or, alternatively, were harvested several days sooner or at a different
confluency (data not shown).
3.1.5 Arsenite stress causes UNR but not TP53 to become localised in punctate
structures within 30 minutes
Results in the literature and from the lab suggested that UNR is found in stress granules following
arsenite stress (White & Lloyd 2011; Ray, Ó Catnaigh & Anderson [in preparation]). As will be
mentioned later, results in the lab also linked UNR to TP53 (see below). It was therefore decided
to carry out an immunofluorescence microscopy-based investigation into the distribution of
UNR and TP53 in HeLa cells that were either unstressed or stressed with 500 μM sodium arsenite 
for 30 minutes. To do this, HeLa cells were grown on cover slips before treated with 0.5 mM
sodium arsenite in fresh DMEM (containing 10% FCS) or mock treated with a similar volume of
sterile PBS in fresh DMEM (containing 10% FCS) for 30 minutes. After this time, the cells were
fixed, permeabilised, blocked, treated with primary and then secondary antibodies before being
mounted with DAPI (Figure 3.7). Subsequent immunofluorescence imaging was carried out with
or without DAPI as shown in each figure. Prior to carrying out analysis looking for UNR and other
specific proteins, it was considered useful to carry out a control experiment using stressed and
unstressed HeLa cells, treated as above but without primary antibodies. This was intended to
give an idea of the background staining expected of our fluorophore-conjugated secondary
antibodies (Figure 3.6).
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Figure 3.6: Confocal immunofluorescence microscopy images of non-arsenite treated HeLa cells
(upper panel) or arsenite-stressed HeLa cells (lower panel) that were fixed and stained
immediately after having been treated with 0.5 mM sodium arsenite in fresh DMEM (containing
10% FCS) or mock treated with sterile PBS in fresh DMEM (containing 10% FCS) for 30 minutes.
The images show background staining from the fluorophore-conjugated secondary antibodies,
as coloured, in the absence of primary antibodies. The scale bars are all 25 µm.
A
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Figure 3.7: Confocal immunofluorescence microscopy images of non-arsenite treated HeLa cells
(A) or arsenite-stressed HeLa cells (B) that were fixed and stained immediately after having been
treated with 0.5 mM sodium arsenite in fresh DMEM (containing 10% FCS) or mock treated with
sterile PBS in fresh DMEM (containing 10% FCS) for 30 minutes. The images show staining for
UNR (red), TP53 (green), the DNA-binding dye DAPI (blue) or a combination of these (as stated).
The white arrows in Figure 3.7B show UNR concentrated in a punctate structure. The scale bars
are all 25 µm.
There was little observed background staining caused by the secondary antibodies alone (Figure
3.6).
It was observed that UNR had a predominantly cytoplasmic distribution in both unstressed
(Figure 3.7A) and arsenite stressed (Figure 3.7B) HeLa cells. It was also noted that UNR was
present in a number of punctate structures in arsenite stressed but not unstressed cells. An
example of one of these structures is highlighted with arrows in Figure 3.7B. The structures could
have been stress granules but it was not possible to state that with confidence. It was noted that
TP53 did not appear to colocalize with UNR under either condition.
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3.1.6 TP53 may colocalize with UNR in stress granules following arsenite stress for
1 or 2 hours
Seeing that UNR, but not TP53, migrated to stress granule-like structures following 30 minutes
of arsenite stress, it was decided to widen the investigation to include the stress granule marker
TIA1 to ascertain whether or not UNR and TIA1 colocalised within the same structures. It was
also decided to look at longer time points (one and two hours) in order to see whether or not
TP53 might colocalize with UNR over a longer time frame. HeLa cells were used as before and
the time points are taken from the point of the administration of 1 mM sodium arsenite (zero
minutes = arsenite was not added) (Figure 3.8). Previous results in the lab had suggested that
the higher concentration of arsenite generated clearer images without having an additional
detrimental effect on cell viability.
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Figure 3.8: Confocal immunofluorescence microscopy images of non-arsenite treated HeLa cells
(upper panel) or HeLa cells that were arsenite-stressed for 1 hour or 2 hours (as stated) and that
were fixed and stained immediately after having been treated with 1 mM sodium arsenite in
fresh DMEM (containing 10% FCS) or mock treated with sterile PBS in fresh DMEM (containing
10% FCS). The images show staining for UNR (red), TP53 (green), the stress granule marker TIA1
(blue) or a combination of all three (as stated). The white arrows at 1 and 2 hours show
colocalisation of all three proteins into stress granules. The lower images are zoomed-in versions
of a collection of cells from the 120 minute panels with 10 μm scale bars. All other scale bars are 
25 μm.  
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UNR was shown to become locally concentrated in punctate structures by 60 minutes post-
application of 1 mM sodium arsenite (Figure 3.8). The co-localisation of TIA1 and UNR in these
punctate structures corroborates the hypothesis that the structures are stress granules (Figure
3.8). Furthermore, TP53 also appeared to co-localise with UNR and TIA1 in the structures after
60 minutes, with particularly clear co-localisation being apparent at 120 minutes (Figure 3.8). It
was shown in the lab that UNR and TP53 can co-localise following stress with sodium arsenite in
U2OS cells by IP-Western when pulling down with an antibody against TP53 (Ray, Ó Catnaigh
and Anderson, manuscript in preparation). Confusingly, this interaction was never seen in the
other direction (i.e. pulling down with an antibody against UNR and looking for TP53 by Western
or in mass spectrometry data). These IF images corroborate the finding that UNR interacts with
TP53 in stressed U2OS cells and this interaction will be the subject of ongoing investigation in
the Anderson lab.
3.2 UNR can be immunoprecipitated and then detected by Western blotting
3.2.1 Immunoprecipitation of recombinant UNR
It was then decided to show that it was possible to immunoprecipitate UNR from IP buffer
containing pure, though degraded, recombinant UNR protein.
To do this, 25 μl of Protein A-conjugated magnetic bead slurry was washed and placed in a 
blocking solution (5% BSA (w/v) in 400 μl of NT2) in a 1.5 ml tube. This was spun at 18rpm for 
one hour in a refrigerated room. Following this, 5 μg of an anti-UNR immunoglobulin raised in 
rabbit (see section 2.1.1), or a conspecific IgG was added and the solution was spun at 18rpm
for four hours in a refrigerated room prior to washing. Finally, 10 ng of recombinant protein was
dissolved in 100 μl of NT2 buffer. This was then added to a solution containing 857 μl of NT2, 40 
μl of 0.5 M EDTA (at pH=8), 2 μl of VRC and 1 μl of 1 M DTT and the entire solution was added 
to the magnetic beads. The IP was then carried out overnight with spinning at 18rpm in a
refrigerated room. The next day, the beads were washed and boiled in SDS loading buffer to
dissociate the immunoprecipitated material. This was run on a 10% polyacrylamide gel prior to
transferring the proteins to nitrocellulose membrane. The membrane was then blocked and
probed with antibodies against UNR that were raised in goat. A HRP-conjugated anti-goat IgG
secondary antibody was then applied and the membrane was ultimately developed using an
enhanced chemiluminescence-based approach (Figure 3.9).
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Figure 3.9: Result of an IP-Western probing for UNR in which an anti-UNR immunoglobulin
raised in rabbit or a conspecific control IgG, as stated, was used to immunoprecipitate
recombinant UNR protein from an IP buffer solution. The immunoprecipitated proteins were
boiled in loading buffer and run on a 10% polyacrylamide gel prior to being transferred onto
nitrocellulose membrane which was blocked, probed with an anti-UNR immunoglobulin raised
in goat followed by a HRP-conjugated anti-goat IgG secondary antibody, and then developed
using an enhanced chemiluminescence-based approach. The numbers on the left hand side of
the image are approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus
Prestained Protein Ladder (ThermoFisher).
Although the legacy antibody (see section 2.1.1) was able to detect multiple degradation
products in the pure recombinant UNR Western (Figure 3.1), none were detected in the IP
(Figure 3.9). This suggested that the immunoprecipitating antibody did not immunoprecipitate
these or that the anti-UNR immunoglobulin raised in goat (see section 2.1.1) could not detect
them by Western blot. Either suggestion would be surprising as the antibodies were both
polyclonal. It had been decided not to run an input lane as the presence of UNR in the sample
was known. In hindsight, it would have been interesting to prove that full length UNR was
exclusively immunoprecipitated in the presence of multiple degradation products by including
an input lane.
3.2.2 Immunoprecipitation of UNR from HeLa cell lysate
Carrying out an UNR IP-Western and probing for UNR with a different antibody showed that
UNR could be pulled down from HeLa cell lysate (Figure 3.10).
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Figure 3.10: Result of an IP-Western probing for UNR in which an anti-UNR immunoglobulin
raised in rabbit or a conspecific control IgG, as stated, was used to immunoprecipitate proteins
from HeLa cell lysate. An input lane containing 5% of the total amount of lysate used in the
experiment was loaded (labelled lysate). The immunoprecipitated proteins were boiled in
loading buffer and run on a 10% polyacrylamide gel prior to being transferred onto nitrocellulose
membrane which was blocked, probed with an anti-UNR immunoglobulin raised in goat
followed by a HRP-conjugagted anti-goat IgG secondary antibody and then developed using an
enhanced chemiluminescence-based approach. The numbers on the left hand side of the image
are approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained
Protein Ladder (ThermoFisher).
3.2.3 Co-immunoprecipitation of PABP with UNR
It has been recorded in the literature that UNR interacts with the PABP protein and additional
interactions could be assumed from the pulldown of intact ribonucleoprotein complexes (RNPs).
It was decided to show whether or not this protein could be detected by Western blot analysis
from proteins immunoprecipitated with UNR (Figure 3.11).
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Figure 3.11: Result of an IP-Western probing for PABP in which an anti-UNR immunoglobulin
raised in goat or a conspecific control IgG, as stated, was used to immunoprecipitate proteins
from HeLa cell lysate. The immunoprecipitated proteins were boiled in loading buffer and run
on a 10% polyacrylamide gel prior to being transferred onto nitrocellulose membrane which was
blocked, probed with an anti-PABP immunoglobulin raised in rabbit followed by a HRP-
conjugated anti-rabbit IgG secondary antibody and then developed using an enhanced
chemiluminescence-based approach. This is the only IP recorded in this thesis that was carried
out using the anti-UNR immunoglobulin raised in goat (Santa Cruz [sc-79292]; see section 2.1.1).
It was shown that UNR interacts with PABP (Figure 3.11). It was clear that the UNR pulldown
sample included a protein at the size of PABP whereas the IgG pulldown had a much weaker
band at that size.
3.2.4 Co-immunoprecipitation of the P ABP transcript with UNR
It has also been stated in the literature that UNR interacts with the PABP transcript. It was also
decided to show that this finding could be reproduced in the lab. This experiment was carried
out with assistance from Dr Swagat Ray using cDNA he had generated previously from RNA he
obtained from HeLa cell lysate and UNR/IgG IPs using the same lysate.
Briefly, 10pmol each of forward and reverse PABP primers were mixed with with nuclease-free
water and Biomix Red (Bioline, to an end concentration of 1x). To 18 μl of this mixture was added 
2 μl of test solution. The test solutions were cDNA from a UNR IP, cDNA from an IgG IP, a total 
cell cDNA positive control and a nuclease-free water negative control. The mixes were then
subjected to amplification in a PCR machine with the following conditions:
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1) Heat lid to 105°C
2) 30s at 94°C
3) 30s at 57°C
4) 30s at 72°C
5) Repeat steps 2-4 a further 29 times
6) Hold at 4°C until samples are removed
The cDNA samples subjected to electrophoresis on a 2% agarose gel containing ethidium
bromide with a DNA ladder (the gel was run at 100 V / 60 mA for 90 minutes). The gel was then
imaged in a UV box (Figure 3.12).
Figure 3.12: Polymerase chain reaction amplification of cDNA generated from the PABP
transcript in HeLa cells. The lanes show cDNA amplified from PABP transcripts present in:
complexes immunoprecipitated using an anti-UNR immunoglobulin (UNR), complexes
immunoprecipitated using a control IgG (IgG), total cell RNA (total) and nuclease-free water
(water). In each case, RNA was converted to cDNA prior to the PCR reaction being performed.
It seemed clear that UNR interacts with the PABP transcript as the band formed using the RNA
from the UNR IP was more intense than that formed using the RNA from the IgG pulldown
(Figure 3.12).
3.3 UNR distribution in the osteosarcoma cell lines U2OS and SaOS-2
3.3.1 UNR distribution in arsenite-stressed and unstressed U2OS and SaOS-2 cells
by immunofluorescence microscopy
The confirmation in HeLa was considered strong enough evidence to proceed with initial IP-mass
spectrometry experiments, initially with HeLa cells and subsequently with U2OS and SaOS-2
cells. As other cell types were to be used, it was decided to first check by immunofluorescence
microscopy that the distribution of UNR was the same in U2OS (Figure 3.13) and SaOS-2 (Figure
3.14).
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Figure 3.13: Confocal immunofluorescence microscopy images of non-arsenite treated U2OS
cells (upper panel) or arsenite-stressed U2OS cells (lower panel) that were fixed and stained
immediately after having been treated with 1 mM sodium arsenite in fresh DMEM (containing
10% [v/v] FCS) (lower panel) or mock treated with sterile PBS in fresh DMEM (containing 10%
FCS [v/v]) (upper panel) for 1 hour. The images show staining for UNR (red), the DNA-binding
dye DAPI (blue) or a combination of these (as stated). The scale bars are all 25 µm.
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Figure 3.14: Confocal immunofluorescence microscopy images of non-arsenite treated SaOS-2
cells (upper panel) or arsenite-stressed SaOS-2 cells (lower panel) that were fixed and stained
immediately after having been treated with 1 mM sodium arsenite in fresh DMEM (containing
10% [v/v] FCS) (lower panel) or mock treated with sterile PBS in fresh DMEM (containing 10%
[v/v] FCS) (upper panel) for 1 hour. The images show staining for UNR (red), the DNA-binding
dye DAPI (blue) or a combination of these (as stated). The white arrows in the lower panel show
UNR concentrated in a punctate structure. The scale bars are all 25 µm.
This showed that UNR is predominantly cytoplasmic in U2OS and SaOS-2 cells. It also showed
that the addition of sodium arsenite made both types of osteosarcoma cells to become less
uniform (Figures 3.13, 3.14) in distribution and to become concentrated in areas of cell-cell
contact, at least in SaOS-2 cells (Figure 3.14). This work was developed further in the lab and it
was shown that arsenite stress causes UNR to localise to large stress granules in HeLa and
SaOS-2 cells but that this was almost completely absent in U2OS cells. Smaller TIA1- but not
UNR-containing structures were observed in arsenite-stressed U2OS cells. Interestingly, it was
shown that UNR did become localised to large stress granules following arsenite stress in U2OS
cells that had TP53 knocked down with siRNA (Ray, Ó Catnaigh and Anderson, manuscript in
preparation). This led to the assumption that wild type TP53 is able to prevent the formation
large UNR-containing stress granules.
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3.3.2 UNR levels increase with increasing cell confluency in U2OS cells
Finally, it was decided to see if the cellular concentration of UNR exhibited the same inverse
relationship with confluency that was observed in HeLa cells (Figure 3.4). It was decided to carry
out a confluency course experiment using the wild type TP53-containing U2OS line. This allowed
for both UNR and TP53 levels to be assessed to explore whether there could be a positive or
negative correlation between levels of the two proteins. It was also decided to carry out the
experiment using both unstressed and arsenite-stressed cells (Figure 3.15).
Figure 3.15: Western blot detection of UNR or TP53 (as stated) and Ponceau S staining of the
pertinent regions of the membrane, by confluency at the point of harvesting U2OS cells, as
stated. The cells were either treated with 1 mM of sodium arsenite (“+”), or a similar volume of
sterile PBS (“-“), in fresh DMEM (containing 10% FCS) for 1 hour immediately prior to harvesting.
50 μg of total protein was loaded per lane. The numbers on the left hand side of the image are 
approximate molecular masses (in kilodaltons) as estimated using PageRuler Plus Prestained
Protein Ladder (ThermoFisher).
This showed the opposite relationship between UNR levels and cell confluency in unstressed
U2OS to that observed in HeLa cells (Figures 3.4, 3.15). It also showed positive correlation
between the levels of UNR and TP53 and that levels of both proteins were reduced at all
confluencies following arsenite stress (with the exception of 25% confluency where little or no
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UNR or TP53 was observed in either the plus or minus arsenite samples) (Figure 3.15). The
reason for the difference in the confluency-UNR level relationships in HeLa and U2OS is currently
unknown. The confluency-UNR level pattern in HeLa cells had been observed on multiple
occasions (data not shown) and it was considered possible that the TP53 status of the cells could
affect the relationship. It would be interesting to explore this possibility further. Likewise, it
would be interesting to explore how the expression of wild type TP53 in U2OS cells is able to
prevent the formation of large stress granules following arsenite stress. It was confusing that
knocking down TP53 allowed the formation of large stress granules following arsenite stress in
U2OS cells (Ray, Ó Catnaigh and Anderson, manuscript in preparation). This was because
arsenite stress itself was shown to reduce the cellular level of TP53 (Figure 3.15) without the
formation of large stress granules (Ray, Ó Catnaigh and Anderson, manuscript in preparation,
Figure 3.13).
Having seen that UNR is expressed in all three cell types to be used and demonstrated that it is
possible to pull it down with antibodies available to the group, it was decided to proceed to carry
out large-scale experiments to discover novel UNR-interacting proteins and RNAs.
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4 Identification of UNR-interacting proteins
As explored in Chapter 1, much remains to be elucidated with respect to the function of UNR in
mammalian cells. In order to build upon the current knowledge of UNR function, it was decided
to search for novel UNR-interacting proteins by carrying out ribonucleoprotein
immunoprecipitations with an antibody against UNR, or a conspecific control IgG, followed by
subjecting the immunoprecipitated samples to analysis by mass spectrometry.
Dr Swagat Ray kindly assisted with the ribonucleoprotein immunoprecipitations using the HeLa
(see section 4.3) and U2OS (see section 4.5) lysates. In particular, he carried out the post-IP
Dynabead washes for these cell types prior to the samples being split for mass spectrometry or
RIP-Seq (see section 2.2.9).
4.1 RIP-mass spec
4.1.1 Introduction to RIP
In order to explore the cellular functions of UNR, it was first necessary to build upon the known
repertoire of UNR-interacting proteins and RNAs that are recorded in the literature. Given that
it had previously been shown that the presence or absence of UNR appeared to lead to
differences in the transcriptome (Dormoy-Raclet, 2005; Elatmani et al., 2011) and that UNR has
been recorded in the literature as binding to a variety of proteins and transcripts (reviewed in
Ray et al. 2015), it was decided to take a methodical look at the proteins and RNA species to
which it can bind. In order to obtain UNR in natural ribonucleoprotein (RNP) complexes, as well
as UNR in specific complexes with proteins or RNAs alone, a series of ribonucleoprotein
immunoprecipitations (RIP) were undertaken (Keene et al., 2006). RIPs have an advantage over
standard immunoprecipitations in that they can allow for the same samples to be used for both
protein and RNA analysis.
Briefly, cells of the given cell type were grown in multiple 15 cm plates (i.e. circular plates with
a diameter of 15 cm and a surface area of 56.25π cm2). One hour prior to harvesting, half the
plates were treated with sodium arsenite at an end concentration of 1 mM in fresh DMEM
containing 10% FBS. The other half were fed with fresh DMEM containing 10% FBS with the same
volume of sterile PBS as sodium arsenite as a mock treatment. This was repeated on two further
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occasions for each cell type, so as to generate three biological repeats. After harvesting, each
lysate was assayed for protein concentration, separated into two and RIPs were carried out using
an antibody against UNR or a nonspecific control IgG raised in the same animal (Figure 4.1). The
samples were then separated into two, with 80% being processed to extract RNA for RNA
sequencing. The remaining 20% was processed to prepare proteins for mass spectrometry.
Initial trial runs were carried out using unstressed HeLa cells. In these cases, less material was
used and none was set aside for RNA purification (see below).
Figure 4.1: Schematic flow chart of main steps involved in the preparation of samples for mass
spectrometry. α-Unr refers to using an antibody against UNR for the RIP whereas IgG refers to 
the use of a conspecific nonspecific control antibody. Further details on the individual steps can
be found in the text.
4.1.2 Introduction to RIP-mass spectrometry
In order to discover a selection of direct and indirect UNR-interacting proteins, it was decided
to subject the proteinaceous portion of the pulldown sample to analysis by mass spectrometry
(Aebersold & Mann, 2003).
Briefly, Protein A-bound magnetic beads were used to bind to the immunoprecipitating
immunoglobulins that were, in turn, used either to pull down the protein of interest or act as a
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negative control. The samples were then washed and processed, prior to being treated with
modified pig trypsin that cleaves proteins at predictable sites. This generated mixes of peptides
that were separated by nano-liquid chromatography before being ionised (electrospray
ionisation) over time and analysed by an Ultimate 3000/Orbitrap Fusion mass spectrometer
(Thermo Scientific). This takes a series of ionised peptides over a given time interval and
generates an MS1 spectrum, internal software then selects some individual peptides for
fragmentation and further analysis, yielding MS/MS spectra (Aebersold & Mann, 2003). By the
end of the run, the amassed data can be used to reconstruct the likely components of the
original mixture based on algorithms that piece together the predicted peptides into the most
likely combination of proteins that could have generated the mixture.
4.2 Choice of mass spectrometry sample preparation method
4.2.1 IP-mass spec basics
Immunoprecipitations, be they RIPs or standard IPs, are used to pull down a bait protein bound
to a mixture of other proteins (Figure 4.2).
Figure 4.2: Schematic diagram of a UNR immunoprecipitation. ‘Protein A’ is bound to suitable
beads and then used to bind to an anti-UNR IgG. The antibody then pulls down its bait protein
and an array of associated molecules. Non-specific interactors will also be pulled down and some
will remain after washing. N.B. the term ‘non-specific interactor’ is used to refer to molecules
not binding specifically to the bait protein or other molecules in complex with it; these
interactions may actually be quite strong.
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4.2.2 On-bead sample preparation compared with SDS-PAGE gel slice method
Initial experiments were carried out to compare two different methods of sample preparation
for subsequent mass spectrometry experiments. The two methods considered were termed the
‘gel slice’ method and the ‘on-bead’ method, with the latter also being termed ‘in solution’.
Unstressed HeLa cells were used for the trial experiments.
4.2.3 Additional steps are required for the gel slice method over the on-bead
method
Whereas the IP samples are processed immediately for the on-bead tryptic digest method, for
the gel slice method the samples must first be stripped from the beads, separated by mass in an
SDS-PAGE gel using electrophoresis and the gel must then be cut before the individual gel pieces
can be prepared for mass spectrometry (Figure 4.3).
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Figure 4.3: Extra processing steps are required for the gel slice method over the on-bead
method. This diagram is purely schematic and neither to scale nor representative of the actual
laboratory equipment used to carry out each step. Also see key from Figure 4.2.
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4.2.4 Advantages and disadvantages of the on-bead and gel slice methods
Of the two methods, the on-bead method had advantages in terms of being more quantitative,
requiring less processing time and being less technically challenging. All proteins can be
submitted without losses due to small proteins running off gels. Another reason for the gel slice
method being less quantitative is due to almost unavoidable small differences in where gels are
cut between samples. This can alter the distribution of proteins between slices which, in turn,
can alter their probability of being detected as their peptides will be competing with peptides
from a different set of proteins.
On the positive side for the gel slice method, having a rough idea of the where a gel has been
cut can offer an additional layer of confidence that a hit is genuine by cross referencing its
predicted size to the gel slices in which it was detected (Figure 4.4).
Figure 4.4: Schematic diagram of a gel that has been cut relative to hypothetical coloured marker
bands. The faint grey lines refer to the cut points of the gel, such that the slices numbered to
the right of the figure are generated. The blue lines signify a selection of hypothetical proteins
separated by size by passing an electrical current through the gel.
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Using the example above, should a putative protein be 50 kDa in mass and it was found to have
no peptides in slices 1-4 but lots in slices 5 and 6 and fewer in 7 and 8, the data would be in
keeping with a hypothesis that the gel was sliced through the protein and that some degradation
products were found further down the gel. If a protein that was predicted to be 175 kDa were
to have the same distribution, that may imply that the hit was a false positive. Such information
would not be available should the on-bead method be used.
4.2.5 Results for trial run using the on-bead method
For the on-bead method, HeLa samples were prepared as stated previously. An initial injection
of 2 μl per sample was run for 30 minutes, followed by a run of 5 μl for three hours. A final run 
of 20 μl for three hours was then carried out and the data were merged in Scaffold after Mascot 
searches were carried out, as per [supplementary data]. The RIPs were carried out using proteins
that were estimated to fall within the suggested range of 2-5 mg total protein per IP (Keene et
al., 2006). As the samples were ultimately resuspended in 50 μl, this implied that 2 μl 
corresponded to 40-100 μg of starting material, 5 μl corresponded to 100-250 μg of starting 
material and 20 μl corresponded to 400-1000 μg of starting material. 
Within Scaffold, the data from the three runs were merged for each of the two conditions (IgG
and UNR) and protein quantification was set to total spectra. Fisher’s Exact test was used
protein-wise and the level of significance was set to p=0.05, modified for multiple testing using
the Hochberg-Benjamini correction. The correction lowered the cut off level of significance to
p=0.01623.
With the minimum number of peptides required to identify a protein set at two, the peptide
threshold set at 95% and the protein threshold at 99%, 228 proteins were detected. In terms of
presence/absence, 34 proteins were detected in the IgG samples only, 64 in the UNR samples
only and 130 proteins in both samples. Using Scaffold’s inbuilt Quantitative Profile function, 41
proteins were detected as significantly higher in the IgG samples, 32 proteins as higher in the
UNR samples and 155 proteins as not significantly higher in either sample (Figure 4.5). It was
noted that a proportion of the proteins identified were either keratins or non-human.
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Figure 4.5: Venn diagrams summarising the results of the on-bead HeLa sample preparation test
run. The numbers depict the number of proteins detected by Scaffold under the given
thresholds, either in presence/absence (A) or by quantitative profile (B). The yellow shading
depicts the number of proteins present in both samples (A) or not significantly over represented
in either sample (B). Significance in this respect is assessed on whether or not the Fisher’s exact
test p-value for the protein is less than the adjusted p-value stated in the text (p<0.01623). The
unshaded portions contain the number of proteins only present in the stated condition (A), or
significantly overrepresented in the stated condition (B). The threshold for peptide identity was
95%, the threshold for protein identity was 99% with a minimum of two different peptides.
The volcano plot function in Scaffold graphically presents the log2 fold change between two
conditions on the x-axis against the negative log10 of the p-value of a statistical test, in this case
the Fisher exact test (Figure 4.6).
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Figure 4.6: Scaffold volcano plot of the on-bead HeLa sample preparation test run. The log2 of
the fold change between IgG and UNR is shown on the x-axis with a dark line at zero fold change.
The y-axis plots the negative log10 of the Fisher exact test p-value for a given protein. The red
line signifies the selected, though unadjusted, cut-off point for statistical significance (p=0.05).
Orange dots beneath the red line have unadjusted p-values over 0.05. The green dots above the
line have p-values at or below 0.05. The yellow circles highlighting certain green dots indicate
proteins that pass the multiple testing correction for being over-represented in the UNR
pulldown samples. Figure reproduced from Scaffold.
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Several of the top hits were keratins and there were more hits for IgG than UNR. Positively, UNR
and UNRIP were both present and considered significant (Figures 4.7A and 4.7B). There were
also several proteins associated with RNA metabolism as well as a number of unexpected hits,
including Lim domain binding protein 1 (LDB1) and single stranded DNA binding protein 3
(SSBP3) (Figures 4.7C and 4.7D).
Figure 4.7: Number of spectra for specified proteins from normalised total spectra for IgG and
UNR using the on-bead trial run data, as stated: UNR (A), UNRIP (B), LCB1 (C), SSBP3 (D). The
scale for A and B is 0 – 25 spectral counts and the scale for C and D is 0 – 45 spectral counts. The
counts were: UNR=22, UNRIP=18, LDB1=41, SSBP3=25.
4.2.6 Results for trial run using the gel slice method
For the gel slice method, HeLa samples were prepared as stated previously. RIP samples were
boiled in loading buffer and separated by gel electrophoresis. The UNR and IgG sample lanes
were then cut into 7 pieces arranged by size (first slice containing the largest proteins) and
processed for further mass spectrometric analysis. 20 μl per sample was then run for 60 minutes. 
The same amount of total protein was used for the RIPs as for the on-bead method (2-5 mg per
RIP). The samples were boiled in approximately 30 μl of loading buffer. Therefore, excluding 
sample concentration, due to buffer evaporation, approximately 1.3-3.3 mg of starting material
were used to generate the samples loaded on each lane on the gel.
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The data from the seven slices was then recombined into a single file and analysed by Fisher’s
exact test as above. The Hochberg-Benjamini correction lowered the cut off level of significance
to p=0.01353.
With the minimum number of peptides required to identify a protein set at two, the peptide
threshold set at 95% and the protein threshold at 99%, 510 proteins were detected. In terms of
presence/absence, 292 proteins were detected in the IgG samples only, 67 in the UNR samples
only and 151 proteins in both samples. Using Scaffold’s inbuilt Quantitative Profile function, 87
proteins were detected as significantly higher in the IgG samples, 50 proteins were significantly
higher in the UNR samples and 373 proteins were not significantly higher in either sample (Figure
4.8). It was noted that a proportion of the proteins identified were either keratins or non-human.
Figure 4.8: Venn diagrams summarising the results of the gel slice HeLa sample preparation test
run. The numbers depict the number of proteins detected by Scaffold under the given
thresholds, either in presence/absence (A) or by quantitative profile (B). The yellow shading
depicts the number of proteins present in both samples (A) or not significantly over represented
in either sample (B). Significance in this respect is assessed on whether or not the Fisher’s exact
test p-value for the protein is less than the adjusted p-value stated in the text (p<0.01353). The
unshaded portions contain the number of proteins only present in the stated condition (A), or
significantly overrepresented in the stated condition (B). The threshold for peptide identity was
95%, the threshold for protein identity was 99% with a minimum of two different peptides.
Figure reproduced from Scaffold.
The volcano plot for the gel slice method, highlighting the proteins that passed the multiple
testing correction, is shown below (Figure 4.9).
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Figure 4.9: Scaffold volcano plot of the gel slice HeLa sample preparation test run. The log2 of
the fold change between IgG and UNR is shown on the x-axis with a dark line at zero fold change.
The y-axis plots the negative log10 of the Fisher exact test p-value for a given protein. The red
line signifies the selected, though unadjusted, cut-off point for statistical significance (p=0.05).
Orange dots beneath the red line have unadjusted p-values over 0.05. The green dots above the
line have p-values at or below 0.05. The yellow circles highlighting certain green dots indicate
proteins that pass the multiple testing correction for being over-represented in the UNR
pulldown samples. Figure reproduced from Scaffold.
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As with the on-bead method, several hits were either keratin or non-human. It was noted that
there was some cross-over between the two sets of hits. For example, the selection of top hits
shown in Figure 4.7 were also top hits by the gel slice method (Figure 4.10).
Figure 4.10: Number of spectra for specified proteins from normalised total spectra for IgG and
UNR using the gel slice trial run data, as stated: UNR (A), UNRIP (B), LCB1 (C), SSBP3 (D). The
scale for A and B is 0 – 25 spectral counts and the scale for C and D is 0 – 45 spectral counts. The
counts were: UNR=21, UNRIP=15, LDB1=20, SSBP3=9. The scales used here are the same as
those used in Figure 4.7.
4.2.7 Comparison of the results from the trial runs
The UNR-enriched quantitative hits flagged up by Scaffold for the different methods (using the
parameters in the text) were considered, together with lists of proteins present in the UNR data
but not in the IgG data for the two methods. The data for the two methods were combined in
the following ways:
1) On-bead quantitative hits with gel slice quantitative hits
2) On-bead presence/absence data with gel slice presence/absence data
3) On-bead quantitative hits with on-bead presence/absence data
4) Gel slice quantitative hits with gel slice presence/absence data
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In each case, duplicated Accession numbers were highlighted. In the case of 3 and 4, one copy
of the duplicated values was removed and then the remaining proteins in each case were
combined in a separate file (5). Duplicates within file 5 were then highlighted. The duplicated
Accession numbers from (1), (2) and (5) were then tabulated and any keratins and non-human
proteins were removed. Finally, only one copy of any duplicated values was retained (Table 4.1).
Table 4.1: Proteins statistically over-represented in UNR data over IgG data and/or only
present in UNR data by both methods. Accession numbers referring to keratins
and non-human proteins were removed, as were extra copies of duplicates
Accession Protein Name
Q86U70 LIM domain-binding protein 1 (GN=LDB1)
O96028 Histone-lysine N-methyltransferase NSD2 (GN=WHSC1)
G5E9Q2 Cold shock domain containing E1, RNA-binding, isoform CRA_d (GN=CSDE1)
Q9BWW4 Single-stranded DNA-binding protein 3 (GN=SSBP3)
Q9UHX1 Poly(U)-binding-splicing factor PUF60 (GN=PUF60)
Q13435 Splicing factor 3B subunit 2 (GN=SF3B2)
A8K963
cDNA FLJ77516, highly similar to Homo sapiens LIM domain only 4 (LMO4),
mRNA
Q5W009 RNA binding motif protein 17, isoform CRA_a (GN=RBM17)
O75376 Nuclear receptor corepressor 1 (GN=NCOR1)
P0DI83 Ras-related protein RAB34, isoform NARR (GN=RAB34)
B7Z475 cDNA FLJ55712, highly similar to F-box-like/WD repeat protein TBL1XR1
B4E2Z3 cDNA FLJ54090, highly similar to 4F2 cell-surface antigen heavy chain
E7EMC7 Sequestosome-1 (GN=SQSTM1)
F5GWP8 Junction plakoglobin (GN=JUP)
A8K9P0 cDNA FLJ78413, highly similar to Homo sapiens albumin, mRNA
P49756 RNA-binding protein 25 (GN=RBM25)
B3KWX7
cDNA FLJ44170 fis, clone THYMU2035319, highly similar to RNA-binding
region-containing protein 2
It was considered reassuring that the bait protein was considered over-represented in both
cases. This gave confidence that the RIPs and mass spec both worked. Both methods also
allowed the mass spectrometry machine to detect a selection of peptides from other proteins
in such quantities that Scaffold was able to flag up a significant over-representation of them in
the UNR samples. The presence of keratins in the data was unwelcome but to be expected.
Likewise, non-human proteins such as bovine serum albumin were used in the RIPs and their
presence was also not unexpected. It was noted that a strange Accession number was assigned
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to UNR (G5E9Q2) and UNRIP had different Accession numbers assigned to it between the two
methods (Q9Y3F4 and B4DNJ6), explaining why it was excluded from Table 4.1. It should
be noted that a Uniprot search for B4DNJ6 redirects to Q9Y3F4. Likewise, G5E9Q2 redirects to
O75534. It was considered likely that these anomalies were down to the use of old Mascot
searches. Unfortunately, as these were carried out by mass spectrometry technicians no longer
employed by the University of Warwick, it is not possible to ascertain retrospectively if there
were any non-documented differences in the methodology used by different proteomics
technicians.
It was noted that more overall hits were detected for the gel slice method over the on-bead
method. For this reason, two interesting proteins flagged up by the gel slice method were
searched for within the on-bead data.
Due to the possible link between UNR and cancer, multiple myeloma tumor-associated protein
2 (MMTAG2) was considered (Figure 4.11). This protein was flagged as both significantly over-
represented in the UNR data and also only present in the UNR data for the gel slice method. It
was not significant for the on-bead method although it was detected.
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Figure 4.11: Number of MMTAG2 spectra for IgG and UNR by the on-bead method (A) and the
gel slice method (B). The scales for A and B are both 0 – 15 spectral counts. The counts were -
on-bead: IgG=3, UNR=13; gel slice: IgG=0, UNR=7.
Whilst MMTAG2 was not present in the IgG data for the gel slice method, the number of total
spectra for it was almost twice as high in the on-bead method (13 versus 7). The detection of 3
MMTAG2 spectra in the on-bead IgG data changed the Fisher’s exact test p-value for MMTAG2
such that it no longer passed the multiple testing correction.
This draws attention to the problem of looking at single sets of data without repeats.
Biologically, pulling down 3 lots of a protein with IgG to 13 lots with an antibody against a protein
of interest implies that the protein interacts in some way with the protein of interest. On the
other hand, there were 361 spectra with IgG for keratin, type II cytoskeletal 1 (KRT1) in the gel
slice data and 399 spectra for UNR and those data yielded a Fisher’s exact test p-value of
2.6x10-23 even though it was very close to the zero fold change line on the volcano plot (Figure
4.9). An alternative would have been to use fold changes but that method also has shortcomings
with regards to small absolute values (e.g. the change between 1 and 2 is more likely to be down
to chance than a change between 100 and 200, even though the ratios would be the same). It
also yields regular infinite values that need to be checked individually to see if they were of the
order of 1 versus 0 or 100 versus 0 as the former is more likely to be a false positive whereas the
latter is likely to be a true positive. As the purpose of this section was merely to compare two
methods rather than making any biological conclusions, it was decided to choose the option that
avoided infinities.
It was then decided to investigate 78 kDa glucose-regulated protein (HSPA5) because of recent
literature linking UNR to diabetes, implying that UNR transcripts are downregulated more than
6 fold in patients with excessively high glucose levels over the same patients following treatment
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that returned their blood glucose levels to lower and, in most cases, normal levels (Figure 4.12)
(Xavier et al., 2014). This protein was flagged as significant by the gel slice method but not by
the on-bead method, although it was detected in both.
Figure 4.12: Number of HSPA5 spectra for IgG and UNR by the on-bead method (A) and the gel
slice method (B). The scales for A and B are both 0 – 25 spectral counts. The counts were - on-
bead: IgG=3, UNR=10; gel slice: IgG=14, UNR=21.
This case shows a different problem to that of detecting MMTAG2 as a hit. Akin to the situation
with KRT1, HSPA5 was flagged up as a hit using the gel slice method because of absolute values.
The absolute difference in detected spectra was exactly the same between the two methods (21
for UNR, 14 for IgG with the gel slice method and 10 for UNR and 3 for IgG with the on-bead
method). In terms of fold change, a better value was obtained with the on-bead method even
though HSPA5 was not detected as significant by that method.
The real problem here lies in the fact that detecting significance is a means to an end as opposed
to an end in itself. Whilst it is impossible to know which, if either, of the two methods yields a
true result when the true result is unknown and the two methods disagree, it is clear that both
methods here can detect HSPA5.
Assuming that the UNR and IgG slices cover exactly the same range of protein masses, both the
UNR and IgG slices will contain some shared non-specific proteins (which may also be UNR-
specific proteins but are not bound in the classical antibody-bait-interactor manner). The IgG
slice will contain a little more non-specific protein due to the space on the antibody that would
otherwise bind UNR is free to bind to other things. The UNR slice will additionally contain some
true UNR-interacting proteins. The relative proportions of specific UNR-bound proteins in a
particular UNR gel slice will ultimately affect the ratio of specific and non-specific peptides
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available to be fed into the mass spectrometer at a given point in time. That will, in turn, affect
the ratio of the protein detected by UNR compared to IgG.
In conclusion, it was decided that there was not much difference between the two methods in
terms of confidently predicting which proteins are true hits. It was ultimately decided that the
benefits of cross-referencing putative interacting proteins by their relative molecular masses
were more than compensated by the less biased quantification offered by the on-bead method
coupled with the financial savings that could be used for additional experiments later in the
project.
4.3 Main RIP-mass spectrometry experiments using HeLa cell lysates
Three sets of RIPs were carried out using HeLa cell lysates (arsenite and mock treated) prepared
as outlined above and processed for mass spectrometry by the on-bead method. Initial trial
injections of 2 µl for 30 minutes were followed by injections of 8 µl for 120 minutes. 15 mg of
total protein were used per RIP with 12 µg of immunoprecipitating immunoglobulin (anti-UNR
or control IgG) and 50 µl of Protein A slurry. The reactions were carried out in 15 ml tubes. As
20% of the RIP samples were set aside for mass spec and were ultimately resuspended in 50 µl,
the 2 µl injections came from 120 µg of starting material, 96 ng of antibody and 400 nl of bead
slurry. Likewise, the 8 µl injections came from 480 µg of starting material, 384 ng of antibody
and 1.6 µl of bead slurry.
4.3.1 Data analysed using Scaffold software
In order to obtain an overview of the HeLa IP data that was obtained by mass spectrometry, it
was decided to use the same software that was used with the trial data. Whilst it had been
decided to use different software to quantify the data and generate ultimate observations and
hypotheses based upon them, it was considered prudent to first check that the data were
reproducible using similar tools to those used with the trial runs. To that end, the data were
initially inputted into Scaffold (version Scaffold_4.5.3, Proteome Software Inc., Portland, OR,
USA), as per the following Scaffold-generated report:
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“DATABASE SEARCHING-- Tandem mass spectra were extracted by Unspecified version
Unspecified. Charge state deconvolution and deisotoping were not performed. All MS/MS
samples were analysed using Mascot (Matrix Science, London, England; version 2.5.0). Mascot
was set up to search the human_uniprot_18June2015_Angela database (selected for Homo
sapiens, unknown version, 90612 entries) assuming the digestion enzyme trypsin. Mascot was
searched with a fragment ion mass tolerance of 0.80 Da and a parent ion tolerance of 10.0 PPM.
Carbamidomethyl of cysteine was specified in Mascot as a fixed modification. Oxidation of
methionine was specified in Mascot as a variable modification.
“CRITERIA FOR PROTEIN IDENTIFICATION-- Scaffold (version Scaffold_4.5.3, Proteome Software
Inc., Portland, OR, USA) was used to validate MS/MS based peptide and protein identifications.
Peptide identifications were accepted if they could be established at greater than 95.0%
probability by the Scaffold Local FDR algorithm. Protein identifications were accepted if they
could be established at greater than 99.0% probability and contained at least 2 identified
peptides. Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii et
al., 2003). Proteins that contained similar peptides and could not be differentiated based on
MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins sharing
significant peptide evidence were grouped into clusters.”
The raw protein data were quantified by Scaffold using its normalised total ion current setting.
According to the Proteome Software website:
“The total ion current (TIC) is the sum of the areas under all the peaks contained in a MS/MS
spectrum. Scaffold assumes that the area under a peak is proportional to the height of the peak
and approximates the TIC value by summing the intensity of the peaks contained in the peak list
associated to a MS/MS sample.”
(https://proteome-software.wikispaces.com/Calculations+in+Scaffold+FAQs)
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This assumption is then used to approximate the TIC value for a peptide by adding together the
heights of all peaks in an MS/MS sample. It then sums all TIC values associated with peptides
that were assigned to given proteins to give a value for at the protein or cluster level.
4.3.2 Data exported from Scaffold to Excel for further analysis
The resultant estimates of protein levels in each sample were then exported to Microsoft Excel
(Microsoft Corp.). Following the removal of the trial injection data, paired two tail t-tests were
carried out on the plus arsenite and minus arsenite samples separately. There were 316 protein
clusters, of which 95 had no values recorded with the minus arsenite samples and 4 that had no
values recorded in the plus arsenite samples. In order to get a general feel for the data, a liberal
significance cut off point of p=0.1 was selected without a multiple testing correction. As some
proteins were present at higher levels in the IgG samples, these were removed from further
consideration. In addition to this, all proteins that were present in every UNR sample but absent
in every IgG sample were considered, even if they were not considered significant by t-test
(protein name shaded yellow). The proteins/protein clusters considered significant, by the
parameters laid out above, from the HeLa minus arsenite samples are presented in Table 4.2B
by p-value. The top 10 putative UNR interacting proteins are tabulated by t-test p-value with the
total ion current values for each replicate (Table 4.2A). Likewise, the top ten putative UNR
interacting proteins from the HeLa plus arsenite samples are presented in Table 4.2C and all
putative interactors, by the criteria outlined above, are presented in Table 4.2D.
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Table 4.2A: Top ten hits HeLa minus arsenite, by t-test p-value
Protein HeLa1 HeLa2 HeLa3 HeLa4 HeLa5 HeLa6 p-value
SSBP4 0 0 0 685800 555720 676130 0.0043
UNRIP 0 0 0 2243600 1895500 1477100 0.0137
HUWE1 0 0 0 386300 265730 425550 0.0175
NARR 0 0 0 1972000 1237800 1377100 0.0210
RPL23A 0 0 0 118830 67403 86181 0.0263
HSPD1 0 0 130270 40965 34231 150430 0.0352
LDB1 0 0 0 442690 308230 214140 0.0400
UNR 0 0 0 3420100 1988100 1163000 0.0799
RPS5 155490 45419 0 273250 228700 56890 0.0822
SQSTM1 0 38981 0 181450 443410 160790 0.0858
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa1-HeLa3). The corresponding
UNR samples are shaded green and also run left to right (HeLa4-HeLa6). The t-test p-values are
for a two tailed paired t-test without multiple testing correction. Yellow shading denotes
proteins that were recorded in UNR samples only. The full names for each protein can be found
in Table 4.2B.
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Table 4.2B: Putative UNR-interacting proteins from unstressed HeLa cells, by t-test p-
value
Protein p-value
Cluster of U3KPY3_HUMAN Single-stranded DNA-binding protein 4 (Fragment)
GN=SSBP4 0.0043
Cluster of STRAP_HUMAN Serine-threonine kinase receptor-associated protein
GN=STRAP 0.0137
Cluster of HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 GN=HUWE1 0.0175
NARR_HUMAN Ras-related protein RAB34, isoform NARR GN=RAB34 0.0210
Cluster of K7EJV9_HUMAN 60S ribosomal protein L23a (Fragment) GN=RPL23A 0.0263
CH60_HUMAN 60 kDa heat shock protein, mitochondrial GN=HSPD1 0.0352
Cluster of LDB1_HUMAN Isoform 2 of LIM domain-binding protein 1 GN=LDB1 0.0400
Cluster of CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein
E1 GN=CSDE1 0.0799
M0R0F0_HUMAN 40S ribosomal protein S5 (Fragment) GN=RPS5 0.0822
Cluster of SQSTM_HUMAN Sequestosome-1 GN=SQSTM1 0.0858
LMO4_HUMAN LIM domain transcription factor LMO4 GN=LMO4 0.0872
Cluster of TFG_HUMAN Protein TFG GN=TFG 0.1878
Cluster of MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 GN=MYCBP2 0.2842
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
Yellow shading denotes proteins that were recorded in UNR samples only.
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Table 4.2C: Top ten hits HeLa plus arsenite, by t-test p-value
HeLa7 HeLa8 HeLa9 HeLa10 HeLa11 HeLa12 p-value
DYNC1H1 0 0 2597900 778280 905160 3459800 0.0019
RPS2 121020 249370 111950 536230 704780 599190 0.0021
SSBP4 0 0 0 558350 425290 503750 0.0060
RPS3A 0 0 0 131180 172260 146250 0.0063
RPS4X 491630 569950 478130 1157600 1081000 1124200 0.0064
PRKDC 0 685150 6091400 797870 1753200 7197100 0.0094
HUWE1 0 0 0 667350 555970 458200 0.0114
LDB1 0 0 0 311660 268440 206310 0.0133
RPL28 0 0 175820 105510 160420 314300 0.0137
FAU 24481 23947 0 113530 101430 116240 0.0145
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa7-HeLa9). The corresponding
UNR samples are shaded green and also run left to right (HeLa10-HeLa12). The t-test p-values
are for a two tailed paired t-test without multiple testing correction. Yellow shading denotes
proteins that were recorded in UNR samples only. The full names for each protein can be found
in Table 4.2D.
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Table 4.2D: Putative UNR-interacting proteins from arsenite stressed HeLa cells, by t-test p-
value
Protein p-value
Cluster of DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 GN=DYNC1H1 0.0019
Cluster of RS2_HUMAN 40S ribosomal protein S2 GN=RPS2 0.0021
Cluster of U3KPY3_HUMAN Single-stranded DNA-binding protein 4 (Fragment)
GN=SSBP4 0.0060
D6RG13_HUMAN 40S ribosomal protein S3a (Fragment) GN=RPS3A 0.0063
Cluster of RS4X_HUMAN 40S ribosomal protein S4, X isoform GN=RPS4X 0.0064
PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit GN=PRKDC 0.0094
Cluster of HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 GN=HUWE1 0.0114
Cluster of LDB1_HUMAN Isoform 2 of LIM domain-binding protein 1 GN=LDB1 0.0133
Cluster of H0YKD8_HUMAN 60S ribosomal protein L28 GN=RPL28 0.0137
RS30_HUMAN 40S ribosomal protein S30 GN=FAU 0.0145
A9Z1X7_HUMAN Serine/arginine repetitive matrix protein 1 GN=SRRM1 0.0161
GCN1L_HUMAN Translational activator GCN1 GN=GCN1L1 0.0211
Cluster of HSPB1_HUMAN Heat shock protein beta-1 GN=HSPB1 0.0234
Cluster of H0YI37_HUMAN ATP synthase subunit beta, mitochondrial (Fragment)
GN=ATP5B 0.0323
Cluster of M0R2B0_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment)
GN=FBL 0.0363
Cluster of CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein E1
GN=CSDE1 0.0369
Cluster of TADBP_HUMAN TAR DNA-binding protein 43 GN=TARDBP 0.0370
Cluster of RL27_HUMAN 60S ribosomal protein L27 GN=RPL27 0.0377
Cluster of RBM39_HUMAN RNA-binding protein 39 GN=RBM39 0.0379
Cluster of COF1_HUMAN Cofilin-1 GN=CFL1 0.0412
Cluster of SYYC_HUMAN Tyrosine--tRNA ligase, cytoplasmic GN=YARS 0.0445
E2AK2_HUMAN Interferon-induced, double-stranded RNA-activated protein
kinase GN=EIF2AK2 0.0448
FAS_HUMAN Fatty acid synthase GN=FASN 0.0449
Cluster of TFG_HUMAN Protein TFG GN=TFG 0.0468
Cluster of STRAP_HUMAN Serine-threonine kinase receptor-associated protein
GN=STRAP (Q9Y3F4) 0.0478
LARP4_HUMAN Isoform 5 of La-related protein 4 GN=LARP4 0.0482
Cluster of SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic GN=AARS 0.0485
LMO4_HUMAN LIM domain transcription factor LMO4 GN=LMO4 0.0519
Cluster of HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L
GN=HNRNPL 0.0532
RS10_HUMAN 40S ribosomal protein S10 GN=RPS10 0.0572
NARR_HUMAN Ras-related protein RAB34, isoform NARR GN=RAB34 0.0578
FSCN1_HUMAN Fascin GN=FSCN1 0.0716
KEAP1_HUMAN Kelch-like ECH-associated protein 1 GN=KEAP1 0.0718
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Cluster of H0YDD8_HUMAN 60S acidic ribosomal protein P2 (Fragment)
GN=RPLP2 0.0732
Cluster of MCM7_HUMAN DNA replication licensing factor MCM7 GN=MCM7 0.0736
RL27A_HUMAN 60S ribosomal protein L27a GN=RPL27A 0.0759
Cluster of HNRPF_HUMAN Heterogeneous nuclear ribonucleoprotein F
GN=HNRNPF 0.0774
Cluster of HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K
GN=HNRNPK 0.0782
Cluster of PFKAM_HUMAN ATP-dependent 6-phosphofructokinase, muscle type
GN=PFKM 0.0785
RL7A_HUMAN 60S ribosomal protein L7a GN=RPL7A 0.0814
Cluster of ECM29_HUMAN Proteasome-associated protein ECM29 homolog
GN=ECM29 0.0827
Cluster of D3DQV9_HUMAN Eukaryotic translation initiation factor 4 gamma 2
(Fragment) GN=EIF4G2 0.0853
KPRP_HUMAN Keratinocyte proline-rich protein GN=KPRP 0.0862
SND1_HUMAN Staphylococcal nuclease domain-containing protein 1 GN=SND1 0.0897
Cluster of ZCCHV_HUMAN Isoform 3 of Zinc finger CCCH-type antiviral protein 1
GN=ZC3HAV1 0.0947
Cluster of F5H5D3_HUMAN Tubulin alpha-1C chain GN=TUBA1C 0.0973
Cluster of HNRPQ_HUMAN Isoform 3 of Heterogeneous nuclear
ribonucleoprotein Q GN=SYNCRIP 0.0978
JAK1_HUMAN Tyrosine-protein kinase JAK1 GN=JAK1 0.1113
Cluster of B4DUR8_HUMAN T-complex protein 1 subunit gamma GN=CCT3 0.1129
Cluster of SRRM2_HUMAN Serine/arginine repetitive matrix protein 2
GN=SRRM2 0.1218
Cluster of ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 GN=ZNFX1 0.1499
DHX9_HUMAN ATP-dependent RNA helicase A GN=DHX9 0.1631
Cluster of SQSTM_HUMAN Sequestosome-1 GN=SQSTM1 0.1741
Cluster of MCTP2_HUMAN Multiple C2 and transmembrane domain-containing
protein 2 GN=MCTP2 0.1799
Cluster of H0YBN4_HUMAN Polyadenylate-binding protein 1 (Fragment)
GN=PABPC1 0.1889
Cluster of FXR2_HUMAN Fragile X mental retardation syndrome-related protein 2
GN=FXR2 0.2260
Cluster of RBP2_HUMAN E3 SUMO-protein ligase RanBP2 GN=RANBP2 0.3235
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
Yellow shading denotes proteins that were recorded in UNR samples only.
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4.3.3 General consideration of the Excel analysis
Some things were immediately apparent from the analysis of this data set. Firstly, there
appeared to be more putative UNR interactors in arsenite treated cells. Also, without accounting
for hits obscured by differences in nomenclature between Mascot database labels, there were
at least 5 putative hits from both the gel slice and on-bead HeLa trial runs that were considered
significant in the larger scale HeLa minus arsenite experiment, by the criteria laid out in the text
above (Tables 4.1, 4.2B). Those proteins were:
UNR, LDB1, LMO4, NARR and SQSTM1.
It was further noted that UNRIP was significant (t-test p-value <0.05) in both the plus and minus
arsenite samples. UNRIP had been flagged up by both the gel slice and on-bead trial runs but a
difference in the associated Accession number made it fail to appear on the list of hits for both
as the hits had been compared by Accession number. That means that there was at least one
more protein that was considered significant in at least three independent experiments, one
with three biological repeats. Another point that was noted was that UNR was not found to
associate significantly with SSBP3 in this experiment. The lowest p-value from the minus arsenite
t-tests and the third lowest from the plus arsenite t-tests, however, was associated with the
closely related SSBP4 protein. It has been noted, and will be discussed in more length later, that
LDB1 and a number of the SSBP proteins, as well as other potential UNR-interactors such as
LMO4, have been linked to a number of malignancies (see below). It was also noted that the five
proteins (plus UNRIP) that were flagged up as putative UNR-interactors in the three different
unstressed HeLa experiments were also suggested UNR interactors in the HeLa plus arsenite
experiment (Tables 4.1, 4.2D).
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4.3.4 Consideration of the minus arsenite data
It was noted that there was cross-over between the putative UNR interactors suggested by three
different experiments using unstressed HeLa cell lysates – the gel slice trial run, the on-bead trial
run and the main experiment with repeats. It was then decided to get a rough idea of how likely
it would be that such a cross over could be obtained by chance alone.
In order to estimate this, it was first assumed that the joint hits from the trial run were correct
and the probability of selecting the cross-over by chance was then estimated. It should be noted
that this over-estimates any p-values as it assumes that the cross over between the trial runs
has a probability of 1 when such an assumption is clearly invalid.
UNR was first removed from the list in Table 4.1. That was because, whilst it was reassuring to
see UNR in all the UNR pull down samples, seeing it could not be a random event as the
experiment was designed with the specific intention of pulling it down. UNRIP was then added
to the list for the reasons stated above, making 17 proteins. This was then compared to the 12
non-UNR proteins in Table 4.2B that also contained putative UNR-interacting proteins from non-
arsenite-treated HeLa cells.
It was noted that 5 proteins were suggested by both the trial experiments and the main HeLa
minus arsenite experiment (LDB1, LMO4, NARR, SQSTM1 and UNRIP). The Scaffold report for
the trial run proteins stated that the Uniprot database used (the earlier of the two, implying
fewer proteins) contained 134431 protein entries. As many of those will be repeated, a more
conservative estimate of 20000 proteins encoded by the human genome was considered. The
estimate was then framed as a question in the format of “given that there are 20000 balls in a
bag, of which 17 are red, and 12 balls are drawn at random, what is the probability that exactly
5 drawn balls are red?”.
Taking the 17 proteins suggested by the trial runs and comparing this to the 12 found by the
larger scale experiment, this implies that the probability of seeing 5 on both lists by chance alone
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is the product of the number of unique combinations of 5 red balls chosen from 12 (12!/(5!x(12-
5)!)) and the probability of drawing any 5 red balls among a random selection of 12 in 20000:
This is around 1.83*10-13, so it seems that there is a genuine signal present and that the
techniques we used were likely to be discovering some real UNR interacting proteins. Another
way of generating the exact probability is to use the hypergeometric test. Using the statistical
language R (https://www.r-project.org/about.html), two hypergeometric tests were carried out.
The first was for choosing more than 4 red balls from a subset of 17 red balls within a total
population of 20000 balls with 12 random selections. The second was the same calculation for
choosing more than 5 red balls. The second value was taken away from the first, thereby giving
the probability of drawing exactly 5 red balls.
>phyper(4,17,20000-17,12,lower.tail=FALSE)-phyper(5,17,20000-17,12,lower.tail=FALSE)
[1] 1.831043e-13
It is customary to give the probability of observing a value at least as extreme as a given
observation as opposed to that of observing an exact value. This is obtained by not subtracting
the second hypergeometric test value. Due to the high total population of proteins (balls), the
probability of seeing more extreme values falls off quickly and, as a result, the probability of
seeing an observation as least as extreme as 5 rounds to the same value to 3 significant figures:
> phyper(4,17,20000-17,12,lower.tail=FALSE)
[1] 1.832327e-13
One potential criticism of using an approach such as this surrounds the assumption that all
20000 proteins are equally likely to be expressed and detected. It could be that a much smaller
selection of proteins could be detected. To see the effect of population size on the probability
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of seeing a degree of cross-over at least as extreme as was observed, the test was repeated
using total populations of 10000, 5000, 1000 and 500 proteins:
> phyper(4,17,10000-17,12,lower.tail=FALSE)
[1] 5.845847e-12
> phyper(4,17,5000-17,12,lower.tail=FALSE)
[1] 1.859436e-10
> phyper(4,17,1000-17,12,lower.tail=FALSE)
[1] 5.534081e-07
> phyper(4,17,500-17,12,lower.tail=FALSE)
[1] 1.663646e-05
Assuming that there were only 500 proteins in the HeLa minus arsenite samples that could be
detected by the mass spectrometer, the probability of choosing more than 4 red balls from a
subset of 17 red balls within a total population of 500 balls with 12 random selections would still
be significant (p = 1.66x10-5). This strongly suggests that the cross-over was not random and that
the 5 proteins were likely to be true UNR-interactors.
4.3.5 Consideration of the plus arsenite data
The top hit by t-test p-value for arsenite treated HeLa cells was dynein heavy chain 1. This was
considered interesting as DHC1 had been shown, together with microtubules, to be required for
the proper establishment of stress granules in HeLa and other cell lines. (Loschi et al., 2009).
Another promising sign was that there was a degree of cross-over between the plus and minus
arsenite samples with ten of the top 25 putative hits for the minus arsenite samples also being
top putative hits for the plus arsenite samples and that these included the five hits previously
noted to be constant between the trial runs and the main minus arsenite experiments (LDB1,
LMO4, NARR, SQSTM1 and UNRIP). (Table 4.3).
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Table 4.3: Putative UNR interacting proteins in both plus and minus arsenite HeLa samples
Cluster of U3KPY3_HUMAN Single-stranded DNA-binding protein 4 (Fragment) (GN=SSBP4)
Cluster of CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein E1 GN=CSDE1
Cluster of HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1)
Cluster of LDB1_HUMAN Isoform 2 of LIM domain-binding protein 1 (GN=LDB1)
Cluster of SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1)
Cluster of STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP)
Cluster of TFG_HUMAN Protein TFG (GN=TFG)
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4)
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34)
PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit (GN=PRKDC)
4.3.6 Consideration of some of the most reproducible putative hits
UNR and UNRIP have been discussed previously in the introduction. The DNA that encodes
NARR, standing for ‘nine amino-acid residue-repeats’, overlaps that of the RAB34 proto-
oncogene (Zougman et al., 2011). It is a nucleolar protein that associates with rDNA clusters
and is well conserved among the mammals (Zougman et al., 2011). The thirteen nine amino-acid
repeats of the human protein contain one serine or threonine residue that is phosphorylated
during M-phase (Zougman et al., 2011). Should UNR be interacting with a nucleolar protein, one
of three things must be true:
1) UNR is interacting with the protein inside the nucleus
2) UNR interacts with the protein in the cytoplasm prior to it entering the nucleus
3) UNR interacts with the protein during mitosis when nuclear proteins can come into
contact with cytoplasmic proteins.
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Whilst it is not clear which of these is true, it has been noted elsewhere that UNR concentration
can spike during mitosis (Schepens et al., 2007). It should also be noted that the production of
cell lysate can rupture intracellular membranes, thereby creating a non-physiological
environment in which nuclear and non-nuclear proteins can come into contact with each other.
Sequestosome 1 is a well conserved metazoan stress-induced protein involved in regulating a
variety of cellular functions including selective autophagy, lipogenesis and apoptosis as well as
a number of signalling pathways including activation of both the Raptor-containing mTOR
complex 1 and NF-κB. It also contains a zinc finger and can interact with DNA (reviewed in 
Katsuragi et al. 2015). Interestingly, it has also been reported to be involved in the development
of Alzheimer’s disease (Salminen et al., 2012) and tumour proliferation and metastasis through
an interaction with, and stabilisation of, the EMT-promoting Twist1 (Qiang et al., 2014). Many
of these processes, such as apoptosis, metastasis and Alzheimer’s disease have also been
associated with UNR.
LIM domain binding protein 1 (LDB1) has a wide range of cellular functions, of which only a few
will be mentioned here for the sake of brevity. Ldb1 is associated with pancreatic development
and the expression of certain genes, such as insulin, in conjunction with the transcription factor
Islets 1 (Isl1) and other genes, such as Glucose transporter type 2 (Glut2) in an Isl1-independent
manner (Hunter et al., 2013). UNR has also been associated with glucose levels and diabetes
(Xavier et al., 2014). Ldb1 is required for erythropoiesis (Li et al., 2010). Finally, LDB1 has been
shown to co-immunoprecipitate with Tripartite Motif-Containing Protein 33 (TRIM33) (Bai et al.,
2010). Furthermore, TRIM33 has been shown to decrease the cellular LDB1 level (Howard et al.,
2010). This is interesting on several UNR-related levels:
1) UNR and TRIM33 lie in extremely close proximity on human chromosome 1.
2) UNR and TRIM33 have been functionally linked to autism (Xia et al., 2013).
3) Like UNR, TRIM33 is related to embryonic development (see below).
4) Like UNRIP (see above), TRIM33 is linked TGF-β signalling generally (see below). 
5) Like UNR, TRIM33 is linked to erythropoiesis (see below) and to Diamond Blackfan
Anaemia in particular (Ge et al., 2015).
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TRIM33 interacts with SMAD proteins in various biological settings, including development and
haematopoiesis ((Ransom et al., 2004)Dupont et al. 2005; He et al. 2006; Morsut et al. 2010).
TRIM33 inhibits signalling through SMAD4 via a ubiquitylation event that reduces the proportion
of SMAD4 found in the nucleus, both in the presence and absence of TGF-β1 (Dupont et al.,
2005). It also further shown that TRIM33 monoubiquitylation of SMAD4 destabilises the
interaction between SMAD4 and activated SMAD2/3, and that the ubiquitylation is antagonised
by USP9x (Dupont et al., 2009).
LIM domain only 4 is a transcription factor that has been reported to be involved in a variety of
cancers. For example, an LDB1-LMO4 interaction was suggested to be involved in oral cavity
squamous carcinoma (Mizunuma et al., 2003). Likewise, LMO4 was shown to be frequently
upregulated in invasive breast carcinomas (Visvader et al., 2001) and to interact with and
negatively regulate the tumour suppressor BRCA1 protein (Sum et al., 2002). At least one LMO4
and LDB1-containing complex, that also contains GATA6, functions as a tumour suppressor by
activating p21 in a potentially TP53-independent manner (Setogawa et al., 2006). As this
involves GATA6, it thereby provides an indirect link to the work of Elatmani and others in the
Jacquemin-Sablon lab (Elatmani et al., 2011).
Ssbp3 stabilises the interaction between Ldb1 and Lhx1 in early development (Costello et al.,
2015). Also, both this protein and SSBP4 were both shown to co-immunoprecipitate with
TRIM33 (Bai et al., 2010).
4.4 Choice of additional cell types to extend the experiment
Having made some initial observations using HeLa cells, it was decided to extend the work to
carry out repeats with other cell types. That was with the intention of discovering whether the
observations were cell type specific.
The osteosarcoma cell line U2OS was selected because it was available in the lab and was known
to express wild type TP53. That was important as some exciting findings in the lab had potentially
linked UNR to TP53 (Ray, Ó Catnaigh and Anderson, manuscript in preparation). To get an insight
into any potential functional interaction between UNR and TP53, it was also decided to carry
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out RIPs using the related TP53-null osteosarcoma cell line, SaOS-2 (Diller et al., 1990). It should
also be considered that, while U2OS contains wild type TP53, it also over-expresses HDM2
(Florenes et al., 1994).
It had been noted that the p-values associated with many putative hits observed to this point
were too high to pass a multiple testing correction. It was therefore considered welcome that
the same proteins were coming up in multiple independent experiments. It was hoped that
seeing the same hits in additional experiments in other cell types would further confirm that the
approach taken was valid and that many of the observed hits were unlikely to be false positives.
In short, the additional work was undertaken in the hope of lending further support to findings
already made in HeLa cells as well as finding putative UNR interactors in other cell types.
4.5 Main RIP-mass spectrometry experiments using U2OS cell lysates
Three sets of RIPs were carried out using U2OS cell lysates (arsenite and mock treated) prepared
as outlined above and processed for mass spectrometry by the on-bead method. Initial trial
injections of 2 µl for 30 minutes were followed by injections of 8 µl for 120 minutes. 7 mg of
total protein was used per RIP with 12 µg of immunoprecipitating immunoglobulin (anti-UNR or
control IgG) and 50 µl of Protein A slurry. The reactions were carried out in 15 ml tubes. As 20%
of the RIP samples were set aside for mass spec and were ultimately resuspended in 50 µl, the
2 µl injections came from 56 µg of starting material, 96 ng of antibody and 400 nl of bead slurry.
Likewise, the 8 µl injections came from 224 µg of starting material, 384 ng of antibody and
1.6 µl of bead slurry.
A Scaffold file was made as before; the publication report for the U2OS run was exactly the same
as for the HeLa report and the same pipeline was used for analysis as had been used for the
HeLa samples.
34Chapter 4
There were 368 clusters, of which 115 were not detected in any of the minus arsenite samples
and 8 were not detected in any of the plus arsenite samples. The data were sorted using the
same significance criteria as for the HeLa samples (see section 4.3.2).
4.5.1 Putative UNR interactors found using U2OS cell lysates
There were 21 putative hits for the U2OS minus arsenite samples (Table 4.4B), the top ten of
which by p-value are presented in Table 4.4A. There were 76 putative hits for the U2OS plus
arsenite samples (Table 4.4D), of which the top ten by p-value are tabulate below (Table 4.4C).
There were 9 proteins that were putative hits under both conditions (Table 4.4E).
Table 4.4A: Top ten hits U2OS minus arsenite, by t-test p-value
Protein U2OS1 U2OS2 U2OS3 U2OS4 U2OS5 U2OS6 p-value
EWSR1 220690 79529 100240 316360 171140 180290 0.0027
VIM 102930 164410 127120 138130 192810 160180 0.0039
LDB1 0 0 0 245600 208200 300600 0.0112
RPS27 64800 111000 122000 104000 165000 190000 0.0234
UNR 0 0 0 644760 328380 580240 0.033
ACTN1 0 367530 0 85461 453590 45127 0.0334
DDX3X 591330 228460 573350 970920 411940 933630 0.0387
TMEM97 0 0 0 87815 59805 128300 0.0437
ATP5A1 151760 872820 76693 1127100 1344900 683320 0.045
RPS7 189240 0 0 224140 55669 79267 0.0476
HSPA5 0 449500 0 51703 578090 99651 0.0532
N.B. IgG samples shaded lilac repeat 1-3 running left to right (U2OS1-U2OS3). The corresponding
UNR samples are shaded green and also run left to right (U2OS4-U2OS6). The t-test p-values are
for a two tailed paired t-test without multiple testing correction. Yellow shading denotes
proteins that were recorded in UNR samples only.
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Table 4.4B: Putative UNR-interacting proteins from unstressed U2OS cells, by t-test p-value
Protein p-value
Cluster of B0QYK0_HUMAN RNA-binding protein EWS (GN=EWSR1) 0.0027
Cluster of VIME_HUMAN Vimentin (GN=VIM) 0.0039
Cluster of LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 0.0112
RS27_HUMAN 40S ribosomal protein S27 (GN=RPS27) 0.0234
CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein E1
(GN=CSDE1) 0.0330
Cluster of ACTN1_HUMAN Alpha-actinin-1 (GN=ACTN1) 0.0334
Cluster of A0A0D9SF53_HUMAN ATP-dependent RNA helicase DDX3X
(GN=DDX3X) 0.0387
TMM97_HUMAN Transmembrane protein 97 (GN=TMEM97) 0.0437
ATPA_HUMAN ATP synthase subunit alpha, mitochondrial (GN=ATP5A1) 0.0450
RS7_HUMAN 40S ribosomal protein S7 (GN=RPS7) 0.0476
GRP78_HUMAN 78 kDa glucose-regulated protein (GN=HSPA5) 0.0532
Cluster of SSBP3_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 0.0544
Cluster of HUWE1_HUMAN Isoform 3 of E3 ubiquitin-protein ligase HUWE1
(GN=HUWE1) 0.0686
RS8_HUMAN 40S ribosomal protein S8 (GN=RPS8) 0.0768
SRSF2_HUMAN Serine/arginine-rich splicing factor 2 (GN=SRSF2) 0.0812
RL29_HUMAN 60S ribosomal protein L29 (GN=RPL29) 0.0845
H4_HUMAN Histone H4 (GN=HIST1H4A) 0.0850
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 0.1160
E9PK91_HUMAN Bcl-2-associated transcription factor 1 (GN=BCLAF1) 0.1264
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 0.1670
U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit (GN=U2AF2) 0.1769
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
Yellow shading denotes proteins that were recorded in UNR samples only.
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Table 4.4C: Top ten hits U2OS plus arsenite, by t-test p-value
Protein U2OS7 U2OS8 U2OS9 U2OS10 U2OS11 U2OS12 p-value
ANXA2 0 0 0 91468 90853 81731 0.0013
UNRIP 0 0 0 3243000 3005700 3508700 0.002
UNR 0 0 0 3774400 3703900 4439600 0.0035
HSPA9 0 0 0 161500 127070 186940 0.0118
RPL11 35120 59251 118000 102600 157590 193990 0.0128
TUBB6 0 85370 347680 626070 893540 1367000 0.0188
LDB1 0 0 0 285440 209560 356440 0.0216
RPS2 332580 172460 302870 733490 874400 880930 0.0235
NARR 0 0 0 282330 159030 290080 0.029
RBM14 0 0 0 105720 72114 138340 0.0314
TUBB 407100 1326300 1790500 4629400 3511500 4856900 0.0332
N.B. IgG samples shaded lilac repeat 1-3 running left to right (U2OS7-U2OS9). The corresponding
UNR samples are shaded green and also run left to right (U2OS10-U2OS12). The t-test p-values
are for a two tailed paired t-test without multiple testing correction. Yellow shading denotes
proteins that were recorded in UNR samples only.
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Table 4.4D: Putative UNR-interacting proteins from arsenite stressed U2OS cells, by t-test
p-value
Protein p-value
Cluster of ANXA2_HUMAN Annexin A2 (GN=ANXA2) 0.0013
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 0.0020
CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein E1
(GN=CSDE1) 0.0035
Cluster of GRP75_HUMAN Stress-70 protein, mitochondrial (GN=HSPA9) 0.0118
RL11_HUMAN 60S ribosomal protein L11 (GN=RPL11) 0.0128
TBB6_HUMAN Tubulin beta-6 chain (GN=TUBB6) 0.0188
Cluster of LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 0.0216
Cluster of RS2_HUMAN 40S ribosomal protein S2 (GN=RPS2) 0.0235
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 0.0290
Cluster of RBM14_HUMAN RNA-binding protein 14 (GN=RBM14) 0.0314
Cluster of TBB5_HUMAN Tubulin beta chain (GN=TUBB) 0.0332
Cluster of C9JJQ8_HUMAN Tubulin alpha-4A chain (Fragment) (GN=TUBA4A) 0.0344
A0A087WXM6_HUMAN 60S ribosomal protein L17 (Fragment) (GN=RPL17) 0.0348
Cluster of RINI_HUMAN Ribonuclease inhibitor (GN=RNH1) 0.0371
Cluster of HUWE1_HUMAN Isoform 3 of E3 ubiquitin-protein ligase HUWE1
(GN=HUWE1) 0.0400
RL8_HUMAN 60S ribosomal protein L8 (GN=RPL8) 0.0444
Cluster of HS71A_HUMAN Heat shock 70 kDa protein 1A (GN=HSPA1A) 0.0461
Cluster of B5MDF5_HUMAN GTP-binding nuclear protein Ran (GN=RAN) 0.0468
Cluster of J3KQ22_HUMAN Pyrroline-5-carboxylate reductase (Fragment)
(GN=PYCR1) 0.0510
HSPB1_HUMAN Heat shock protein beta-1 (GN=HSPB1) 0.0526
Cluster of RS30_HUMAN 40S ribosomal protein S30 (GN=FAU) 0.0561
DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 (GN=DYNC1H1) 0.0563
Cluster of SSBP3_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 0.0565
AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK
(GN=AHNAK) 0.0567
RS8_HUMAN 40S ribosomal protein S8 (GN=RPS8) 0.0580
MCM7_HUMAN DNA replication licensing factor MCM7 (GN=MCM7) 0.0634
Cluster of FLNC_HUMAN Filamin-C (GN=FLNC) 0.0650
Cluster of H2B1A_HUMAN Histone H2B type 1-A (GN=HIST1H2BA) 0.0655
Cluster of H0Y449_HUMAN Nuclease-sensitive element-binding protein 1
(Fragment) (GN=YBX1) 0.0681
Cluster of RS3_HUMAN 40S ribosomal protein S3 (GN=RPS3) 0.0682
Cluster of H7C1H2_HUMAN 26S proteasome non-ATPase regulatory subunit 2
(Fragment) (GN=PSMD2) 0.0686
Cluster of RS9_HUMAN 40S ribosomal protein S9 (GN=RPS9) 0.0704
Cluster of BAG2_HUMAN BAG family molecular chaperone regulator 2
(GN=BAG2) 0.0731
FAS_HUMAN Fatty acid synthase (GN=FASN) 0.0755
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Cluster of HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K
(GN=HNRNPK) 0.0757
K7EJV9_HUMAN 60S ribosomal protein L23a (Fragment) (GN=RPL23A) 0.0811
Cluster of E9PFH4_HUMAN Transportin-3 (GN=TNPO3) 0.0824
Cluster of TFG_HUMAN Protein TFG (GN=TFG) 0.0835
ATPA_HUMAN ATP synthase subunit alpha, mitochondrial (GN=ATP5A1) 0.0848
MSH6_HUMAN DNA mismatch repair protein Msh6 (GN=MSH6) 0.0887
Cluster of PCBP1_HUMAN Poly(rC)-binding protein 1 (GN=PCBP1) 0.0887
RS14_HUMAN 40S ribosomal protein S14 (GN=RPS14) 0.0916
Cluster of ADT2_HUMAN ADP/ATP translocase 2 (GN=SLC25A5) 0.0986
EMD_HUMAN Emerin (GN=EMD) 0.1043
Cluster of A0A0A0MSG2_HUMAN Four and a half LIM domains protein 2
(GN=FHL2) 0.1119
Cluster of COF1_HUMAN Cofilin-1 (GN=CFL1) 0.1119
Cluster of PLEC_HUMAN Plectin (GN=PLEC) 0.1119
Cluster of SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1) 0.1147
Cluster of TRIP6_HUMAN Thyroid receptor-interacting protein 6 (GN=TRIP6) 0.1148
Cluster of IPO4_HUMAN Importin-4 (GN=IPO4) 0.1188
SSRD_HUMAN Translocon-associated protein subunit delta (GN=SSR4) 0.1205
Cluster of TIF1B_HUMAN Transcription intermediary factor 1-beta (GN=TRIM28) 0.1224
U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit (GN=U2AF2) 0.1312
Cluster of ATPO_HUMAN ATP synthase subunit O, mitochondrial (GN=ATP5O) 0.1335
Cluster of MPCP_HUMAN Phosphate carrier protein, mitochondrial
(GN=SLC25A3) 0.1414
Cluster of M0QXS5_HUMAN Heterogeneous nuclear ribonucleoprotein L
(Fragment) (GN=HNRNPL) 0.1428
Cluster of J3QL54_HUMAN Nuclear pore complex protein Nup85 (GN=NUP85) 0.1526
Cluster of F8W6I7_HUMAN Heterogeneous nuclear ribonucleoprotein A1
(GN=HNRNPA1) 0.1541
Cluster of H3BVG0_HUMAN Nuclear pore complex protein Nup93 (GN=NUP93) 0.1559
Cluster of Q5JR05_HUMAN Rho-related GTP-binding protein RhoC (GN=RHOC) 0.1593
Cluster of ATD3A_HUMAN Isoform 2 of ATPase family AAA domain-containing
protein 3A (GN=ATAD3A) 0.1635
EF2_HUMAN Elongation factor 2 (GN=EEF2) 0.1708
Cluster of RL28_HUMAN 60S ribosomal protein L28 (GN=RPL28) 0.1798
Cluster of E9PR16_HUMAN Nuclear pore complex protein Nup160 (Fragment)
(GN=NUP160) 0.1936
Cluster of 1433B_HUMAN 14-3-3 protein beta/alpha (GN=YWHAB) 0.1958
Cluster of IMB1_HUMAN Importin subunit beta-1 (GN=KPNB1) 0.2152
Cluster of H7C2U6_HUMAN Protein NipSnap homolog 1 (Fragment)
(GN=NIPSNAP1) 0.2295
Cluster of C9JZR2_HUMAN Catenin delta-1 (GN=CTNND1) 0.2330
Cluster of B4DR61_HUMAN Protein transport protein Sec61 subunit alpha
isoform 1 (GN=SEC61A1) 0.2499
Cluster of RBP2_HUMAN E3 SUMO-protein ligase RanBP2 (GN=RANBP2) 0.2538
RL4_HUMAN 60S ribosomal protein L4 (GN=RPL4) 0.2648
39Chapter 4
Cluster of PLAP_HUMAN Phospholipase A-2-activating protein (GN=PLAA) 0.2931
A0A0A0MSX9_HUMAN Isoleucine--tRNA ligase, cytoplasmic (GN=IARS) 0.3092
Cluster of Q5SZU1_HUMAN D-3-phosphoglycerate dehydrogenase (GN=PHGDH) 0.3112
SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase (GN=EPRS) 0.3125
MVP_HUMAN Major vault protein (GN=MVP) 0.3478
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
Yellow shading denotes proteins that were recorded in UNR samples only.
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Table 4.4E: Putative UNR interacting proteins in both plus and minus arsenite U2OS samples
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP)
CSDE1_HUMAN Isoform 4 of Cold shock domain-containing protein E1 (GN=CSDE1)
Cluster of LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1)
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34)
Cluster of HUWE1_HUMAN Isoform 3 of E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1)
Cluster of SSBP3_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3)
RS8_HUMAN 40S ribosomal protein S8 (GN=RPS8)
ATPA_HUMAN ATP synthase subunit alpha, mitochondrial (GN=ATP5A1)
U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit (GN=U2AF2)
At first sight, there appeared to be several recurrent proteins that could be true UNR-interactors.
UNRIP, LDB1, NARR and HUWE1 were considered putative hits from both the plus and minus
arsenite U2OS samples (Table 4.4E) and had also been putative hits from the plus and minus
arsenite HeLa samples (Table 4.3). On top of this, it was noted that SSBP3 was a putative UNR-
interactor in stressed and unstressed U2OS cells (Table 4.4E). This had also been a hit in both of
the trial runs that used unstressed HeLa cells (Table 4.1).
Among other observations, it was noted that 78 kDa glucose-regulated protein (HSPA5) was a
hit for the minus arsenite samples, as it was for the HeLa gel slice trial run (Figure 4.12). Also,
SQSTM1 was present in the list of putative hits for U2OS plus arsenite, as was DYNC1H1, the top
hit for HeLa plus arsenite. See the Progenesis/quantitative analysis section below for further
consideration of the similarities and differences between the cell types.
Having had an initial look at the U2OS data, it was decided to have a similar look at the SaOS-2
data prior to moving on to analyse the main data further using Progenesis.
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4.6 Main RIP-mass spectrometry experiments using SaOS-2 cell lysates
Three sets of RIPs were carried out using SaOS-2 cell lysates (arsenite and mock treated)
prepared as outlined above and processed for mass spectrometry by the on-bead method. Initial
trial injections were not carried out on these sample. The only run carried out was the main run
with injections of 8 µl for 120 minutes. 6 mg of total protein was used per RIP with 12 µg of
immunoprecipitating immunoglobulin (anti-UNR or control IgG) and 50 µl of Protein A slurry.
The reactions were carried out in 15 ml tubes. As 20% of the RIP samples were set aside for mass
spec and were ultimately resuspended in 50 µl, the 8 µl injections came from 192 µg of starting
material, 384 ng of antibody and 1.6 µl of bead slurry.
Again, the Scaffold publication report was exactly the same for the SaOS-2 run as for the
previous two cell types and the same steps were used in analysing the data as with the other
cell types. There were 399 clusters, 106 of which were not found in the minus arsenite samples
and 1 was not present in the plus arsenite data.
4.6.1 Putative UNR interactors found using SaOS-2 cell lysates
There were 41 putative hits for the SaOS-2 minus arsenite samples (Table 4.5B), of which the
top ten by p-value are presented below (Table 4.5A). There were 146 putative hits for the
SaOS-2 plus arsenite samples (Table 4.5D), of which the top ten by p-value are documented
below (Table 4.5C). As there were a larger number of hits than before, it was decided to present
only gene names with p-values to save table space (Tables 4.5B and 4.5D). There were 33
proteins that were putative hits under both conditions (Table 4.5E).
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Table 4.5A: Top ten hits SaOS-2 minus arsenite, by t-test p-value
SaOS1 SaOS2 SaOS3 SaOS4 SaOS5 SaOS6 p-value
RPL27 0 0 0 117740 135440 123520 0.0017
LMO4 0 0 0 180810 181340 158960 0.0018
DDX41 0 0 118210 114270 110680 255840 0.0049
SSBP3 0 0 0 632010 526810 726910 0.0083
LDB1 0 0 0 701290 809560 986080 0.0098
PGAM5 0 0 0 342290 553430 441620 0.0182
SQSTM1 0 0 0 358270 476870 609300 0.0219
ARHGEF2 0 0 0 210840 207810 334010 0.0264
RPS27 0 0 0 31990 62522 43473 0.0355
HIST1H4A 83542 0 0 287660 351420 183040 0.0433
HUWE1 0 0 0 3476800 2617600 1487100 0.0482
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (1SaOS-3SaOS). The corresponding
UNR samples are shaded green and also run left to right (4SaOS-6SaOS). The t-test p-values are
for a two tailed paired t-test without multiple testing correction. Yellow shading denotes
proteins that were recorded in UNR samples only.
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Table 4.5B: Putative UNR-interacting proteins from unstressed SaOS-2 cells, by t-test p-
value
p-value
RL27_HUMAN 60S ribosomal protein L27 (GN=RPL27) 0.0017
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4) 0.0018
Cluster of J3KNN5_HUMAN Probable ATP-dependent RNA helicase DDX41
(Fragment) (GN=DDX41) 0.0049
Cluster of SSBP3_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 0.0083
LDB1_HUMAN Isoform 3 of LIM domain-binding protein 1 (GN=LDB1) 0.0098
PGAM5_HUMAN Serine/threonine-protein phosphatase PGAM5, mitochondrial
(GN=PGAM5) 0.0182
Cluster of SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1) 0.0219
Cluster of ARHG2_HUMAN Rho guanine nucleotide exchange factor 2
(GN=ARHGEF2) 0.0264
RS27_HUMAN 40S ribosomal protein S27 (GN=RPS27) 0.0355
H4_HUMAN Histone H4 (GN=HIST1H4A) 0.0433
Cluster of HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1) 0.0482
RS18_HUMAN 40S ribosomal protein S18 (GN=RPS18) 0.0510
Cluster of SRSF6_HUMAN Serine/arginine-rich splicing factor 6 (GN=SRSF6) 0.0550
RS14_HUMAN 40S ribosomal protein S14 (GN=RPS14) 0.0590
Cluster of F1T0I1_HUMAN Protein transport protein Sec16A (GN=SEC16A) 0.0606
EWS_HUMAN RNA-binding protein EWS (GN=EWSR1) 0.0621
Cluster of C9J0D1_HUMAN Histone H2A (GN=H2AFV) 0.0653
RL23_HUMAN 60S ribosomal protein L23 (GN=RPL23) 0.0665
Cluster of A9Z1X7_HUMAN Serine/arginine repetitive matrix protein 1
(GN=SRRM1) 0.0862
Cluster of RS3_HUMAN 40S ribosomal protein S3 (GN=RPS3) 0.0868
Cluster of J3KQE5_HUMAN GTP-binding nuclear protein Ran (Fragment)
(GN=RAN) 0.0910
Cluster of F5H5D3_HUMAN Tubulin alpha-1C chain (GN=TUBA1C) 0.0988
Cluster of CO4A_HUMAN Complement C4-A (GN=C4A) 0.1061
Cluster of SRRM2_HUMAN Serine/arginine repetitive matrix protein 2
(GN=SRRM2) 0.1117
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 0.1119
A6NNN6_HUMAN Pericentriolar material 1 protein (GN=PCM1) 0.1226
Cluster of RS6_HUMAN 40S ribosomal protein S6 (GN=RPS6) 0.1228
Cluster of M0R210_HUMAN 40S ribosomal protein S16 (GN=RPS16) 0.1230
Cluster of CSDE1_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 0.1567
Cluster of TBB5_HUMAN Tubulin beta chain (GN=TUBB) 0.1609
Cluster of H2B1D_HUMAN Histone H2B type 1-D (GN=HIST1H2BD) 0.1640
Cluster of A0A075B7D9_HUMAN TATA-binding protein-associated factor 2N
(GN=TAF15) 0.1674
Cluster of HSP7C_HUMAN Heat shock cognate 71 kDa protein (GN=HSPA8) 0.1701
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RS4X_HUMAN 40S ribosomal protein S4, X isoform (GN=RPS4X) 0.1816
Cluster of J3KP15_HUMAN Serine/arginine-rich-splicing factor 2 (Fragment)
(GN=SRSF2) 0.1857
SETMR_HUMAN Histone-lysine N-methyltransferase SETMAR (GN=SETMAR) 0.1926
GRP78_HUMAN 78 kDa glucose-regulated protein (GN=HSPA5) 0.1956
MCM7_HUMAN DNA replication licensing factor MCM7 (GN=MCM7) 0.2035
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 0.2175
P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 (GN=P4HA2) 0.2547
MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 (GN=MYCBP2) 0.2954
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
Yellow shading denotes proteins that were recorded in UNR samples only.
45Chapter 4
Table 4.5C: Top ten hits SaOS-2 plus arsenite, by t-test p-value
7SaOS 8SaOS 9SaOS 10SaOS 11SaOS 12SaOS p-value
UNR 0 0 0 6458000 6436900 6551900 0.00003
HSPA8 0 0 0 2244300 2392900 2198100 0.0007
TUBA1C 49380 332020 337080 4016900 4695300 4387200 0.0009
IDH2 0 0 0 131460 150880 139760 0.0016
LDB1 0 0 0 1098800 850600 907790 0.0062
MMS19 0 0 0 119790 111960 90865 0.0064
RPL10 0 0 0 197570 153870 200000 0.0066
UNRIP 0 0 0 5408200 4004600 5010700 0.0075
FBL 0 0 0 180900 240000 241440 0.0081
PDXDC1 0 0 0 149730 203760 198450 0.0086
RAP1B 0 0 0 130290 183090 159960 0.0092
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (7SaOS-9SaOS). The corresponding
UNR samples are shaded green and also run left to right (10SaOS-12SaOS). The t-test p-values
are for a two tailed paired t-test without multiple testing correction.
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Table 4.5D: Gene names for putative UNR-interacting proteins from SaOS-2 cells stressed
with arsenite, by t-test p-value
protein p-value protein p-value protein p-value
GN=CSDE1 0.00003 GN=WDR1 0.03440 GN=ANP32E 0.09810
GN=HSPA8 0.00070 GN=ARHGEF1 0.03500 GN=IKBKAP 0.09930
GN=TUBA1C 0.00090 GN=PHGDH 0.04030 GN=PPIA 0.10150
GN=IDH2 0.00160 GN=DHX9 0.04030 GN=P4HA2 0.10480
GN=LDB1 0.00620 GN=MCM7 0.04060 GN=TRAP1 0.10530
GN=MMS19 0.00640 GN=RPL23 0.04170 GN=EMD 0.10590
GN=RPL10 0.00660 GN=P4HB 0.04210 GN=SHMT2 0.10680
GN=STRAP 0.00750 GN=SQSTM1 0.04260 GN=ILF2 0.10980
GN=FBL 0.00810 GN=SPG20 0.04340 GN=FNDC3B 0.11070
GN=PDXDC1 0.00860 GN=TRIM25 0.04410 GN=SRSF6 0.11120
GN=RAP1B 0.00920 GN=GAPVD1 0.04420 GN=HNRNPL 0.11820
GN=RNH1 0.01050 GN=ZNFX1 0.04440 GN=ARF4 0.12170
GN=EEF2 0.01110 GN=CAD 0.04620 GN=GCN1L1 0.13190
GN=BAG2 0.01200 GN=HSPA5 0.04810 GN=RPS2 0.13360
GN=IPO4 0.01210 GN=TNRC6C 0.04910 GN=GCLM 0.13630
GN=TUBB 0.01320 GN=TUFM 0.04930 GN=HIST1H2BD 0.13750
GN=DSTN 0.01400 GN=ATAD3B 0.04980 GN=FHL2 0.13880
GN=PDS5A 0.01470 GN=ENO1 0.05050 GN=HSPBP1 0.13890
GN=EIF4G2 0.01470 GN=PGAM5 0.05070 GN=RPS3 0.14420
GN=PFKL 0.01470 GN=SLC25A3 0.05140 GN=UNC45A 0.14510
GN=RPL27A 0.01490 GN=ANKHD1 0.05470 GN=TRIM28 0.14570
GN=CFL1 0.01520 GN=SRSF3 0.05540 GN=PTPN1 0.16180
GN=PFN2 0.01600 GN=AARS 0.05620 GN=RPS6 0.16290
GN=LMO4 0.01620 GN=RPS14 0.05710 GN=UCHL1 0.16720
GN=RAB34 (NARR) 0.01840 GN=TNPO3 0.05720 GN=SRSF7 0.17890
GN=EIF2A 0.01870 GN=EIF5A 0.05720 GN=LMO7 0.18570
GN=GNAT1 0.01940 GN=RAN 0.05740 GN=RPL18 0.19660
GN=DDX39A 0.01950 GN=FXR2 0.05750 GN=EIF4A3 0.19940
GN=CTNND1 0.01990 GN=PLEKHA5 0.05800 GN=ZC3HAV1 0.20730
GN=KPNB1 0.02050 GN=ACTBL2 0.05940 GN=C4A 0.20970
GN=GNB2L1 0.02070 GN=HSPA9 0.06090 GN=LRPPRC 0.20980
GN=RPS18 0.02080 GN=SEC61A2 0.06310 GN=PLAA 0.22090
GN=H2AFV 0.02200 GN=FASN 0.06400 GN=PSMD2 0.22840
GN=PCBP1 0.02440 GN=RANBP2 0.06450 GN=SETMAR 0.23370
GN=EWSR1 0.02470 GN=RPS13 0.06570 GN=HNRNPH1 0.24060
GN=SRRM1 0.02470 GN=RPS27A 0.06670 GN=UQCRC2 0.24200
GN=SSBP3 0.02610 GN=ACADM 0.06960 GN=SSR4 0.24580
GN=ATP5A1 0.02690 GN=HSPD1 0.07050 GN=RANGAP1 0.24630
GN=TARDBP 0.02710 GN=PRKDC 0.07270 GN=WHSC1 0.24960
47Chapter 4
GN=YARS 0.02720 GN=HADHA 0.07400 GN=VIM 0.25160
GN=SF3B3 0.02750 GN=MARS 0.07520 GN=RPS8 0.25760
GN=HUWE1 0.02850 GN=HIST1H4A 0.07520 GN=TNPO1 0.27170
GN=EEF1A2 0.02890 GN=FBXO45 0.07950 GN=EPRS 0.27820
GN=ARHGEF2 0.03020 GN=RPL27 0.08030 GN=PCK2 0.31720
GN=XPOT 0.03030 GN=SUCLA2 0.08160 GN=PABPC1L 0.32110
GN=RPS16 0.03280 GN=HADHB 0.08670 GN=FLNC 0.34320
GN=ARMC6 0.03290 GN=KPNA6 0.08740 GN=CLTC 0.34360
GN=P4HA1 0.03290 GN=RPS27 0.08840 GN=NUP93 0.36060
GN=HNRNPK 0.03400 GN=TRIP6 0.08840
N.B. Only gene names were given for the putative UNR-interacting proteins to save table space
due to the large number of suggested hits. This means that some identifiers are repeated due
to different isoforms being suggested. The t-test p-values are for a two tailed paired t-test
without multiple testing correction and increase from top to bottom for each column, starting
on the left. Yellow shading denotes proteins that were recorded in UNR samples only.
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Table 4.5E: Top putative UNR interacting proteins in both plus and minus arsenite SaOS-2
samples
RL27_HUMAN 60S ribosomal protein L27 (GN=RPL27)
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4)
Cluster of SSBP3_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3)
LDB1_HUMAN Isoform 3 of LIM domain-binding protein 1 (GN=LDB1)
PGAM5_HUMAN Serine/threonine-protein phosphatase PGAM5, mitochondrial
(GN=PGAM5)
Cluster of SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1)
Cluster of ARHG2_HUMAN Rho guanine nucleotide exchange factor 2 (GN=ARHGEF2)
RS27_HUMAN 40S ribosomal protein S27 (GN=RPS27)
H4_HUMAN Histone H4 (GN=HIST1H4A)
Cluster of HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1)
RS18_HUMAN 40S ribosomal protein S18 (GN=RPS18)
Cluster of SRSF6_HUMAN Serine/arginine-rich splicing factor 6 (GN=SRSF6)
RS14_HUMAN 40S ribosomal protein S14 (GN=RPS14)
EWS_HUMAN RNA-binding protein EWS (GN=EWSR1)
Cluster of C9J0D1_HUMAN Histone H2A (GN=H2AFV)
RL23_HUMAN 60S ribosomal protein L23 (GN=RPL23)
Cluster of A9Z1X7_HUMAN Serine/arginine repetitive matrix protein 1 (GN=SRRM1)
Cluster of RS3_HUMAN 40S ribosomal protein S3 (GN=RPS3)
Cluster of J3KQE5_HUMAN GTP-binding nuclear protein Ran (Fragment) (GN=RAN)
Cluster of F5H5D3_HUMAN Tubulin alpha-1C chain (GN=TUBA1C)
Cluster of CO4A_HUMAN Complement C4-A (GN=C4A)
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34)
Cluster of RS6_HUMAN 40S ribosomal protein S6 (GN=RPS6)
Cluster of M0R210_HUMAN 40S ribosomal protein S16 (GN=RPS16)
Cluster of CSDE1_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1)
Cluster of TBB5_HUMAN Tubulin beta chain (GN=TUBB)
Cluster of H2B1D_HUMAN Histone H2B type 1-D (GN=HIST1H2BD)
Cluster of HSP7C_HUMAN Heat shock cognate 71 kDa protein (GN=HSPA8)
SETMR_HUMAN Histone-lysine N-methyltransferase SETMAR (GN=SETMAR)
GRP78_HUMAN 78 kDa glucose-regulated protein (GN=HSPA5)
MCM7_HUMAN DNA replication licensing factor MCM7 (GN=MCM7)
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP)
P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 (GN=P4HA2)
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4.6.2 Discussion of putative UNR interactors found using SaOS-2 cell lysates
As with the U2OS samples, UNRIP, LDB1, NARR, HUWE1 and SSBP3 were suggested hits in both
the plus and minus arsenite SaOS-2 samples (Tables 4.4E, 4.5E). The first four of these were also
hits for both the plus and minus arsenite HeLa samples (Table 4.3), strongly suggesting that they
may be true UNR-interacting proteins. As stated previously, SSBP3 was flagged as a putative
UNR-interacting protein in both trial runs with unstressed HeLa cells (Table 4.1) and both plus
and minus arsenite U2OS samples (Table 4.4E).
Two general observations were made concerning the SaOS-2 data. The first was that that the
IgG samples did not contain as many proteins relative to the UNR samples, in comparison to the
corresponding IgG/UNR sample pairs in the other cell types. One way this can be seen is by the
number of ‘yellow’ putative hits for SaOS-2 compared with the other cell types. The other
observation was that there were more keratins in the top ten hits by total ion current (Table
4.6).
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Table 4.6: Top hits by Total Ion Intensity by cell type
HeLa U2OS SaOS-2
MYH9 S. aureus Protein A S. aureus Protein A
S. aureus Protein A MYH9 TRYP_PIG
TRYP_PIG TRYP_PIG KRT10
ACTBL2 ACTG1 KRT5
TPM1 KRT1 KRT1
KRT10 TPM3 K1C9
KRT2 ALBU_BOVIN SRRM2
MYO1C KRT14 HUWE1
MYO1E MYL9 CSDE1
ALBU_BOVIN K1C9 PRKDC
It was noted that UNR was one of the top ten hits for SaOS-2 but not the other cell types. Whilst
it is assumed that the observations made were a perfectly representative sample of what would
be seen if the experiment were to be repeated many more times, a few points must first be
considered here. One point concerns myosin which is a top hit for both HeLa and U2OS, but not
for SaOS-2. Exploring the overall SaOS-2 data, there was only one myosin observed as a potential
interactor (MYO1B). This was very close to the bottom of the SaOS-2 list (330/398), only being
observed at a low level (86361 normalised ion counts) and only in one of the twelve samples
(UNR, plus arsenite, repeat 3). Interestingly, osteosarcoma cells overexpress MYH9 and it is
associated with invasion and metastasis (Zhou et al., 2016). Whilst this is potentially interesting,
it must be stated that the final bead washing steps for the U2OS and HeLa RIP samples were
kindly carried out by Dr Swagat Ray (present address University of Sheffield), whereas the author
carried out the wash step for the SaOS-2 samples. The idea that the SaOS-2 washes may have
been more stringent has been considered at several points over the past year. It could
potentially explain the observation that the SaOS-2 IgG samples were cleaner than those of the
other cell types. A highly expressed protein could be expected to bind non-specifically to IgG and
even more so to a test antibody that pulls down some specific protein complexes that increase
the overall protein surface available to bind to non-specific interactors. In the absence of further
investigation, it must remain mere conjecture, but it is possible that myosin is a false positive.
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4.7 Summary of chapter so far
It has been shown that RIP-mass spectrometry can be used to detect putative UNR-interacting
proteins in HeLa cells. This was shown to be reproducible across different experiments, even
where different sample preparation techniques were used. Furthermore, the detection of a
group of similar proteins following arsenite treatment lends further support to the idea that the
data is reproducible. Whereas it is expected from previous work in the lab that UNR localisation
changes following arsenite stress, there is no reason to assume that UNR jettisons its entire set
of interactors and migrates to stress granules with an entirely different set. Indeed, the working
hypothesis in the lab is that at least one intracellular pool of UNR migrates to stress granules, or
has stress granules form around it, whilst still being bound to the same collection of mRNA
species.
It has further been shown that a proportion of the top putative UNR-interacting proteins from
other cell lines are also among the top hits for HeLa cells. The fact that there are differences as
well as similarities supports the idea that UNR binds a common group of proteins but also binds
to others in a cell type-dependent manner.
As a result of these reassuring observations, it was decided to proceed to using more
quantitative software, Progenesis (Nonlinear Dynamics, Newcastle upon Tyne, England), on the
main experimental data to find final lists of putative interacting proteins that could then be
exported for GO term analysis.
4.8 Progenesis
It was considered useful to carry out GO term enrichment analysis on putative UNR interacting
proteins in order to see if UNR binds to functionally related groups of proteins. In order to obtain
more quantitative estimates for the amount of proteins detected by mass spectroscopy, it was
decided to use the Progenesis software.
52Chapter 4
Briefly, files containing raw data from the mass spectrometer for each sample to be compared
were loaded into Progenesis. Default setting were employed in which Progenesis selected a
sample to use as an alignment reference followed by carrying out automatic alignment of the
samples. The degree of similarity between samples was provided by Progenesis, allowing for the
identification and removal of potential outliers. As it was, staff in the proteomics department
assured that all samples were within an acceptable range and no samples were removed.
Following alignment and the quantification of potential peptides, the data were then exported
to the Mascot server (Matrix Science, London, England) for peptide identification. The Mascot
output files were then imported back into Progenesis and were automatically associated with
their respective proteins. Low Mascot scoring proteins (score <30) and all keratins were then
removed from the data. As a result of expected contamination due to the RIP protocol, pig
trypsin and bovine proteins were removed, as were IgG immunoglobulins.
It was decided to use Progenesis’ ‘normalise to all proteins’ function, as outlined at:
http://nonlinear.com/progenesis/qi-for-proteomics/v2.0/faq/how-normalisation-works.aspx.
4.9 Results using Progenesis – HeLa samples
4.9.1 Progenesis analysis
In order to be confident in the identity of the peptides assigned to proteins, a series of tags were
designed to label those with questionable credentials. The tags included:
1) features with no MS/MS data (i.e. things detected by the mass spectrometer, that may
be peptides or contaminants, that Mascot did not recognise as a peptide under the
search parameters selected – these could be modified peptides),
2) putative peptides that did not have protein IDs assigned to them,
3) putative peptides in which the minus arsenite IgG samples were highest,
4) putative peptides in which the plus arsenite IgG samples were highest,
5) putative peptides with statistical power less than 0.7.
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These hits were hidden from subsequent consideration although some were later listed in the
protein report where a protein was considered significant independent of them.
Suggested proteins were then considered. Those that were most abundant in one of the two
IgGs groups were then tagged and removed. Finally, protein and peptide data were exported to
Excel and a Progenesis protein report was generated.
4.9.2 Progenesis results for HeLa RIP dataset
Principal component analysis can be used to locate outliers within a group of samples but it can
also be used to find groupings within samples (Wold et al., 1987). As it shows how the samples
cluster by principal component, it is possible to confirm that known biological variability (e.g.
cell type, drug treatment or whether the RIP was carried out with a test or control antibody,
etc.) is responsible for the observed variation in the data.
The HeLa samples were initially imported with 361527 MS/MS spectra, of which 54635 were
assigned to peptide ions. Prior to exporting to Excel, Principal Component Analysis (PCA) was
carried out on the samples. This can show how samples cluster over different components of
variability in the dataset and can be used to find outliers. It does that by showing whether or not
samples group by sources of known biological variability (e.g. arsenite treatment or
immunoprecipitating antibody) over the top principal components that, by definition, account
for the largest portions of variability in the data (Wold et al., 1987). In terms of the Progenesis-
computed PCA analysis, there are two plots – a loadings plot that shows how the variability
accounted for by each principal component is shared between each sample and a score plot that
shows how the variability accounted for by each principal component is shared between each
observation (e.g. peptide, protein or gene). These plots can be superimposed upon each other,
as in the default images produced by Progenesis (Wold et al., 1987). For further consideration
of the use of PCA as a tool (focusing on loadings plots), see section 4.2 below.
It was decided to remove proteins with an ANOVA p-value over 0.05. This was for several
reasons. Firstly, it improved the clustering of the repeats over the first two principle components
of the PCA which also accounted for more of the variance (Figure 4.13). Secondly, it was decided
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more important to detect a small number of UNR-interacting proteins with greater confidence
than to detect a larger number that was more likely to contain false positives. ANOVA detects
differences between group means, thereby ignoring the pairing in the data (the UNR and IgG
samples from a biological repeat were pulled down from exactly the same lysate and the plus
and minus arsenite treatment lysates from a particular repeat only differed in treatment one
hour prior to harvesting). This makes it more at risk of outliers skewing means and generating
false positives than paired t-tests. Paired t-tests look for differences in the differences between
the UNR and IgG samples for each repeat rather than the difference in their means. This is more
powerful and can better detect hits with small but consistent increases in UNR over IgG. By using
both tests, it makes it more likely that any hits that are detected will have both significantly
higher UNR means than IgG means and also show a general trend of UNR being higher than IgG.
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A
B
Figure 4.13: Progenesis-generated PCA plots for HeLa data. Proteins with all ANOVA p-values (A)
or only those with ANOVA p-values under 0.05 (B) were included. See text for further
information how the data were processed. Numbers are associated with the days upon which
the lysates were made (i.e. the repeats). Blue = no arsenite, IgG; purple = no arsenite, UNR;
orange = plus arsenite, IgG; green = plus arsenite, UNR. In terms of variance accounted for – A:
(PC1 = 59.09%, PC2 = 15.04%); B: (PC1 = 57.61%, PC2 = 23.05%). The grey writing in the
background makes up the protein score plot (see text for discussion of score plots). The red
writing refers to an automatically highlighted protein ID, selected alphabetically.
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Having exported the data into Excel, paired t-tests were carried out on the plus and minus
arsenite samples separately. This suggested 25 putative UNR interacting proteins from the
minus arsenite samples when the cut off p-value was set at 0.1 (Table 4.7B), the top ten putative
UNR interactors being recorded by p-value in Table 4.7A. Meanwhile, 67 putative hits were
suggested for the plus arsenite data (Table 4.8B). The top ten of these, by t test p value, are
presented in Table 4.8A.
Table 4.7A: Top 10 putative HeLa minus arsenite UNR interacting proteins by t-test p-value
(using Progenesis data)
Protein HeLa1 HeLa2 HeLa3 HeLa4 HeLa5 HeLa6 p-value
HNRNPR 1484 4209 1090 18582 20973 17261 0.0003
UNR (E9PLT0) 675629 1432042 978551 8203345 8312966 7468645 0.0019
SSBP2 9576 9430 9565 2855595 2442834 2576302 0.0022
UNR (CSDE1) 617677 1294118 892943 5277410 5125360 4775903 0.0042
SSBP3 13708 20111 42631 3465982 3242002 4053717 0.0043
P2RY12 2339 3920 1969 21546 27268 26049 0.0046
C4A 5006 1456 0 164581 127163 148054 0.0047
NARR 14859 16754 23707 1760160 2189489 2435130 0.0084
LDB1 26760 85648 60981 2145634 1936377 2763112 0.0125
RPS18 2392444 3641255 1930012 3150191 4154056 2662038 0.0133
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa1-HeLa3). The corresponding
UNR samples are shaded green and also run left to right (HeLa4-HeLa6). The t-test p-values are
for a two tailed paired t-test without multiple testing correction. Two UNR proteins were
highlighted in the top ten; the respective Progenesis-derived identifiers are provided in
parentheses.
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Table 4.7B: Putative UNR interacting proteins by t-test from HeLa minus arsenite samples
(using Progenesis data with an unadjusted p-value cut-off of p=0.05)
Protein p-value
HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R (GN=HNRNPR) 0.00026
E9PLT0_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 0.00188
A0A087X159_HUMAN Single-stranded DNA-binding protein 2 (GN=SSBP2) 0.00215
CSDE1_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 0.00419
A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 0.00430
P2Y12_HUMAN P2Y purinoceptor 12 (GN=P2RY12) 0.00463
CO4A_HUMAN Complement C4-A (GN=C4A) 0.00470
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 0.00842
LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 0.01253
RS18_HUMAN 40S ribosomal protein S18 (GN=RPS18) 0.01329
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 0.01465
TRI25_HUMAN E3 ubiquitin/ISG15 ligase TRIM25 (GN=TRIM25) 0.02343
Q05BK6_HUMAN Protein TFG (GN=TFG) 0.02749
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4) 0.03034
A0A087WZL3_HUMAN Tyrosine-protein kinase receptor (GN=ALK) 0.03048
CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1
(GN=CSDE1 0.04178
E9PMM9_HUMAN 40S ribosomal protein S2 (Fragment) (GN=RPS2) 0.05057
FSCN1_HUMAN Fascin (GN=FSCN1) 0.05879
SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic (GN=AARS) 0.05934
SRSF3_HUMAN Serine/arginine-rich splicing factor 3 (GN=SRSF3) 0.06548
I3L182_HUMAN Serine/arginine repetitive matrix protein 2 (Fragment)
(GN=SRRM2) 0.07263
E9PQD7_HUMAN 40S ribosomal protein S2 (GN=RPS2) 0.07390
E7EMC7_HUMAN Sequestosome-1 (GN=SQSTM1) 0.07701
A0A087X1I3_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein
subunit, mitochondrial (GN=SDHA) 0.08195
RINI_HUMAN Ribonuclease inhibitor (GN=RNH1) 0.09982
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Table 4.8A: Top ten putative HeLa plus arsenite UNR interacting proteins by t-test p-value
(using Progenesis data)
Description HeLa7 HeLa8 HeLa9 HeLa10 HeLa11 HeLa12 p-value
RPS23 189587 307227 608349 683612 812599 1136187 0.0004
SSBP3 21971 20181 133066 1972922 2219222 2205696 0.0012
ALK 262326 240564 249102 398416 359831 361803 0.0032
NARR 7306 8763 34080 1671992 1540368 1912650 0.0036
EIF2A 1182 4059 20313 68570 82766 103307 0.0037
RPL38 60934 100721 143662 240446 332399 363123 0.0056
SSBP2 13362 5506 8641 2549008 2247058 1897033 0.0070
RNH1
(E9PIK5) 68991 151294 1121271 944800 1267502 1973206 0.0078
LMO4 8132 13706 3252 1083616 1156444 1436151 0.0080
RNH1
(RNH1) 83883 201182 1698218 1370368 1955670 3032133 0.0102
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa7-HeLa9). The corresponding
UNR samples are shaded green and also run left to right (HeLa10-HeLa12). The t-test p-values
are for a two tailed paired t-test without multiple testing correction. Two RNH1 proteins were
highlighted in the top ten; the respective Progenesis-derived identifiers are provided in
parentheses.
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Table 4.8B: Putative UNR interacting proteins by t-test from HeLa plus arsenite samples
(using Progenesis data with an unadjusted p-value cut-off of p=0.05)
Protein p-value
D6RD47_HUMAN 40S ribosomal protein S23 (GN=RPS23) 0.00038
A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 0.00119
A0A087WZL3_HUMAN Tyrosine-protein kinase receptor (GN=ALK) 0.00321
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 0.00355
F8WAE5_HUMAN Eukaryotic translation initiation factor 2A (GN=EIF2A) 0.00369
J3KSP2_HUMAN 60S ribosomal protein L38 (Fragment) (GN=RPL38) 0.00557
A0A087X159_HUMAN Single-stranded DNA-binding protein 2 (GN=SSBP2) 0.00702
E9PIK5_HUMAN Ribonuclease inhibitor (Fragment) (GN=RNH1) 0.00783
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4) 0.00802
RINI_HUMAN Ribonuclease inhibitor (GN=RNH1) 0.01024
E9PJD9_HUMAN 60S ribosomal protein L27a (GN=RPL27A) 0.01175
PCBP1_HUMAN Poly(rC)-binding protein 1 (GN=PCBP1) 0.01204
F5H2T0_HUMAN Elongator complex protein 1 (GN=IKBKAP) 0.01228
LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 0.01307
CO4A_HUMAN Complement C4-A (GN=C4A) 0.01317
FAS_HUMAN Fatty acid synthase (GN=FASN) 0.01320
I3L182_HUMAN Serine/arginine repetitive matrix protein 2 (Fragment)
(GN=SRRM2) 0.01602
J3KT73_HUMAN 60S ribosomal protein L38 (GN=RPL38) 0.01861
H3BRU6_HUMAN Poly(rC)-binding protein 2 (Fragment) (GN=PCBP2) 0.02154
F6RFD5_HUMAN Destrin (GN=DSTN) 0.02474
D6R9Z1_HUMAN Guanine nucleotide-binding protein subunit beta-2-like 1
(Fragment) (GN=GNB2L1) 0.02519
E9PMM9_HUMAN 40S ribosomal protein S2 (Fragment) (GN=RPS2) 0.02536
SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic (GN=AARS) 0.02577
E9PQD7_HUMAN 40S ribosomal protein S2 (GN=RPS2) 0.02614
HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R (GN=HNRNPR) 0.02710
A0A087WYT3_HUMAN Prostaglandin E synthase 3 (GN=PTGES3) 0.02935
P2Y12_HUMAN P2Y purinoceptor 12 (GN=P2RY12) 0.02989
CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1
(GN=CSDE1) 0.03023
A0A075B730_HUMAN Epiplakin (GN=EPPK1) 0.03178
E9PPT0_HUMAN 40S ribosomal protein S2 (GN=RPS2) 0.03203
Q5T6W2_HUMAN Heterogeneous nuclear ribonucleoprotein K (Fragment)
(GN=HNRNPK) 0.03302
B4DXZ6_HUMAN Fragile X mental retardation syndrome-related protein 1
(GN=FXR1) 0.03337
H0YEU2_HUMAN 40S ribosomal protein S3 (Fragment) (GN=RPS3) 0.03337
A0A0D9SFL3_HUMAN RNA-binding protein EWS (GN=EWSR1) 0.03351
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EF2_HUMAN Elongation factor 2 (GN=EEF2) 0.03383
TADBP_HUMAN TAR DNA-binding protein 43 (GN=TARDBP) 0.03518
CSDE1_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 0.03577
SND1_HUMAN Staphylococcal nuclease domain-containing protein 1
(GN=SND1) 0.03618
B1AH49_HUMAN Sulfurtransferase (GN=MPST) 0.03642
MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 (GN=MYCBP2) 0.03940
ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 (GN=ZC3HAV1) 0.04165
E9PFP8_HUMAN Poly(rC)-binding protein 3 (GN=PCBP3) 0.04277
A0A087X1I3_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein
subunit, mitochondrial (GN=SDHA) 0.04313
E9PLT0_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 0.04357
STRAP_HUMAN Serine-threonine kinase receptor-associated protein
(GN=STRAP) 0.04656
EPIPL_HUMAN Epiplakin (GN=EPPK1) 0.04902
G3V1A4_HUMAN Cofilin 1 (Non-muscle), isoform CRA_a (GN=CFL1) 0.04947
I3L397_HUMAN Eukaryotic translation initiation factor 5A (Fragment)
(GN=EIF5A) 0.05004
IF2G_HUMAN Eukaryotic translation initiation factor 2 subunit 3 (GN=EIF2S3) 0.05009
NSUN2_HUMAN tRNA (cytosine(34)-C(5))-methyltransferase (GN=NSUN2) 0.05026
HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K (GN=HNRNPK) 0.05028
RS18_HUMAN 40S ribosomal protein S18 (GN=RPS18) 0.05052
K7EJT5_HUMAN 60S ribosomal protein L22 (Fragment) (GN=RPL22) 0.05817
XP32_HUMAN Skin-specific protein 32 (GN=XP32) 0.05887
M0QXS5_HUMAN Heterogeneous nuclear ribonucleoprotein L (Fragment)
(GN=HNRNPL) 0.06395
TRI25_HUMAN E3 ubiquitin/ISG15 ligase TRIM25 (GN=TRIM25) 0.06435
TRIP6_HUMAN Thyroid receptor-interacting protein 6 (GN=TRIP6) 0.06435
RS3_HUMAN 40S ribosomal protein S3 (GN=RPS3) 0.06822
I3L3P7_HUMAN 40S ribosomal protein S15a (GN=RPS15A) 0.07117
RS10_HUMAN 40S ribosomal protein S10 (GN=RPS10) 0.07213
M0QZN2_HUMAN 40S ribosomal protein S5 (GN=RPS5) 0.07301
A0A087WZ27_HUMAN Zinc finger protein 90 (GN=ZNF90) 0.07448
X6RLN4_HUMAN La-related protein 4 (Fragment) (GN=LARP4) 0.07573
HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1) 0.08909
MCTP2_HUMAN Multiple C2 and transmembrane domain-containing protein 2
(GN=MCTP2) 0.08947
H0YL92_HUMAN Importin-4 (GN=IPO4) 0.09628
FSCN1_HUMAN Fascin (GN=FSCN1) 0.09700
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The peptides of some of the suggested hits were analysed to check that they were all following
the same general trend in terms of being higher in the group that was suggested to be higher
(e.g. UNR pulldowns from the HeLa plus arsenite lysates) and similar in every repeat (Figure
4.14). Such a pattern would be in keeping with a genuine hit, whereas a more random pattern
would suggest that some of the peptides had been incorrectly assigned and that the protein
was, therefore, a more questionable hit.
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Figure 4.14: Standardised normalised abundances for peptides assigned to specific proteins
(A=UNR, B=UNRIP, C = LDB1, D=SSBP3) from the HeLa samples. The repeats in the blue column
are IgG (minus arsenite), the repeats in the purple column are UNR (minus arsenite), the repeats
in the orange column are IgG (plus arsenite) and the repeats in the green column are UNR (plus
arsenite).
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The peptides for UNR and LDB1 followed approximately the same pattern as each other,
supporting the idea that they may come from the same protein. One peptide for UNRIP (most
pronounced in green, UNR plus arsenite, panel) and one for SSBP3 (low in purple, UNR minus
arsenite, and green, UNR plus arsenite, panels), however, seemed to follow a different pattern
to the others (Figure 4.14). This implies that those peptides may have been incorrectly assigned
to the protein.
Finally, fold change data was considered. A fold change minimum of 10 was set as a significance
cut off point (again only considering the data with ANOVA p-value of 0.05 or less). This gave a
set of suggested UNR-interacting proteins in unstressed HeLa (Table 4.9B) and in arsenite
stressed HeLa (Table 4.10B). The top ten putative UNR-interacting proteins in each case are
presented in Tables 4.9A and 4.10A, respectively.
Table 4.9A: Top 10 putative HeLa minus arsenite UNR interacting proteins by mean UNR/IgG
ratios (using Progenesis data)
Description HeLa1 HeLa2 HeLa3 HeLa4 HeLa5 HeLa6 Ratio
ILF2 0 0 0 10400 11648 1425 ∞ 
LMO4 5126 5328 2150 1875371 1747171 2977132 524
SSBP2 9576 9430 9565 2855595 2442834 2576302 276
TAF15 1324 264 1686 735092 131738 11583 268
FUS 7301 420 919 1244136 272313 28064 179
SSBP3 13708 20111 42631 3465982 3242002 4053717 141
NARR 14859 16754 23707 1760160 2189489 2435130 115
C4A 5006 1456 0 164581 127163 148054 68
HUWE1 859 514 11976 75310 118533 430660 47
LDB1 26760 85648 60981 2145634 1936377 2763112 39
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa1-HeLa3). The corresponding
UNR samples are shaded green and also run left to right (HeLa4-HeLa6). Ratios are
mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value was greater than
zero. The yellow shading highlights a protein absent in every IgG sample but present in every
UNR sample.
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Table 4.9B: Putative HeLa minus arsenite UNR interacting proteins by mean UNR/IgG ratios
(using Progenesis data)
Description Ratio
B4DY09_HUMAN Interleukin enhancer-binding factor 2 (GN=ILF2) ∞ 
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4) 524
A0A087X159_HUMAN Single-stranded DNA-binding protein 2 (GN=SSBP2) 276
RBP56_HUMAN TATA-binding protein-associated factor 2N (GN=TAF15) 268
H3BPE7_HUMAN RNA-binding protein FUS (GN=FUS) 179
A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 141
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 115
CO4A_HUMAN Complement C4-A (GN=C4A) 68
HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1) 47
LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 39
Q05BK6_HUMAN Protein TFG (GN=TFG) 32
MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 (GN=MYCBP2) 21
I3L182_HUMAN Serine/arginine repetitive matrix protein 2 (Fragment) (GN=SRRM2) 18
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 16
D6R9Z1_HUMAN Guanine nucleotide-binding protein subunit beta-2-like 1 (Fragment)
(GN=GNB2L1) 14
SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1) 13
A0A075B7D9_HUMAN TATA-binding protein-associated factor 2N (GN=TAF15) 12
N.B. The yellow shading highlights a protein absent in every IgG sample but present in every
UNR sample – this therefore produces an infinite UNR/IgG ratio.
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Table 4.10A: Top 10 putative HeLa plus arsenite UNR interacting proteins by ratio (using
Progenesis data)
Description HeLa7 HeLa8 HeLa9 HeLa10 HeLa11 HeLa12 Ratio
RANGAP1 126 0 0 11726 50295 4087 526
TAF15 64 0 2142 594692 217939 20502 378
FUS 2940 0 257 690464 339086 43128 335
SSBP2 13362 5506 8641 2549008 2247058 1897033 243
LMO4 8132 13706 3252 1083616 1156444 1436151 147
TFG 781 1316 11614 309614 925356 419564 121
NARR 7306 8763 34080 1671992 1540368 1912650 102
UNR 597845 805286 1371284 75654890 90439807 41375065 75
UNRIP 540420 543636 950744 55449907 65199826 28849813 73
P2RY12 368 1453 5270 146665 163822 91204 57
N.B. IgG samples shaded lilac, repeat 1-3 running left to right (HeLa7-HeLa9). The corresponding
UNR samples are shaded green and also run left to right (HeLa10-HeLa12). Ratios are
mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value was greater than
zero.
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Table 4.10B: Putative HeLa plus arsenite UNR interacting proteins by mean UNR/IgG ratios
(using Progenesis data)
Description Ratio
RAGP1_HUMAN Ran GTPase-activating protein 1 (GN=RANGAP1) 526
RBP56_HUMAN TATA-binding protein-associated factor 2N (GN=TAF15) 378
H3BPE7_HUMAN RNA-binding protein FUS (GN=FUS) 335
A0A087X159_HUMAN Single-stranded DNA-binding protein 2 (GN=SSBP2) 243
LMO4_HUMAN LIM domain transcription factor LMO4 (GN=LMO4) 147
Q05BK6_HUMAN Protein TFG (GN=TFG) 121
NARR_HUMAN Ras-related protein RAB34, isoform NARR (GN=RAB34) 102
E9PLT0_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 75
STRAP_HUMAN Serine-threonine kinase receptor-associated protein (GN=STRAP) 73
P2Y12_HUMAN P2Y purinoceptor 12 (GN=P2RY12) 57
CSDE1_HUMAN Cold shock domain-containing protein E1 (GN=CSDE1) 56
LDB1_HUMAN LIM domain-binding protein 1 (GN=LDB1) 52
CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1 (GN=CSDE1) 52
SQSTM_HUMAN Sequestosome-1 (GN=SQSTM1) 41
B4DY09_HUMAN Interleukin enhancer-binding factor 2 (GN=ILF2) 39
A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 (GN=SSBP3) 37
B1ANR0_HUMAN Polyadenylate-binding protein (GN=PABPC4) 31
E7EMC7_HUMAN Sequestosome-1 (GN=SQSTM1) 28
A0A087WTT1_HUMAN Polyadenylate-binding protein (GN=PABPC1) 25
A0A075B7D9_HUMAN TATA-binding protein-associated factor 2N (GN=TAF15) 18
RBP2_HUMAN E3 SUMO-protein ligase RanBP2 (GN=RANBP2) 16
HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 (GN=HUWE1) 14
I3L182_HUMAN Serine/arginine repetitive matrix protein 2 (Fragment)
(GN=SRRM2) 12
CO4A_HUMAN Complement C4-A (GN=C4A) 12
MCTP2_HUMAN Multiple C2 and transmembrane domain-containing protein 2
(GN=MCTP2) 11
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4.9.3 Discussion of putative UNR-interacting proteins in HeLa (Progenesis)
By eye, the top ten HeLa minus arsenite samples by p-value were encouraging (Table 4.7). The
differences between the IgG and UNR samples were quite pronounced. There were two entries
associated with UNR. As stated previously, it is unlikely that E9PLTO is physiologically relevant
and was likely to have been flagged up as a result of parsimony-based algorithms assigning
relatively more peptides to a shorter entry than for a larger one. It was reassuring to see that it
is not the only entry in the top ten. Furthermore, three of the top ten hits have been mentioned
previously (LDB1, NARR and SSBP3). The last of these was present in the company of the
functionally related SSBP2. The top hit, showing more than a tenfold increase in UNR samples
over IgG samples is HNRNPR. This, and the ribosomal protein S18, were also in keeping with the
assumption that UNR interacts with and modulates the translation of mRNAs. The other two
hits, a P2Y receptor and a complement protein are interesting but their relevance were not
immediately apparent.
There was some overlap between the top ten putative UNR-interacting proteins in non-arsenite
treated HeLa cells by t-test p-value (Table 4.7) and by UNR/IgG ratio (Table 4.9). SSBP2 and SSBP3
were both present, as was NARR, LDB1 and the complement protein C4-A. LMO4 had the highest
non-infinite ratio, giving strong support to the idea that this protein is a true UNR-interactor.
FUS and the related TAF15 are members of the TET family that has a variety of cellular functions
(Takahama et al., 2008). These include the control of alternative splicing and transcription
(Ishigaki et al., 2012), the regulation of a variety of different protein levels in neurons (Ibrahim
et al., 2013) and they are involved in various pathologies (discussed in Schwartz et al. 2015).
Interestingly, although the HeLa cells in this case were unstressed, both FUS and TAF15 are
known to migrate to stress granules in stressed cells (Blechingberg et al., 2012). Another
interesting protein in the top ten UNR/IgG ratio list was the ubiquitin E3 ligase HUWE1. HUWE1,
which has been linked to multiple cancers, has multiple aliases (succinctly reviewed in Choe et
al. 2016). It has been reported to promote the restart of replication at stalled replication forks
(Choe et al., 2016). It is also linked to X-linked intellectual impairment (Orivoli et al., 2016).
Intriguingly, the Huwe1 gene is host to miR-98 and the expression of the pair was shown to be
positively correlated (Xu et al., 2015). Furthermore, miR-98 was shown to downregulate the
effector caspase, Caspase 3 (Xu et al., 2015). Fas expression was also shown to be
downregulated by miR-98 (Wang et al., 2011). Whilst not directly related to the putative
interaction between UNR and HUWE1, per se, these findings regarding miR-98 imply that
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HUWE1 gene can have an oncogenic function beyond the HUWE1 protein by reducing the ability
of the cell to undergo apoptosis. The top hit by ratio was Interleukin enhancer-binding factor 2.
It was not present in the IgG samples and was by far the lowest of the top ten in terms of the
amount being bound to UNR. It is also known as NF45 and can reduce the production of mature
miRNAs in conjunction with ILF3 (also known as NF90) (Sakamoto et al., 2009). It is upregulated
in non-small cell lung cancer, where it is correlated with a poor prognosis (Ni et al., 2015), and
is involved in splicing and in the DNA damage response in 1q21-amplified multiple myeloma
(Marchesini et al., 2014). It was noted that multiple myeloma related proteins had been
discussed previously (Figure 4.11).
The top ten putative UNR-interacting proteins from arsenite-treated HeLa cell lysates by t-test
p-value were also of interest (Table 4.8). As well as many of the common hits (e.g. SSBP3, NARR,
SSBP2 and LMO4), there were five proteins directly linked to RNA. These were the ribosomal
proteins S23 and L38, eukaryotic translation initiation factor 2A and two entries for Ribonuclease
inhibitor. It was worth noting that the recombinant RNase OUT ribonuclease inhibitor
(Invitrogen) had been added to the samples prior to the RIP step. That observation led to two
assumptions; either the highlighted RNase inhibitor was the exogenous RNase Out or,
alternatively, the human protein that was suggested was genuinely present. Given that the
Mascot searches used a human database, either option seems reasonable. As RNase inhibitors
could be associated with the RNA species that were part of RNP complexes with UNR, that could
imply that UNR was associated with more RNA species, or had at least pulled down more RNA
molecules, in the plus arsenite samples than in the minus arsenite samples. The other hit,
anaplastic lymphoma receptor tyrosine kinase, is interesting due to it being a membrane-bound
protein. It is involved in neuronal differentiation (Gouzi et al., 2005) and, unusually, it is activated
in a ligand-independent manner (Deuel, 2013). It can become fused to a variety of proteins by
genetic translocations, these include MYH9 which had been suggested as the top hit by total ion
intensity in Scaffold (Table 4.6) (Lamant et al., 2003).
The top ten putative UNR-interacting proteins in arsenite-treated HeLa cells by UNR/IgG ratio
contained many of the proteins already discussed (Table 4.10). These included; TAF15, FUS,
SSBP2, LMO4, NARR, UNR itself and UNRIP. The remaining proteins included Ran GTPase-
activating protein 1 (RANGAP1). The canonical function of a GAP protein is to activate the
GTPase activity of small monomeric G proteins, thereby causing them to cleave their associated
GTP and functioning as an ‘off switch’. The rangap1 protein was shown to function in the
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regulation of kinetochores and knocking it down prevented activation of the spindle checkpoint
(Arnaoutov & Dasso, 2003). SUMOylation with SUMO1 was involved with causing RANGAP1 to
migrate to the nuclear pore (Matunis et al., 1998). RANGAP1 has also been associated with a
number of cancers including diffuse large B cell lymphoma (Chang et al., 2013). The ‘TRK-fused
gene’ protein is involved in regulating endoplasmic reticulum structure and protein release
(Beetz et al., 2013). It is interesting in that it is a potential fusion partner for one of the proteins
noted above as a top hit by t-test from lysate made from arsenite-treated HeLa cells (ALK, Table
4.8A). The last remaining suggested top hit was the same P2Y receptor (P2RY12) as was
suggested in the untreated HeLa samples by t-test. It is involved in platelet activation (discussed
in Dorsam & Kunapuli 2004) and is the target of clopidogrel (Savi et al., 2001).
4.9.4 Progenesis results for HeLa RIP dataset exported to AmiGO 2
The plus and minus arsenite hits suggested by Progenesis were exported separately to AmiGO 2
version 2.3.2 at http://amigo.geneontology.org/rte.
To do this, all proteins that were considered significant (i.e. having a t-test p-value under 0.1 or
having a UNR/IgG ratio of over ten) were exported to Excel. Gene names (‘GN=’) were then
isolated (except for NARR which is known to function differently to Rab34), duplicates were
removed and the remaining gene names were entered into the tool and searched using the
following annotation data sets:
 GO biological process complete,
 GO molecular function complete,
 GO cellular component complete.
The GO term searches were carried out with the parameters in Table 4.11.
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Table 4.11: AmiGO 2 search parameters
Analysis Type: PANTHER Overrepresentation Test (release 20160321)
Annotation Version and
Release Date:
GO Ontology database Released 2016-04-23
Analysed List: upload_1 (Homo sapiens)
Reference List: Homo sapiens (all genes in database)
Bonferroni correction: TRUE
4.9.5 GO term results for HeLa minus arsenite
A total of 34 individual proteins were entered into AmiGO 2 and all of them were recognised by
the tool expect for NARR. Faced with the decision of including an entirely different protein
(Rab34) or excluding NARR altogether, the latter option was considered more appropriate.
A Bonferroni multiple testing corrected p-value of 0.05 was chosen as the significance cut off
point and the top ten enriched GO terms by adjusted p-value, where possible, were recorded in
Table 4.12 (Table 4.12A = biological process, Table 4.12B = molecular function, Table 4.12C =
cellular component).
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Table 4.12A: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(HeLa minus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process (GO:0016071) 625 13 1 13.1 4.34E-08
RNA processing (GO:0006396) 930 13 1.5 8.82 5.74E-06
mRNA catabolic process (GO:0006402) 206 7 0.3 21.4 2.62E-04
viral transcription (GO:0019083) 119 6 0.2 31.8 2.80E-04
viral gene expression (GO:0019080) 131 6 0.2 28.9 4.91E-04
RNA catabolic process (GO:0006401) 235 7 0.4 18.8 6.37E-04
multi-organism metabolic process
(GO:0044033) 159 6 0.3 23.8 1.52E-03
macromolecule catabolic process (GO:0009057) 1025 11 1.6 6.77 2.40E-03
selenocysteine metabolic process (GO:0016259) 88 5 0.1 35.8 2.40E-03
cellular macromolecule catabolic process
(GO:0044265) 807 10 1.3 7.82 2.58E-03
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp).
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Table 4.12B: All enriched molecular function GO terms, by Bonferroni adjusted p-value (HeLa
minus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
RNA binding (GO:0003723) 1718 21 2.7 7.71 6.40E-12
poly(A) RNA binding (GO:0044822) 1165 18 1.9 9.75 3.61E-11
nucleic acid binding (GO:0003676) 4514 26 7.2 3.63 1.24E-08
heterocyclic compound binding (GO:1901363) 6512 28 10 2.71 7.92E-07
organic cyclic compound binding (GO:0097159) 6581 28 10 2.68 1.04E-06
mRNA binding (GO:0003729) 160 7 0.3 27.6 1.54E-05
protein binding (GO:0005515) 10761 29 17 1.7 3.44E-02
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp). As there were only 7 enriched GO terms that passed the Bonferroni
multiple testing correction, all significantly enriched GO terms were recorded.
73Chapter 4
Table 4.12C: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(HeLa minus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
cytosolic small ribosomal subunit (GO:0022627) 41 5 0.1 76.9 8.68E-06
ribonucleoprotein complex (GO:1990904) 750 11 1.2 9.25 1.59E-05
intracellular ribonucleoprotein complex
(GO:0030529) 750 11 1.2 9.25 1.59E-05
small ribosomal subunit (GO:0015935) 70 5 0.1 45.1 1.22E-04
macromolecular complex (GO:0032991) 4651 21 7.4 2.85 5.60E-04
cytosolic ribosome (GO:0022626) 110 5 0.2 28.7 1.12E-03
extracellular exosome (GO:0070062) 2725 16 4.3 3.7 1.21E-03
extracellular vesicle (GO:1903561) 2738 16 4.3 3.69 1.29E-03
extracellular organelle (GO:0043230) 2740 16 4.3 3.68 1.31E-03
organelle (GO:0043226) 12818 32 20 1.57 3.14E-03
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp).
4.9.6 Consideration of GO term results for HeLa minus arsenite
The top hits were largely related to RNA (Tables 4.12A, 4.12B, 4.12C). As UNR is known to be an
RNA-binding protein, this is not unexpected. Although it is already known, it would seem
reasonable to conclude from this data alone that UNR is likely to be intimately involved with
RNA.
Other than RNA related GO terms, viral gene expression and selenocysteine metabolic processes
were also noted from the biological process data (Table 4.12A). Extracellular
exosome/vesicle/organelle was also noted (Table 4.12C).
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4.9.7 GO term results for HeLa plus arsenite
Other than NARR, which was removed from the data as above, a total of 67 individual proteins
were entered into AmiGO 2 and all of them were recognised by the tool. A Bonferroni multiple
testing corrected p-value of 0.05 was chosen as the significance cut off point and the top ten
enriched GO terms by adjusted p-value were recorded in Table 4.13 (Table 4.13A = biological
process, Table 4.13B = molecular function, Table 4.13C = cellular component).
Table 4.13A: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(HeLa plus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process (GO:0016071) 625 23 2.01 11.4 1.17E-14
RNA processing (GO:0006396) 930 24 2.99 8.02 4.90E-12
RNA catabolic process (GO:0006401) 235 14 0.76 18.5 2.52E-10
translation (GO:0006412) 514 18 1.65 10.9 2.83E-10
peptide biosynthetic process (GO:0043043) 539 18 1.74 10.4 6.29E-10
mRNA catabolic process (GO:0006402) 206 13 0.66 19.6 1.11E-09
viral transcription (GO:0019083) 119 11 0.38 28.7 1.69E-09
nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay (GO:0000184) 119 11 0.38 28.7 1.69E-09
selenocysteine metabolic process (GO:0016259) 88 10 0.28 35.3 3.00E-09
viral gene expression (GO:0019080) 131 11 0.42 26.1 4.71E-09
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp).
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Table 4.13B: Top ten enriched molecular function GO terms, by Bonferroni adjusted p-value
(HeLa plus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
RNA binding (GO:0003723) 1718 45 5.53 8.14 2.05E-29
poly(A) RNA binding (GO:0044822) 1165 39 3.75 10.4 4.90E-28
nucleic acid binding (GO:0003676) 4514 51 14.53 3.51 9.33E-18
heterocyclic compound binding
(GO:1901363) 6512 53 20.96 2.53 2.82E-12
organic cyclic compound binding
(GO:0097159) 6581 53 21.18 2.5 4.62E-12
structural constituent of ribosome
(GO:0003735) 231 11 0.74 14.79 6.19E-07
protein binding (GO:0005515) 10761 58 34.64 1.67 4.76E-06
binding (GO:0005488) 14353 65 46.2 1.41 1.99E-05
mRNA binding (GO:0003729) 160 8 0.52 15.53 1.44E-04
structural molecule activity (GO:0005198) 775 14 2.49 5.61 4.04E-04
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp).
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Table 4.13C: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(HeLa plus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
ribonucleoprotein complex (GO:1990904) 750 29 2.41 12 3.70E-21
intracellular ribonucleoprotein complex
(GO:0030529) 750 29 2.41 12 3.70E-21
macromolecular complex (GO:0032991) 4651 47 14.97 3.14 1.39E-13
ribosome (GO:0005840) 257 13 0.83 15.7 2.73E-09
cytosolic ribosome (GO:0022626) 110 10 0.35 28.2 4.14E-09
extracellular exosome (GO:0070062) 2725 32 8.77 3.65 8.41E-09
extracellular vesicle (GO:1903561) 2738 32 8.81 3.63 9.56E-09
ribosomal subunit (GO:0044391) 167 11 0.54 20.5 9.74E-09
extracellular organelle (GO:0043230) 2740 32 8.82 3.63 9.75E-09
small ribosomal subunit (GO:0015935) 70 8 0.23 35.5 1.16E-07
N.B. Ref = the number of proteins with a given annotation from the entire human reference list
used (20814 entries), Obs = number of proteins observed with specified annotation, Exp =
number of proteins expected by chance alone based on the given sample size, FE = fold
enrichment (i.e. Obs/Exp).
4.9.8 Consideration of GO term results for HeLa plus arsenite
As with the minus arsenite samples, the top hits for HeLa plus arsenite were also largely related
to RNA (Tables 4.13A, 4.13B, 4.13C). As there were 67 proteins in the plus arsenite dataset that
were tested for GO term enrichment, as opposed to 34 for the minus arsenite samples, the p-
values were much lower. It would therefore seem even more reasonable to conclude from this
data set that UNR is likely to be intimately involved with RNA than was the case for the minus
arsenite samples. It is unclear as to why more RNA-associated proteins were considered
significant in the plus arsenite samples than in the minus arsenite samples. A working hypothesis
in the lab is that UNR is localised to stress granules following arsenite stress which may make it
easier to pull down. Assuming that the immunoprecipitating antibody is saturated, that would
make UNR from a pool bound to non-RNA-associated proteins become diluted in the end
sample. Alternatively, it could allow the antibody to become more saturated with the possibly
more accessible stress granule-located UNR.
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Viral transcription was considered among the most significant biological processes again, as
were selenocysteine metabolic processes (Table 4.13A) and extracellular
exosome/vesicle/organelle (Table 4.13C).
4.10 Progenesis results for U2OS RIP dataset
The U2OS samples were initially imported into Progenesis with 348082 MS/MS spectra, of which
50393 were re-imported from MASCOT having been assigned to peptide ions. As with the HeLa
samples, expected contaminants were removed from the data. As before, proteins with an
ANOVA p-value over 0.05 were also removed as this caused the samples to group more closely
by treatment over PC1 and PC2 (Figure 4.15). This means that the main sources of variability in
the data were more closely aligned with the treatments (arsenite treatment and
immunoprecipitating immunoglobulin). Generally positive normalised and standardised values
for PC1 (above 0.1) are UNR pulldown samples. Negative values (strictly, less than 0.1) are IgG
pulldown samples. This implies that the main source of variation in the data (accounting for
57.0% of all the variation) is accounted for by immunoprecipitating antibody (Figure 4.15B).
Likewise, positive values in PC2 are linked to plus arsenite samples and negative PC2 samples
(other than one slightly negative value that touches the line PC2=0) are unstressed samples. This
means that arsenite treatment accounts for most of the second largest component of variability
in the data, which itself accounts for 23.4% of the total variation (Table 4.14B).
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A
B
Figure 4.15: Progenesis-generated PCA plots for U2OS data. Proteins with all ANOVA p-values
(A) or only those with ANOVA p-values under 0.05 (B) were included. See text for further
information how the data were processed. Numbers are associated with the days upon which
the lysates were made (i.e. the repeats). Blue = no arsenite, IgG; purple = no arsenite, UNR;
orange = plus arsenite, IgG; green = plus arsenite, UNR. In terms of variance accounted for – A:
(PC1 = 49.42%, PC2 = 19.89%); B: (PC1 = 56.98%, PC2 = 23.36%).
Having exported the data into Excel, paired t-tests were carried out on the plus and minus
arsenite U2OS samples separately. This suggested 63 putative UNR interacting proteins from the
minus arsenite samples when the cut off p-value was set at 0.1 (Table 4.14B). The top ten
putative UNR-interactors by p-value are presented below (Table 4.14A). Meanwhile, 87 putative
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hits were suggested from the U2OS plus arsenite data (Table 4.15B). The top ten values are
additionally presented below (Table 4.15A).
Table 4.14A: Top 10 putative U2OS minus arsenite UNR interacting proteins by t-test p-value
(using Progenesis data)
protein U2OS1 U2OS2 U2OS3 U2OS4 U2OS5 U2OS6 p-value
GUCY2D 0 3011 868 156011 153812 160214 0.00026
TRA2B 153315 286102 158026 241178 376746 241157 0.00063
SYNCRIP 181666 115723 118102 364396 306211 320994 0.00093
RPN1 254 2048 2601 13934 14081 15274 0.00140
NARR 2069 9147 6106 545559 530244 467932 0.00228
RPL35 143303 131817 124007 182065 170266 171242 0.00478
RPS8 938342 971227 461141 1526198 1553166 931819 0.00482
HNRNPR 314777 198519 237638 770567 572489 718462 0.00541
FBL 8003 21814 1442 20538 36152 12530 0.00547
HNRNPH1 50847 49523 11328 86975 76420 42451 0.00715
N.B The t-test p-values are for a two tailed paired t-test without multiple testing correction.
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Table 4.14B: Gene names for putative UNR-interacting proteins from unstressed U2OS, by t-
test p-value
Description p-value Description p-value Description p-value
GN=GUCY2D 0.00026 GN=PCBP2 0.01665 GN=KPNB1 0.05098
GN=TRA2B 0.00063 GN=RPS8 0.01739 GN=RPL27 0.05193
GN=SYNCRIP 0.00093 GN=SLC25A6 0.01875 GN=RPS2 0.05556
GN=RPN1 0.00140 GN=CSDE1 0.01878 GN=RPS3 0.05655
GN=RAB34 (NARR) 0.00228 GN=RPS9 0.01958 GN=RPL29 0.05655
GN=RPL35 0.00478 GN=TRIP6 0.02137 GN=RPS3 0.05702
GN=RPS8 0.00482 GN=OAT 0.02323 GN=RPS2 0.05739
GN=HNRNPR 0.00541 GN=LDB1 0.02522 GN=FBL 0.05956
GN=FBL 0.00547 GN=RPS26P11 0.02896 GN=RPS2 0.06098
GN=HNRNPH1 0.00715 GN=RBMX 0.03079 GN=RPS2 0.06255
GN=HNRNPR 0.00797 GN=RPL26 0.03292 GN=RPS6 0.06266
GN=LMO7 0.00873 GN=DDX5 0.03305 GN=C19orf68 0.06281
GN=HNRNPH1 0.00900 GN=SSBP2 0.03373 GN=CSDE1 0.06393
GN=SSBP2 0.01091 GN=DDX5 0.03755 GN=RPS6 0.06652
GN=DDX3X 0.01326 GN=RPS9 0.03778 GN=HNRNPU 0.07406
GN=DDX5 0.01330 GN=RPL36A 0.03987 GN=HUWE1 0.08014
GN=SLC25A5 0.01544 GN=KPNB1 0.03992 GN=SRSF7 0.08554
GN=CSDE1 0.01552 GN=RPS3 0.04192 GN=CSDE1 0.09049
GN=EWSR1 0.01566 GN=HNRNPF 0.04228 GN=RPS15A 0.09157
GN=DDX5 0.01660 GN=RPS9 0.04754 GN=HNRNPK 0.09443
GN=C4A 0.01663 GN=RPS2 0.04987 GN=HNRNPA3 0.09911
N.B. Only gene names were given for the putative UNR-interacting proteins to save table space
due to the large number of suggested hits. This means that some identifiers are repeated due
to different isoforms being suggested. The t-test p-values are for a two tailed paired t-test
without multiple testing correction and increase from top to bottom for each column, starting
on the left.
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Table 4.15A: Top ten putative U2OS plus arsenite UNR interacting proteins by t-test p-value
(using Progenesis data)
protein U2OS7 U2OS8 U2OS9 U2OS10 U2OS11 U2OS12 p-value
HNRNPF 46540 59224 31029 690448 674700 629441 0.00046
ANXA2 1786.9 4173.2 3312.8 32360.6 37457.4 33359.8 0.00102
HNRNPR 186734 44852 16708 382456 220243 209490 0.00114
FLNA 17574 43072 14970 380004 362924 318690 0.00283
SSBP2 70.834 107.77 33.396 1119110 1072048 913000 0.00361
HNRNPK 56620 66225 50738 929805 958167 1159729 0.00618
LDB1 28094 15251 17432 739164 914811 961052 0.00694
HNRNPR 207000 57053 24121 374470 264043 250067 0.00733
C4A 5576.5 10878 12473 163916 138351 131491 0.00775
FLNC 30001 53146 40043 646044 486618 613826 0.01024
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
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Table 4.15B: Gene names for putative UNR-interacting proteins from arsenite-treated U2OS,
by t-test p-value
Description p-value Description p-value Description p-value
GN=HNRNPF 0.00046 GN=GUCY2D 0.02816 GN=RPS6 0.05906
GN=ANXA2 0.00102 GN=FASN 0.02861 GN=RPS3 0.05989
GN=HNRNPR 0.00114 GN=RBMX 0.02897 GN=STRAP 0.06014
GN=FLNA 0.00283 GN=RPS2 0.03100 GN=RPS3 0.06639
GN=SSBP2 0.00361 GN=DDX5 0.03141 GN=MRPS7 0.06905
GN=HNRNPK 0.00618 GN=C19orf68 0.03375 GN=RPS6 0.06943
GN=LDB1 0.00694 GN=UQCRQ 0.03400 GN=SLC25A6 0.07148
GN=HNRNPR 0.00733 GN=RPS2 0.03405 GN=SLC25A5 0.07250
GN=C4A 0.00775 GN=HNRNPU 0.03443 GN=RPS16 0.07277
GN=FLNC 0.01024 GN=RPS13 0.03458 GN=RPS11 0.07285
GN=HUWE1 0.01235 GN=RPS2 0.03474 GN=CSDE1 0.07301
GN=SYNCRIP 0.01265 GN=RPS8 0.03662 GN=RPS11 0.07560
GN=SSBP2 0.01325 GN=RPS2 0.03737 GN=PCBP1 0.07698
GN=SRSF2 0.01365 GN=DARS 0.03768 GN=VIM 0.07699
GN=HNRNPH1 0.01559 GN=RPS2 0.03779 GN=MRPL16 0.07838
GN=HNRNPK 0.01673 GN=RPS8 0.03823 GN=DDX3X 0.07874
GN=FLNA 0.01788 GN=RPL23 0.04232 GN=EIF3B 0.07904
GN=C1orf167 0.01819 GN=DDX5 0.04656 GN=HNRNPH1 0.08205
GN=FBL 0.02070 GN=TRIM28 0.04732 GN=TRA2B 0.08516
GN=OAT 0.02190 GN=PTRF 0.04734 GN=RPS9 0.08677
GN=DDX5 0.02208 GN=RPS14 0.04770 GN=HNRNPA2B1 0.08780
GN=RPS13 0.02289 GN=SQSTM1 0.04778 GN=RPS3 0.08941
GN=RPS4X 0.02401 GN=DDX5 0.04778 GN=RBMX 0.09033
GN=RPS10-
NUDT3
0.02429 GN=PCBP2 0.04798 GN=CSDE1 0.09342
GN=RPS15A 0.02458 GN=HSPA1A 0.04814 GN=RPS3 0.09586
GN=RPL36A 0.02485 GN=RPS9 0.04887 GN=RPS23 0.09626
GN=RPS26P11 0.02518 GN=RPS3 0.05618 GN=TFG 0.09767
GN=SRSF3 0.02534
GN=RAB34
(NARR)
0.05740 GN=TAF15 0.09863
GN=LMO7 0.02770 GN=SQSTM1 0.05806 GN=PCBP2 0.09998
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N.B. Only gene names were given for the putative UNR-interacting proteins to save table space
due to the large number of suggested hits. This means that some identifiers are repeated due
to different isoforms being suggested. The t-test p-values are for a two tailed paired t-test
without multiple testing correction and increase from top to bottom for each column, starting
on the left.
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Figure 4.16: Standardised normalised abundances for peptides assigned to specific proteins
(A=UNR (‘different’ forms combined), B = UNRIP, C = TRIM28, D = HUWE1) from the U2OS data.
The repeats in the blue column are IgG (minus arsenite), the repeats in the purple column are
UNR (minus arsenite), the repeats in the orange column are IgG (plus arsenite) and the repeats
in the green column are UNR (plus arsenite).
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On this occasion, as well as UNR and UNRIP, it was decided to show peptide data for the TRIM33-
related TRIM28 (also known as TIF1-β) and HUWE1. Each of these proteins shows something 
about the data. Firstly, it must be assumed that UNR is a genuine hit; should it not be a true hit
in both the plus and minus arsenite samples, then the entire experiment and all inferred results
are invalid. It can be seen that much more UNR was detected in the plus arsenite UNR pulldowns
(Figure 4.16A, green column) than in the minus arsenite samples (Figure 4.16A, purple column),
although both are higher than the IgG samples in the other columns. It can also be seen that the
peptides that were assigned to UNR all followed the same basic detection level pattern between
the different samples (Figure 4.16A). This implies that they were correctly assigned. A very
similar pattern was seen for UNRIP as was seen for UNR, given that the scale on the y axis is the
same between the two proteins – ranging between -2 and +4 (Figures 4.16B, 4.16A). This could
imply that the levels of UNR and UNRIP vary together and both increase upon arsenite stress. It
could also be that UNR and UNRIP interact together in unstressed cells and stressed cells equally
but that the RIP process becomes more efficient in stressed cells, possibly due to UNR and UNRIP
becoming concentrated in stress granules. TRIM28 shows an interesting peptide pattern – only
three peptides were assigned to it but the detected levels of each are tightly correlated with the
samples, implying that the assignment was probably correct. TRIM28 appears to only be
associated with UNR in arsenite stressed cells (Figure 4.16C). Most, but not all, the peptides
assigned to the last protein, HUWE1, follow a constant pattern between the samples (Figure
4.16D). This implies that some (3 or 4) of the peptides may have been misassigned. HUWE1
appears to associate strongly with UNR in U2OS whether or not the cells have been stressed
(Figure 4.16D, purple/green UNR pulldown columns versus blue/orange IgG pulldown columns).
Finally, a fold change minimum of 10 was set as a significance cut off point (again only
considering the data with ANOVA p-values of 0.05 or less). This gave a set of ten putative UNR-
interactors for the minus arsenite U2OS samples (Table 4.16) and 48 for the plus arsenite U2OS
samples (Table 4.17B). The top ten hits by ratio for U2OS plus arsenite are presented in Table
4.17A.
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Table 4.16: Putative U2OS minus arsenite UNR interacting proteins by ratio (using
Progenesis data)
Protein U2OS1 U2OS2 U2OS3 U2OS4 U2OS5 U2OS6 ratio
SSBP2
(A0A087X159) 0 0 0 274510 546075 433402 ∞ 
SSBP2 (D6RAC5) 108 285 153 767310 842104 1080423 4932
TFG (Q05BK6) 10 1 33 474 5451 58232 1445
GUCY2D 0 3011 868 156011 153812 160214 121
NARR 2069 9147 6106 545559 530244 467932 89
LMO4 7194 0 171 52845 79396 383006 70
OAT 24 892 0 10631 18960 13406 47
HUWE1 96423 138564 73000 1299253 4195472 3848769 30
LDB1 29913 35416 15096 591143 994118 688242 28
TFG (Q05BK6) 194 18301 0 6502 56466 161279 12
N.B. Ratios are mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value
was greater than zero. The yellow shading highlights a protein absent in every IgG sample but
present in every UNR sample.
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Table 4.17A: Top 10 putative U2OS plus arsenite UNR interacting proteins by ratio (using
Progenesis data)
Protein U2OS7 U2OS8 U2OS9 U2OS10 U2OS11 U2OS12 ratio
PPIA 0 0 0 53820 6285 13257 ∞ 
PABPC5 0 0 0 3312 5290 87639 ∞ 
SSBP2 (D6RAC5) 71 108 33 1119110 1072048 913000 14642
PDIA6 0 0 10 82803 1166 1551 8868
SQSTM1 12 3 0 12442 17093 26903 3749
TFG (C9JJP5) 0 25 55 22380 79601 95845 2464
LMO4 0 0 593 117167 159453 589844 1461
OAT 180 0 0 36907 27848 21809 480
RANGAP1 176 275 0 19614 7132 144834 381
SSBP2
(A0A087X159) 2675 1646 0 407577 587656 591665 367
N.B. Ratios are mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value
was greater than zero. The yellow shading highlights a protein absent in every IgG sample but
present in every UNR sample.
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Table 4.17B: Putative U2OS plus arsenite UNR interacting proteins by mean UNR/IgG ratios
(using Progenesis data)
Description ratio Description ratio Description ratio
GN=PPIA ∞ GN=ATP5O 57 GN=RNH1 17
GN=PABPC5 ∞ GN=CSDE1 51 GN=C4A 15
GN=SSBP2 14642 GN=CFL1 51 GN=HNRNPF 15
GN=PDIA6 8868 GN=RANBP2 51 GN=EIF2A 14
GN=SQSTM1 3749 GN=LDB1 43 GN=FLNC 14
GN=TFG 2464 GN=FASN 39 GN=FLNA 14
GN=LMO4 1461 GN=PCBP2 38 GN=VIM 14
GN=OAT 480 GN=RPN1 37 GN=PPP2R1A 14
GN=RANGAP1 381 GN=CSDE1 35 GN=RPS3 13
GN=SSBP2 367 GN=HUWE1 33 GN=FBL 13
GN=GUCY2D 320 GN=FHL2 33 GN=RBM14 13
GN=RAB34 (NARR) 170 GN=STRAP 32 GN=SQSTM1 12
GN=TFG 118 GN=KPNB1 30 GN=PCBP2 12
GN=EIF3B 86 GN=TRIM28 22 GN=HSPA1A 12
GN=CSDE1 68 GN=KPNB1 18 GN=HNRNPK 11
GN=CSDE1 59 GN=HNRNPK 18 GN=ANXA2 11
N.B. Only gene names were given for the putative UNR-interacting proteins to save table space
due to the large number of suggested hits. This means that some identifiers are repeated due
to different isoforms being suggested. The t-test p-values are for a two tailed paired t-test
without multiple testing correction and increase from top to bottom for each column, starting
on the left.
4.10.1 Discussion of U2OS RIP dataset in comparison to the HeLa dataset
The top ten putative UNR interactors by t-test p-value for the U2OS minus and plus arsenite
(Tables 4.14A, 4.15A) were quite different to those for HeLa minus and plus arsenite (Tables
4.7A, 4.8A). In terms of the top ten putative interactors by fold enrichment in UNR pulldowns
over IgG pulldowns, there was more similarity between the cell types. SSBP2 (twice in U2OS),
NARR, LMO4, HUWE1 and LBD1 were all present in the top ten HeLa minus arsenite list (Table
4.9A) and the U2OS minus arsenite list (Table 4.16). Some of those proteins had very large fold
enrichments in the UNR samples. SSBP2, for example, had a UNR/IgG ratio of 276 in HeLa minus
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arsenite and the two entries for U2OS minus arsenite had ratios of almost 5000 and infinity,
respectively.
The top ten by fold enrichment for U2OS plus arsenite (Table 4.17A) and HeLa plus arsenite
(Table 4.10A) also had some cross-over. SSBP2 (twice in U2OS), TFG, LMO4 and RANGAP1 were
on both lists. The lowest entry on the top ten fold enrichment list for U2OS plus arsenite had a
rounded UNR/IgG ratio of 367:1 whereas it the tenth most significant entry on the HeLa plus
arsenite ratio list only had a UNR/IgG fold increase of 57.
Another point of discussion was the number of hits between the two cell types. There were 25
proteins with t-test p-values less than 0.1 for HeLa minus arsenite. The number for U2OS was
64. By fold enrichment, HeLa minus arsenite had 17 proteins with fold enrichments over 10, in
U2OS, there were only 10. With the plus arsenite samples, HeLa had 67 proteins with a p-value
less than 0.1, whereas U2OS had 88. By fold enrichment, there were 17 proteins with a fold
enrichment over 10, whereas the number was 48 for U2OS.
4.10.2 Progenesis results for U2OS RIP dataset exported to AmiGO 2
The plus and minus arsenite hits suggested by Progenesis were exported separately to AmiGO 2
version 2.3.2 following removal of NARR, TRIP6 (for minus arsenite as was higher minus arsenite
IgG compared to minus arsenite UNR and was only present as it was highest in plus arsenite UNR
overall) and heavy and light chains (for both plus and minus arsenite) that were assigned to non-
IgG antibodies. Other than that, processing was as per the HeLa samples (see section 4.9.4).
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4.10.3 GO term results for U2OS minus arsenite
A total of 45 individual proteins were entered into AmiGO 2 and all of them were recognised by
the tool.
A Bonferroni multiple testing corrected p-value of 0.05 was chosen as the significance cut off
point and top ten lists of overrepresented GO terms by p-value, for each set of GO terms, were
recorded in Table 4.18 (Table 4.18A = biological process, Table 4.18B = molecular function, Table
4.18C = cellular component).
Table 4.18A: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(U2OS minus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process (GO:0016071) 625 24 1.35 17.76 4.87E-21
RNA processing (GO:0006396) 930 24 2.01 11.94 4.97E-17
SRP-dependent cotranslational protein
targeting to membrane (GO:0006614) 111 12 0.24 50 1.07E-13
cotranslational protein targeting to
membrane (GO:0006613) 114 12 0.25 48.69 1.46E-13
protein targeting to ER (GO:0045047) 114 12 0.25 48.69 1.46E-13
establishment of protein localization to
endoplasmic reticulum (GO:0072599) 118 12 0.26 47.04 2.20E-13
selenocysteine metabolic process
(GO:0016259) 88 11 0.19 57.82 5.66E-13
protein localization to endoplasmic
reticulum (GO:0070972) 138 12 0.3 40.22 1.40E-12
selenium compound metabolic process
(GO:0001887) 114 11 0.25 44.63 9.39E-12
viral transcription (GO:0019083) 119 11 0.26 42.76 1.49E-11
91Chapter 4
Table 4.18B: Top ten enriched molecular function GO terms, by Bonferroni adjusted p-value
(U2OS minus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
poly(A) RNA binding (GO:0044822) 1165 33 2.52 13.1 1.92E-28
RNA binding (GO:0003723) 1718 34 3.71 9.15 1.61E-24
nucleic acid binding (GO:0003676) 4514 37 9.76 3.79 2.41E-14
structural constituent of ribosome
(GO:0003735) 231 14 0.5 28.03 1.41E-13
heterocyclic compound binding
(GO:1901363) 6512 39 14.08 2.77 5.19E-11
organic cyclic compound binding
(GO:0097159) 6581 39 14.23 2.74 7.62E-11
mRNA binding (GO:0003729) 160 11 0.35 31.8 1.20E-10
structural molecule activity
(GO:0005198) 775 14 1.68 8.36 1.49E-06
binding (GO:0005488) 14353 45 31.03 1.45 1.48E-04
single-stranded RNA binding
(GO:0003727) 65 5 0.14 35.58 8.87E-04
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Table 4.18C: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(U2OS minus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
ribonucleoprotein complex (GO:1990904) 750 24 1.62 14.8 5.34E-20
intracellular ribonucleoprotein complex
(GO:0030529) 750 24 1.62 14.8 5.34E-20
cytosolic ribosome (GO:0022626) 110 13 0.24 54.66 2.02E-16
ribosomal subunit (GO:0044391) 167 13 0.36 36.01 4.24E-14
cytosolic part (GO:0044445) 225 14 0.49 28.78 4.68E-14
ribosome (GO:0005840) 257 13 0.56 23.4 1.01E-11
cytosolic small ribosomal subunit
(GO:0022627) 41 8 0.09 90.25 5.91E-11
macromolecular complex (GO:0032991) 4651 34 10.06 3.38 6.64E-11
catalytic step 2 spliceosome (GO:0071013) 88 9 0.19 47.3 4.31E-10
small ribosomal subunit (GO:0015935) 70 8 0.15 52.86 4.08E-09
4.10.4 Consideration of GO term results for U2OS minus arsenite
The top ten enriched biological process GO terms contained were quite varied (Table 4.18A).
RNA-related proteins were the most numerous in terms of the number of observed proteins.
Other top hits included terms related to protein localisation, viral transcription and selenium
metabolism. The top molecular function GO terms (Table 4.18B) implied a previously established
role for UNR in translation with the top hit being poly(A) RNA binding and other top hits including
mRNA binding, structural component of ribosome and single stranded RNA binding. The most
enriched cellular component GO terms were also largely related to RNA processes. The top hit
was ribonucleoprotein complex and other top hits included ribosome and catalytic step 2
spliceosome. These results point to a clear role for UNR in the translation and related processes.
The observation that 12.5% of all proteins annotated to selenocysteine metabolic process (11
out of 88) is interesting. Whilst it is not going to be considered further here, the information is
there for workers in the field of selenocysteine biochemistry who may wish to explore any
potential role for UNR in relation to their research.
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4.10.5 GO term results for U2OS plus arsenite
A total of 76 individual proteins were entered into AmiGO 2 and all of them were recognised by
the tool. It should be noted that, due to inconsistencies in the proteins used for the initial GO
term analysis for U2OS plus arsenite (an immunoglobulin had remained in the putative UNR-
interactor data), it was decided to run the analysis again with an updated database (Table
4.19A). There was no change in the identity of the top GO terms and little change in their order.
The number of proteins annotated to many GO terms in the reference set had changed,
however, and this resulted in small changes to the p-values. It is not expected that this should
change any inferences about UNR-interactors but any direct comparisons with the U2OS minus
arsenite results should take this difference into consideration.
A Bonferroni multiple testing corrected p-value of 0.05 was chosen as the significance cut off
point and the top ten UNR-enriched GO terms were recorded in Table 4.19 (Table 4.19B =
biological process, Table 4.19C = molecular function, Table 4.19D = cellular component).
Table 4.19A: Technical data pertaining to the GO term enrichment analyses carried out on
putative UNR interacting proteins from arsenite treated U2OS cells
Analysis Type: PANTHER Overrepresentation Test (release 20160715)
Annotation Version and Release
Date: GO Ontology database Released 2016-07-29
Analyzed List: upload_1 (Homo sapiens)
Reference List: Homo sapiens (all genes in database)
Bonferroni correction: TRUE
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Table 4.19B: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(U2OS plus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process
(GO:0016071) 621 32 2.28 14.03 1.24E-24
RNA processing (GO:0006396) 860 31 3.16 9.82 4.05E-19
multi-organism metabolic
process (GO:0044033) 138 18 0.51 35.53 4.93E-19
viral gene expression
(GO:0019080) 126 17 0.46 36.75 4.92E-18
viral life cycle (GO:0019058) 292 21 1.07 19.59 1.61E-17
translational initiation
(GO:0006413) 153 17 0.56 30.26 1.24E-16
translation (GO:0006412) 450 23 1.65 13.92 2.73E-16
viral process (GO:0016032) 822 28 3.02 9.28 3.94E-16
multi-organism cellular process
(GO:0044764) 825 28 3.03 9.24 4.33E-16
cellular nitrogen compound
metabolic process
(GO:0034641)
5131 57 18.84 3.03 6.94E-16
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Table 4.19C: Top ten enriched molecular function GO terms, by Bonferroni adjusted p-value
(U2OS plus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
RNA binding (GO:0003723) 1623 53 5.96 8.89 2.72E-37
poly(A) RNA binding (GO:0044822) 1163 47 4.27 11.01 9.60E-36
nucleic acid binding (GO:0003676) 4046 56 14.86 3.77 1.22E-20
structural constituent of ribosome
(GO:0003735) 226 20 0.83 24.1 9.57E-19
heterocyclic compound binding
(GO:1901363) 5922 59 21.74 2.71 4.91E-15
organic cyclic compound binding
(GO:0097159) 6005 59 22.05 2.68 1.01E-14
mRNA binding (GO:0003729) 164 15 0.6 24.91 1.47E-13
rRNA binding (GO:0019843) 58 10 0.21 46.96 6.36E-11
structural molecule activity
(GO:0005198) 774 22 2.84 7.74 1.11E-10
protein binding (GO:0005515) 10839 68 39.8 1.71 2.26E-08
Table 4.19D: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(U2OS plus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
ribonucleoprotein complex (GO:1990904) 762 35 2.8 12.51 1.14E-26
intracellular ribonucleoprotein complex
(GO:0030529) 762 35 2.8 12.51 1.14E-26
cytosolic small ribosomal subunit (GO:0022627) 45 15 0.17 90.79 3.71E-22
small ribosomal subunit (GO:0015935) 70 16 0.26 62.25 3.39E-21
ribosomal subunit (GO:0044391) 172 19 0.63 30.09 9.45E-20
cytosolic ribosome (GO:0022626) 121 17 0.44 38.27 3.90E-19
macromolecular complex (GO:0032991) 4795 57 17.61 3.24 3.42E-18
ribosome (GO:0005840) 250 19 0.92 20.7 9.36E-17
adherens junction (GO:0005912) 680 26 2.5 10.41 1.12E-16
anchoring junction (GO:0070161) 698 26 2.56 10.15 2.12E-16
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4.10.6 Consideration of GO term results for U2OS plus arsenite
The most enriched biological process GO terms included a number that were related to RNA
processing and translational initiation (Table 4.19B). Interestingly, virus-related GO terms were
among the most numerous enriched GO terms, both in terms of the maximum number of
proteins annotated to a particular GO term (28 to viral processes was the third highest after the
32 to mRNA metabolic processes and 31 to the highly related RNA processing GO term) and also
in terms of the number of GO terms – 4 out of the top 10.
When it is considered that these GO terms become top hits in stressed U2OS cells, it possibly
implies a role for UNR in both viral infection and cancer. It is known that Unr is among other
pieces of proteinaceous cellular machinery that can become usurped by viruses following
infection (Boussadia et al., 2003). Hijacking or neutralisation of cellular proteins is a common
theme in both viral infection and the development of the cancer phenotype. For example, the
DNA virus adenovirus reprograms infected cells to create a pseudo-S phase environment that is
conducive to viral replication using a combination of virally-expressed and hijacked cellular
proteins (Turnell, 2008). By generating an S phase-like environment in which DNA can be
replicated without appropriate growth signals, adenovirus-infected cells exhibit one of Hanahan
and Weinberg’s six classic hallmarks of cancer (Hanahan & Weinberg, 2000). Whilst an in-depth
discussion of the molecular biology of adenovirus is beyond the scope of this work (for review,
see Leppard, (2014)), it should be considered that its E1 region has transformed a variety of cell
lines, starting with HEK293 (Graham et al., 1977), thereby giving the cells limitless replicative
potential – another classic hallmark of cancer (Hanahan & Weinberg, 2000). The large E1B
protein, in conjunction with the E4orf6 protein, can target TP53 for degradation – helping the
virally infected cell to overcome antigrowth signals and apoptosis (Turnell, 2008). Other
evidence shows that adenovirus can also help a cell to evade immune detection, by reducing the
cell surface expression of both major histocompatibility complex (MHC) class I proteins and
activating natural killer cell receptors (Sester et al. 2010). That prevents detection of cell
infection by both T cells and natural killer cells and thereby confers one of Hanahan and
Weinberg’s ‘emerging’ hallmarks of cancer upon the infected cell (Hanahan & Weinberg, 2011).
To summarise, a link between UNR and viral life cycles could well provide insight into any
potential role of UNR in cancer because, as has been briefly considered here in relation to
adenovirus, similar mechanisms are involved in both. The important point in relation to UNR is
that it interacts with a large number of proteins that may be targeted by viruses as part of their
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life cycle. In such, certain viruses may have a selective pressure to impede one or more
physiological functions of UNR, as may certain cancer cells.
As with the U2OS minus arsenite samples, most of the top ten enriched molecular function GO
terms (Table 4.19C) and cellular component GO terms (Table 4.19D) were related to RNA and
translation. Interestingly, however, two of the top ten cellular component GO terms were to do
with cell-cell interaction, e.g. adherens junction. It was later shown that UNR (and HUWE1), are
found concentrated at areas close to points of cell-cell interaction in unstressed U2OS cells
(Figure 4.22) and in stressed HeLa cells that appeared to be undergoing cytokinesis (Figure 4.23).
4.11 Progenesis results for SaOS-2 RIP dataset
The U2OS samples were initially imported into Progenesis with 319420 MS/MS spectra, of which
27819 were re-imported from MASCOT having been assigned to peptide ions. As with the HeLa
and U2OS samples, it was decided to remove proteins with an ANOVA p-value over 0.05 (Figure
4.17).
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A
B
Figure 4.17: Progenesis-generated PCA plots for SaOS-2 data. Proteins with all ANOVA p-values
(A) or only those with ANOVA p-values under 0.05 (B) were included. See text for further
information how the data were processed. Numbers are associated with the days upon which
the lysates were made (i.e. the repeats). Blue = no arsenite, IgG; purple = no arsenite, UNR;
orange = plus arsenite, IgG; green = plus arsenite, UNR. In terms of variance accounted for – A:
(PC1 = 66.03%, PC2 = 9.07%); B: (PC1 = 77.72%, PC2 = 7.64%).
The PC1vPC2 PCA image in Figure 4.17(B) shows that the line PC1 = 0 delineates the IgG samples
(PC1 < 0) from the UNR samples (PC1 > 0). The line PC2 = 0 also separates the minus arsenite
UNR samples (PC2 < 0) plus arsenite UNR samples (PC2 > 0), PC2 does not distinguish between
the plus and minus arsenite IgG samples. That could be explained by arsenite treatment only
changing the SaOS-2 proteome by a small amount, but the changes that did occur being UNR-
specific. That way, the background available to bind to IgG would have been fairly similar,
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leading to clustering of the plus and minus arsenite IgG samples. The UNR samples, however,
could have changed more substantially, leading to clear separation of the plus and minus
arsenite UNR samples by PC2 (Figure 4.17B). It should also be considered that principal
components do not have to be releated exclusively to a given treatment and are likely to be
influenced by different treatments and, more so with lower components, background noise.
Having exported the data into Excel, paired t-tests were carried out on the plus and minus
arsenite SaOS-2 samples separately. This suggested 39 putative UNR interacting proteins from
the minus arsenite samples when the cut off p-value was set at 0.1 (Table 4.20B). The top ten
suggested proteins are presented in Table 4.20A. Meanwhile, 176 putative hits were suggested
for the plus arsenite data (Table S1). The top ten of these are tabulated below (Table 4.21).
Table 4.20A: Top 10 putative SaOS-2 minus arsenite UNR interacting proteins by t-test p-
value (using Progenesis data)
Description SaOS1 SaOS2 SaOS3 SaOS4 SaOS5 SaOS6 p-value
SQSTM1
(E3W990) 1129 629 2736 469171 438770 432590 0.00068
TBC1D10C 25531 20939 15411 118367 117525 103569 0.00069
CCDC50 8485 11291 9414 437035 427868 399030 0.00078
LDB1 79228 62590 91126 6597521 7479055 6860085 0.00150
ATRX 16515 8301 15982 137541 115317 116785 0.00296
SQSTM1
(E7EMC7) 1888 4624 4903 492722 601250 610768 0.00425
FXR1 26395 17312 17945 15140 7862 9106 0.00538
SSBP3 41088 27850 95677 9575659 11932766 9774793 0.00543
C4A 866 576 1198 18148 16042 21293 0.00579
LMO7 1072254 833296 882401 2227386 2185545 1915409 0.00615
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
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Table 4.20B: Gene names for putative SaOS-2 minus arsenite UNR interacting proteins by t-
test p-value (using Progenesis data)
Description p-value Description p-value Description p-value
GN=SQSTM1 0.00068 GN=LDB2 0.01258 GN=UBR5 0.05733
GN=TBC1D10C 0.00069 GN=SQSTM1 0.01360 GN=ALK 0.05920
GN=CCDC50 0.00078 GN=TRMT1L 0.01781 GN=RPS26P11 0.06206
GN=LDB1 0.00150 GN=SIRT1 0.01847 GN=ERCC4 0.06351
GN=ATRX 0.00296 GN=ARHGEF2 0.01990 GN=H3F3A 0.07115
GN=SQSTM1 0.00425 GN=RPS4X 0.02033 GN=RPS25 0.07260
GN=FXR1 0.00538 GN=RYR1 0.02089 GN=HUWE1 0.07327
GN=SSBP3 0.00543 GN=RAB34 (NARR) 0.02114 GN=ATP5F1 0.07865
GN=C4A 0.00579 GN=CCDC137 0.02986 GN=P2RY12 0.08035
GN=LMO7 0.00615 GN=RPL27A 0.03928 GN=KHDRBS1 0.08213
GN=LMO4 0.00698 GN=TNRC6C 0.04198 GN=SRSF3 0.08437
GN=SSBP3 0.00986 GN=RPS27A 0.04354 GN=DDX41 0.09079
GN=SYCP2L 0.01110 GN=LRRC16A 0.04709 GN=RPS13 0.09422
N.B. Only gene names were given for the putative UNR-interacting proteins to save table space
due to the large number of suggested hits. This means that some identifiers are repeated due
to different isoforms being suggested. The t-test p-values are for a two tailed paired t-test
without multiple testing correction and increase from top to bottom for each column, starting
on the left.
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Table 4.21: Top ten putative SaOS-2 plus arsenite UNR interacting proteins by t-test p-value
(using Progenesis data)
Protein SaOS7 SaOS8 SaOS9 SaOS10 SaOS11 SaOS12 p-value
PFKL 1083 508 363 74500 71001 74644 0.00025
SETMAR 3937878 4202472 3573164 5430246 5815543 5147986 0.00052
IKBKAP 2085 2843 5216 81333 85611 95102 0.00139
ALK 234128 237994 236891 353285 358164 371992 0.00170
WDR1 15347 16102 32227 225332 263873 271295 0.00241
PCBP1 10192 10964 7337 922498 1101934 989078 0.00272
CCDC50 8577 7835 11619 515228 428615 503208 0.00312
HSPA6 274 367 1752 110832 131579 134049 0.00320
RNH1 199137 234258 218004 3683184 4546813 4031052 0.00385
TRMT1L 14279737 11323838 11379714 18564392 15513882 16510141 0.00432
N.B. The t-test p-values are for a two tailed paired t-test without multiple testing correction.
102Chapter 4
Figure 4.18: Standardised normalised abundances for peptides assigned to specific proteins
(A=UNR [‘different’ forms combined], B = UNRIP, C = LDB1, D = LMO4) from the SaOS-2 data.
The repeats in the blue column are IgG (minus arsenite), the repeats in the purple column are
UNR (minus arsenite), the repeats in the orange column are IgG (plus arsenite) and the repeats
in the green column are UNR (plus arsenite).
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On this occasion, as well as UNR and UNRIP, it was decided to show peptide data for the LDB1
and LMO4. The peptides for each protein generally followed the same detection level pattern
as each other with only one or two peptides deviating from the general pattern for a given
protein (Figure 4.18). This implies that most of the peptides were correctly assigned to their
given protein.
Finally, a fold change minimum of 10 was set as a significance cut off point (again only
considering the data with ANOVA p-values of 0.05 or less). This gave a set of 158 putative UNR
interactors for the minus arsenite samples following the removal of uncharacterised proteins
(Table S2). The twelve SaOS-2 minus arsenite hits with infinite ratios, where all UNR pulldown
values were non-zero, were tabulated in Table 4.22. There were 211 putative UNR interacting
proteins suggested in SaOS-2 plus arsenite (Table S3). Of these, 24 had infinite ratios where all
UNR pulldown values were >0. These are presented in Table 4.23.
Table 4.22: Putative SaOS-2 minus arsenite UNR interacting proteins with infinite ratios
(using Progenesis data, all IgG=0, all UNR>0)
Protein SaOS1 SaOS2 SaOS3 SaOS4 SaOS5 SaOS6 Ratio
TRA2B 0 0 0 4435 66929 109404 ∞
DDX17 0 0 0 20405 43751 82584 ∞
TUBA4A 0 0 0 5975 2818 61712 ∞
NUMA1 0 0 0 10252 3348 29572 ∞
TNRC6C 0 0 0 9070 19130 13192 ∞
BMP15 0 0 0 1668 623 35507 ∞
P4HB 0 0 0 2762 3967 23743 ∞
RPS3A 0 0 0 1526 7190 17108 ∞
SAP18 0 0 0 164 5828 19799 ∞
LDB2 0 0 0 3602 5300 4232 ∞
RPL8 0 0 0 217 6172 2664 ∞
ANP32E 0 0 0 6 1626 709 ∞
N.B. Ratios are mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value
was greater than zero. The yellow shading highlights a protein absent in every IgG sample but
present in every UNR sample.
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Table 4.23: Putative SaOS-2 plus arsenite UNR interacting proteins with infinite ratios (using
Progenesis data, all IgG=0, all UNR>0)
Description SaOS7 SaOS8 SaOS9 SaOS10 SaOS11 SaOS12 ratio
PFN2 0 0 0 354772 473127 509770 ∞
TBR1 0 0 0 127885 135678 343814 ∞
NUMA1 0 0 0 148541 226850 205414 ∞
LARS 0 0 0 12124 17343 268166 ∞
DDX17 0 0 0 71030 69665 121418 ∞
USMG5 0 0 0 10089 21651 184153 ∞
ANP32E 0 0 0 34789 54185 115721 ∞
FBXO45 0 0 0 39403 54938 22251 ∞
NUP107 0 0 0 39403 54938 22251 ∞
TTLL12 0 0 0 38540 24738 48882 ∞
TBL1XR1 0 0 0 34212 38801 23504 ∞
PPIA 0 0 0 12439 5854 77771 ∞
FNDC3B 0 0 0 24194 34413 22260 ∞
TNRC6C 0 0 0 29062 25800 19529 ∞
MAGED1 0 0 0 19160 42866 10798 ∞
SUMO1 0 0 0 7477 46151 16560 ∞
RPS3A 0 0 0 2396 35868 23634 ∞
ABCE1 0 0 0 5212 19789 30993 ∞
ARF4 0 0 0 10906 3557 39720 ∞
SRSF2 0 0 0 2308 31211 2710 ∞
GNB2L1 0 0 0 3319 8353 22353 ∞
BMP15 0 0 0 4030 5669 19563 ∞
RPS9 0 0 0 1882 20677 4400 ∞
LDB2 0 0 0 1336 4452 3650 ∞
N.B. Ratios are mean(UNR)/mean(IgG) and all infinities were ignored unless every UNR value
was greater than zero. The yellow shading highlights a protein absent in every IgG sample but
present in every UNR sample.
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4.11.1 Discussion of SaOS-2 RIP dataset comparison to the HeLa and U2OS
datasets
The top ten putative UNR interacting proteins by t-test p-value for SaOS-2 minus arsenite were
all different to those for unstressed U2OS (Tables 4.14, 4.20). There was some cross-over
between the top ten hits for unstressed SaOS-2 and unstressed HeLa (Tables 4.7A, 4.20). LDB1,
SSBP3 and C4A were top ten hits for both SaOS-2 and HeLa (Tables 4.7A, 4.20).
As with the top ten putative UNR interacting proteins in unstressed SaOS-2 and U2OS, there was
no cross-over between the top ten putative UNR interactors by t-test p-value for arsenite
treated SaOS-2 and stressed U2OS (Tables 4.15, 4.21). The cross-over between the top ten hits
for stressed SaOS-2 and stressed HeLa included ALK and RNH1 (Tables 4.8A, 4.21).
Whereas the top ten hits by UNR/IgG ratio were presented for HeLa and U2OS, there were more
than ten infinite ratios for both stressed and unstressed SaOS-2. All infinite ratios where all three
UNR samples had non-zero Progenesis quantification values were presented. Having taken that
caveat into consideration, comparison was then made between the infinite ratio hits for
SaOS-2 and the top ten hits for the same arsenite treatment state in the other two cell types.
For the unstressed samples, there was no cross-over between top hits for U2OS and SaOS-2
(Tables 4.16, 4.22). Likewise, there was no cross-over between top hits for HeLa and SaOS-2
(Tables 4.9A, 4.22). For the stressed samples, PPIA was an infinite ratio hit for both U2OS and
SaOS-2 although there was no other cross-over between the top hits lists for the two cell types
(Tables 4.17, 4.23). There was no cross-over between the top lists for stressed HeLa and SaOS-2
(Tables 4.10A, 4.23).
The lack of appreciable cross-over is interesting but not unexpected. In order to get a better idea
of hits that were shared between cell types, all putative UNR-interacting proteins from the minus
arsenite samples with a unique gene ID and t-test p-value <0.1 were aligned by cell type and
Microsoft Excel was used to highlight duplicates. Of 21 putative hits in HeLa, 15 were present in
one of the other two cell types and five were present in both the other cell types (C4A, LDB1,
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NARR, SQSTM1 and SRSF3). Of 36 putative UNR interactors in SaOS-2, 14 were present in at least
one of the other cell types. Of 61 U2OS hits, 16 were present in at least one of the other cell
types.
That analysis was then repeated with the plus arsenite data. Of 58 putative UNR interactors in
stressed HeLa cells, 41 were present in at least one of the osteosarcoma cell lines and ten were
present in all three cell types (C4A, EWSR1, HNRNPK, HUWE1, LDB1, NARR, PCBP2, RPS2, TRIP6
and UNR itself). Of 42 hits in U2OS, 19 were present in at least one other cell type and, of 142
hits in SaOS-2, 42 were present in at least one other cell type. C4A, LDB1 and NARR were hits in
all cell types, both stressed and unstressed. It was noted that HeLa hits were more reproducible
than hits in other the other cell types.
4.11.2 Progenesis results for SaOS-2 RIP dataset exported to AmiGO 2
The plus and minus arsenite hits suggested by Progenesis were exported separately to AmiGO 2
version 2.3.2 following removal of NARR and heavy and light chains (for both plus and minus
arsenite) that were assigned to non-IgG antibodies. Other than that, processing was as per the
HeLa samples (see section 4.9.4).
In each case, AmiGO 2 failed to recognise three proteins (suggested functions from Uniprot):
H3BN98 (a possible structural component of the ribosome that interacts with MYH9),
B4DLN1 (a possible structural component of the ribosome that interacts with subunits of the
mitochondrial ribosome),
F5H423 (that may be involved in binding to GTP and small GTPase mediated signalling activity).
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4.11.3 GO term results for SaOS-2 minus arsenite
A total of 171 individual proteins were entered into AmiGO 2 but three were not recognised by
the tool and were removed from further consideration.
A Bonferroni multiple testing corrected p-value of 0.05 was chosen as the significance cut off
point and the top ten hits by adjusted p-value were recorded in Table 4.24 (Table 4.24A =
biological process, Table 4.24B = molecular function, Table 4.24C = cellular component).
Table 4.24A: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(SaOS-2 minus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process (GO:0016071) 625 40 4.98 8.02 1.15E-20
RNA processing (GO:0006396) 930 45 7.42 6.07 6.24E-19
single-organism intracellular transport
(GO:1902582)
1372 53 10.94 4.84 1.05E-18
intracellular transport (GO:0046907) 1529 55 12.19 4.51 3.55E-18
establishment of localization in cell
(GO:0051649)
1670 56 13.32 4.2 3.52E-17
SRP-dependent cotranslational protein
targeting to membrane (GO:0006614)
111 20 0.89 22.59 4.28E-17
selenium compound metabolic process
(GO:0001887)
114 20 0.91 22 7.15E-17
cotranslational protein targeting to
membrane (GO:0006613)
114 20 0.91 22 7.15E-17
protein targeting to ER (GO:0045047) 114 20 0.91 22 7.15E-17
protein localization to endoplasmic
reticulum (GO:0070972)
138 21 1.1 19.08 1.29E-16
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Table 4.24B: Top ten enriched molecular function GO terms, by Bonferroni adjusted p-value
(SaOS-2 minus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
poly(A) RNA binding (GO:0044822) 1165 67 9.29 7.21 3.41E-36
RNA binding (GO:0003723) 1718 77 13.7 5.62 2.03E-35
heterocyclic compound binding
(GO:1901363)
6512 120 51.94 2.31 7.09E-24
organic cyclic compound binding
(GO:0097159)
6581 120 52.49 2.29 2.02E-23
protein binding (GO:0005515) 10761 149 85.82 1.74 1.78E-22
binding (GO:0005488) 14353 163 114.47 1.42 3.10E-19
nucleic acid binding (GO:0003676) 4514 93 36 2.58 1.97E-18
small molecule binding (GO:0036094) 3096 71 24.69 2.88 1.43E-14
nucleotide binding (GO:0000166) 2772 67 22.11 3.03 1.44E-14
nucleoside phosphate binding
(GO:1901265)
2773 67 22.12 3.03 1.46E-14
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Table 4.24C: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(SaOS-2 minus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
intracellular organelle part
(GO:0044446)
7968 132 63.55 2.08 2.82E-24
macromolecular complex (GO:0032991) 4651 102 37.09 2.75 4.49E-24
extracellular exosome (GO:0070062) 2725 78 21.73 3.59 3.86E-23
organelle part (GO:0044422) 8176 132 65.21 2.02 4.90E-23
extracellular vesicle (GO:1903561) 2738 78 21.84 3.57 5.26E-23
extracellular organelle (GO:0043230) 2740 78 21.85 3.57 5.51E-23
ribonucleoprotein complex
(GO:1990904)
750 42 5.98 7.02 1.56E-20
intracellular ribonucleoprotein complex
(GO:0030529)
750 42 5.98 7.02 1.56E-20
organelle (GO:0043226) 12818 157 102.23 1.54 4.83E-20
vesicle (GO:0031982) 3642 84 29.05 2.89 3.37E-19
4.11.4 Consideration of GO term results for SaOS-2 minus arsenite
More than half of the ten most significant biological process GO terms, using putative UNR-
interacting proteins from unstressed SaOS-2 cells, were related to intracellular transport and
localisation (Table 4.24A). The top two hits by p-value were related to mRNA and RNA
processing. As seen with the U2OS minus arsenite GO term analysis, selenium compound
metabolic processes was also a top biological process GO term with SaOS-2 cells (Tables 4.18A,
4.24A). Many of the top ten molecular function and cellular component GO terms were related
to RNA or very general terms like protein binding, binding and organelle, all of which have over
10000 proteins annotated to them in the reference set. Interestingly, 78 putative UNR-
interacting proteins were annotated to extracellular exosome, extracellular vesicle and
extracellular organelle (presumably exactly the same proteins in each case, although that wasn’t
specifically confirmed). This is interesting on several levels. Firstly, previous work in the lab had
provided hints that UNR may be present in vesicles that had blebbed off cells undergoing
apoptosis. On the other hand, it is not immediately obvious why UNR would be interacting with
extracellular proteins outside the cell in unstressed cells. One consideration is that cancer cells
have been reported to usurp exosome function to change the proteome or expel intracellular
drugs, as reviewed in (Azmi et al., 2013). It is possible that UNR was being expelled from the cell
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or being hijacked to cause the expulsion of other proteins or RNAs. This could potentially
become an interesting new avenue in UNR-related research.
4.11.5 GO term results for SaOS-2 plus arsenite
A total of 219 individual proteins were entered into AmiGO 2 but three were not recognised by
the tool and were removed from further consideration.
A Bonferroni multiple testing corrected p-value of 0.05 was chosen as the significance cut off
point and the top ten hits by adjusted p-value were recorded in Table 4.25 (Table 4.25A =
biological process, Table 4.25B = molecular function, Table 4.25C = cellular component).
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Table 4.25A: Top ten enriched biological process GO terms, by Bonferroni adjusted p-value
(SaOS-2 plus arsenite samples)
GO biological process complete Ref Obs Exp FE p-value
mRNA metabolic process (GO:0016071) 625 50 6.49 7.71 1.60E-25
selenium compound metabolic process
(GO:0001887)
114 28 1.18 23.67 1.78E-25
SRP-dependent cotranslational protein
targeting to membrane (GO:0006614)
111 27 1.15 23.44 2.39E-24
cotranslational protein targeting to
membrane (GO:0006613)
114 27 1.18 22.82 4.78E-24
protein targeting to ER (GO:0045047) 114 27 1.18 22.82 4.78E-24
RNA processing (GO:0006396) 930 57 9.65 5.91 6.32E-24
establishment of protein localization to
endoplasmic reticulum (GO:0072599)
118 27 1.22 22.05 1.17E-23
single-organism intracellular transport
(GO:1902582)
1372 67 14.24 4.71 2.03E-23
peptide biosynthetic process (GO:0043043) 539 45 5.59 8.04 2.74E-23
protein localization to endoplasmic
reticulum (GO:0070972)
138 28 1.43 19.55 3.03E-23
112Chapter 4
Table 4.25B: Top ten enriched molecular function GO terms, by Bonferroni adjusted p-value
(SaOS-2 plus arsenite samples)
GO molecular function complete Ref Obs Exp FE p-value
RNA binding (GO:0003723) 1718 107 17.83 6 1.71E-53
poly(A) RNA binding (GO:0044822) 1165 91 12.09 7.53 1.01E-51
heterocyclic compound binding
(GO:1901363)
6512 163 67.58 2.41 4.75E-37
organic cyclic compound binding
(GO:0097159)
6581 163 68.3 2.39 2.05E-36
nucleic acid binding (GO:0003676) 4514 130 46.84 2.78 7.98E-31
protein binding (GO:0005515) 10761 193 111.67 1.73 4.78E-29
binding (GO:0005488) 14353 211 148.95 1.42 2.70E-24
nucleotide binding (GO:0000166) 2772 86 28.77 2.99 9.64E-19
nucleoside phosphate binding
(GO:1901265)
2773 86 28.78 2.99 9.87E-19
structural molecule activity
(GO:0005198)
775 45 8.04 5.6 1.60E-17
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Table 4.25C: Top ten enriched cellular component GO terms, by Bonferroni adjusted p-value
(SaOS-2 plus arsenite samples)
GO cellular component complete Ref Obs Exp FE p-value
extracellular exosome (GO:0070062) 2725 108 28.28 3.82 9.84E-36
extracellular vesicle (GO:1903561) 2738 108 28.41 3.8 1.52E-35
extracellular organelle (GO:0043230) 2740 108 28.43 3.8 1.63E-35
macromolecular complex (GO:0032991) 4651 131 48.27 2.71 1.70E-30
vesicle (GO:0031982) 3642 115 37.8 3.04 1.84E-29
ribonucleoprotein complex (GO:1990904) 750 56 7.78 7.19 1.82E-28
intracellular ribonucleoprotein complex
(GO:0030529)
750 56 7.78 7.19 1.82E-28
intracellular organelle part (GO:0044446) 7968 164 82.69 1.98 3.12E-26
extracellular region part (GO:0044421) 3745 111 38.86 2.86 1.59E-25
organelle part (GO:0044422) 8176 165 84.85 1.94 1.87E-25
4.11.6 Consideration of GO term results for SaOS-2 plus arsenite
The SaOS-2 plus arsenite samples generated more putative UNR interactors than any of the
other conditions. The top two most enriched biological process GO terms were mRNA metabolic
processes and selenium compound metabolic process. Whilst GO terms related to RNA were to
be expected, it is worth considering some of the numbers associated with the selenium-related
GO term. There were 114 proteins annotated to the selenium compound metabolic process GO
term. Of these, 5 were putative UNR interactors detected in unstressed HeLa cells (Table 4.12A).
Ten suggested UNR interacting proteins from stressed HeLa cells were annotated to the GO term
(Table 4.13A). Eleven of the annotated proteins were flagged as putative UNR-interactors in
U2OS minus arsenite cells (Table 4.18A). Whilst it didn’t make the top ten biological process GO
terms by p-value from the U2OS plus arsenite cells, 15 putative UNR interactors were annotated
to the GO term (data not shown). Twenty were flagged as possible UNR interactors in SaOS-2
minus arsenite. The latest condition considered (SaOS-2 plus arsenite) had 28 of the 114 proteins
annotated to selenium compound metabolic process as putative UNR-interactors (Table 4.25A).
The Bonferroni-adjusted p-value associated with the GO term for SaOS-2 plus arsenite was
1.78x10-25. The differences in the number of putative UNR interactors annotated to the GO term
in different cell types/stress conditions retrospectively supports having used different cell types
in this experiment. It seems highly likely that UNR regulates selenium compound metabolism in
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some way, but that finding may have been overlooked if only HeLa cells had been used. Other
top biological process GO terms for SaOS-2 plus arsenite include terms relating to translation
and localisation (Table 4.25A).
The top molecular function GO terms associated with potential UNR-interacting proteins from
SaOS-2 plus arsenite are largely related to RNA/nucleotide binding (Table 4.25B).
Whereas the SaOS-2 minus arsenite samples yielded 78 putative UNR-interacting proteins
annotated to extracellular exosome, SaOS-2 plus arsenite yielded 108, making it the top cellular
component GO term by p-value, 9.84x10-36, (Table 4.25C). Another top cellular component GO
term was the more expected, based on the literature, ribonucleoprotein complex (Table 4.25C).
4.12 Validation of selected putative UNR interacting proteins
4.12.1 HUWE1
In order to validate one of the putative UNR interacting proteins that had been consistently
flagged up across each of the cell types examined, HUWE1, an IP-Western was carried out to
ascertain if it could be pulled down with UNR from HeLa cell lysate.
The IP was carried out using the RIP protocol described previously using lysates left over from
the main experiments. Two sets of two RIPs were undertaken, one set using lysate from
unstressed HeLa cells and the other using arsenite treated HeLa cell lysate. Each set contained
two IPs – one with an antibody against UNR and the other with a conspecific control IgG. 5% of
the total lysate used was retained from each set to run an input lane on a Western. The
remainder of the lysate was divided equally between the UNR and control IgG IPs. The resultant
Western was quite dirty in the HUWE1 region (Figure 4.19).
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Figure 4.19: Result of an IP-Western probing for HUWE1 in which an anti-UNR immunoglobulin
or a conspecific control IgG, as stated, was used to pulldown proteins from cell lysates that had
been treated with 1 mM of sodium arsenite, or a similar volume of sterile PBS, in fresh DMEM
for 1 hour immediately prior to harvesting (as stated). Input lanes containing 5% of the total
amount of lysate used in the experiment were loaded in each case (labelled “lysate”). The
immunoprecipitated proteins were boiled in loading buffer and run on a 10% polyacrylamide gel
prior to being transferred onto nitrocellulose membrane which was blocked, probed with an
anti-HUWE1 immunoglobulin raised in rabbit (see section 2.1.1) followed by a HRP-conjugated
anti-rabbit IgG secondary antibody and then developed using an enhanced chemiluminescence-
based approach. The number on the left hand side of the image shows approximate molecular
masses (in kilodaltons), as estimated using PageRuler Plus Prestained Protein Ladder
(ThermoFisher). This experiment was only carried out on one occasion due to time constraints
at the end of the project.
Whilst it looked like there may be differential binding to UNR over IgG, it was decided to look
for co-localisation of UNR and HUWE1 by immunofluorescence microscopy across all three cell
types in search of further corroboration (Figures 4.20-4.26).
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Figure 4.20: Confocal immunofluorescence microscopy images of non-arsenite treated HeLa
cells fixed and stained immediately after having been mock treated with sterile PBS in fresh
DMEM for 1 hour. The upper images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The lower
images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing staining
for both UNR and HUWE1. The white arrows show an area of apparent diffuse co-localisation
between UNR and HUWE1. The yellow arrows demonstrate that neither UNR nor HUWE1 were
visible in structures that had the appearance of nucleoli, although the lack of staining for a
nucleolar marker makes it impossible to state this with certainty. The scale bars are all 25 µm.
Diffuse co-localisation of UNR and HUWE1 was observed in unstressed HeLa cells. Both proteins
were predominantly cytoplasmic in distribution although some staining for both was visible in
the nucleus outside of structures that appeared to be nucleoli (Figure 4.20).
Punctate co-localisation of UNR and HUWE1 was observed in arsenite stressed HeLa cells (Figure
4.21). These regions were believed to be stress granules.
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Figure 4.21: Confocal immunofluorescence microscopy images of arsenite treated HeLa cells
fixed and stained immediately after having been treated with 1 mM sodium arsenite in fresh
DMEM for 1 hour. The upper images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The lower
images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing staining
for both UNR and HUWE1. The white arrows show a punctate area of co-localisation between
UNR and HUWE1. The scale bars are all 25 µm.
Whilst co-localisation by immunofluorescence does not prove that there is a direct, or even
indirect, interaction between UNR and HUWE1, it does support the mass spectrometry data that
suggested such a link.
There was an interesting co-localisation pattern between UNR and HUWE1 in unstressed U2OS
cells in which there was a large amount of diffuse co-localisation that appeared particularly
pronounced at some cell-cell junctions (Figure 4.22).
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Figure 4.22: Confocal immunofluorescence microscopy images of non-arsenite treated U2OS
cells fixed and stained immediately after having been mock treated with sterile PBS in fresh
DMEM for 1 hour. The upper images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The lower
images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing staining
for both UNR and HUWE1. The white arrows show areas of apparent diffuse co-localisation
between UNR and HUWE1 at cell extremities or areas of physical cell-cell interaction. The scale
bars in all images are 25 µm.
Diffuse co-localisation of UNR and HUWE1 at cell-cell junctions had been noted in arsenite-
stressed HeLa cells that appeared to be undergoing cytokinesis (Figure 4.23).
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Figure 4.23: Confocal immunofluorescence microscopy images of arsenite treated HeLa cells
fixed and stained immediately after having been treated with 1 mM sodium arsenite in fresh
DMEM for 1 hour. The images show staining for UNR (blue), HUWE1 (green), and an overlaid
image showing staining for both UNR and HUWE1. The white arrows show an area of diffuse co-
localisation between UNR and HUWE1, possibly in a cytokinetic contractile ring. The scale bars
are 10 µm.
It was noted previously that adherens junction and anchoring junction were on the top ten list
of enriched cellular component GO terms for U2OS, albeit from the plus arsenite samples (Table
4.19D). Taken together, these observations support the idea that UNR and HUWE1 co-localise
at cell-cell junctions under certain conditions and are possibly present in the contractile ring
during cytokinesis.
As in arsenite-treated HeLa cells (Figure 4.21), UNR and HUWE1 appear to co-localise to stress
granules in arsenite treated U2OS cells (Figure 4.24). Unlike unstressed U2OS cells (Figure 4.22),
however, there did not appear to be areas of co-localisation at cell-cell junctions in arsenite-
stressed U2OS cells (Figure 4.24). It was noted previously in the lab that arsenite treatment
appears to cause the breakdown of cell-cell interactions (data not shown).
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Figure 4.24: Confocal immunofluorescence microscopy images of arsenite treated U2OS cells
fixed and stained immediately after having been treated with 1 mM sodium arsenite in fresh
DMEM for 1 hour. The right hand images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The left
hand images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing
staining for both UNR and HUWE1. The white arrows show an area of punctate co-localisation
of UNR and HUWE1. The scale bar in all images is 25 µm.
Some areas of apparent co-localisation between UNR and HUWE1 were observed in unstressed
SaOS-2 cells. There were both punctate areas of co-localisation (Figure 4.25, white arrows) and
larger areas of co-localisation around the nucleus (Figure 4.25, yellow arrows). UNR had
previously been recorded to be concentrated around the nucleus and endoplasmic reticulum by
immunofluorescence microscopy in the MCF7 cell line (Jacquemin-Sablon et al., 1994). Whilst
this is interesting in terms of seeing UNR concentrated around the nucleus, in general, the
distribution of UNR in the cell types used during this project has been quite different to the
images obtained by Jacquemin-Sablon.
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Figure 4.25: Confocal immunofluorescence microscopy images of non-arsenite treated SaOS-2
cells fixed and stained immediately after having been mock treated with sterile PBS in fresh
DMEM for 1 hour. The upper images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The lower
images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing staining
for both UNR and HUWE1. The white arrows show punctate areas of co-localisation between
UNR and HUWE1. The yellow arrows show larger areas of UNR co-localisation with HUWE1 near
the nucleus. The scale bar in all images is 25 µm.
Arsenite-stressed SaOS-2 cells also showed some areas of apparent co-localisation of UNR and
HUWE1. The co-localisation appeared to be diffuse even though UNR had adopted a more
punctate localisation (Figure 4.26, yellow arrows). Interestingly, there were clear stress granule-
like structures that contained UNR but did not contain HUWE1 (Figure 4.26, white arrows).
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Figure 4.26: Confocal immunofluorescence microscopy images of arsenite treated SaOS-2 cells
fixed and stained immediately after having been treated with 1 mM sodium arsenite in fresh
DMEM for 1 hour. The upper images show background staining from the fluorophore-
conjugated secondary antibodies, as coloured, in the absence of primary antibodies. The lower
images show staining for UNR (blue), HUWE1 (green), and an overlaid image showing staining
for both UNR and HUWE1. The yellow arrows show areas of co-localisation of UNR and HUWE1.
The white arrows show a punctate area of UNR staining without any HUWE1. The scale bar in all
images is 25 µm.
It is interesting to consider the TP53 status of the cell lines used here. Whilst at least one
subclone of HeLa (HeLa S3) lacks the TP53 gene, other HeLa cells do possess it (Jia et al., 1997).
The exact identity of the HeLa cells used here was unknown. It was nevertheless clear that they
did express TP53 as the protein was observed, for example, by immunofluorescence microscopy
(e.g. Figure 3.8). It should also be considered that the HeLa cell line was transformed with
genetic information from human papilloma virus type 16. The viral E6 protein is expressed in
HeLa and can both repress the transcriptional output of TP53 (Hoppe-Seyler & Butz, 1993) and
target the protein itself for proteosomal degradation (Scheffner et al., 1990). SaOS-2 has been
shown to have lost the TP53 gene whereas the related U2OS cell line retains the gene and
expresses the protein at equivalent levels to that seen in fibroblasts (Diller et al., 1990). It should
be noted that U2OS also overexpress HDM2 (Florenes et al., 1994). Whilst TP53 expression in
U2OS cells has been shown in this thesis by Western blotting (Figure 3.15), it is still possible that
HDM2 could be acting to prevent TP53 transactivation or interaction with transcriptional co-
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activators (discussed in Shi & Gu 2012). To summarise, SaOS-2 does not contain any TP53 (gene,
transcript or protein) whereas both U2OS and HeLa express TP53 transcripts and protein. For
this reason, differences in UNR distribution between SaOS-2 and both U2OS and, though to a
lesser extent, HeLa could be related to TP53. On the other hand, beyond other differences
between the cell type proteomes, any comparison of TP53 status is confounded with Hdm2
over-expression/E6 expression. Further research is required to ascertain which, if any, of the
myriad cellular functions of TP53 could be involved.
4.12.2 Sequestosome-1
Having some evidence that UNR really does interact with HUWE1, it was decided to carry out an
IP-Western on another protein that had been suggested as a top putative UNR-interactor across
all three cell types, SQSTM1, using arsenite-stressed and unstressed HeLa cell lysates (Figure
4.27).
Figure 4.27: Result of an IP-Western in which an anti-UNR immunoglobulin or a conspecific
control IgG, as stated, was used to pulldown proteins from cell lysates that had been treated
with 1 mM of sodium arsenite, or a similar volume of sterile PBS, in fresh DMEM for 1 hour
immediately prior to harvesting (as stated). Input lanes containing 5% of the total amount of
lysate used in the experiment were loaded in each case (labelled lysate). The
immunoprecipitated proteins were boiled in loading buffer and run on a 10% polyacrylamide gel
prior to being transferred onto nitrocellulose membrane which was blocked, probed with an
anti-SQSTM1 immunoglobulin raised in goat (see section 2.1.1) followed by a HRP-conjugated
anti-goat IgG secondary antibody and then developed using an enhanced chemiluminescence-
based approach. The number on the left hand side of the image is an approximate molecular
mass (in kilodaltons), as estimated using PageRuler Plus Prestained Protein Ladder
(ThermoFisher).
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The IP-Western showed clear binding of SQSTM1 to UNR over the control IP, especially in
arsenite treated HeLa cells, thereby validating SQSTM1 as a UNR-interacting protein (at least in
HeLa cells). Whilst only a small selection of the total number of novel putative UNR-interacting
proteins suggested by the work in this chapter, seeing evidence of a likely interaction in the two
that were actually tested was promising. Whilst it remains to be seen whether the other
suggested hits are genuine or not, evidence has been provided showing that not all the putative
interactors are false positives.
4.13 Summary of chapter
Immunoprecipitations were carried out with an antibody against UNR in three different cell
types (HeLa, U2OS and SaOS-2), both arsenite stressed and unstressed. The immunoprecipitate
samples were then separated and a portion was subjected to analysis by mass spectrometry in
an attempt to locate some previously unknown UNR interacting proteins.
Initial trial runs using unstressed HeLa cell lysates implied that there were some reproducible
hits although it was not known how significant this was as it was not known how many proteins
could be located by the mass spectrometer. Later, an estimate of over 2000 proteins was
obtained using UNR knockdown data (number of proteins identified by Scaffold with a minimum
of 2 peptides when the peptide cut off was 95% and the protein cut off was 99%, data not
shown).
Paired t-tests were carried out on proteins quantified using the Progenesis software. As the t-
test p-values were not strong enough, a multiple testing correction was not used. Validation was
instead left to protein hit reproducibility between conditions and whether or not strong p-values
were obtained for significantly overrepresented GO terms.
Among the most reproducible protein hits were UNRIP, which was expected, HUWE1, NARR,
SQSTM1 and LDB1. HUWE1 was validated by IP-Western blot and immunofluorescence
microscopy and SQSTM1 was validated by IP-Western blot.
The GO term overrepresentation data were extremely promising. The top biological process GO
term for all conditions was ‘mRNA metabolic process’ (Table 4.26).
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Table 4.26: Bonferroni-adjusted p-value for the overrepresentation of the ‘mRNA metabolic
process’ biological process GO term across all conditions
Top biological process GO term Cell type Arsenitetreatment
Bonferroni-adjusted
p-value
mRNA metabolic process HeLa No 4.34x10-8
mRNA metabolic process HeLa Yes 1.17x10-14
mRNA metabolic process U2OS No 4.87x10-21
mRNA metabolic process U2OS Yes 1.24x10-24
mRNA metabolic process SaOS-2 No 1.15x10-20
mRNA metabolic process SaOS-2 Yes 1.60x10-25
Other recurring, and less expected top ten biological process GO terms included selenium-
related GO terms (all groups except arsenite stressed U2OS) and ‘SRP-dependent cotranslational
targeting to membrane’.
‘RNA binding’ and ‘poly(A) RNA binding’ were the top two molecular function GO terms for all
conditions. ‘Adherens junction’ was a top ten molecular function hit in stressed U2OS cells
(adjusted p-value = 1.12x10-16).
‘Ribonucleoprotein complex’ was the top cellular component GO term for U2OS (stressed and
unstressed) and stressed HeLa. It was the second top hit for unstressed HeLa (after ‘cytosolic
small ribosomal subunit). It was the top hit among GO terms to which are annotated less than
1000 proteins in both SaOS-2 samples although it fell beneath other GO terms, such as
‘extracellular exosome’ (Bonferroni adjusted p-values = 1.56x10-20 [unstressed], 1.82x10-28
[stressed]).
From this chapter, it is claimed that HUWE1, SQSTM1, NARR and LDB1 are novel UNR-interacting
proteins. It is further claimed that UNR mainly interacts proteins within ribonucleoprotein
complexes, and that it may bind to proteins involved in selenium metabolism and at adherens
junctions.
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5 Identification of UNR-interacting transcripts
UNR is known to be an RNA binding protein, yet few UNR-interacting transcripts are currently
recorded in the literature (Ray et al. 2015). Initial results in the lab had suggested that UNR may
bind to a large number of transcripts in human cells (data not shown). Following on from those
initial observations, this chapter set out to identify more UNR-interacting transcripts. The
remaining 80% of the RIP samples generated for mass spectrometry (see sections 4.3, 4.5 and
4.6) were used to extract RNA that was then sequenced by RNA-Seq. The intention was to find
RNAs that were present in statistically significantly higher quantities in the UNR
immunoprecipitation samples than in the control IgG immunoprecipitation samples. Such RNAs
would be expected to have be associated with UNR.
Dr Swagat Ray kindly carried out RNA extraction from the HeLa samples (section 2.2.13, steps 1-
19) and partly carried out the RNA extraction from the U2OS samples (section 2.2.13, steps 1-
12). Dr Emma Anderson kindly carried out the final resuspension and storage steps for the U2OS
and SaOS-2 samples (section 2.2.13, steps 13-19). Lesley Ward of the University of Warwick
Genomics Facility further processed the samples (see sections 2.2.15 and 5.1.1) before sending
them to the Wellcome Trust for analysis (see section 5.1.1). Dr Nigel Dyer kindly pre-processed
the raw RNA-Seq data that was received back from the Wellcome Trust (see section 5.1.1). He
also allowed me to use and customise pieces of generic code that he had written to run PCA
analysis in Matlab and DESeq2 analysis in R (see sections 2.2.18, 5.2 and 5.3).
5.1 RIP-RNA-Seq
5.1.1 Introduction to RNA-Seq
As stated previously, 80% of the RIP samples were set aside for the extraction and sequencing
of UNR-associated RNA species (Section 4.1.1).
Briefly, a phenol/chloroform-based method was used to extract RNA from the
immunoprecipitates directly from the beads. The RNA was then passed on to the University of
Warwick genomics department who further processed the RNA using the low sample protocol
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from the Illumina TruSeq RNA sample preparation v2 guide (see methods section), with the
following modifications:
1) The oligo-dt purification step was omitted
2) Where possible, 100 ng of RNA was used per sample
3) Whereas the suggested bioanalyzer chip was used to verify RNA purity, the libraries
were quantified using Qubit Fluorometry, which yields more precise results (Davies et
al. 2016)
The libraries were normalised to 10 nM, made into two 10 nM pools and sent offsite to be
sequenced by the Wellcome Trust facility in Oxford, using an Illumina HiSeq4000 on a 75 base
pair paired end run. Illumina claim that their TruSeq RNA sample prep v2 fragmentation protocol
generates fragments in the range of 120-200 base pairs with a median of 150 base pairs.
Whereas conventional DNA sequencing allows for direct mapping of reads to a reference
genome, after accounting for intraspecific genetic variation, RNA sequencing has the additional
problem of sequencing across splice junctions. This arises due to the process of splicing (Green
1986). Pre-messenger RNA (pre-mRNA) is transcribed from the antisense strand of DNA,
resulting in a copy of the sense strand with thymine replaced with uracil. Pre-mRNA can contain
introns that are spliced out as part of the process of generating mature mRNA. As part of the
processing carried out by genomics, the first strand of complementary DNA (cDNA) was
generated by reverse transcription of fragmented RNA, followed by the removal of the RNA
template and the generation of a complementary strand of DNA. In the case of fragments of
mRNAs that cross splice junctions, this can result in the generation of cDNA sequences that are
not present in the genomic DNA from which they were ultimately generated (Figure 5.1).
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Figure 5.1: How cDNA differs from genomic DNA. Schematic diagram showing part of an mRNA
fragment and how this is related to the DNA from which it is transcribed and to cDNA that can
be generated from it.
Dr Nigel Dyer of the Ott lab kindly processed the raw data using Tophat2 and the HTSeq tool,
htseq-count, before providing the author with raw count data within a Microsoft Excel file.
Tophat2 is a program that uses Bowtie2 to map reads directly to a reference genome and this
can deal with the problem of introns by locating regions of the genome that would align with a
given sequence assuming that a single sequence was inserted into it (Kim et al. 2013; Langmead
& Salzberg 2012). Htseq-count tallies unambiguous reads that overlap exons of specific genes
(Anders et al. 2015). Raw count data at the gene level, as opposed to the transcript level, was
thereby produced that was then exported to Microsoft Excel and passed on to the author for
further analysis.
5.2 Principal component analysis on RNA-Seq data
Prior to proceeding with analysis of the RNA-Seq data, principal component analysis was first
undertaken. Principal component analysis can be used to locate outliers and groupings within a
group of samples (Wold et al. 1987). As it shows how the samples cluster by principal
component, it is possible to confirm that known biological variability (e.g. cell type, drug
treatment or whether the RIP was carried out with a test or control antibody, etc.) is responsible
for the observed variation in the data.
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Principal component analysis was carried out using Matlab, running a standard script used in the
Ott lab that was kindly provided by Dr Nigel Dyer.
5.2.1 Initial round of PCA identifies 4 outliers in PC2 and/or PC1
The samples were identified by cell type, repeat number and drug treatment (i.e. arsenite
stressed or unstressed), as with the mass spectrometry data. Due to potential confusion should
the SaOS-2 cell type be followed by numbers, ‘SaOS’ was used as the cell name. How the
numbers equate to condition is summarized below:
1, 2 and 3 = IgG pulldown repeats (1-3), unstressed,
4, 5 and 6 = UNR pulldown repeats (1-3), unstressed,
7, 8 and 9 = IgG pulldown repeats (1-3), arsenite stressed,
10, 11 and 12 = UNR pulldown repeats (1-3), arsenite stressed.
An initial round of PCA was carried out looking for outliers in the first two principal components,
as these provide the greatest individual contributions to the overall variance in the data.
Considering an outlier to be any sample that lies far away from the main cluster/clusters of
samples, the first search showed that there were four clear outliers (Figure 5.2). As they lay far
from the main cluster of samples, they contained a large source of variation of unknown origin
that would confound subsequent analyses that included them. Those samples were therefore
removed from subsequent rounds of PCA.
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Figure 5.2: First round of PCA on RNA-Seq data. Red dots denote HeLa samples, green dots
represent SaOS-2 samples and blue dots signify U2OS samples. The highlighted samples lay
outside the general cluster and were rejected as outliers. They were removed from subsequent
rounds of PCA.
5.2.2 Second round of PCA locates a further outlier in PC1 and PC2
Having removed the four outliers from the data, a second round of PCA was carried out on the
remaining data, again looking for outliers in the first two principal components. Following the
same reasoning as in section 5.2.1, this round of PCA highlighted one further outlier that was
removed as with the previous four outliers (Figure 5.3).
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Figure 5.3: Second round of PCA on RNA-Seq data, having already removed four outliers. Red
dots denote HeLa samples, green dots represent SaOS-2 samples and blue dots signify U2OS
samples. The highlighted sample (SaOS-2 minus arsenite, IgG repeat 1) lies outside the general
cluster and was rejected as an outlier from the subsequent round of PCA.
5.2.3 Third round of PCA locates no further outliers in the top two principal
components
Having removed the fifth outlier, it was decided to look at whether or not the remaining samples
clustered by cell type over the top six PCs (Figure 5.4).
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Figure 5.4: Third round of PCA on RNA-Seq data, having removed five outliers. Samples are
coloured by cell type (HeLa = red, SaOS-2 = green and U2OS = blue) over PC1 and PC2 (Figure
5.4A), PC3 and PC4 (Figure 5.4B) and PC5 and PC6 (Figure 5.4C). The highlighted samples in
Figures 5.4B and 5.4C lay outside the general cluster but were not rejected as outliers.
It was shown that the cell types were separated by PC1 (Figure 5.4A), implying that cell type
accounts for the largest source of variation in the data. The T P 53-wild type U2OS cell type was
separated from the T P 53-null SaOS-2 cell type and the T P 53-disregulated HeLa cell type by PC2
(Figure 5.4A), although it is not fair to assume that T P 53 status was in any way responsible for
this observation. None of PC3, PC4, PC5 nor PC6 appeared to account for variance due to
differences in cell type as there was no clear clustering by cell type over these components
(Figures 5.4B and 5.4C).
5.2.4 It was decided not to remove any further outliers from the third round of PCA
Two further potential outliers were flagged up in the third round of PCA; one in PC4 (Figure 5.4B)
and one in PC5 (Figure 5.4C). It was decided not to remove these samples from the data as the
variance accounted for by PC4 and PC5 is relatively small (Table 5.1). As a result of that, the
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removal of more samples could not be justified. That is because, ceterisparibus, the removal of
replicates reduces the ability of statistical tests to detect true differences and to reject false
positives (Cohen 1992).
Table 5.1: The variance and cumulative variance accounted for by the first six principal
components following the removal of 5 outliers.
Principal component Associated variance Cumulative variance
PC1 34.0 34.0
PC2 17.9 51.9
PC3 7.6 59.5
PC4 5.7 65.3
PC5 4.5 69.7
PC6 3.5 73.3
It would take the sum of all principal components up to PC7 to attain a cumulative variance over
75% (76.1%), up to PC15 to reach 90% (90.5%) and up to PC20 to get to 95% (95.4%) (data not
shown). Whilst the PCs lower than PC6 account for 26% of the variance in total, each individual
component contributes relatively little to that total. Outliers confined to the lower principal
components were therefore retained and principal components beneath PC6 were not
examined graphically.
5.2.5 Third round of PCA shows effect of the choice of immunoprecipitating
antibody is partly accounted for over the top three principal components
Having explored the way in which differences due to cell type are distributed over the top six
principal components, it was decided to investigate whether or not some of the differences due
to the choice of immunoprecipitating antibody (control IgG or anti-UNR) were also shared
between the top six principal components (Figure 5.5).
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Figure 5.5: Third round of PCA on RNA-Seq data, having removed five outliers. Samples are
coloured by immunoprecipitation antibody (control IgG = blue and anti-UNR = pink [termed ‘Unr’
in key]) over PC1 and 2 (Figure 5.5A), PC3 and 4 (Figure 5.5B) and PC5 and 6 (Figure 5.5C). The
highlighted samples in Figures 5.5B and 5.5C lay outside the general cluster but were not
rejected as outliers.
This suggested an interesting cell type dependent relationship over the first two principal
components. In SaOS-2 (Figure 5.5A, bottom right cluster - see Figure 5.4A), the variance due to
antibody choice appears to be in part explained by PC2. In U2OS (Figure 5.5A, top cluster - see
Figure 5.4A), that variance seems to be shared between PC1 and PC2. In the HeLa samples
(Figure 5.5A, bottom left cluster - see Figure 5.4A), the variance due to antibody choice does not
seem to be so clearly explained by PC1 and/or PC2 as in the other cell types.
Principal component 3 appears to explain some of the variance due to the difference in antibody
used in that most IgG samples tend to have values less than zero, whereas most UNR samples
tend to have values greater than zero (Figure 5.5B). PC4, PC5 and PC6 do not appear to explain
antibody-related variance (Figures 5.5B, 5.5C).
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5.2.6 Third round of PCA shows effect of arsenite treatment is partly accounted for
by PC1 and PC2 in HeLa samples and PC4 and PC5 more generally
Having looked at how the top six principal components can account for the variance due to cell
type and immunoprecipitating antibody, it was considered prudent to look into how they could
account for the other controlled variable in the experiment – arsenite treatment. This analysis
is graphically displayed below (Figure 5.6).
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Figure 5.6: Third round of PCA on RNA-Seq data, having removed five outliers. Samples are
coloured by whether or not the samples had been subjected to arsenite treatment (no arsenite
treatment = purple and 1 mM arsenite for one hour immediately prior to harvesting = red) over
PC1 and 2 (Figure 5.6A), PC3 and 4 (Figure 5.6B) and PC5 and 6 (Figure 5.6C). The highlighted
samples in Figures 5.6B and 5.6C lay outside the general cluster but were not rejected as outliers.
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There is some evidence for the variance due to arsenite treatment in HeLa being shared between
PC1 and PC2, although this is less apparent for the other cell types (Figure 5.6A, compare Figure
5.4A for cell types). There is some evidence for PC4 (untreated samples generally more positive)
and PC5 (untreated samples generally more positive) explaining some of the variability due to
arsenite treatment, but this is not true for PC3 and PC6 (Figures 5.6B and 5.6C).
5.2.7 Summary of PCA work
Two rounds of PCA were carried out, during which five outliers were detected in the first two
principal components. These outliers were the samples with the lowest total number of reads
aligned to the human genome (Table 5.2).
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Table 5.2: Total number of reads aligning to the human genome, by sample
Sample Genome reads %age of max Sample Genome reads %age of max
HeLa1 15526162 54.0 U2OS1 16183300 56.3
HeLa2 15495709 53.9 U2OS2 19966464 69.5
HeLa3 12385277 43.1 U2OS3 20162372 70.1
HeLa4 720695 2.5 U2OS4 12252870 42.6
HeLa5 20301255 70.6 U2OS5 17327799 60.3
HeLa6 13866858 48.2 U2OS6 14690132 51.1
HeLa7 11878865 41.3 U2OS7 6517352 22.7
HeLa8 12375112 43.1 U2OS8 13011 0.0 (sic)
HeLa9 21143086 73.6 U2OS9 22790129 79.3
HeLa10 7051332 24.5 U2OS10 16715423 58.2
HeLa11 2409881 8.4 U2OS11 25932440 90.2
HeLa12 12996747 45.2 U2OS12 28743669 100
SaOS1 2235222 7.8 SaOS7 5379622 18.7
SaOS2 5605892 19.5 SaOS8 161914 0.6
SaOS3 110964 0.4 SaOS9 10224470 35.6
SaOS4 5203729 18.1 SaOS10 4509713 15.7
SaOS5 4627719 16.1 SaOS11 6952330 24.2
SaOS6 3486047 12.1 SaOS12 3690268 12.8
Key: Yellow = removed after first round of PCA (Figure 5.2), green = removed after second round
of PCA (Figure 5.3), purple = the only other value less than 10% of maximum number of reads.
This sample was one of the two samples suggested for removal after the third round of PCA
(Figure 5.4B).
It has been shown that much of the expected variability due to the controlled experimental
variables can be accounted for, at least in part, by the top 5 PCs. These components were
furthermore calculated to account for around 70% of the total variation, implying that any
expected variability accounted for by lower principal components would probably be small in
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proportion to the total as each lower component accounts for an ever decreasing proportion of
the overall variation.
As all of the controlled variables (cell type, arsenite treatment and immunoprecipitating
antibody) had an effect on the samples, as visualized by PCA, the experimental approach was
valid and there is likely to be useful information in the data.
Having decided upon which of the samples to remove as outliers, it was decided to proceed and
to analyse the data further using DESeq2.
5.3 DESeq2
DESeq2 is an R-based bioinformatics tool that can analyse count data, such as RNA-Seq data,
and provide information about differential expression (Love et al. 2014). It is worth pointing out
that the interesting comparisons between these data are not strictly questions of differential
expression, but of differential immunoprecipitation.
DESeq2 was compared against a variety of similar programs in the Ott lab by Dr Nigel Dyer, who
concluded that DESeq2 was the most consistent and reliable program (personal
correspondence). Other work in the literature has also suggested that DESeq2 is a good choice
of program for differential expression (Ching et al. 2014).
5.3.1 Summary of samples remaining following rejection of five samples following
PCA
The RIP-Seq experiment had 6 conditions – plus and minus arsenite for each of the three cell
types. There were three UNR pulldown samples for each condition, each of which had a paired
IgG sample. There were three repeats, thereby making 36 samples in total. It had been decided
following principal component analysis that five samples were to be treated as outliers and
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removed (see section 5.2.6). The total number of samples remaining following the rejection of
suggested outliers was, therefore, 31.
Each cell type/arsenite treatment condition started with three pairs (i.e. the three repeats).
Following outlier removal, only HeLa plus arsenite and U2OS minus arsenite retained all three
UNR/IgG pairs (Tables 5.2A and 5.2B). SaOS-2 minus arsenite, on the other hand, retained only
one IgG sample but all three UNR samples (Table 5.3).
As no UNR/IgG pairs were both designated as outliers, five of the eighteen possible pairs were
lost. HeLa plus arsenite and U2OS minus arsenite retained 3 pairs, SaOS-2 minus arsenite
retained one pair and the other three conditions had retained two pairs each (Table 5.4).
Table 5.3: Remaining samples following the removal of outliers
Cell type - arsenite IgG - arsenite UNR + arsenite IgG + arsenite UNR
HeLa H1, H2, H3 H5, H6 H7, H8, H9 H10,H11, H12
U2OS U1, U2, U3 U4, U5, U6 U7, U9 U10, U11, U12
SaOS-2 S2 S4, S5, S6 S7,S9 S10, S11, S12
Table 5.4: Remaining pairs following the removal of outliers and their paired samples
Remaining pairs
Cell type - arsenite + arsenite
HeLa H2/5, H3/6 H7/10, H8/11, H9/12
U2OS U1/4, U2/5, U3/6 U7/10, U9/12
SaOS-2 S2/5 S7/10, S9/12
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In order to look at the retained data graphically, all the samples in Table 5.4 were normalized by
their total read counts and arranged in UNR/IgG pairs by gene. These data then had 1 added to
every count value prior to having their log2 value calculated. The reason for adding 1 was to
avoid the risk of having to take logs of values less than one and potentially zero, which would
make the point unplottable. By adding 1, every log value had to be greater than or equal to 0.
Every retained pair of UNR and IgG samples for each condition then had their log2 values plotted
for every gene, thereby generating six plots (Figure 5.7). As the data had been normalized, the
total number of adjusted reads for each sample were the same. Nevertheless, there appeared
to be a general trend for points (i.e. gene observations) to lie further above the line y=x than to
lie under it. Due to normalization, it is expected that this is explained by there being more
individual points under the line than over it but the high concentration of points mean that this
is not visible. Such a trend does imply that UNR is binding to some RNAs specifically. Individual
points that lay far from the cluster around y=x were expected to be more significant than those
that lay closer to the line y=x. Such graphs are plotted below by cell type and arsenite treatment
(Figure 5.7).
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Figure 5.7: Log/log plots of normalized UNR (termed ‘Unr’) and IgG read count pairs for each
gene, by cell type (A = HeLa, B= SaOS-2, C = U2OS) and arsenite treatment (as stated). Points
refer to genes from the respective UNR/IgG paired samples in Table 5.4 (therefore, other than
for SaOS-2 minus arsenite, every gene is present more than once). Briefly, 1 was added to each
read count and the log2 of these values was taken and used to plot the graphs. Points lying on
the red y=x line refer to RNAs that bound equally to UNR and IgG in a given repeat.
In general, the log transformation plots showed that there was a slight general skew towards
more binding in the UNR samples. It is difficult to infer much about significance from these plots
but it does look as though HeLa minus arsenite, for example, may have some genes that could
be overrepresented in UNR at moderate read counts (log values 13-16) and a smaller number
overrepresented in IgG (log value 12-15) (Figure 5.7A). Only following analysis using DESeq2 will
it be apparent if there are any significant hits.
5.3.2 Strategy for using DESeq2 analysis to look for UNR-associated RNAs
It had been decided to use DESeq2 to look for differences between the RNAs pulled down by
UNR and IgG for different groups of samples. The data were fed into DESeq2 for one factor
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analysis (i.e. UNR for one condition being compared against IgG for the same condition) or, when
considered appropriate, two factor analysis. In this case, the two factors would be:
1) Differences due to immunoprecipitating antibody,
2) Differences due to date of sample preparation.
Every cell type was processed individually and, therefore, the maximum number of members of
each of the second factor groups was four – two pairs (UNR or IgG pulldown using lysates formed
from stressed or unstressed cell harvested on a given day).
The choice of using one or two factor analysis was decided based upon the question that each
method addresses. One factor analysis simply compares overall mean values for UNR and IgG.
It therefore addresses the question of whether or not a given RNA bound preferentially and
consistently in UNR pulldowns over IgG pulldowns.
As cell type accounted for the largest portion of variation in the data, comparing sample means
across cell types could miss trends in preferential binding that could be skewed by differential
expression levels between cell types. Where only one cell type was considered, one factor
analysis was considered preferable as demonstrating a clear difference between means is
intuitively pleasing.
The two factor analysis addresses a different question – whether there is a consistent difference
between UNR and IgG pulldowns using lysates made on the same day. That consideration made
it more appropriate for investigating UNR-interacting RNAs across cell types. Under such
circumstances, it may find more UNR-interacting RNAs but the individual hits would be
confounded with variation in expression levels. It could also generate results that are
confounded with arsenite treatment as some cell type repeats have four samples (UNR and IgG,
plus and minus arsenite) and some only have two (UNR and IgG, plus or minus arsenite).
To summarise, one factor analysis would be able to locate a subset of true hits that did not bind
to IgG at any appreciable level (Figure 5.8A) or that were expressed at similar levels in all cell
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types (Figure 5.8B) but two factor analysis would be required to locate true hits where
expression varied greatly between, or within, cell types (Figure 5.8C).
Figure 5.8: Schematic representation of three scenarios in which a hypothetical RNA binds
preferentially to UNR (blue) over IgG (green) in three repeats of three cell types (HeLa, U2OS
and SaOS-2). The scenarios show (A) a situation in which there is no appreciable binding of the
RNA to IgG, (B) a situation in which there are similar levels of expression in all three cell types,
(C) a situation in which the expression level varies between the cell types.
As two factor analysis compared results from UNR and IgG samples prepared on the same day,
it was decided to reject all unpaired samples and only the pairs documented in Table 5.4 were
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retained for further consideration by two factor analysis. As results obtained by two factor
analysis and one factor analysis were to be compared and contrasted, it was considered helpful
to also exclude unpaired samples from consideration by one factor analysis.
It was decided to compare samples on four levels:
1) By cell type and arsenite treatment
2) By cell type only (i.e. arsenite treatment independent)
3) By arsenite treatment only (i.e. cell type independent)
4) All samples combined (i.e. arsenite treatment and cell type independent)
By only providing DESeq2 with a subset of the samples, variation present in other groups of
samples could not affect the ability of the program to detect differences that were specific to
the subset (e.g. the HeLa plus arsenite samples would not be merged with HeLa minus arsenite
nor samples from other cell types that could have a different distribution of read counts).
A problem with working with small groups of samples is that they are more affected by outliers.
In this work, PCA analysis was used to highlight and remove outliers but the final round of
analysis suggested further outliers that were retained for the reasons explained previously. On
top of this, small groups of samples could be unrepresentative of a parent population containing
all possible samples. It has been suggested that the majority of all biomedical research findings
are wrong because of reasons such as small sample sizes (Ioannidis 2005). In order to increase
the number of repeats for statistical testing using DESeq2, it was decided to merge similar
groups. Firstly, as the PCA analysis suggested that the majority of the variability in the data was
due to cell type differences rather than arsenite treatment, it was decided to merge the plus
and minus arsenite samples for each cell type. This would have the positive effect of increasing
the number of replicates for each condition, the condition always being the counts from UNR or
IgG pull downs. On the other hand, the effect of arsenite would become a confounding variable.
Where an RNA binds well to UNR under arsenite stress but poorly otherwise, merging the
samples would reduce the significance of such an RNA. These mergers, therefore, look primarily
for RNAs that bind preferentially to UNR irrespective of whether or not the cells from which they
were obtained had been treated with arsenite or not.
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A second merger went by arsenite treatment rather than cell type. This merger was looking for
RNAs that bound to UNR across more than one cell type but that may have been affected by
arsenite treatment. As discussed below, two factor DESeq2 analysis was considered more
appropriate for analyzing these data.
Finally, all samples were merged together. This provided the greatest number of repeats but
was confounded with both cell type differences and arsenite treatment. It was hoped that two
factor DESeq2 analysis could find some UNR-associated RNAs that interact independently of cell
type and arsenite treatment. Findings from this grouping and the previous merged groups were
considered most likely to give information about any highly conserved roles for UNR in human
cells.
5.3.3 A brief word on nomenclature
RNAs were pulled down in the RIPs and these were converted to cDNA for sequencing. Pre-
processing of the sequencing data by Dr Nigel Dyer produced a list of non-transcript specific
genes that were then used for further analysis (e.g. GO term analysis). In general, only protein
coding genes were considered. Where protein coding genes were considered, this implied that
their transcripts were pulled down in the RIP. Nevertheless, the data referred to genes and the
term ‘gene’ will be used to describe the pulled down RNAs. Likewise, consideration will be made
as to the function of proteins encoded by the significant genes. It should always be borne in
mind that the original RIPs pulled down RNAs for sequencing and that consideration of proteins
and the use of the word ‘gene’ in analytical discussion of the sequencing data should be
understood in that context.
Where required, recommended protein names were used, as per www.uniprot.org, as well as
the short version of gene names (associated gene names) for the GRCh38.p5 version of the
human genome that was previously available for download via
http://www.ensembl.org/biomart/martview/.
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5.3.4 Technical details for gene ontology (GO) term overrepresentation analyses
Unless specified otherwise, the technical details of the GO term searches carried out for this
chapter, as obtained from the GO tool, are presented in Table 5.5.
Table 5.5: Technical information associated with GO term searches
Analysis Type: PANTHER Overrepresentation Test (release20160715)
Annotation Version and Release
Date: GO Ontology database Released 2016-06-22
Analyzed List: upload_1 (Homo sapiens)
Reference List: Homo sapiens (all genes in database)
Bonferroni correction: TRUE
5.4 DESeq2 results for HeLa samples
5.4.1 Results comparing HeLa minus arsenite samples by immunoprecipitating
antibody
The two pairs of HeLa minus samples (Table 5.4) were compared by whether they were from
UNR or IgG pulldowns. DESeq2 only highlighted one gene as having a Benjamini-Hochberg (BH)
adjusted p-value less than 0.05 – ZN F8 (adjusted p=0.0397). This gene was higher in the UNR
samples and was protein coding.
Zinc finger proteins contain the zinc finger DNA binding motif (Berg 1990). Znf8 (Zinc Finger
Protein 8) is a repressor of expression as a result of Tgf-/Bmp signaling (Jiao et al. 2002). This
is interesting as the UNR-interacting protein (UNRIP) is also involved in TGF- signaling and this
opens the possibility that UNR could influence signaling through protein-protein interactions as
well as protein-transcript interactions.
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Whilst it was decided to use one factor DESeq2 analysis to generate results that are easier to
interpret, it was decided to carry out two factor analysis on the HeLa minus arsenite samples.
This changed the comparison from one in which all UNR samples should be higher than all IgG
samples to one in which all comparisons should bind more to UNR than to IgG. That can be
considered a positive change in one respect as the idea of these analyses was to find RNA species
that are pulled down preferentially in UNR pull downs over over IgG pull downs. Also, it is more
difficult to interpret plots of the results of two factor analyses as mean read counts may be
skewed up or down by the absolute read count whereas the comparison was carried out on the
difference between pairs of read counts. Nevertheless, it was considered useful to carry out a
two factor analysis for the HeLa minus arsenite samples to see if it generated more hits and, if
so, if they could be used to generate significant GO terms.
The two factor analysis generated 42 genes with a BH-adjusted p-value less than 0.05, of which
41 were higher in the UNR samples, of which 37 were protein coding. ZN F8 remained a hit (new
adjusted p-value = 0.01722) but the new top hit was EIF2AK2 (Interferon-induced, double-
stranded RNA-activated protein kinase) which had an adjusted p-value of 1.39x10-11. EIF2AK2 is
a proapoptotic factor (Lee & Esteban 1994) as well as acting to shut off translation in response
to infection with certain viruses (Garcia et al. 2006). More recently, it has also been implicated
in Alzheimer’s disease (Bullido et al. 2008). Interestingly, UNR has been associated with
apoptosis, viral translation and Alzheimer’s disease (all discussed in chapter 1).
Entering the 37 protein coding genes into the GO term enrichment tool at
http://amigo.geneontology.org/rte generated no significant Bonferroni-adjusted GO terms
(biological process, molecular function and cellular component).
In the absence of significant GO terms, the protein coding genes are tabulated below with their
DESeq2-calculated UNR/IgG fold changes and BH-adjusted p-values (Table 5.6).
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Table 5.6: Putative UNR-interacting transcripts from the HeLa minus arsenite samples
with two factor DESeq2 analysis-calculated UNR:IgG ratios and BH-adjusted p-
values
Gene UNR/IgGratio
BH-adjusted
p-value Gene
UNR/IgG
ratio
BH-adjusted
p-value
EIF2AK2 3.95 1.39E-11 T IM M 50 2.27 0.014295
L YR M 7 3.59 1.67E-05 ZN F8 2.55 0.017221
X IAP 3.14 5.68E-05 N DU FV3 2.38 0.017546
M R I1 2.81 0.000127 AHR 2.35 0.017546
VHL 3.02 0.000172 ZN F714 2.45 0.022859
ZN F587 3.14 0.000259 GN B4 2.07 0.031744
CYP 20A1 3.03 0.000608 M CM 8 2.39 0.031785
L IM D1 2.63 0.000828 AT P 5S 2.43 0.032897
BR I3BP 2.45 0.000828 BP N T 1 2.36 0.032897
M DM 4 2.51 0.001199 YIP F4 2.27 0.032897
DFFA 2.37 0.002511 S P P L 2A 2.17 0.032897
CCN YL 1 2.61 0.002634 EM P 2 1.95 0.036506
M M ACHC 2.57 0.005900 M IER 1 2.10 0.036727
M ET T L 2B 2.54 0.005900 DT W D2 2.35 0.044065
P S M D12 2.33 0.005900 ZN F556 2.36 0.044687
AP O O L 2.59 0.009157 T M O D3 1.98 0.044687
M YL K3 2.22 0.011044 P O L R 2D 2.10 0.047449
M P V17L 2.62 0.012438 CR CP 2.15 0.049507
FAM 20B 2.11 0.013412
5.4.2 Results comparing HeLa plus arsenite samples by immunoprecipitating
antibody
The three pairs of HeLa plus samples (Table 5.4) were then compared by whether they were
from UNR or IgG pulldowns. DESeq2 highlighted 65 genes as having a Benjamini-Hochberg (BH)
adjusted p-value less than 0.05 of which 51 were higher in the UNR samples. Of the 51 genes
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that were significantly higher in the UNR samples, 46 were protein coding. The significant
protein coding genes are presented on a log/log graph below (Figure 5.9). Normalized read
counts from two HeLa plus arsenite UNR pulldown samples are plotted to give an idea of the
spread of count read due to biological variation between samples. The values plotted were log2
values of the read counts for each condition, as stated on the graph axes, plus one. The graph
also shows the average values for the significant genes. These were calculated by taking a mean
value for the UNR and IgG counts of each gene, adding one and taking the log2 value of the
result. The resultant UNR and IgG values were plotted, as stated on the axis labels.
Figure 5.9: Log/log plot of one factor DESeq2 hits (red) and variability between two
representative UNR pulldown samples (black) for HeLa plus arsenite. The name and location
within the graph of the top hit is highlighted.
29Chapter 5
The top hit was P ABP C1 (BH adjusted p-value = 2.52x10-12). It has already been well established
that UNR interacts with both the mRNA and protein products of the P ABP gene, both in the
Anderson lab and in the literature (Patel et al. 2005; Chang et al. 2004).
With the exception of PABPC1, the significant hits had small UNR/IgG fold changes and were
within the range of variation between HeLa10 and HeLa11 (Figure 5.9). This was in keeping with
the PCA analysis that suggested that the immunoprecipitating antibody was a relatively minor
contributor to the overall variation in the data.
The 46 protein coding genes were entered into the GO tool which returned no Bonferroni-
multiple testing correction-adjusted molecular function nor cellular component GO terms. It
gave 6 significant biological process GO terms (Table 5.7).
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Table 5.7: Over-represented biological process GO terms generated using putative UNR-
interacting protein coding genes designated as significant at a BH-adjusted p-
value cut off of 0.05 using one factor DESeq2 analysis of arsenite stressed HeLa
samples.
GO biological process
complete Total Observed Expected
Fold
change
Adjusted
p-value
heterocycle metabolic
process (GO:0046483) 4620 25 10.13 2.47 1.46E-02
cellular aromatic
compound metabolic
process (GO:0006725)
4669 25 10.24 2.44 1.79E-02
aromatic compound
biosynthetic process
(GO:0019438)
3085 20 6.77 2.96 2.05E-02
nucleobase-containing
compound metabolic
process (GO:0006139)
4484 24 9.84 2.44 3.48E-02
organic cyclic compound
biosynthetic process
(GO:1901362)
3193 20 7 2.86 3.53E-02
organic cyclic compound
metabolic process
(GO:1901360)
4856 25 10.65 2.35 3.80E-02
In total, 16 gene were considered significant by two factor analysis of the HeLa minus arsenite
data and by one factor analysis of the HeLa plus arsenite data (AHR ,AT P 5S ,BP N T 1,CR CP ,
CYP 20A1,EIF2AK2,L IM D1,L YR M 7,M DM 4,M ET T L 2B,M M ACHC,M P V17L ,M R I1,T IM M 50,
ZN F556,ZN F587).
5.4.3 Results comparing all HeLa samples by immunoprecipitating antibody
It was then decided to merge all the HeLa samples together for analysis. Of the five pairs of
samples, 40% were non-arsenite treated and 60% were arsenite treated (Table 5.4).
One factor DESeq2 analysis of the merged data resulted in 132 BH-adjusted significant genes. Of
these, 124 were higher in UNR, of which 111 were protein coding. P ABP C1 was the top hit from
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the merged data, with an adjusted p-value of 2.36x10-14. A log/log graph showing the significant
protein coding genes is presented below (Figure 5.10).
Figure 5.10: Log/log plot of one factor DESeq2 hits (red) and variability between two
representative UNR pulldown samples (black) for all HeLa samples. The name and location
within the graph of the top hit is highlighted.
In keeping with the PCA results and the observations made for the HeLa plus arsenite one factor
analysis, the fold changes for the significant genes were small. A large number of the significant
hits lay within the main body of the HeLa10/HeLa11 plot (Figure 5.10). The same samples were
used as representative of all HeLa samples as the black dots would be exactly the same and the
change in the location of the red dots could be viewed in relation to them. As could be seen, the
significant hits using all HeLa samples increased in number relative to those for HeLa plus
arsenite samples alone and expanded into the main body of the black dots.
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The 111 significant protein coding genes that were higher in UNR were submitted to the GO tool
which could not recognise two of them, resulting in 109 genes being considered in total. This
found four related significant biological process GO terms but no significant molecular function
nor cellular component GO terms (Table 5.8).
Table 5.8: Over-represented biological process GO terms generated using putative UNR-
interacting protein coding genes designated as significant at a BH-adjusted p-
value cut off of 0.05 using one factor DESeq2 analysis of all HeLa samples.
GO biological process complete Total Observed Expected Foldchange
Adjusted
p-value
cellular nitrogen compound
metabolic process
(GO:0034641)
5090 49 26.45 1.85 1.55E-02
heterocycle metabolic process
(GO:0046483) 4620 46 24.01 1.92 1.58E-02
nucleobase-containing
compound metabolic process
(GO:0006139)
4484 45 23.31 1.93 1.78E-02
cellular aromatic compound
metabolic process
(GO:0006725)
4669 46 24.27 1.9 2.14E-02
5.4.4 Summary of the DESeq2 analyses using HeLa samples
It was noted that there were more putative UNR-interacting transcripts detected by DESeq2 in
the HeLa plus arsenite samples than in the HeLa minus arsenite samples. Initial biological process
GO term analysis suggested that UNR may interact with transcripts that encode proteins
involved in such things as “nucleobase-containing compound metabolic processes”, at least in
HeLa cells where at least 60% of samples had been stressed with arsenite.
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5.5 DESeq2 results for U2OS samples
5.5.1 Results comparing U2OS minus arsenite samples by immunoprecipitating
antibody
U2OS minus arsenite was one of the two conditions in which there were no outliers removed,
the other being HeLa plus arsenite (Table 5.4). DESeq2 analysis of the U2OS minus arsenite
samples gave 3 hits with a BH-adjusted p-value under 0.05, all of which were higher in the UNR
samples. Only one of the three was protein coding, Interleukin-8 CX CL 8 (adjusted p-value =
0.0022).
CXCL8 is involved in various lung pathologies (Mukaida et al. 2003). One biological function of
CXCL8 is to induce angiogenesis, which it carries out by interaction with CXCR2 (Heidemann et
al. 2003). As well as a potentially pro-oncogenic role in stimulating angiogenesis, CXCL8 has also
been shown to promote metastatic events in colorectal cancer (Xiao et al. 2015).
As there was only one gene found by the one factor analysis, it was decided to carry out two
factor analysis on the U2OS minus arsenite samples. This resulted in the loss of the single protein
coding hit (CX CL 8). In summary, five genes were significant at a BH-adjusted p-value cut off of
0.05, of which 3 were higher in the UNR samples but none of these three were protein coding.
5.5.2 Results comparing U2OS plus arsenite samples by immunoprecipitating
antibody
One factor DESeq2 failed to locate any significant hits from among the genes present in the two
pairs of U2OS plus arsenite samples (Table 5.4). Two factor analysis located 75 hits, 7 of which
were both protein coding and higher in the UNR samples. P R R 11 had the most significant BH-
adjusted p-value (0.0011). The seven genes did not yield any significant GO terms. The seven
genes are tabulated in Table 5.9. PRR11 has been associated with epithelial-mesenchymal
transition (EMT) and, thereby, metastasis in breast cancer (Zhou et al. 2014). EMT is important
in both development and tumour metastasis (Yang et al. 2008). Interestingly, adherens junctions
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are involved in binding epithelial cells together (Yap et al. 1997) and the loss of these structures
can cause transcriptional reprogramming. The adherens junction GO term was a top ten
enriched cellular component GO term generated using UNR-associated proteins from U2OS plus
arsenite (Table 4.19D) and UNR was shown to localize to areas of cell-cell interaction under
certain conditions (Figures 4.22, 4.23).
Table 5.9: Seven putative UNR-interacting transcripts in arsenite stressed U2OS samples
by two factor DESeq2 analysis
Genes
AL CAM P L EKHA5
BCAT 1 P R R 11
EDIL 3 ZN F608
P IK3R 1
5.5.3 Results comparing U2OS (all samples) by immunoprecipitating antibody
Having seen few DESeq2-derived putative UNR-interacting RNAs from U2OS minus or plus
arsenite, it was decided to merge the two and carry out DESeq2 analysis on all five pairs of U2OS
samples.
As with the U2OS plus arsenite samples alone, one factor DESeq2 analysis failed to propose any
putative UNR-interacting RNAs. Two factor analysis generated 30 significant hits, of which 12
were higher in the UNR samples. Of the 12, ten were protein coding (Table 5.10). Whilst none
of the ten genes were particularly significant (all having BH-adjusted p-values between 0.04 and
0.05), two shared the lowest p-value (by the number of significant figures provided in the
DESeq2 output); P R R 11 (see section 5.5.2) and EFHC1. EFHC1 has been linked to juvenile
myoclonic epilepsy and is believed to be a regulator of mitosis and of neuronal migration during
brain development (de Nijs et al. 2009). UNR has already been shown to be directly involved in
neuronal migration in the developing brain (Kobayashi et al. 2013).
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Another interesting hit was ADAM 19 which is involved in the pathogenesis of Alzheimer’s
disease (Tanabe et al. 2007). UNR was previously shown to be associated with the related
ADAM 10 transcript which is also implicated in Alzheimer’s (Renner 2014; Kim et al. 2009).
Table 5.10: Ten putative UNR-interacting transcripts in U2OS (all samples) by two factor
DESeq2 analysis
Genes
ACBD7 FAM 171B
ADAM 19 P DGFA
AR L 10 P R R 11
EFHC1 R S R P 1
EGR 1 S ER P IN E1
5.5.4 Summary of the DESeq2 analyses using U2OS samples
DESeq2 detected fewer putative UNR-interacting transcripts from the U2OS data than it did
from the HeLa data. A possible reason for this is discussed below (see section 5.7.4). It was noted
that the putative UNR-interacting CX CL 8 transcript from the U2OS minus arsenite samples was
not suggested as a UNR interactor when DESeq2 carried out a two factor analysis of all U2OS
samples. Also, of the seven putative UNR-interacting transcripts from the U2OS plus arsenite
samples (Table 5.9), only one transcript, P R R 1 (see section 5.5.2), was a hit when all U2OS
samples were analysed (Table 5.10). Interestingly, P R R 11 was also the only UNR-interactor
suggested using U2OS cells that was also suggested as a hit using HeLa (HeLa plus arsenite).
Some evidence was found that strengthened suggestions in the literature linking UNR to
Alzheimer’s disease and metastasis. It should be noted that all cell types used in this experiment
were immortalised cancer cell lines. Suggested links to cancer may say something about the
function of UNR in non-cancer cells but it may be that the role of UNR in cancer cells is altered
by the cellular reprogramming caused by the development of the cancer phenotype.
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5.6 DESeq2 results for SaOS-2 samples
It was decided not to consider the SaOS-2 minus arsenite samples directly as there was only one
SaOS-2 minus arsenite pair remaining after the removal of two IgG outliers and their paired UNR
samples (Tables 5.2A, 5.2B). It was felt that the complete loss of biological replicates would make
the risk of accepting false positives too high. This was, in part, due to the shape of the plot in
Figure 5.7B.
5.6.1 Results comparing SaOS-2 plus arsenite samples by immunoprecipitating
antibody
Two pairs of SaOS-2 plus arsenite samples remained after the removal of a single outlier and its
paired sample (Tables 5.2A, 5.2B). One factor DESeq2 analysis of these samples suggested that
74 genes were significant at the BH-adjusted p-value cut off of 0.05 and that 10 of those were
both protein coding and higher in UNR. The top hit was CCN L 2 with a BH-adjusted p-value of
0.0111.
The 10 genes did not yield any significantly over-represented GO terms. The genes are tabulated
in Table 5.11.
Table 5.11: Ten putative UNR-interacting transcripts in arsenite stressed SaOS-2 by one
factor DESeq2 analysis
Genes
R BM 10 CEP 95
S R R T BR D8
HGS P L CB4
CCN L 2 KIAA0907
M AP K8IP 3 S N R N P 70
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As there were no significant GO terms, it was decided to carry out two factor analysis on these
samples.
Two factor analysis generated 291 genes with BH-adjusted p-values less than 0.05, of which 121
were higher in the UNR samples. Of the 121 genes, 117 were protein coding. Feeding the 117
protein coding genes that were higher in the UNR samples into the GO tool yielded 26 significant
biological process GO terms, 22 significant molecular function GO terms and 25 significant
cellular component GO terms. The top ten GO terms for each class are provided in Table 5.12.
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Table 5.12: Over-represented GO terms generated using putative UNR-interacting protein
coding genes designated as significant at a BH-adjusted p-value cut off of 0.05
using two factor DESeq2 analysis of the SaOS-2 plus arsenite samples. (A) =
biological process, (B) = molecular function, (C) = cellular component
A
GO biological process
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
mRNA metabolic process
(GO:0016071) 613 21 3.42 6.14 2.55E-07
RNA splicing (GO:0008380) 373 17 2.08 8.17 3.17E-07
mRNA processing
(GO:0006397) 436 18 2.43 7.4 3.96E-07
RNA processing
(GO:0006396) 849 24 4.74 5.07 4.25E-07
macromolecule metabolic
process (GO:0043170) 7359 73 41.05 1.78 1.37E-05
nucleic acid metabolic
process (GO:0090304) 3942 50 21.99 2.27 1.82E-05
cellular macromolecule
metabolic process
(GO:0044260)
6693 68 37.34 1.82 3.89E-05
nucleobase-containing
compound metabolic
process (GO:0006139)
4484 53 25.02 2.12 5.52E-05
heterocycle metabolic
process (GO:0046483) 4620 53 25.77 2.06 1.61E-04
cellular aromatic
compound metabolic
process (GO:0006725)
4669 53 26.05 2.03 2.34E-04
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B
GO molecular function
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
RNA binding (GO:0003723) 1617 39 9.02 4.32 4.00E-12
poly(A) RNA binding
(GO:0044822) 1159 33 6.47 5.1 1.11E-11
heterocyclic compound
binding (GO:1901363) 5910 70 32.97 2.12 2.45E-09
nucleotide binding
(GO:0000166) 2398 43 13.38 3.21 2.61E-09
nucleoside phosphate
binding (GO:1901265) 2399 43 13.38 3.21 2.65E-09
organic cyclic compound
binding (GO:0097159) 5991 70 33.42 2.09 4.96E-09
small molecule binding
(GO:0036094) 2576 43 14.37 2.99 2.85E-08
protein binding
(GO:0005515) 10751 95 59.98 1.58 4.25E-08
binding (GO:0005488) 14268 109 79.6 1.37 1.32E-07
nucleic acid binding
(GO:0003676) 4039 53 22.53 2.35 3.62E-07
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C
GO cellular component
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
nuclear lumen
(GO:0031981) 3496 58 19.5 2.97 3.01E-13
nuclear part (GO:0044428) 3871 61 21.6 2.82 3.25E-13
nucleoplasm (GO:0005654) 2924 53 16.31 3.25 3.39E-13
nucleus (GO:0005634) 6893 80 38.46 2.08 5.62E-12
intracellular organelle
lumen (GO:0070013) 4217 61 23.53 2.59 1.97E-11
organelle lumen
(GO:0043233) 4289 61 23.93 2.55 4.38E-11
membrane-enclosed
lumen (GO:0031974) 4344 61 24.23 2.52 7.96E-11
intracellular organelle
(GO:0043229) 11885 103 66.3 1.55 2.26E-10
intracellular (GO:0005622) 14051 111 78.39 1.42 2.80E-10
intracellular organelle part
(GO:0044446) 8056 84 44.94 1.87 3.20E-10
5.6.2 Results comparing all SaOS-2 UNR/IgG pairs by immunoprecipitating antibody
The SaOS-2 minus arsenite samples were then merged with the SaOS-2 plus arsenite samples to
increase the number of overall samples and DESeq2 was then used to carry out another round
of one factor analysis. This found 585 genes to have a BH-adjusted p-value less than 0.05, of
which 265 were higher in the UNR samples. Of these 265 genes, 256 were protein coding. A
log/log plot of the significant protein coding genes is given below (Figure 5.11).
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Figure 5.11: Log/log plot of one factor DESeq2 hits (red) and variability between two
representative UNR pulldown samples (black) for all SaOS-2 samples. The name and location
within the graph of the top hit is highlighted.
The suggested hits for all SaOS-2 formed a group that was separate from the main group of
values given for the remaining SaOS-2 plus arsenite UNR samples, although there are some
values that are more extreme in the background data (Figure 5.11). It was expected that there
would be a clearer signal in SaOS-2 than in HeLa based upon the PCA analysis that showed the
SaOS-2 IgG and UNR samples were clearly separated by PC2 (Figures 5.5A, 5.4A). It was decided
to use the UNR plus arsenite samples to estimate the background variability in the data as UNR
plus arsenite samples had been displayed for the HeLa samples.
As this analysis generated a large number of putative hits, it was considered interesting to
consider the putative significant genes that had higher read counts in the IgG samples. If they
were truly random, it would be expected that a lower proportion would be protein coding as
UNR is a protein known to be involved in translational regulation. It was shown that, whereas
96% of the significant genes that had read counts higher in the UNR samples were protein
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coding, only 74% of those higher in IgG were protein coding (238 out of 320 genes were protein
coding). This finding was reassuring.
It was then decided to carry out GO term analysis on the protein coding genes that were higher
in the UNR samples. This showed that there were 41 significantly over-represented biological
process GO terms. Likewise, there were 31 significantly overrepresented molecular function GO
terms and 40 significantly overrepresented cellular component GO terms. The top ten for each
of these classes is presented in Table 5.13.
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Table 5.13: Over-represented GO terms generated using putative UNR-interacting protein
coding genes designated as significant at a BH-adjusted p-value cut off of 0.05
using one factor DESeq2 analysis on all SaOS-2 samples. (A) = biological process,
(B) = molecular function, (C) = cellular component
A
GO biological process
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
nucleic acid metabolic
process (GO:0090304) 3942 100 48.12 2.08 3.08E-10
cellular macromolecule
metabolic process
(GO:0044260)
6693 140 81.7 1.71 3.81E-10
nucleobase-containing
compound metabolic
process (GO:0006139)
4484 108 54.74 1.97 4.89E-10
RNA processing
(GO:0006396) 849 41 10.36 3.96 6.21E-10
heterocycle metabolic
process (GO:0046483) 4620 109 56.4 1.93 1.40E-09
cellular aromatic
compound metabolic
process (GO:0006725)
4669 109 56.99 1.91 2.88E-09
macromolecule
metabolic process
(GO:0043170)
7359 146 89.83 1.63 5.52E-09
organic cyclic
compound metabolic
process (GO:1901360)
4856 111 59.28 1.87 6.16E-09
cellular nitrogen
compound metabolic
process (GO:0034641)
5090 114 62.13 1.83 9.43E-09
cellular metabolic
process (GO:0044237) 8525 160 104.06 1.54 1.24E-08
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B
GO molecular function
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
protein binding
(GO:0005515) 10751 207 131.23 1.58 1.80E-19
binding (GO:0005488) 14268 237 174.17 1.36 6.47E-18
RNA binding
(GO:0003723) 1617 59 19.74 2.99 6.52E-11
poly(A) RNA binding
(GO:0044822) 1159 48 14.15 3.39 3.12E-10
molecular_function
(GO:0003674) 17018 247 207.73 1.19 4.03E-10
nucleotide binding
(GO:0000166) 2398 72 29.27 2.46 7.38E-10
nucleoside phosphate
binding (GO:1901265) 2399 72 29.28 2.46 7.53E-10
small molecule
binding (GO:0036094) 2576 74 31.44 2.35 2.72E-09
organic cyclic
compound binding
(GO:0097159)
5991 127 73.13 1.74 2.75E-09
heterocyclic
compound binding
(GO:1901363)
5910 125 72.14 1.73 6.01E-09
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C
GO cellular component
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
intracellular organelle
part (GO:0044446) 8056 180 98.34 1.83 6.18E-22
organelle part
(GO:0044422) 8240 181 100.58 1.8 3.31E-21
nuclear part
(GO:0044428) 3871 118 47.25 2.5 6.79E-21
nuclear lumen
(GO:0031981) 3496 111 42.67 2.6 1.44E-20
nucleoplasm
(GO:0005654) 2924 99 35.69 2.77 1.48E-19
intracellular organelle
lumen (GO:0070013) 4217 121 51.48 2.35 2.39E-19
organelle lumen
(GO:0043233) 4289 121 52.35 2.31 1.05E-18
membrane-enclosed
lumen (GO:0031974) 4344 121 53.03 2.28 3.15E-18
intracellular part
(GO:0044424) 13672 232 166.89 1.39 4.02E-18
intracellular organelle
(GO:0043229) 11885 215 145.08 1.48 1.10E-17
5.6.3 Summary of the DESeq2 analyses using SaOS-2 samples
It was decided not to consider the SaOS-2 minus arsenite samples as there was only one pair
remaining after the removal of outliers and their pairs (Table 5.4). DESeq2 suggested that there
were a number of putative UNR-interacting transcripts in the plus arsenite SaOS-2 samples,
especially in the two factor analysis. Two factor analysis was not required for the combined
SaOS-2 plus and minus arsenite samples due to a large number of putative hits from the one
factor analysis. It was interesting that “nucleobase-containing compound metabolic process”
was a top enriched biological process GO term for the SaOS-2 samples (plus arsenite or all
samples), as for the HeLa samples. The most enriched biological process GO terms were largely
related to binding to or modulating nucleic acids. This suggests that UNR could function as a
modulator of RNAs both directly, as is already known, and indirectly by modulating the
expression of other RNA-modulators. Further support is given to this hypothesis by the finding
that the most enriched molecular function GO terms included “RNA binding” and “poly(A) RNA
binding”. In terms of enriched cellular component GO terms, some of the top hits were related
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to the nucleus. It is worth considering that mature transcripts do not tend to be found in the
nucleus. This supports a role for UNR in modulating nuclear RNA processes such as splicing from
the cytoplasm. Indeed, splicing was a top biological process GO term for the plus arsenite
SaOS-2 samples. It is currently unknown why these findings were observed. Nevertheless, it is
considered possible that UNR may have evolved to interact with and stabilise transcripts that
are involved in splicing when a cell is stressed, and that it can then launch a translational
response to the removal of the stress to help the cell recover by reprogramming its proteome
following removal of the stress. In some ways, the increase in UNR observed during mitosis,
coupled with it reprograming the proteome (e.g. by increasing translation of CDK11 through an
IRES in its transcript (Schepens et al. 2007)), can be thought of as UNR in part mediating recovery
from the stress of mitosis.
A direct comparison was made between the 111 UNR-interacting transcripts suggested in HeLa
to the 256 suggested inn SaOS-2. Only three transcripts were common to both lists – C1orf35,
CL AS R P and T ADA2A .
5.7 Cell type independent DESeq2 analysis
Having compared the samples by cell type and arsenite treatment, it was decided to look for
additional hits by merging more samples together. There were three ways in which this was to
be done:
1) All non-arsenite treated pairs irrespective of cell type
2) All arsenite treated pairs irrespective of cell type
3) All samples irrespective of both cell type and arsenite treatment.
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It was clear by doing this that the number of repeats would go up. On the other hand, the PCA
analysis showed that most of the variation in the data was related to cell type. For this reason,
it was reasoned that information may come out of both one and two factor analyses. As
discussed previously, the one factor analysis would be able to locate a subset of true hits that
did not bind to IgG at any appreciable level (Figure 5.8A) or that were expressed at similar levels
in all cell types (Figure 5.8B) but would not be so able to locate true hits where expression varied
greatly between cell types (Figure 5.8C).
Two factor analysis, was considered more suited to detecting the differences in Figure 5.8C and
was chosen over one factor analysis for consideration of the cell type independent samples.
5.7.1 DESeq2 results for all non-arsenite treated UNR/IgG sample pairs
Two factor DESeq2 analysis on all minus arsenite samples showed that only three genes had a
BH-adjusted p-value less than 0.05, of which all three were putative UNR interactors. Two of
these three genes were protein coding – CCN L 2 (adjusted p-value = 0.0076) and L IM D1 (adjusted
p-value = 0.0326). CCN L 2 has been mentioned previously as the top UNR hit from DESeq2
analysis of the SaOS-2 plus arsenite samples. As there were only two protein coding hits, GO
term analysis was not attempted.
5.7.2 DESeq2 results for all arsenite treated UNR/IgG sample pairs
Two factor DESeq2 analysis of all arsenite treated samples following the removal of outliers and
their paired IgG/UNR samples suggested that 369 genes were significant at the BH-adjusted
p<0.05 significance level. 157 of these were higher in the UNR samples, of which 149 were
protein coding. P ABP C1 was the top hit with a p-value of 3.11x10-11. The 149 genes were fed into
the GO tool which yielded a total of 67 significantly enriched biological process GO terms. By the
hierarchical lay out option in the tool, it was seen that there were a lot of related terms, largely
related with the regulation of transcription (e.g. direct positive or negative regulation of
transcription or indirectly via processes such as histone/chromatin modification, data not
shown). In total there were 67 significant biological GO terms. There were 14 significant
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molecular function GO terms and 29 cellular component GO terms. The top ten most significant
GO terms from each class, by Bonferroni-adjusted p-value, are tabulated below (Table 5.14).
Table 5.14: Over-represented GO terms generated using putative UNR-interacting protein
coding genes designated as significant at a BH-adjusted p-value cut off of 0.05
using two factor DESeq2 analysis on all arsenite treated samples. (A) = biological
process, (B) = molecular function, (C) = cellular component
A
GO biological process
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
chromosome organization
(GO:0051276) 984 34 6.99 4.86 1.13E-10
nucleic acid metabolic
process (GO:0090304) 3942 62 28.01 2.21 9.04E-07
nucleobase-containing
compound metabolic
process (GO:0006139)
4484 67 31.86 2.1 9.19E-07
heterocycle metabolic
process (GO:0046483) 4620 68 32.82 2.07 1.18E-06
cellular macromolecule
metabolic process
(GO:0044260)
6693 85 47.55 1.79 1.87E-06
cellular aromatic
compound metabolic
process (GO:0006725)
4669 68 33.17 2.05 1.91E-06
negative regulation of
gene expression
(GO:0010629)
1412 34 10.03 3.39 2.21E-06
chromatin modification
(GO:0016568) 289 16 2.05 7.79 2.96E-06
cellular nitrogen
compound metabolic
process (GO:0034641)
5090 71 36.16 1.96 4.06E-06
macromolecule metabolic
process (GO:0043170) 7359 89 52.28 1.7 6.30E-06
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B
GO molecular function
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
binding (GO:0005488) 14268 133 101.37 1.31 2.83E-06
protein binding
(GO:0005515) 10751 112 76.38 1.47 4.87E-06
nucleic acid binding
(GO:0003676) 4039 57 28.7 1.99 1.48E-04
heterocyclic compound
binding (GO:1901363) 5910 73 41.99 1.74 1.61E-04
organic cyclic compound
binding (GO:0097159) 5991 73 42.56 1.72 2.93E-04
RNA binding
(GO:0003723) 1617 31 11.49 2.7 8.95E-04
nucleotide binding
(GO:0000166) 2398 39 17.04 2.29 1.38E-03
nucleoside phosphate
binding (GO:1901265) 2399 39 17.04 2.29 1.39E-03
chromatin binding
(GO:0003682) 450 15 3.2 4.69 2.37E-03
small molecule binding
(GO:0036094) 2576 40 18.3 2.19 3.08E-03
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C
GO cellular component
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
nucleoplasm
(GO:0005654) 2924 65 20.77 3.13 1.76E-15
nuclear lumen
(GO:0031981) 3496 71 24.84 2.86 2.40E-15
nuclear part
(GO:0044428) 3871 73 27.5 2.65 3.66E-14
organelle lumen
(GO:0043233) 4289 75 30.47 2.46 6.90E-13
intracellular organelle
lumen (GO:0070013) 4217 74 29.96 2.47 1.06E-12
membrane-enclosed
lumen (GO:0031974) 4344 75 30.86 2.43 1.41E-12
intracellular organelle
part (GO:0044446) 8056 105 57.24 1.83 2.86E-12
nucleus (GO:0005634) 6893 96 48.97 1.96 4.19E-12
intracellular part
(GO:0044424) 13672 138 97.14 1.42 4.20E-12
organelle part
(GO:0044422) 8240 105 58.54 1.79 1.65E-11
Chromosome organization, chromosome modification and negative regulation of gene
expression were among the top biological process GO terms. This is interesting in light of the
hypothesis put forward in section 5.6.3 that stated UNR could be involved in stabilising
transcripts during stress that are later involved in recovery from stress. As well as a translational
control of proteins involved in splicing and other RNA modifications, UNR may also modulate
the transcriptional output in response to the removal of a stress. This would not be the first
observation linking UNR to the regulation of transcription (e.g. UNR was shown to interact
directly with the histone methyl transferase transcriptional regulator ALL-1 [Leshkowitz et al.
1996]).
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The top ten most enriched molecular function GO terms, whilst including very general GO terms
like binding, contained chromatin binding. There were also 57 hits for nucleic acid binding but
only 31 for RNA binding, further implying that UNR may be interacting with transcripts encoding
transcription factors.
The most enriched cellular component GO terms included ‘nucleus’, with 96 associated genes.
As well as ‘nucleus’, the top three hits were also nucleus-related.
5.7.3 DESeq2 results for all UNR/IgG sample pairs
Finally, it was decided to merge all samples together, irrespective of both their cell type and
arsenite treatment state. This merger gave the highest possible number of repeats for paired
two factor analysis. On the other hand, it also maximised the effect of the two major
confounding variables – cell type and arsenite treatment. To discuss that effect directly, the
identifier table inputted into DESeq2 is provided in Table 5.15.
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Table 5.15: Identifiers for all samples for two factor DESeq2 analysis
Sample RNA-Seq ID condition rep
HeLa2 238128_001 I H1
HeLa3 238128_004 I H2
HeLa5 238128_008 U H1
HeLa6 238128_006 U H2
HeLa7 238129_007 I H0
HeLa8 238128_010 I H1
HeLa9 238129_012 I H2
HeLa10 238129_013 U H0
HeLa11 238128_011 U H1
HeLa12 238128_014 U H2
SaOS2 238129_003 I S1
SaOS5 238129_010 U S1
SaOS7 238129_020 I S0
SaOS9 238129_002 I S2
SaOS10 238129_004 U S0
SaOS12 238129_006 U S2
U2OS1 238128_015 I U0
U2OS2 238128_016 I U1
U2OS3 238128_018 I U2
U2OS4 238128_019 U U0
U2OS5 238128_003 U U1
U2OS6 238128_009 U U2
U2OS7 238128_020 I U0
U2OS9 238128_022 I U2
U2OS10 238129_023 U U0
U2OS12 238129_027 U U2
As with all previous analyses, the first (or only) factor considered by DESeq2 was provided in the
“condition” column (e.g. whether the samples were IgG [I] or UNR [U]). Also, as with analyses
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on all samples from individual cell types, the plus and minus arsenite samples made on the same
day were given the same “rep” value where “rep” was the second factor used in two factor
analysis. DESeq2 was therefore programmed to consider every day upon which samples were
made as a factor. For SaOS-2, all the samples were produced on separate days as the pairs lost
to outliers in the minus arsenite sample were complementary to the pair lost to an outlier in the
plus arsenite samples. On the other hand, there were four “rep” identifiers with four members
(H1, H2, U0 and U2). There were therefore variable degrees of mixture of plus and minus
arsenite samples – both overall and within specific “rep” values. On top of this, the majority of
the variability had been shown by PCA analysis to have been related to cell type differences and
merging all samples together mixes up the cell types. That was the reason for using two factor
analysis; looking for differences between UNR/IgG differences between samples made on the
same day. Unlike the plus or minus arsenite samples, however, the plus and minus arsenite data
has the additional confounding effect of arsenite treatment. In summary, it was not expected to
find many large fold change differences but it was hoped that a number of smaller fold changes
would nevertheless prove significant due to the larger number of repeats.
The two factor DESeq2 analysis suggested that 829 genes were significant, of which 454 were
higher in the UNR samples, of which 417 were protein coding. GO term analysis yielded 61
significantly enriched biological process GO terms, 37 significantly enriched molecular function
GO terms and 35 significantly enriched cellular component GO terms. The top ten from each
class is tabulated in Table 5.16. Other observations from less significant biological process GO
terms implied a role for proteins translated from UNR-interacting transcripts in RNA
metabolism, mitosis and gene expression (data not shown). Likewise, there was evidence for a
role for proteins encoded by UNR-interacting transcripts in molecular functions such as S-
adenosylmethionine-dependent methyltransferase activity, chromatin binding and DNA binding
(data not shown). In terms of cellular component GO terms, UNR was implicated in binding to
transcripts that encode centrosomal, nucleolar and spindle proteins (data not shown).
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Table 5.16: Over-represented GO terms generated using putative UNR-interacting protein
coding genes designated as significant at a BH-adjusted p-value cut off of 0.05
using two factor DESeq2 analysis on all samples. (A) = biological process, (B) =
molecular function, (C) = cellular component
A
GO biological process
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
nucleobase-containing
compound metabolic
process (GO:0006139)
4484 160 89.16 1.79 1.97E-11
nucleic acid metabolic
process (GO:0090304) 3942 146 78.38 1.86 3.42E-11
heterocycle metabolic
process (GO:0046483) 4620 161 91.86 1.75 1.29E-10
cellular aromatic
compound metabolic
process (GO:0006725)
4669 161 92.84 1.73 3.30E-10
organic cyclic compound
metabolic process
(GO:1901360)
4856 163 96.56 1.69 2.21E-09
cellular nitrogen
compound metabolic
process (GO:0034641)
5090 168 101.21 1.66 3.18E-09
cellular macromolecule
metabolic process
(GO:0044260)
6693 204 133.08 1.53 3.35E-09
chromosome
organization
(GO:0051276)
984 57 19.57 2.91 6.52E-09
organelle organization
(GO:0006996) 3133 117 62.3 1.88 3.94E-08
chromatin modification
(GO:0016568) 289 28 5.75 4.87 1.07E-07
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B
GO molecular function
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
binding (GO:0005488) 14268 358 283.7 1.26 1.16E-13
protein binding
(GO:0005515) 10751 295 213.77 1.38 1.16E-12
organic cyclic
compound binding
(GO:0097159)
5991 193 119.12 1.62 3.59E-11
heterocyclic
compound binding
(GO:1901363)
5910 191 117.51 1.63 4.11E-11
nucleic acid binding
(GO:0003676) 4039 145 80.31 1.81 1.88E-10
RNA binding
(GO:0003723) 1617 77 32.15 2.39 2.51E-09
poly(A) RNA binding
(GO:0044822) 1159 57 23.05 2.47 1.08E-06
nucleotide binding
(GO:0000166) 2398 92 47.68 1.93 1.33E-06
nucleoside phosphate
binding (GO:1901265) 2399 92 47.7 1.93 1.36E-06
small molecule
binding (GO:0036094) 2576 96 51.22 1.87 2.29E-06
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C
GO cellular component
complete Reference Observed Expected
Fold
increase
Adjusted
p-value
nuclear part
(GO:0044428) 3871 170 76.97 2.21 4.51E-23
nuclear lumen
(GO:0031981) 3496 158 69.51 2.27 3.89E-22
nucleoplasm
(GO:0005654) 2924 140 58.14 2.41 3.94E-21
intracellular part
(GO:0044424) 13672 363 271.85 1.34 4.03E-21
intracellular
(GO:0005622) 14051 366 279.39 1.31 1.19E-19
nucleus (GO:0005634) 6893 234 137.06 1.71 2.11E-19
intracellular organelle
lumen (GO:0070013) 4217 163 83.85 1.94 6.02E-16
intracellular organelle
(GO:0043229) 11885 323 236.32 1.37 6.53E-16
organelle lumen
(GO:0043233) 4289 164 85.28 1.92 1.28E-15
membrane-enclosed
lumen (GO:0031974) 4344 164 86.37 1.9 4.52E-15
As with the plus arsenite samples, chromatin organization and chromatin modification were
among the top ten enriched biological process GO terms. In both cases, the number of significant
genes annotated to the GO terms increased (57 versus 34 and 28 versus 16, respectively).
Nevertheless, the observed/expected fold increases decreased in both cases. The p-values were
still strong, and actually decreased in the case of chromatin modification. Beyond the chromatin-
related GO terms, most of the other top ten biological process GO terms were also similar to
those for the plus arsenite samples alone. Chromatin binding was not on the top ten enriched
as it was for the plus arsenite samples. The strongest p-values were for binding and protein
binding, with 358 and 295 genes annotated, respectively. There were 145 genes annotated to
nucleic acid binding and only 77 to RNA binding, again implying that at least some of the
transcripts to which UNR binds may encode proteins that can bind to DNA. As with the plus
arsenite samples, the top three enriched cellular component GO terms by p-value were nuclear
related and nucleus, to which 234 genes were annotated, was in sixth place with a p-value of
2.11x10-19.
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5.7.4 Review of DESeq2 results for cell independent samples
The first main observation was that there were few hits for the minus arsenite samples (section
5.7.1), both in absolute terms and relative to the plus arsenite samples (section 5.7.2). One
possible explanation for this finding is that UNR binds to fewer transcripts under non-stress
conditions (possibly due to there being less UNR protein in the cell or to UNR being sequestered
away from the transcripts to which it binds following arsenite stress). Stresses, such as oxidative
stress with arsenite or the stress associated with mitosis could result in UNR levels increasing
and/or UNR binding to different groups of transcripts.
In terms of mitosis, it has been reported that UNR represses its own translation until hnRNP
C1/C2 proteins are released from the nucleus following the breakdown of the nuclear envelope.
These then replace UNR on its transcript and drive its translation (Schepens et al. 2007). This
results in an increase in free UNR that can then bind to certain transcripts, among them cdk11
(Tinton et al. 2005). The problem with discovering the identity of mitosis-specific UNR-
interactors was that the cells used in the experiments had been grown to 70-80% confluent.
That means that relatively few would have been undergoing mitosis at the point of lysis and any
differences may have been diluted by the majority of UNR-interactors coming from cells that
were either in G0 or some other phase of the cell cycle prior to nuclear envelope breakdown.
In terms of arsenite stress, it has been shown that overexpressed UNR goes to stress granules in
HeLa cells following arsenite stress (White & Lloyd 2011). Furthermore, work in the Anderson
lab has confirmed that UNR is found in the numerous stress granules that form following
arsenite stress in TP53 compromised cells (HeLa and SaOS-2). Many fewer stress granules were
found in wild type TP53 cells (U2OS). It was hypothesised that UNR was part of active translation
complexes that are taken to stress granules upon arsenite stress (Ray, Ó Catnaigh and Anderson,
manuscript in preparation). The larger number of UNR-associated HeLa transcripts found in the
plus arsenite samples relative to the minus arsenite samples could be related to the ease of
pulling down multiple UNR-containing complexes if they were concentrated in stress granules.
It was also noted that the T P 53-null SaOS-2 plus arsenite samples had more hits than the wild
type T P 53 U2OS plus arsenite samples, even though they had the same number of pairs (Table
5.4).
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Hits detected following the merging of samples from all cell types were interesting in that they
implied a role for UNR that may be cell type independent. Many of the significant GO terms in
the plus arsenite were related to transcription and the cell cycle. It is fair to infer that, if a cell
survives a particular stress, it would have to change its transcriptional output to revert from
having a proteome that is geared towards surviving the stress to one that is more geared
towards an unstressed state. These findings could suggest that UNR is involved in protecting a
specific subset of transcripts following stress with arsenite. They are also in keeping with the
hypothesis, as postulated in (Ray, Ó Catnaigh and Anderson, manuscript in preparation) that
UNR is a general translation factor. There are three possible situations:
1) UNR is bound to active translation complexes that are all translocated to stress granules
upon arsenite stress (possibly via UNRIP).
2) UNR is bound to active translation complexes, a subset of which are translocated to
stress granules upon arsenite stress (possibly via UNRIP).
3) UNR is not bound to active translation complexes but recruits a subset of them for
translocation to stress granules following arsenite stress.
The merging of all samples, independent of both arsenite treatment and cell type, provided a
slightly different set of results. Some of the suggested UNR-interacting transcripts, for example,
may be strong hits in the plus arsenite samples but not hits in the minus arsenite samples. Others
may be due to hits that were genuinely higher in UNR across all samples. Looking at the top
biological process GO term for the plus arsenite samples – “chromosome organization”, it had
an adjusted p-value of around 1.1x10-10, 34 observed proteins and a fold enrichment of just
under 5 (Table 5.14A). The same GO term was the eighth highest when putative UNR-interacting
transcripts calculated using two factor DESeq2 analysis of all samples. The adjusted p-value did
become less significant – raising to around 6.5x10-9 and the fold change fell to just under 3 (Table
5.16A). On the other hand, there were then 57 observed proteins. These observations imply that
the actual situation, at least for this GO term, may be affected by both considerations. DESeq2
detected almost twice as many putative UNR-interacting transcripts that are annotated to that
GO term when all samples were merged over when only the plus arsenite samples were merged.
At the same time, the distribution of transcripts changed and the proportion annotated to that
GO term fell. Comparing Tables 5.14 and 5.16 in their entireties, it seems likely that UNR has a
role in binding to transcripts involved in processes such as gene expression and mitosis,
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functions such as RNA binding and that tend to be located in the nucleus. The slight differences
between the significant GO terms for all samples and the plus arsenite samples only implied that
UNR may be more involved in binding to mitosis-related transcripts when unstressed. As an
example, CDK11A (Tinton et al. 2005) had an adjusted p-value of 0.0249 when all samples were
merged but the same gene had an adjusted p-value of 0.6589 in the plus arsenite samples.
5.8 General summary of DESeq2 results
A number of putative UNR-interacting, protein coding RNAs was discovered using RIP-Seq and
post-experimental analysis with DESeq2. Among the RNAs that were previously shown to
interact with UNR, there were not many calculated to be significant by DESeq2. Indeed, of the 7
mammalian RNAs mentioned in (Ray, Ó Catnaigh, & Anderson, 2015), only two were considered
significant under any conditions. Parathyroid hormone receptor was not present in any of the
datasets. Some of the data for the other transcripts is presented below (Table 5.17).
Table 5.17: DESeq2 adjusted p-values for 6 known UNR-interacting transcripts over a
selection of conditions with significant BH-adjusted p-values in yellow
Analysis:
One factor Two factor
HeLa +As HeLa (all) Plus As All samples
Transcript BH-adjusted p-values
AP AF1 0.9744 0.9571 0.9401 0.7268
CDK11 - 0.4355 0.6589 0.0249
FO S 0.9812 0.9985 0.4602 0.6168
GAT A6 - 0.9171 0.9974 0.9580
P ABP 1 2.52E-12 2.36E-14 3.11E-11 1.08E-05
U N R 0.7865 0.8472 0.9808 0.9713
Given that many known UNR-associated transcripts were not found to be significant by DESeq2,
it could be that these results, the published results, or both results are incorrect (Ioannidis 2005).
60Chapter 5
Alternatively, UNR may bind to many more transcripts than is currently known and the small
scale observations previously made, whilst true, may be a small subset of the total array of
transcripts to which UNR actually does bind. If that is true, then it may not be surprising that not
all hits would be seen in a high throughput experiment such as was carried out for this work. On
top of this, some of the known interactors were context dependent (e.g. pertaining to apoptosis,
mitosis, development in mouse embryonic fibroblasts, etc.).
5.9 Future direction for study
It would be helpful to carry out a second round of RIPs followed by qPCR on some if not all of
the DESeq2-discovered putative UNR-interacting transcripts with a view to validating them. Even
in the absence of qPCR, it would be interesting to see if a repeat of these experiments yielded
the same results. It would also be useful to check all putative UNR-interacting transcripts both
for IRES sequences and known UNR binding motifs. Putative UNR-interacting transcripts may
not be direct interacting transcripts but part of an overall RNP that contains UNR. It would
therefore be useful to ascertain how many of the putative UNR-interacting transcripts are both
real and direct interactors. Cdk11, for example, is known to possess an IRES through which UNR
directs translation at a specific part of the cell cycle. It could be that UNR acts via IRES structures
on a wide range of transcripts.
It was also noted that some non-coding RNAs were considered significant in some of the DESeq2
analyses. As a result of this project being geared towards discovering UNR-interacting proteins
and transcripts, a body of information was left uninvestigated. As more information is
discovered about non-coding RNAs and suitable bioinformatics tools become available to
process them, it would be interesting to see if UNR has any role in modulating cellular functions
via non-coding RNAs.
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6 Identification of proteins with expression levels that are modulated by UNR
Having explored UNR-interacting proteins and transcripts, it was then decided to carry out UNR
knockdown experiments (see sections 6.1 and 6.2) followed by mass spectrometry in an attempt
to discover proteins and/or groups of proteins that have their expression level modulated by
UNR. These experiments were based upon the assumption that, if a protein is differentially
expressed when UNR is reduced to relatively very low levels, it is likely that the presence of UNR
affects the expression of that protein.
6.1 RNA interference and gene knockdown
Gene knockdown is a technique that takes advantage of the phenomenon of RNA interference
to greatly reduce the expression of targeted proteins by causing the degradation of their
transcripts.
RNA interference is currently understood to have three pathways based upon which of three
groups of small RNA molecule is involved. There are three such groups – PIWI-interacting RNA
(piRNA), microRNA (miRNA) and small interfering RNA (siRNA) (reviewed by Wilson & Doudna
2013). In each case, the small RNA interacts with one of the four Argonaute proteins (in humans);
AGO1, AGO2, AGO3 and AGO4 (reviewed in Ender & Meister 2010). The three groups of small
RNA molecule differ in terms of their origin and the processing steps required before they can
integrate into functional RNA-induced silencing complexes (RISC) (Kobayashi & Tomari 2016).
Further consideration will be given to the miRNA and siRNA pathways. miRNAs are transcribed
from endogenous genes as hairpin loop structure-containing primary miRNAs (Kobayashi &
Tomari 2016). These then have their stems cleaved in the nucleus by the DROSHA-containing
microprocessor complex, leaving a stem of around 25 imperfectly matched base pairs with a two
nucleotide 3’ overhang and a small hairpin loop of around 10 nucleotides (Lee et al. 2003; Denli
et al. 2004; Kobayashi & Tomari 2016). A group of primary miRNAs only have a one nucleotide
3’ overhang and require the addition of a 3’ uridine (Heo et al. 2012). Exportin 5-mediated
transport to the cytoplasm then occurs where DICER cleaves off the hairpin loop, leaving an
imperfectly base paired double stranded RNA molecule with 2 nucleotide 3’ overhangs (Wilson
& Doudna 2013; Kobayashi & Tomari 2016). This interacts with an Argonaute protein as part of
an miRISC complex, where one strand (the guide strand) will be retained to act as a substrate
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recognition molecule for target mRNAs and the other (the passenger stand) is ejected. This can
then lead to translational repression and/or transcript degradation via slicing and deadenylation
(Jonas & Izaurralde 2015).
Unlike miRNA, siRNA can have an exogenous source such as being formed from the cleavage of
viral dsRNA (Ender & Meister 2010). Endogenous sources of siRNA have also been reported, such
as antisense transcript products of pseudogenes that can interact with sense transcripts of the
original gene to generate a duplex (Tam et al. 2008; Ender & Meister 2010). In relation to this
source of siRNA, it is interesting to consider the presence of UNR-like sequences in other regions
of the human genome (see section 1.1.5). As with pre-miRNA, DICER processes pre-siRNA
duplexes and generates duplexes with 3’ overhangs (Carthew & Sontheimer 2009). Unlike
miRNA, siRNA base pairing is perfectly complementary (Carthew & Sontheimer 2009). Both
miRNA and siRNA duplexes can activate all four Argonaute proteins to generate functional
miRNA/siRNA-RISC complexes following passenger strand ejection that can then function in
gene silencing (Nakanishi 2016).
Exogenous siRNA duplexes can be transfected into transfectable cells to activate gene silencing
(Elbashir et al. 2002; O’Keefe 2013). The experiments in this chapter were carried out using a
commercial siRNA against UNR or a commercially available control siRNA that does not have a
known target in the human transcriptome (see section 2.1.2). The siUNR was used to reduce the
amount of UNR mRNA and, over time, reduce the cellular level of the UNR protein.
6.2 Experimental approach
In order to do this, two experiments were devised. In the first, unstressed HeLa cells were used
and, in the second, unstressed and arsenite stressed U2OS cells were used. In both cases, cells
were split into 10cm tissue culture plates and were allowed to grow to a confluency of 50-70%.
A lipofectamine-based knockdown was then undertaken. Briefly, for each plate, 1 ml of Opti-
MEM was mixed with 20 μl of Lipofectamine 2000 and left for 5 minutes at room temperature. 
Meanwhile, 2 μl of either siUNR or control siRNA were added to another 1 ml of Opti-MEM. The
two solutions were then mixed by inversion and left for 20 minutes at room temperature. During
this time, the cells were fed with 18 ml of fresh DMEM containing 10% FBS. Finally, the Opti-
MEM mixture was added dropwise around the plates which were then returned to the incubator
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for 42-48 hours. After this time, the cells were either treated with 1 mM sodium arsenite in fresh
DMEM or a similar volume of sterile PBS in fresh DMEM for one hour prior to harvest. Cell
harvesting was carried out using polysome lysis buffer without RNase OUT. A small amount of
lysate (about 5%) was removed to run on a Western and the rest was frozen at -80°C prior to
preparation for analysis by mass spectrometry.
A different protocol was used for processing these samples for mass spectrometry than those
that had been used in Chapter 4. The protocol used was the standard ‘Filter Aided Sample
Preparation’ (FASP) method used in the Life Sciences proteomics facility at the University of
Warwick which was adapted from Wiśniewski et al. (2009). 
The HeLa samples were run as 15 μl injections for 4 hours and the U2OS samples were run as  
10 μl injections for 3 hours. 
6.3 UNR knockdown in HeLa cells
6.3.1 Only two repeats were considered
A trial run was carried out using the new mass spectrometry preparation method, followed by
two further repeats. Unfortunately, the proteomics department changed their FASP protocol
slightly between the two sets. According to an explicit warning stated within the protocol, there
is an essential acidification step that promotes the binding of peptides to the C18 column that
is used to collect peptides prior to elution and analysis by mass spectrometry. An insufficient
amount of acid had been stated in the earlier version of the protocol and this was increased
twenty-fold in the updated version. When the two groups of samples were considered together
by the proteomics department, they advised that there were significant differences between
the trial run and the two subsequent repeats (data not shown). It was therefore decided to
present only the data from the latter two repeats.
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6.3.2 Western blot confirmation of successful knockdown
As stated previously, a proportion (approximately 1/20) of the cell lysates were retained for
analysis by Western blot in order to confirm that the knockdown had been successful. In the
case of the samples in question, the knockdowns had worked as expected (Figure 6.1)
Figure 6.1: Western blot showing reduction in UNR levels following UNR knockdown. HeLa cells
were treated with siUNR or a control siRNA (as stated) 48 hours prior to harvesting. The images
show UNR (top panel) or α/β-tubulin (lower panel) and come from a single gel that was 
transferred to nitrocellulose membrane that was cut at a 70kDa marker so as to allow probing
for both proteins.
6.3.3 Progenesis analysis of HeLa UNR knockdown data
It was previously stated that the use of the Progenesis software was preferred over Scaffold. As
a result of that, it was decided to only provide Progenesis data for the HeLa samples. As before,
files containing raw data from the mass spectrometer for each sample to be compared were
loaded into Progenesis and processed with the aid of Mascot (see section 4.8). Automatic
alignment showed that all samples were well aligned and there were 141066 features (i.e.
putative peptides) in total, 2243 of which were removed when a maximum charge of 6 and
maximum run time of 225 minutes was employed. Features with no MS/MS data or no protein
ID were removed, as were peptides with Mascot scores less than 25 and those assigned to
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keratins, pig proteins and bovine proteins. As proteins had not been immunoprecipitated in this
experiment, immunoglobulins were not removed from the data.
An image was made of principal component 1 against principal component 2 from a PCA analysis
using suggested proteins using all data (Figure 6.2A). A second PCA analysis was then carried out
on the remaining data after all proteins with ANOVA p-values greater than or equal to 0.1 were
removed (Figure 6.2B).
Figure 6.2: Progenesis-generated PCA plots for HeLa knockdown data. Proteins with all ANOVA
p-values (A) or only those with ANOVA p-values under 0.1 (B) were included. See text for further
information on how the data were processed. Numbers are associated with the days upon which
the lysates were made (i.e. the repeats). Blue = siUNR samples (siUnr); purple = control siRNA
samples (Control). In terms of variance accounted for – A: (PC1 = 50.96%, PC2 = 35.29%); B: (PC1
= 91.54%, PC2 = 4.83%). The grey writing in the background makes up the protein score plot (see
section 4.9.2). The red writing refers to an automatically highlighted protein ID, selected to be
UNR.
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Examination of the PCA plots showed that PC1 accounted for over 50% of the total variability in
both cases and clearly divided the samples by whether they were siUNR or control treated. The
source of variation within PC2 was less obvious. Whereas PC2 accounted for over 35% of the
total variability when all proteins were considered, it only accounted for around 3.6% when
proteins with ANOVA p-values greater than or equal to 0.1 were excluded. There was an
argument not to exclude proteins based on their ANOVA values alone because there were only
two groups, thereby effectively reducing the ANOVA to an unpaired t-test. The proteins were
removed nonetheless because:
a) Removing them greatly increased the amount of variability accounted for by PC1 (which
was closely associated with the treatment – i.e. they were well separated by the line
PC1 =0), and
b) Paired and unpaired t-tests ask different questions of groups of samples and it seemed
useful to remove proteins that did not have any particular difference in their means. It
was considered possible that using both tests could potentially remove some false
positives at the cost of removing some weaker true positives.
Although it had already been shown that the knockdown had worked well (Figure 6.1), it was
considered useful to confirm that the reduction in UNR was also apparent in the Progenesis
analysis. A graphical confirmation of the knockdown showed that the peptides assigned to UNR
all followed a similar distribution between the samples, corroborating the idea that they came
from the same protein, and were higher in the control siRNA sample than in the siUNR samples
(Figure 6.3).
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Figure 6.3: Standardised normalised abundances for peptides assigned to UNR from the HeLa
knockdown samples. The repeats in the blue column are the siUNR-treated samples and the
repeats in the purple column are the control siRNA-treated samples. This image was produced
using Progenesis.
6.3.4 Detection of proteins that are differentially expressed following UNR
knockdown in HeLa cells
The protein abundance data was then exported to Microsoft Excel and paired t-tests were
carried out between the siUNR and corresponding control siRNA samples for each observed
protein that passed the ANOVA p-value <0.1 significance level cut off. Ratios of the sum of the
siUNR-treated sample abundances for each protein to the sum of the sample abundances for
the control siRNA-treated sample abundances were also calculated for each observed protein.
From those calculations, putative proteins with UNR-mediated expression were taken to be
those with:
1) t-test p-value less than 0.05, higher in siUNR samples
2) t-test p-value less than 0.05, higher in control siRNA samples
3) siUNR/control siRNA ratio greater than 10*
4) siUNR/control siRNA ratio less than 0.1*
* if the ratio was infinite, only proteins with both siUNR values greater than zero were accepted
and, if the ratio was zero, only proteins with both control siRNA values greater than zero were
accepted.
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It should be explicitly noted here that the t-test p-values were not adjusted using a multiple
testing correction.
6.3.5 Discovery of proteins whose expression level changes on siUNR treatment in
unstressed HeLa cells
The changes in protein levels were explored in turn for each of the four groups stated in the
previous section.
1) t-test p-value less than 0.05, higher in siUNR samples
In total, there were 128 proteins that had p-values under 0.05 and higher abundances in the
siUNR-treated samples. These may have included multiple versions of a given protein but any
such duplicates were later removed prior to carrying out GO-term overrepresentation analysis
on the putative hits (v.i.). The top ten hits that were higher in the siUNR-treated samples, by t-
test p-value, are presented in Table 6.1.
Table 6.1: Top ten proteins with higher expression in siUNR-treated HeLa cells than in
control siRNA-treated HeLa cells, by t-test p-value
Protein p-value
Thymidylate synthase GN=TYMS 0.00093
Isoform 2 of 60S ribosomal protein L11 GN=RPL11 0.00168
Macrophage-capping protein GN=CAPG 0.00210
Translation machinery-associated protein 7 GN=TMA7 0.00224
TRPM8 channel-associated factor 1 GN=TCAF1 0.00235
Adenosylhomocysteinase GN=AHCY 0.00246
Tubulin gamma-2 chain GN=TUBG2 0.00254
Transient receptor potential cation channel subfamily V member 2 GN=TRPV2 0.00307
Isoform 2 of Protein arginine N-methyltransferase 5 GN=PRMT5 0.00339
Nucleosome assembly protein 1-like 1 (Fragment) GN=NAP1L1 0.00371
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The top hit, thymidylate synthase (TYMS), is interesting (Table 6.1). This oncogene encodes a
protein that is essential for the de novo production of deoxythymidine-5′-monophoshate and, 
through that, for DNA synthesis. Its upregulation is associated with a poor prognosis in a number
of cancers (Rahman et al. 2004; Lenz et al. 1996; Popat et al. 2004). It is possible that the protein
is present in higher amounts in U2OS cells due to their malignant phenotype. Nevertheless,
seeing a rise in TYMS levels following siUNR treatment suggests that UNR could possibly function
as a tumour suppressor by keeping the levels of TYMS low.
The second top hit was the ribosomal protein, RPL11 (Table 6.1). That protein was shown to be
associated with Diamond Blackfan anaemia (Quarello et al. 2010). That finding links into the
UNR-related work being carried out in the Von Lindern lab (Horos et al. 2012). The protein also
regulates TP53 activity through HDM2 (Lohrum et al. 2003). Three other genes from Table 6.1
are TUBG2, TCAF1 and TRPV2 (Table 6.1). TUBG2 encodes a subunit of γ-tubulin. Noting a link 
between UNR levels and γ-tubulin at this point was interesting in that the lab had previously 
used γ-tubulin as a loading control for Western blots. It was noted that confluency course 
experiments that showed changing amounts of UNR also showed changing amounts of the
control relative to Ponceau S staining (e.g. Figure 3.4). Whilst a direct link between UNR and γ-
tubulin had not been expected at the time, it was nevertheless considered helpful to change the
loading control to Ponceau S staining. TCAF1 is involved in promoting the delivery of the TRPM8
channel to the membrane (Gkika et al. 2015). Trpm8 is a cold-activated ion channel, essential
for cold sensation in mice (Dhaka et al. 2007) and TRPV2 is an extreme heat-activated ion
channel (Caterina et al. 1999). That these proteins are up-regulated following siUNR treatment
is interesting as it implies a role for UNR in responding to extremes of temperature. Whilst the
observation is likely to be coincidental, it is interesting to consider this finding in conjunction
with the historic link between cold shock domains and the bacterial cold shock response.
2) t-test p-value less than 0.05, higher in control siRNA samples
In total, there were 104 proteins that had p-values under 0.05 and higher abundances in the
control siRNA-treated samples. These may have included multiple versions of a protein with the
same gene name, but any such duplicates were later removed prior to carrying out GO-term
overrepresentation analysis on the putative hits. The top ten hits that were higher in the control
siRNA-treated samples, by t-test p-value, are presented in Table 6.2.
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Table 6.2: Top ten proteins with expression levels higher in control siRNA-treated HeLa
cells than in siUNR-treated HeLa cells, by t-test p-value
Protein p-value
Prohibitin GN=PHB 5.8E-06
SRA stem-loop-interacting RNA-binding protein, mitochondrial (Fragment)
GN=SLIRP 0.00035
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial
GN=NDUFA9 0.00074
Actin-like protein 6A GN=ACTL6A 0.00094
Calnexin GN=CANX 0.00103
Voltage-dependent anion-selective channel protein 3 GN=VDAC3 0.00285
Nucleolar complex protein 2 homolog GN=NOC2L 0.00304
DNA-(apurinic or apyrimidinic site) lyase GN=APEX1 0.00346
NADH dehydrogenase (Ubiquinone) flavoprotein 1, 51kDa, isoform CRA_c
GN=NDUFV1 0.00368
Dedicator of cytokinesis protein 7 GN=DOCK7 0.00397
The protein potentially down-regulated following siUNR treatment with the strongest t-test p-
value was prohibitin (Table 6.2). Indeed, this protein had the strongest p-value of any protein
differentially regulated between siUNR and control siRNA samples recorded in this chapter.
Prohibitin is up-regulated in a many cancers as well as being involved in the regulation of
mitochondrial membranes, mitochondrial stress and replicative potential (Coates et al. 2001;
Coates et al. 1997; Osman et al. 2009). With two of the top hits coming from the ubiquinone
complex (NDUFA9 and NDUFV1) and SLIRP also encoding a mitochondrial protein, this implies
that UNR may play a role in regulating mitochondrial proteins (Table 6.2). Specifically, it may
play a role in the regulation of oxidative phosphorylation. This link to cellular metabolism is
interesting when taken in conjunction with the link between UNR and diabetes (Xavier et al.
2014). Such links suggest that UNR may affect cellular respiration at multiple levels from the
intake of foodstuffs to the production of ATP.
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3) siUNR/control siRNA ratio greater than 10
Only five proteins were considered significant on the grounds of having siUNR/control siRNA
abundance ratios above 10:1 (Table 6.3). None of these were considered significant by t-test p-
value (i.e. all p>0.05).
Table 6.3: Proteins with a siUNR/control siRNA ratio greater than 10:1
Protein p-value siUNR/controlsiRNA
Nucleus accumbens-associated protein 1 GN=NACC1 0.160 ∞
Isoform 2 of PITH domain-containing protein 1 GN=PITHD1 0.259 ∞
Isovaleryl-CoA dehydrogenase, mitochondrial GN=IVD 0.424 13928.28
Isoform 2 of Apoptosis-inducing factor 2 GN=AIFM2 0.205 41.09
Isoform A of Arfaptin-1 GN=ARFIP1 0.063 10.59
NACC1 was only present in the siUNR samples (Table 6.3). This suggests that UNR may act to
prevent its expression in vivo. NACC1 is an oncogene that represses the expression of
GAD45GIP1 (Nakayama et al. 2006; Nakayama et al. 2007). Interestingly, GAD45GIP1 was shown
to be somewhat down-regulated on siUNR knockdown but the p-value was not considered
significant (p=0.268, data not shown).
4) siUNR/control siRNA ratio less than 0.1
No proteins had a siUNR/control siRNA ratio less than 0.1; the lowest ratio was 0.2152 for
Voltage-dependent anion-selective channel protein 3 (Table 6.4).
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Table 6.4: Protein with lowest siUNR/control siRNA ratio
Protein p-value siUNR/control siRNA
Voltage-dependent anion-selective channel protein 3 GN=VDAC3 0.0648 0.2152
There was a lack of evidence for the removal of UNR causing any proteins to be down-regulated
in terms of having a fold-change greater than ten times (Table 6.4). This suggests that, whilst
UNR may modulate the expression of many proteins, it is probably neither essential for their
expression nor capable of completely ablating their expression (with the possible exception of
the two proteins with infinite ratios in Table 6.3).
6.4 GO-term overrepresentation analyses on UNR knockdown-mediated differentially
expressed proteins
In order to carry out GO term analyses on the HeLa knockdown data, the proteins that were
statistically up-regulated on siUNR treatment were added to the 5 proteins that had
siUNR/control siRNA ratios over 10. Those represented the total number of proteins considered
to be up-regulated by siUNR treatment. As there were no proteins with siUNR/control siRNA
ratios under 0.1, those that were statistically down-regulated on siUNR treatment were used
alone.
6.4.1 GO-term overrepresentation analysis on proteins up-regulated by siUNR
treatment
The merged protein list was listed by gene name and the single duplicate value was removed,
leaving 127 of 128 gene names to be fed into the GO tool at http://amigo.geneontology.org/rte.
That returned an unmapped gene and six genes with multiple entries. Acceptable Uniprot
identifiers were obtained for these genes and were used to replace them. The gene/protein list
was re-entered into the GO tool. The list, as used, is presented in Table 6.5.
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Table 6.5: Gene/protein* list corresponding to proteins that are higher in siUNR-treated
HeLa cells over control siRNA HeLa cells
* if gene names were ambiguous or not recognised by the tool, Uniprot identifiers were used.
Brief points concerning two of the genes in Table 6.5:
1) PABPC1 – as stated previously, this protein has its translation repressed by UNR. It is
totally expected, therefore, to become up-regulated on UNR knockdown (Patel et al.
2005).
2) MYH9 – as was stated in section 4.6.2, MYH9 is associated with invasion and metastasis
in osteosarcoma cells (Zhou et al. 2016) and was the highest or second highest protein
by total ion intensity observed in the immunoprecipitation data for HeLa and U2OS,
respectively (Table 4.6). If siUNR treatment in HeLa cells increases the expression of the
Myh9 protein, that implies that UNR may repress the expression of the protein, as well
as physically binding to it.
The 127 proteins were fed into the GO tool with the following parameters (Table 6.6):
AADAT DDX3X HSP90AB4P NELFA PRPS1 SELENBP1 TYMS
ABCF2 DDX5 HSPA14 NFKBIE PSMC3 SERPINB6 UBE4B
ABCF3 DDX60 HSPA1A NUBP1 PSMD9 SH3PXD2B UCHL5
AHCY DKC1 HSPA1L P12081 PUS7 SMAD2 UCK2
AHNAK2 DLGAP4 HSPA2 P27361 Q9BY44 SNCG UGP2
AIFM2 DNAJC7 HSPA8 P40121 Q9H2G2 SSSCA1 UROD
ALDH9A1 DR1 HSPB1 PABPC1 Q9NR30 SUPT6H YKT6
AP3M1 DYNC1I2 IVD PARP4 Q9Y3F4 TCAF1
AP3S1 EIF3I KIAA1524 PCYT2 RHOA TIPIN
ARFIP1 ERVK-5 KIF2A PEPD RHOC TMA7
C11orf54 FADD KPNA2 PFN1 RNPEP TPT1
C12orf10 FKBP1A LIMS2 PGD RPL11 TRAPPC3
C12orf57 GAPVD1 MAGED2 PGLS RPL12 TRIM25
C19orf53 GATAD2A MOGS PI4KB RPL13A TRPV2
CBR1 GCA MRI1 PIR RPL21 TTC9C
CDC123 GLO1 MTHFD1 PITHD1 RRM1 TUBB
CHMP4B GNE MYH9 POLR2H RUFY1 TUBB4A
CLIC4 HGS NACC1 PPIA_HUMAN RXRB TUBB4B
CUL1 HMGCS1 NAP1L1 PPM1B S100A4 TUBG2
DDX17 HSD17B4 NAP1L4 PRMT5 S100P TXLNA
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Table 6.6: AmiGO 2 search parameters for all knockdown GO-term analyses
Analysis Type: PANTHER Overrepresentation Test (release20160715)
Annotation Version and Release Date: GO Ontology database Released 2016-09-24
Analyzed List: upload_1 (Homo sapiens)
Reference List: Homo sapiens (all genes in database)
Bonferroni correction: TRUE
The results to this section are to be presented in three sections, by GO term category (biological
process, molecular function and cellular component). It should be noted that, whereas the
significance-detecting t-tests generated non-multiple testing corrected p-values, the GO tool
generated multiple testing corrected p-values using the Bonferroni correction.
1) Overrepresented biological process GO terms using proteins that were more abundant
in siUNR-treated HeLa cells than in control siRNA-treated cells
There were 21 overrepresented biological process GO terms among those annotated to the
proteins in Table 6.5. It was decided to present the top ten over-represented GO terms by p-
value and by fold enrichment. The other overrepresented GO terms can be reproduced by
entering the gene/Uniprot IDs in Table 6.5 with the parameters in Table 6.6 into the GO tool at
http://amigo.geneontology.org/rte.
The top ten over-represented GO terms by p-value are presented in Table 6.7 and the top ten
by fold enrichment in Table 6.8.
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Table 6.7: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by p-value
GO biological process complete Ref Obs Exp FE p-value
viral process (GO:0016032) 831 25 5.03 4.97 2.87E-07
multi-organism cellular process (GO:0044764) 836 25 5.06 4.94 3.26E-07
interspecies interaction between organisms
(GO:0044419) 872 25 5.28 4.73 7.86E-07
symbiosis, encompassing mutualism through
parasitism (GO:0044403) 872 25 5.28 4.73 7.86E-07
protein refolding (GO:0042026) 20 6 0.12 49.54 2.92E-05
cellular process (GO:0009987) 14523 115 87.95 1.31 7.33E-05
biological_process (GO:0008150) 17008 123 103 1.19 8.13E-04
protein folding (GO:0006457) 227 11 1.37 8 1.39E-03
posttranscriptional regulation of gene
expression (GO:0010608) 473 15 2.86 5.24 1.78E-03
positive regulation of viral process
(GO:0048524) 105 8 0.64 12.58 2.59E-03
N.B. As in chapter 4, Ref = number of genes with given annotation in the database, Obs = number
of genes/proteins observed in experiment, Exp = expected number of genes based on sample
size assuming random selection, FE = fold enrichm3ent, p-value as calculated by the GO tool.
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Table 6.8: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by fold enrichment
GO biological process complete Ref Obs Exp FE p-value
protein refolding (GO:0042026) 20 6 0.12 49.54 2.92E-05
positive regulation of viral life cycle (GO:1903902) 91 7 0.55 12.7 1.36E-02
positive regulation of viral process (GO:0048524) 105 8 0.64 12.58 2.59E-03
positive regulation of multi-organism process
(GO:0043902) 161 9 0.97 9.23 6.03E-03
translational initiation (GO:0006413) 154 8 0.93 8.58 4.33E-02
regulation of viral life cycle (GO:1903900) 174 9 1.05 8.54 1.14E-02
protein folding (GO:0006457) 227 11 1.37 8 1.39E-03
posttranscriptional regulation of gene expression
(GO:0010608) 473 15 2.86 5.24 1.78E-03
viral process (GO:0016032) 831 25 5.03 4.97 2.87E-07
multi-organism cellular process (GO:0044764) 836 25 5.06 4.94 3.26E-07
Viral process-related GO terms were among the most significant, both by p-value (Table 6.7) and
fold enrichment (Table 6.8). Protein folding was the top hit by fold enrichment (Table 6.8).
2) Overrepresented molecular function GO terms using proteins that were more abundant
in siUNR-treated HeLa cells than in control siRNA-treated cells
There were 34 overrepresented molecular function GO terms among those annotated to the
proteins in Table 6.5. The top ten over-represented GO terms by p-value are presented in Table
6.9 and the top ten by fold enrichment in Table 6.10.
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Table 6.9: Top ten overrepresented molecular function GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by p-value
GO molecular function complete Ref Obs Exp FE p-value
protein binding (GO:0005515) 10901 106 66.01 1.61 2.67E-10
cadherin binding involved in cell-cell adhesion
(GO:0098641) 277 16 1.68 9.54 4.67E-08
heterocyclic compound binding (GO:1901363) 5953 72 36.05 2 6.50E-08
protein binding involved in cell-cell adhesion
(GO:0098632) 287 16 1.74 9.21 7.83E-08
protein binding involved in cell adhesion
(GO:0098631) 292 16 1.77 9.05 1.01E-07
cadherin binding (GO:0045296) 295 16 1.79 8.96 1.17E-07
organic cyclic compound binding (GO:0097159) 6037 72 36.56 1.97 1.32E-07
small molecule binding (GO:0036094) 2597 44 15.73 2.8 2.15E-07
nucleotide binding (GO:0000166) 2411 42 14.6 2.88 2.94E-07
nucleoside phosphate binding (GO:1901265) 2412 42 14.61 2.88 2.98E-07
Table 6.10: Top ten overrepresented molecular function GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by fold enrichment
GO molecular function complete Ref Obs Exp FE p-value
unfolded protein binding (GO:0051082) 106 8 0.64 12.46 8.91E-04
cadherin binding involved in cell-cell adhesion
(GO:0098641) 277 16 1.68 9.54 4.67E-08
protein binding involved in cell-cell adhesion
(GO:0098632) 287 16 1.74 9.21 7.83E-08
protein binding involved in cell adhesion
(GO:0098631) 292 16 1.77 9.05 1.01E-07
cadherin binding (GO:0045296) 295 16 1.79 8.96 1.17E-07
isomerase activity (GO:0016853) 171 9 1.04 8.69 3.16E-03
cell adhesion molecule binding (GO:0050839) 456 16 2.76 5.79 5.52E-05
nucleoside-triphosphatase activity (GO:0017111) 787 18 4.77 3.78 3.75E-03
poly(A) RNA binding (GO:0044822) 1168 26 7.07 3.68 2.03E-05
pyrophosphatase activity (GO:0016462) 832 18 5.04 3.57 8.13E-03
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The most significant molecular function GO terms were shown to have stronger Bonferroni-
corrected p-values than the most significant biological process GO terms, with the top hit having
a p-value 1000 times lower. The tenth most significant molecular function GO term had a similar
p-value to that of the top biological process GO term (Table 6.7, Table 6.9). It is possible that
UNR regulates the expression of groups of proteins by their molecular function more than by
their biological processes. Cadherin binding in cell-cell adhesion was the second highest hit by
both p-value and fold enrichment (Tables 6.9 and 6.10). This is interesting in view of the IF work
that showed UNR being concentrated at cell-cell interfaces (see section 4.12.1). Poly(A) RNA
binding had a fold enrichment of 3.68 and an adjusted p-value of 2x10-5. This is interesting as
UNR is known to interact with a number of mRNAs and to modulate their stability and/or
translation. This finding implies that UNR modulates the expression of other proteins that bind
to poly(A) regions and are expected, therefore, also to exhibit an effect on translation. Results
like that imply that UNR may have a crucial role in the spatiotemporal control of translation.
3) Overrepresented cellular component GO terms using proteins that were more abundant
in siUNR-treated HeLa cells than in control siRNA-treated cells
There were 36 overrepresented and 2 underrepresented cellular component GO terms among
those annotated to the proteins in Table 6.5. The underrepresented GO terms were the closely
related ‘intrinsic component of membrane’ (GO:0031224) and ‘integral component of
membrane’ (GO:0016021). The top ten over-represented GO terms by p-value are presented in
Table 6.11 and the top ten by fold enrichment in Table 6.12.
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Table 6.11: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by p-value
GO cellular component complete Ref Obs Exp FE p-value
cytosol (GO:0005829) 3487 69 21.12 3.27 5.23E-19
cytoplasm (GO:0005737) 10781 109 65.29 1.67 3.67E-13
cytoplasmic part (GO:0044444) 8144 93 49.32 1.89 5.07E-12
intracellular part (GO:0044424) 13819 119 83.68 1.42 1.00E-10
extracellular exosome (GO:0070062) 2735 49 16.56 2.96 6.07E-10
extracellular vesicle (GO:1903561) 2749 49 16.65 2.94 7.36E-10
extracellular organelle (GO:0043230) 2750 49 16.65 2.94 7.46E-10
intracellular (GO:0005622) 14192 119 85.94 1.38 1.57E-09
adherens junction (GO:0005912) 684 24 4.14 5.79 5.06E-09
anchoring junction (GO:0070161) 702 24 4.25 5.65 8.66E-09
Table 6.12: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in siUNR treated HeLa cells, by fold enrichment
GO cellular component complete Ref Obs Exp FE p-value
cell-cell adherens junction (GO:0005913) 320 16 1.94 8.26 1.84E-07
cytosolic part (GO:0044445) 243 9 1.47 6.12 2.52E-02
adherens junction (GO:0005912) 684 24 4.14 5.79 5.06E-09
anchoring junction (GO:0070161) 702 24 4.25 5.65 8.66E-09
focal adhesion (GO:0005925) 393 12 2.38 5.04 7.09E-03
cell-substrate adherens junction (GO:0005924) 396 12 2.4 5 7.65E-03
cell-substrate junction (GO:0030055) 400 12 2.42 4.95 8.46E-03
cell-cell junction (GO:0005911) 641 18 3.88 4.64 9.42E-05
cytosol (GO:0005829) 3487 69 21.12 3.27 5.23E-19
cell junction (GO:0030054) 1371 26 8.3 3.13 2.37E-04
It is clear that the cellular component GO terms have the strongest p-values of the three groups
(Table 6.11 versus Tables 6.7 and 6.9). That said, the top four hits are extremely general and
more important are possibly the extracellular exosome (as it has been seen previously [e.g. Table
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4.12C]) and adherens junction (as it had also been seen previously and it has a much smaller
reference list [e.g. Table 4.19D, Table 6.12]). The cell-cell adherens junction had the greatest
fold enrichment (8.26) and also had a strong adjusted p-value (p=1.84x10-7).
6.4.2 Consideration of GO-term overrepresentation analysis on proteins present at
higher levels in siUNR-treated HeLa cells than in control siRNA-treated HeLa
cells
It appears that UNR could possibly be regulating the expression of groups of proteins based on
their cellular location more than the biological process in which they are involved. It is not
immediately obvious why that should be the case. It is possible that UNR is involved in the
sequestration of mRNA. The removal of UNR could then either release the mRNA to be
translated and the resultant protein to be transported to its site of action, or the transcript itself
could be localised to a specific region to be translated locally. Another possibility is that UNR is
itself localised within the cell and either increases or decreases the translation of transcripts
concentrated in those areas. However, a localised concentration of UNR in specific regions of
the cell under all conditions is not in keeping with IF work carried out in the Anderson lab over
the past few years (data not shown). A third possibility is that UNR aids somehow in the
degradation of mRNA or protein. It is also possible that UNR exerts an effect on translation that
exists outside a three dimensional snapshot of the cell. By controlling the translation of some
transcription factors, UNR could affect the transcription of groups of transcripts that are
involved in specific functions at specific regions of the cell. Also, by controlling the translation of
a large number of poly(A) binding proteins (at least 26 – Table 6.10), UNR could control
translation generally across almost all transcripts whilst also binding to and affecting the
translation of a smaller subset of transcripts directly. The top molecular function GO terms are
intermediate in p-value between the biological process GO terms and the cellular component
GO terms.
6.4.3 GO-term overrepresentation analysis on proteins down-regulated by siUNR
treatment
The merged protein lists were listed by gene name and any duplicate values were removed.
These were then initially fed into the GO tool at http://amigo.geneontology.org/rte. That
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returned two genes with multiple entries. Acceptable Uniprot identifiers were obtained for
those genes and were used to replace them. The gene/protein list was re-entered into the GO
tool. The 104 entry list, as used, is presented in Table 6.13.
Table 6.13: Gene/protein* list corresponding to proteins that are higher in control siRNA-
treated HeLa cells over siUNR-treated HeLa cells
ABCE1 CDH10 EXOSC5 LAMB3 PTPN1 TOMM70A
ACOT13 CELF1 FAM192A MBOAT7 PTRH2 TOR1AIP1
ACTL6A CISD1 FTH1 MPDU1 Q9H910 TST
ADD3 COA7 FUNDC2 MTCH2 RAB35 TTC7B
AGO2 COX4I1 FUS MYO6 RANBP9 UBR4
AGTPBP1 COX5A GALNT2 NDRG1 RBM14 UGGT1
AK2 COX6B1 GALNT7 NDUFA9 RCC2 UQCRC2
ALG11 CPOX GLOD4 NDUFS5 SDHA VAPA
APEX1 CSDE1 GSTK1 NDUFV1 SEC62 VDAC1
ATG5 CTNNA2 HDAC3 NOC2L SLC25A3 VDAC3
ATP2A2 CYC_HUMAN HDLBP NOTCH2 SLC2A14 WDR33
ATP2A3 DDX1 HIBADH NR3C1 SLIRP WRNIP1
ATP5L DOCK7 HSPE1 P31947 SNRPB2 YWHAG
BNIP3 DSG2 IGF2R PDCD4 SQRDL YWHAH
C8orf82 ECH1 ITGB1 PDIA6 STAT6
CANX EHD4 JUP PHB STT3A
CCDC51 EPHX1 KHSRP PPP4R2 TMEM194A
CCDC58 ERGIC3 KIAA0319L PRRC2A TOMM40
* if gene names were ambiguous, appropriate Uniprot identifiers were entered into the tool.
Fortunately, UNR was shown to be down-regulated following UNR knockdown (Table 6.13).
Another gene that seemed important on the author’s uneducated cursory scan of Table 6.13
was AGO2 (i.e. there may be much more important genes in the list with functions with which
the author is unfamiliar). Argonaut-2 is responsible for the RISC-mediated cleavage of mRNA
following siRNA treatment (Matranga et al. 2005). This was considered interesting because it
was down-regulated on siUNR treatment over control siRNA treatment, implying that UNR may
be involved in the expression of AGO2.
As with the previous GO term analyses, these results are presented in three sections by GO term
category.
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1) Overrepresented biological process GO terms using proteins that were more abundant
in control siRNA-treated HeLa cells than in siUNR-treated cells
There were 24 overrepresented biological process GO terms among those annotated to the
proteins in Table 6.13. The top ten over-represented GO terms by p-value are presented in Table
6.14 and the top ten by fold enrichment in Table 6.15.
Table 6.14: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in control siRNA treated HeLa cells, by p-value
GO biological process complete Ref Obs Exp FE p-value
oxidative phosphorylation (GO:0006119) 98 9 0.49 18.52 1.62E-05
respiratory electron transport chain (GO:0022904) 108 9 0.54 16.8 3.74E-05
electron transport chain (GO:0022900) 111 9 0.55 16.35 4.73E-05
mitochondrial ATP synthesis coupled electron
transport (GO:0042775) 88 8 0.44 18.33 1.44E-04
ATP synthesis coupled electron transport
(GO:0042773) 89 8 0.44 18.13 1.57E-04
mitochondrial transport (GO:0006839) 186 10 0.92 10.84 3.05E-04
ATP metabolic process (GO:0046034) 204 10 1.01 9.88 7.15E-04
mitochondrion organization (GO:0007005) 632 16 3.13 5.11 8.20E-04
cellular respiration (GO:0045333) 164 9 0.81 11.07 1.28E-03
purine ribonucleoside triphosphate metabolic
process (GO:0009205) 227 10 1.13 8.88 1.89E-03
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Table 6.15: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in control siRNA treated HeLa cells, by fold
enrichment
GO biological process complete Ref Obs Exp FE p-value
mitochondrial electron transport, cytochrome c to
oxygen (GO:0006123) 20 4 0.1 40.33 2.92E-02
oxidative phosphorylation (GO:0006119) 98 9 0.49 18.52 1.62E-05
mitochondrial ATP synthesis coupled electron
transport (GO:0042775) 88 8 0.44 18.33 1.44E-04
ATP synthesis coupled electron transport
(GO:0042773) 89 8 0.44 18.13 1.57E-04
respiratory electron transport chain (GO:0022904) 108 9 0.54 16.8 3.74E-05
electron transport chain (GO:0022900) 111 9 0.55 16.35 4.73E-05
cellular respiration (GO:0045333) 164 9 0.81 11.07 1.28E-03
mitochondrial transport (GO:0006839) 186 10 0.92 10.84 3.05E-04
ATP metabolic process (GO:0046034) 204 10 1.01 9.88 7.15E-04
purine ribonucleoside triphosphate metabolic
process (GO:0009205) 227 10 1.13 8.88 1.89E-03
Whilst many of the GO terms shared the same proteins, it appeared that the top biological
process GO terms overrepresented on UNR downregulation with siUNR were related to
oxidative phosphorylation and closely related mitochondrial GO terms. This was both in terms
of p-value (Table 6.14) and fold enrichment (Table 6.15).
2) Overrepresented molecular function GO terms using proteins that were more abundant
in control siRNA-treated HeLa cells than in siUNR-treated cells
There were 8 overrepresented molecular function GO terms among those annotated to the
proteins in Table 6.13. All 8 over-represented GO terms by p-value are presented in Table 6.16.
As all overrepresented GO terms are presented in Table 6.16, there was no reason to include a
separate fold enrichment table.
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Table 6.16: Overrepresented molecular function GO terms associated with proteins that
were higher in abundance in control siRNA treated HeLa cells, by p-value
GO molecular function complete Ref Obs Exp FE p-value
protein binding involved in cell-cell adhesion
(GO:0098632) 287 12 1.42 8.43 6.19E-05
protein binding involved in cell adhesion
(GO:0098631) 292 12 1.45 8.29 7.46E-05
cadherin binding involved in cell-cell adhesion
(GO:0098641) 277 11 1.37 8.01 4.10E-04
cadherin binding (GO:0045296) 295 11 1.46 7.52 7.62E-04
cell adhesion molecule binding (GO:0050839) 456 12 2.26 5.31 8.05E-03
RNA binding (GO:0003723) 1631 23 8.09 2.84 1.11E-02
porin activity (GO:0015288) 6 3 0.03 > 100 1.11E-02
poly(A) RNA binding (GO:0044822) 1168 18 5.79 3.11 4.60E-02
It was noted that there were fewer significant molecular function GO terms using the proteins
down-regulated following siUNR treatment compared to those found using up-regulated
proteins. It was noted that the same general themes were present with both the up-regulated
and down-regulated proteins, however. For example, cadherin binding, cell-cell adhesion and
poly(A) RNA binding GO terms are present in both Table 6.10 and Table 6.16. It was noted that
the p-values for these were much stronger with the up-regulated proteins than the down-
regulated ones. This could in part be due to there being more proteins in the up-regulated list
(Table 6.5 versus Table 6.13). Whatever the reason, however, it appears that UNR knockdown
both increases and decreases the level of proteins with given molecular function GO term
annotations. This is to be expected if UNR exerts an effect on whole molecular function GO terms
and, as discussed at length in the introduction, UNR is already known to promote the translation
of certain mRNAs and repress the translation of others.
3) Overrepresented cellular component GO terms using proteins that were more abundant
in control siRNA-treated HeLa cells than in siUNR-treated cells
There were 58 overrepresented cellular component GO terms among those annotated to the
proteins in Table 6.13. The top ten over-represented GO terms by p-value are presented in Table
6.17 and the top ten by fold enrichment in Table 6.18.
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Table 6.17: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in control siRNA treated HeLa cells, by p-value
GO cellular component complete Ref Obs Exp FE p-value
intracellular membrane-bounded organelle
(GO:0043231) 10985 99 54.47 1.82 4.84E-19
mitochondrion (GO:0005739) 1717 45 8.51 5.29 7.22E-19
membrane-bounded organelle (GO:0043227) 12122 100 60.11 1.66 3.10E-16
intracellular organelle part (GO:0044446) 8167 85 40.5 2.1 5.88E-16
intracellular organelle (GO:0043229) 12049 99 59.75 1.66 2.63E-15
organelle part (GO:0044422) 8351 85 41.41 2.05 2.98E-15
cytoplasmic part (GO:0044444) 8144 84 40.39 2.08 3.23E-15
organelle envelope (GO:0031967) 1145 33 5.68 5.81 8.06E-14
envelope (GO:0031975) 1151 33 5.71 5.78 9.38E-14
mitochondrial part (GO:0044429) 998 31 4.95 6.26 1.17E-13
Table 6.18: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in control siRNA treated HeLa cells, by fold
enrichment
GO cellular component complete Ref Obs Exp FE p-value
intercalated disc (GO:0014704) 53 5 0.26 19.02 9.94E-03
respiratory chain complex (GO:0098803) 81 7 0.4 17.43 2.53E-04
organelle envelope lumen (GO:0031970) 85 7 0.42 16.61 3.49E-04
mitochondrial respiratory chain (GO:0005746) 87 7 0.43 16.23 4.08E-04
respiratory chain (GO:0070469) 100 8 0.5 16.13 5.92E-05
mitochondrial intermembrane space (GO:0005758) 77 6 0.38 15.71 3.53E-03
cell-cell contact zone (GO:0044291) 66 5 0.33 15.28 2.83E-02
inner mitochondrial membrane protein complex
(GO:0098800) 130 8 0.64 12.41 4.27E-04
mitochondrial protein complex (GO:0098798) 163 10 0.81 12.37 1.39E-05
mitochondrial membrane part (GO:0044455) 204 12 1.01 11.86 7.00E-07
The top ten overrepresented cellular component GO terms for the proteins down-regulated by
siUNR treatment were quite different to those using up-regulated proteins (Tables 6.17 and
6.11). Nevertheless, there were 58 significant cellular component GO terms found using the
down-regulated proteins. Those 58 GO terms were listed with the top ten cellular component
GO terms by p-value for the up-regulated proteins and Microsoft Excel was used to find
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duplicates. This showed that nine out of the ten GO terms in Table 6.11 (all except cytosol) were
also considered significantly overrepresented among siUNR-mediated down-regulated proteins
(Bonferroni corrected p-value<0.05 - the actual p-value range was 0.000816 to 0.00999). The
data in Tables 6.17 and 6.18 do seem reliable as the p-values in them are strong. It is possible
that UNR controls the expression of different functional groups of proteins by generally
promoting their expression or generally inhibiting their expression.
6.4.4 Consideration of GO-term overrepresentation analysis on proteins down-
regulated by siUNR treatment
The siUNR-mediated knockdown of UNR in HeLa cells resulted in approximately the same
number of significantly up-regulated (127, Table 6.5) and down-regulated (104, Table 6.13)
proteins by the criteria set out in the text. As with the up-regulated protein data, the most
significantly overrepresented biological process and molecular function GO terms had weaker
p-values than the most significant cellular component GO terms. The most significant GO term
p-values were 1.62x10-5, 6.19x10-5 and 4.84x10-19, respectively. There were more significant
mitochondrion-related biological process and cellular component GO terms with the down-
regulated proteins compared to the up-regulated proteins, for example the ‘mitochondrion’ GO
term had an adjusted p-value of 7.22x10-19 (Table 6.17). It is possible therefore that UNR has a
role in the promotion of mitochondrial protein expression as knocking down UNR
downregulates the proteins. Further work would be needed to see if UNR acts on translation of
mitochondrial genes directly, either in the mitochondrion or in the cytoplasm for proteins
targeted to the mitochondrion. It is also possible that UNR exerts its control on mitochondrial
protein levels indirectly, for example by modulating the expression of transcription factors or by
physically binding to other proteins (see section 6.6.3).
6.5 Knockdown of UNR in U2OS cells
Two sets of three repeats were carried out for the UNR knockdown experiments in U2OS cells.
One set was stressed with 1 mM sodium arsenite for 1 hour prior to harvesting whereas the
other set were mock treated with the same volume of sterile PBS.
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6.5.1 Western blot confirmation of successful knockdown
Approximately one twentieth of the cell lysates was retained for analysis by Western blot in
order to confirm that the knockdown had been successful. In the case of the U2OS samples, all
the unstressed U2OS knockdowns clearly worked as expected although most of the tubulin blots
were a bit out of focus (Figure 6.4). The second and third stressed U2OS samples also worked as
expected but there was very little staining for UNR in the first control sample (Figure 6.4). It was
decided to proceed to process all of the plus arsenite samples, however, as there did appear to
be more UNR in lane stressed C1 than in lane stressed U1 even though there was less tubulin in
in lane stressed C1 than in lane stressed U1 (Figure 6.4). On top of this, it was noted that there
were around 30% fewer overall proteins detected in the unstressed C1 samples compared to
the other 5 unstressed samples (Figure 6.5). Whilst there could be differences between the
stressed and unstressed samples, there would not be expected to be extreme differences in the
total number of proteins observed and any differences would be expected to occur over all
samples. As it was, there were 31.4% fewer proteins detected by Scaffold in the first unstressed
control U2OS sample compared to the first unstressed siUNR sample. Compared to this, the
equivalent differences for the other two repeats were 5.1% more proteins (repeat 2) and 3.7%
more proteins (repeat 3) (Figure 6.5). This led to the assumption that there were fewer overall
proteins in the first repeat arsenite-stressed control siRNA-treated sample. Whilst some proteins
would not be present in that control sample that were present in the other repeats, it was hoped
that Progenesis’ normalisation function would make those that were present adequately
comparable with the abundance present in the equivalent siUNR sample.
Due to the unconventional presentation of Figure 6.4, it is worth pointing out exactly what it
shows. Additional knockdowns of TP53 and a combination of UNR and TP53 were between each
set of siUNR and control samples. As there will be no discussion of the additional knockdowns
in this thesis, it was considered helpful to block out those lanes with orange rectangles to make
the pertinent samples more obvious. At the same time, it was considered useful to show the
initial images from which the altered images were made. The fourth well from the left was blank;
this can be best seen in the bottommost tubulin panel and the drawn-on red and blue marks to
the left of centre refer to bands from a marker than was run in that lane.
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Figure 6.4: Western blot showing UNR knockdown. U2OS cells were treated with siUNR or a
control siRNA (as stated) 48 hours prior to harvesting. One hour prior to harvesting, the cells
were fed with fresh growth medium with (stressed, pink) or without (unstressed, blue) 1 mM
sodium arsenite. The images show UNR (upper two panels) or α/β-tubulin (lower two panels). U 
= siUNR sample, C = control siRNA sample, numbers = repeat. The top two panels are identical,
as are the lower two. The orange boxes in the middle panels hide bands that are visible in the
other panels but do not form part of the discussion. The red and blue marks on the panels refer
to protein size markers (upper markers: red = 70kDa, blue = 100kDa; lower markers: red = 70kDa,
blue = 55kDa).
6.5.2 Error in processing the unstressed U2OS samples in Progenesis
Due to a labelling error in processing the unstressed U2OS samples in Progenesis, compounded
by its late detection and loss of access rights to Life Sciences, a decision had to be made between
presenting Progenesis analysis of two of the three sets of repeats based upon normalisation
calculations that included an incorrect sample, and reanalysing the unstressed samples using
Scaffold. It was decided to use Scaffold.
6.5.3 Justification of the use of Scaffold
Looking at the immunoprecipitation data from unstressed HeLa cell lysates, it was clear that the
Scaffold hits and the Progenesis hits were similar, although there were more hits with
Progenesis. Taking the 13 proteins listed in Table 4.2B (Scaffold data), seven are listed in the
equivalent Progenesis analysis (Table 4.7B) (UNRIP, NARR, LDB1, UNR, SQSTM1, LMO4 and TFG).
One further protein is listed as having a high UNR/IgG ratio in Table 4.9B (MYCBP2). Two further
proteins were listed as having been pulled down with UNR in arsenite-treated HeLa cells
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(HUWE1 and RPS5) (Table 4.8B). The SSBP4 protein was not found in the Progenesis data, but
both the SSBP2 and SSBP3 proteins were (Table 4.7B). Using the protein alignment tool at
www.uniprot.org on 13/10/16, SSBP4 showed 69.5% identity with SSBP2, 71.0% identity with
SSBP3 and 62.7% identity was retained across all three. It may be the case that these proteins
were confused between the two programs. Of the other two proteins present in Table 4.2B but
not in Table 4.7B, HSPD1 showed a distribution that questioned whether or not it was a genuine
hit. The largest value in the IgG repeats (130270) was larger than that of two of the UNR values
(40965 and 34231). Whilst there was more of the protein present in every UNR sample over the
equivalent IgG sample, the large amount that was pulled down by IgG on one occasion suggested
that HSPD1 may be false positive.
Both MYCBP2 and HUWE1 had protein distributions that would suggest that they were true
positives as all UNR pulldown values were at least an order of magnitude greater than the
corresponding IgG pulldowns and, in the case of HeLa5 versus HeLa2 for HUWE1, more than two
orders of magnitude (Table 6.19). That, and the fact that HUWE1 and RPS5 had the same p-value
even though the IgG pulldown values for RPS5 were much closer (ratios= 1:1.08, 1:1.09, 1:2.10,
Table 6.19), supports the idea that t-tests are not an ideal way to decide on significance.
Table 6.19: t-test p-values using Progenesis-calculated protein levels for selected proteins
considered significant by Scaffold but not by Progenesis
Protein HeLaIgG_1
HeLa
IgG_2
HeLa
IgG_3
HeLa
Unr_1
HeLa
Unr_2
HeLa
Unr_3 p-value
MYCBP2 10,756 14,613 11,058 422,964 192,383 137,694 0.1130
HUWE1 859 514 11,976 75,310 118,533 430,660 0.2005
RPS5 461,654 630,056 189,952 499,451 688,074 398,701 0.2005
Due to the fact that most putative hits using Scaffold were also flagged up by Progenesis and
that at least some of those that were not nevertheless appear to be valid, it was considered
acceptable to analyse the knockdown data using Scaffold and paired t-tests alone. The
advantages of Progenesis were still acknowledged, and the use of Scaffold was only intended to
give an initial general insight into the identity of proteins and groups of proteins that may be
affected by UNR knockdown, purely because circumstances prevented equivalent analysis with
Progenesis.
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6.6 Analysis of data obtained from U2OS cells following siUNR or a control siRNA
treatment, without exogenous stress
The raw mass spectrometry data from the lysates made from unstressed U2OS cells that had
been treated with siUNR or a control siRNA were fed into Scaffold by the proteomics department
of Warwick University. The publication report for this was exactly the same as that in section
4.3.1. Scaffold was set to give quantitative output as normalised total ion current. There were
1917 protein clusters identified across the six samples and, with the exception of the first control
siRNA repeat, there were approximately the same number of proteins identified and spectra
detected for each sample (Figure 6.5).
Figure 6.5: Scaffold-derived table showing the number of spectra per sample (#Spec) and
number of proteins detected under the parameters laid out in the text (#Prot).
6.6.1 Detection of proteins that are differentially expressed in U2OS cells following
treatment with siUNR or a control siRNA, without exogenous stress
The Scaffold data were then exported to Microsoft Excel for further analysis. As in chapter 4, a
liberal two-tailed paired t-test p-value significance level of p<0.1 was used. This was used to
increase the number of significant proteins detected by t-test to make it more comparable to
the number detected from the HeLa samples. That was, in turn, to make the p values obtained
from the GO tool more comparable between the HeLa and U2OS samples. It also made the
Scaffold analysis more comparable with the Scaffold analyses carried out in Chapter 4, which
were discussed in section 6.5.3 in respect to validating the use of Scaffold in this section).
Proteins that were at least ten times more abundant in one of the conditions (siUNR or control)
were also included. Where the siUNR/control siRNA ratio was 0 or infinite, the protein was
included only when it was present in all three of the repeats for the condition in which it was
detected. Lists were made for those proteins that went up on siUNR by t-test p-value or ratio
and duplicated proteins were removed after the lists were merged. This was repeated for
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proteins that were down-regulated following siUNR treatment. Finally, both lists were merged
to give a list of proteins that were differentially expressed following treatment with siUNR.
6.6.2 Discovery of proteins with significantly different expression levels in U2OS
cells following treatment with siUNR, without exogenous stress
The changes in protein levels were explored in turn for each of the four groups used for the HeLa
samples.
1) t-test p-value less than 0.1, higher in siUNR samples
There were 100 proteins with a p-value less than 0.1 that were higher in the siUNR samples. The
top ten of these are presented in Table 6.20.
Table 6.20: Top ten proteins whose expression is up-regulated following siUNR treatment
in unstressed U2OS cells, by t-test p-value
Protein p-value
Nuclease EXOG, mitochondrial GN=EXOG 0.00227
Isoform 3 of Proteasome subunit beta type-5 GN=PSMB5 (P28074-3) 0.00440
Transcription factor A, mitochondrial GN=TFAM 0.00554
E3 SUMO-protein ligase RanBP2 GN=RANBP2 0.00626
Serine/threonine-protein phosphatase 1 regulatory subunit 10 GN=PPP1R10 0.00668
A-kinase anchor protein 1, mitochondrial GN=AKAP1 0.00728
Interferon regulatory factor 2-binding protein 2 GN=IRF2BP2 0.00729
G protein-regulated inducer of neurite outgrowth 1 GN=GPRIN1 0.00975
Cytochrome c oxidase assembly protein COX19 GN=COX19 0.01064
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11,
mitochondrial GN=NDUFB11 0.01216
2) t-test p-value less than 0.1, higher in control siRNA samples
There were 53 proteins with a p-value less than 0.1 that were higher in the control siRNA
samples. The top ten of these are presented in Table 6.21.
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Table 6.21: Top ten proteins whose expression is lower following siUNR treatment in
unstressed U2OS cells, by t-test p-value
Protein p-value
Nucleolysin TIA1 isoform p40 GN=TIA1 0.00027
Prosaposin GN=PSAP 0.00522
Putative G antigen family E member 3 GN=PAGE2B 0.00683
Nectin-3 GN=PVRL3 0.00706
AP2-associated protein kinase 1 (Fragment) GN=AAK1 0.00921
Proteasome subunit beta type-3 GN=PSMB3 0.01066
Density-regulated protein GN=DENR 0.01109
Microtubule-associated protein GN=MAP4 0.01129
Poly(rC)-binding protein 1 GN=PCBP1 0.01282
MICOS complex subunit MIC19 GN=CHCHD3 0.01438
3) siUNR/control siRNA ratio greater than 10
There were 19 proteins that were at least ten times higher in the siUNR samples. Of these, 14
were only observed in the siUNR samples (Table 6.22). It should be reiterated here that proteins
with zero or infinite ratios were only included when they had zero abundance in all samples from
one group and non-zero abundances in all samples from the other group.
Table 6.22: Proteins observed in siUNR samples only
Zinc finger protein 106 GN=ZNF106
Isoform 2 of Suprabasin GN=SBSN (Q6UWP8-2)
Protein NipSnap homolog 3A GN=NIPSNAP3A
Ferritin GN=FTH1
Vitamin K epoxide reductase complex subunit 1-like protein 1 GN=VKORC1L1
Nuclease EXOG, mitochondrial GN=EXOG
Transcription factor A, mitochondrial GN=TFAM
RNA binding motif protein 10, isoform CRA_d GN=RBM10
Serine/threonine-protein phosphatase 1 regulatory subunit 10 GN=PPP1R10
Dipeptidyl peptidase 1 GN=CTSC
Fibronectin GN=FN1
Cytochrome c oxidase assembly protein COX19 GN=COX19
Isoform 6 of RNA binding protein fox-1 homolog 2 GN=RBFOX2 (O43251-6)
SAFB-like transcription modulator GN=SLTM
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4) control siRNA/siUNR ratio greater than 10
There were four proteins that were present in the control siRNA samples more than ten times
more than in the siUNR samples (Table 6.23).
Table 6.23: Proteins with a control siRNA/siUNR ratio greater than 10:1
Protein control siRNA/siunr ratio
MICOS complex subunit MIC19 GN=CHCHD3 ∞ 
Glutathione S-transferase P GN=GSTP1 15.52
Lactoylglutathione lyase GN=GLO1 13.69
Translin-associated protein X GN=TSNAX 11.88
When the proteins (or protein clusters) with significantly greater abundances in the siUNR-
treated samples by t-test p-value were merged with those at least ten times more abundant in
the siUNR-treated samples and duplicate gene names were removed, 101 entries were left.
MIC19 was present in both Table 6.21 and Table 6.23, but the other three proteins that were
significantly lower in the siUNR samples by ratio were not significant by p-value. 56 proteins (or
protein clusters) were therefore accepted as being significantly lower in the siUNR samples (i.e.
53 by p value and three by ratio).
6.6.3 Consideration of token proteins that were differentially expressed between
siUNR-treated and control siRNA-treated U2OS cells, without exogenous
stress
1) Proteins higher in siUNR samples
With respect to the musings in section 6.4.4 as to the possibility of UNR controlling the
expression of mitochondrial proteins, the third most significantly up-regulated protein following
UNR knockdown in unstressed U2OS cells, by t-test p-value, was TFAM (Table 6.20). That protein
is a mitochondrial transcription factor (Parisi& Clayton 1991). Only seeing it upon UNR
knockdown would imply that UNR may have a role in supressing its expression. This observation
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may merit future investigation as a result of it offering a potential route by which UNR can
modulate the expression of mitochondrial proteins. Other proteins in the top ten up-regulated
following siUNR treatment included a mitochondrial AKAP, COX19, a ubiquinone subunit and
the top hit was the mitochondrial nuclease, EXOG (Table 6.20). This implies that the removal of
UNR may preferentially upregulate mitochondrial proteins in U2OS cells. Looking at one of these
proteins, COX19, showed that two exclusive unique peptides for the protein, equating to 24%
coverage, had been observed (Figure 6.6A). The protein was observed in all siUNR samples but
in none of the control siRNA samples (Figure 6.6B).
A
B
Figure 6.6: Graphical exploration of the validity of COX19 as a protein with higher abundance in
unstressed U2OS cells following treatment with siUNR. (A) – primary sequence of the protein
with yellow shading showing the observed peptides, (B) – bar chart showing the amount of
observed COX19 in different samples, as stated. Images were taken from the Scaffold software
and (B) was altered to make its text clearer.
2) Proteins higher in control siRNA samples
Among the proteins that were lower in the siUNR-treated samples was the top hit, TIA1 (Table
6.21). TIA1 aggregates form stress granules and it has been shown here, in the literature (White
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& Lloyd 2011), and by other work in the Anderson lab that UNR is found in stress granules in
certain arsenite stressed cells. Stress granules contain non-translating mRNAs and can offer
protection to the transcripts whilst changing the translational output through their alternate
sequestration and liberation (Buchan & Parker 2009). If TIA1 levels decrease on UNR knockdown,
this implies that UNR may play a role in promoting the translation of TIA1. The TIA1 protein has
two forms that vary by the presence or absence of a glutamine residue (QQ QQQ) and Scaffold
assigned peptides to the shorter (F8W8I6) version to maximise coverage. The peptide coverage
is otherwise exactly the same (Figure 6.7A). There were four peptides and three exclusive unique
peptides recorded for TIA1, equating to 11% coverage (Figure 6.7B). The control siUNR samples
all contained approximately twice the level of TIA1 observed in their associated siUNR samples
(Figure 6.7C).
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A
B
C
Figure 6.7: Graphical exploration of the validity of TIA1 as a protein with lower abundance in
unstressed U2OS cells following treatment with siUNR. (A) – schematic diagram showing the
coverage of TIA1 and F8W8I6, (B) – the primary sequence of the F8W8I6 version of TIA1 with
yellow shading showing the observed peptides, (C) – bar chart showing the amount of observed
COX19 in different samples, as stated. Images were taken from the Scaffold software and (C)
was altered to make its text clearer.
6.6.4 Putative hits exported to the AMIGO2 GO-term overrepresentation tool
The full list of putative siUNR-mediated up- or down-regulated proteins were fed into the GO
tool at http://amigo.geneontology.org/rte. The gene names were obtained as before and
ambiguous or unrecognised terms were replaced with Uniprot identifiers where possible. The
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gene DKFZp566H192 was found to encode the protein neuroplastin (Q9UFM8) which was up-
regulated following siUNR treatment. That said, neither the gene name nor the Uniprot ID were
recognised by the GO tool, so the gene/protein was removed. Likewise, the down-regulated but
Uniprot-uncharacterised protein A0A087WV05 was removed.
These alterations resulted in 100 proteins that were more abundant in unstressed siUNR-treated
U2OS cells and 55 proteins that were more abundant in unstressed control siRNA-treated U2OS
cells being used for GO term overrepresentation analysis. The full lists, as used, are presented
in Table 6.24.
Table 6.24: Gene names* of proteins differentially regulated following siUNR treatment
A: Proteins higher in siUNR-treated samples
AHNAK2 CLCC1 FN1 ITGB5 PALM SCRIB TP53BP1
AKAP1 CNPY3 FTH1 KAT7 PCM1 SERBP1 TPD52L2
AKAP12 COX19 GATAD2B KTN1 POLR2G SGTA VDAC3
ALDH2 CPD GGCT LBR PPP1R10 SLAIN2 VKORC1L1
ARPC2 CTSC GIGYF2 LEMD3 PRPF3 SLC30A1 WBP11
BAD DAB2 GLRX5 LETM1 PSMB5 SLC44A1 YLPM1
BCAM DCBLD2 GPRIN1 LGALS3 Q8IWI9 SLC9A3R2 ZC3H11A
BPTF DECR1 HIST1H1T MRPS36 RANBP2 SLTM ZNF106
BSG EEA1 HMGN5 MT-ATP8 RBFOX2 SRRM2 ZNF185
C1QBP EIF3J HNRNPA2B1 NCOA6 RBM10 TACC1 ZYX
CALR EPB41 HNRNPM NDUFA7 RBM27 TAGLN
CATD EXOG HRSP12 NDUFB11 RPL19 TFAM
CD3EAP FAM136A IRF2BP2 NES SBSN THBS1
CDC5L FAM3C ISCA2 NIPSNAP3A SCAF11 TJP1
CDH13 FIS1 ITGA6 P32004 SCAMP1 TNS1
B: Proteins higher in control siRNA-treated samples
AAK1 CFL2 F8W031 H0YHG0 P14174 PPM1G S100A2 TIMM8A
ADNP CHCHD3 FAM192A HSPB8 PAGE2B PSAP SDC4 TSNAX
ARPP19 CNN3 FAM195B JAM3 PALLD PSMA5 SKP1 UBAP2
ATOX1 DENR G3BP1 LDHA PCBP1 PSMA7 SNAP23 UBE2V2
CAPN2 DLGAP5 GLO1 MAP4 PDLIM7 PSMB3 SPAG7 UBXN1
CEP131 ECI1 GPHN MYL12A PGM2 PSME3 SUPT5H UBXN7
CFDP1 EEF1B2 GSTP1 NPC2 PLP2 PVRL3 TIA1
* as explained in text, some gene names have been replaced with Uniprot identifiers.
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6.6.5 GO term overrepresentation analysis 1: Proteins that were more abundant in
siUNR-treated U2OS cells than in equivalent control siRNA-treated U2OS cells
There were seven over represented biological process GO terms using the proteins up-regulated
following siUNR treatment (Table 6.25A). There were nine overrepresented molecular function
GO terms (Table 6.25B). There were 34 overrepresented cellular component GO terms, the top
ten of which are presented by p-value (Table 6.25C) and by fold enrichment (Table 6.25D).
Table 6.25: Top overrepresented GO terms associated with proteins that were higher in
abundance in unstressed siUNR-treated U2OS cells than in unstressed control
siRNA-treated U2OS cells, by p-value or fold enrichment (as stated)
A: Biological process GO terms, by p-value
GO biological process complete Ref Obs Exp FE p-value
mRNA processing (GO:0006397) 445 14 2.12 6.6 2.48E-04
RNA splicing (GO:0008380) 377 12 1.8 6.68 2.29E-03
mRNA metabolic process (GO:0016071) 627 15 2.99 5.02 2.59E-03
biological_process (GO:0008150) 17008 97 81.1 1.2 1.55E-02
cellular component organization or biogenesis
(GO:0071840) 5481 48 26.13 1.84 1.87E-02
cellular component organization (GO:0016043) 5318 47 25.36 1.85 2.02E-02
cellular process (GO:0009987) 14523 89 69.25 1.29 2.33E-02
B: Molecular function GO terms, by p-value
GO molecular function complete Ref Obs Exp FE p-value
poly(A) RNA binding (GO:0044822) 1168 31 5.57 5.57 5.11E-12
RNA binding (GO:0003723) 1631 34 7.78 4.37 1.70E-10
protein binding (GO:0005515) 10901 77 51.98 1.48 5.95E-04
binding (GO:0005488) 14421 90 68.76 1.31 1.22E-03
nucleic acid binding (GO:0003676) 4068 41 19.4 2.11 1.50E-03
cell adhesion molecule binding (GO:0050839) 456 12 2.17 5.52 5.30E-03
molecular_function (GO:0003674) 17134 97 81.7 1.19 9.27E-03
cadherin binding (GO:0045296) 295 9 1.41 6.4 3.45E-02
laminin binding (GO:0043236) 31 4 0.15 27.06 4.45E-02
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C: Cellular component GO terms, by p-value
GO cellular component complete Ref Obs Exp FE p-value
intracellular organelle part (GO:0044446) 8167 74 38.94 1.9 1.52E-09
organelle part (GO:0044422) 8351 74 39.82 1.86 5.50E-09
intracellular part (GO:0044424) 13819 93 65.89 1.41 1.83E-07
organelle (GO:0043226) 13070 90 62.32 1.44 5.16E-07
adherens junction (GO:0005912) 684 19 3.26 5.83 7.66E-07
intracellular organelle (GO:0043229) 12049 86 57.45 1.5 9.23E-07
cytoplasm (GO:0005737) 10781 81 51.41 1.58 9.76E-07
anchoring junction (GO:0070161) 702 19 3.35 5.68 1.17E-06
intracellular (GO:0005622) 14192 93 67.67 1.37 1.52E-06
intracellular organelle lumen (GO:0070013) 4379 48 20.88 2.3 1.90E-06
D: Cellular component GO terms, by fold enrichment
GO cellular component complete Ref Obs Exp FE p-value
spliceosomal complex (GO:0005681) 178 7 0.85 8.25 3.29E-02
focal adhesion (GO:0005925) 393 14 1.87 7.47 8.28E-06
cell-substrate adherens junction (GO:0005924) 396 14 1.89 7.41 9.11E-06
cell-substrate junction (GO:0030055) 400 14 1.91 7.34 1.03E-05
cell-cell adherens junction (GO:0005913) 320 9 1.53 5.9 3.16E-02
adherens junction (GO:0005912) 684 19 3.26 5.83 7.66E-07
anchoring junction (GO:0070161) 702 19 3.35 5.68 1.17E-06
mitochondrial part (GO:0044429) 998 19 4.76 3.99 3.06E-04
cell junction (GO:0030054) 1371 22 6.54 3.37 5.50E-04
organelle envelope (GO:0031967) 1145 18 5.46 3.3 9.75E-03
6.6.6 Consideration of the overrepresented GO terms from proteins that were more
abundant in siUNR-treated U2OS cells than in equivalent control siRNA-
treated U2OS cells
As was observed with the unstressed HeLa samples, the strongest p-value for the
overrepresented biological process GO terms (p=2.48x10-4) are higher than that for the other
two groups of GO terms. Unlike the situation with the HeLa samples, however, the strongest
molecular function GO term (p=5.11x10-12) was stronger than that for the best cellular
component GO term (p=1.52x10-9) (Table 6.25).
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The top three overrepresented biological process GO terms were related to RNA processing,
lending further support to the idea that UNR may affect protein expression at multiple levels
(Table 6.25A). The strongest molecular function GO term by p-value, ‘poly(A) RNA binding’, had
the lowest p-value of all overrepresented GO terms and the second strongest p-value was the
more general ‘RNA binding’ (Table 6.25B). Interestingly, there were only 3 additional
observations for the more general GO term, thereby implying that UNR is involved in regulating
the expression of poly(A) binding proteins in a fairly specific way. In addition to this, the third
strongest p value for a molecular function GO term was around 3,500,000 times higher than that
for the second (i.e. 1.16x108 higher than that for ‘poly(A) RNA binding’) – further implying that
UNR may have a specific role in regulating poly(A) binding. The strongest p-value for an
overrepresented non-general GO term (taken to be a GO term with over 1000 annotated
proteins) was ‘adherens junction’ with a Bonferroni adjusted p-value of 7.66x10-7 (Table 6.25C).
This GO term had the highest fold change of any of the top 10 overrepresented cellular
component GO terms by p-value and also made the top ten overrepresented cellular component
GO terms by fold change (Table 6.25D).
These observations lead to a hypothesis whereby UNR may have a general role in suppressing
the expression of a wide array of proteins but that it could have a specific role in suppressing
the expression of proteins involved in poly(A) binding and those that localise to adherens
junctions.
6.6.7 GO term overrepresentation analysis 2: Proteins that were less abundant in
siUNR-treated U2OS cells than in equivalent control siRNA-treated U2OS cells
There were eight overrepresented biological process GO terms using the proteins down-
regulated following siUNR treatment (Table 6.26A). There were two overrepresented molecular
function GO terms (Table 6.26B). There were 14 overrepresented cellular component GO terms,
the top ten of which are presented by p-value (Table 6.26C) and by fold enrichment (Table
6.26D).
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Table 6.26: Top overrepresented GO terms associated with proteins that were higher in
abundance in unstressed control siRNA-treated U2OS cells than in unstressed
siUNR-treated U2OS cells, by p-value or fold enrichment (as stated)
A: Biological process GO terms, by p-value
GO biological process complete Ref Obs Exp FE p-value
positive regulation of ubiquitin-protein ligase
activity involved in regulation of mitotic cell
cycle transition (GO:0051437)
76 5 0.2 25.09 1.55E-02
regulation of proteolysis involved in cellular
protein catabolic process (GO:1903050) 228 7 0.6 11.71 1.91E-02
positive regulation of ubiquitin protein ligase
activity (GO:1904668) 81 5 0.21 23.54 2.11E-02
NIK/NF-kappaB signaling (GO:0038061) 85 5 0.22 22.43 2.67E-02
regulation of ubiquitin protein ligase activity
(GO:1904666) 85 5 0.22 22.43 2.67E-02
regulation of cellular protein catabolic process
(GO:1903362) 250 7 0.66 10.68 3.49E-02
positive regulation of protein ubiquitination
involved in ubiquitin-dependent protein
catabolic process (GO:2000060)
92 5 0.24 20.72 3.91E-02
positive regulation of proteolysis involved in
cellular protein catabolic process (GO:1903052) 170 6 0.45 13.46 4.85E-02
B: Molecular function GO terms, by p-value
GO molecular function complete Ref Obs Exp FE p-value
protein binding (GO:0005515) 10901 50 28.59 1.75 1.63E-06
binding (GO:0005488) 14421 52 37.82 1.37 8.43E-03
C: Cellular component GO terms, by p-value
GO cellular component complete Ref Obs Exp FE p-value
anchoring junction (GO:0070161) 702 12 1.84 6.52 2.92E-04
extracellular exosome (GO:0070062) 2735 22 7.17 3.07 7.29E-04
extracellular vesicle (GO:1903561) 2749 22 7.21 3.05 7.96E-04
extracellular organelle (GO:0043230) 2750 22 7.21 3.05 8.01E-04
proteasome complex (GO:0000502) 69 5 0.18 27.63 1.51E-03
endopeptidase complex (GO:1905369) 69 5 0.18 27.63 1.51E-03
adherens junction (GO:0005912) 684 11 1.79 6.13 1.82E-03
cytoplasm (GO:0005737) 10781 45 28.27 1.59 3.53E-03
membrane-bounded vesicle (GO:0031988) 3547 24 9.3 2.58 4.10E-03
extracellular region part (GO:0044421) 3819 25 10.02 2.5 4.12E-03
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D: Cellular component GO terms, by fold enrichment
GO cellular component complete Ref Obs Exp FE p-value
proteasome core complex (GO:0005839) 22 3 0.06 52 3.75E-02
proteasome complex (GO:0000502) 69 5 0.18 27.63 1.51E-03
endopeptidase complex (GO:1905369) 69 5 0.18 27.63 1.51E-03
peptidase complex (GO:1905368) 90 5 0.24 21.18 5.47E-03
anchoring junction (GO:0070161) 702 12 1.84 6.52 2.92E-04
adherens junction (GO:0005912) 684 11 1.79 6.13 1.82E-03
extracellular exosome (GO:0070062) 2735 22 7.17 3.07 7.29E-04
extracellular vesicle (GO:1903561) 2749 22 7.21 3.05 7.96E-04
extracellular organelle (GO:0043230) 2750 22 7.21 3.05 8.01E-04
membrane-bounded vesicle (GO:0031988) 3547 24 9.3 2.58 4.10E-03
6.6.8 Consideration of the overrepresented GO terms from proteins that were less
abundant in siUNR-treated U2OS cells than in equivalent control siRNA-
treated U2OS cells
In terms of the data entered into the GO tool, it was noted that there were fewer proteins that
had their expression lowered by siUNR treatment (55) than had it increased (100) in unstressed
U2OS cells (section 6.6.4). In HeLa, the numbers were 127 (increased on siUNR) and 104
(decreased on siUNR). It should be noted that different programs were used to analyse the two
sets of data and that different p-value cut-offs were used. In both HeLa and U2OS, the strongest
p-value for their overrepresented biological process and molecular function GO terms were
higher for proteins that decreased on siUNR treatment relative to those that increased. With
the U2OS samples, there was also a very substantial weakening of the best p-value for
overrepresented cellular component GO terms on moving from proteins that increased on
siUNR treatment to those than decreased (Tables 6.25C, 6.26C). It should be remembered that
there were approximately twice as many proteins considered significantly up-regulated by
siUNR treatment in unstressed U2OS cells (100) than proteins significantly down-regulated by
siUNR treatment (55) fed into the GO tool.
There were no strong p-values for any of the overrepresented biological process GO terms
generated using the proteins that decreased in abundance in U2OS cells following treatment
with siUNR (Table 6.26A). All of the significantly overrepresented biological process GO terms
had strong fold enrichments of over 10 (Table 6.26A). This was to be expected as there were
fewer proteins to generate a significant p-value with a small fold enrichment. Whereas the top
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hits for HeLa were generally related to oxidative phosphorylation, the top hits in unstressed
U2OS cells were more related to ubiquitin-related proteolysis (Table 6.26A). There were only
two significantly overrepresented molecular function GO terms, and those were both very
general (Table 6.26B). The strongest p-values among the overrepresented cellular component
GO terms included ‘anchoring junction’, the related ‘adherens junction’ and a set of three
related GO terms including ‘extracellular exosome’. The list also included ‘proteasome complex’,
tying in with the ubiquitin-related biological process GO terms (Table 6.26C). There were four
related cellular component GO terms with large fold enrichments over 21; these were related
to the proteasome/proteolysis (Table 6.26D). It would appear, therefore, that UNR both
promotes and suppresses the expression of proteins that localise to adherens junctions.
6.7 Analysis of data obtained from U2OS cells that were stressed with sodium arsenite
following previous treatment with siUNR or a control siRNA
As Progenesis was considered more powerful than Scaffold for protein quantification (see
chapter 4), it was decided to use Progenesis to analyse the mass spectrometry data obtained
using arsenite-stressed U2OS cell lysates. This was considered more useful than having the
stressed and unstressed samples analysed with the same program. The result of that decision is
that the analysis of the stressed U2OS sample would be considered better and direct comparison
between findings between the stressed and unstressed samples should be treated with caution.
Automatic processing of the stressed U2OS lysate samples showed that there were similar
numbers of MS peaks and MS/MS counts across the six samples, as well as similar total ion
intensities (Table 6.27).
Table 6.27: Data from Progenesis pertaining to stressed U2OS knockdown samples
Repeat knockdown MS peak count(x107)
MS/MS
count
total ion intensity
(x1010)
Day 1 siUNR 1.75 40529 1.48
Day 1 control 1.75 44478 2.04
Day 2 siUNR 1.76 39195 1.42
Day 2 control 1.76 42191 1.84
Day 3 siUNR 1.87 34883 1.44
Day 3 control 1.79 43530 2.10
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The samples were processed as for the HeLa knockdown samples (see section 6.3.3) except that,
features coming off before 25 minutes (as dirty) or after 150 minutes (as the U2OS samples were
run for 3 hours and not 4 hours) were rejected.
As with the HeLa knockdown samples, PCA analysis was carried out with and without the
removal of proteins with ANOVA p-values over 0.1 (Figure 6.8).
Figure 6.8: Progenesis-generated PCA plots for HeLa knockdown data. Proteins with all ANOVA
p-values (A) or only those with ANOVA p-values under 0.1 (B) were included. See text for further
information how the data were processed. The numbers in (B) are associated with the days upon
which the lysates were made (i.e. the repeats). Purple circles = siUNR samples (siUnr); blue
circles = control siRNA. In terms of variance accounted for – A: unrecorded, B: (PC1 = 77.46%,
PC2 = 8.17%). The grey writing in the background makes up the protein score plot (see section
4.9.2). The red writing refers to an automatically highlighted protein ID.
The PCA analysis clearly showed that the removal of the proteins with high ANOVA values was
beneficial as doing so resulted in PC1, accounting for 77.46% of the variance, clearly delineating
the control samples from the siUNR samples. When all proteins were included, the siRNA
45Chapter 6
treatment was not the main source of variation in the data (Figure 6.8). It was therefore decided
to use only those proteins with ANOVA p-values less than 0.1.
Whilst there was only one UNR peptide detected across all samples, its distribution provided
additional support to the idea that the knockdowns had been successful (Figure 6.9).
Figure 6.9: Standardised normalised abundances for a peptide assigned to UNR from the
arsenite stressed U2OS knockdown samples. The repeats in the blue column are the control
siRNA-treated samples and the repeats in the purple column are the siUNR-treated samples.
6.7.1 Detection of proteins that are differentially expressed in U2OS cells stressed
with sodium arsenite following previous treatment with either siUNR or a
control siRNA
As with the HeLa knockdown experiment, the protein abundance data was then exported to
Microsoft Excel and paired t-tests were used to find proteins that potentially have their
expression modulated by UNR. Ratios of the sum of the siUNR-treated sample abundances for
each protein to the sum of the sample abundances for the control siRNA-treated sample
abundances were also calculated. From these values, putative UNR-mediated differentially
expressed proteins were selected as those with:
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1) t-test p-value less than 0.1, higher in siUNR samples
2) t-test p-value less than 0.1, higher in control siRNA samples
3) siUNR/control siRNA ratio greater than 10
4) control siRNA/siUNR ratio greater than 10
6.7.2 Discovery of proteins with significantly different expression levels in U2OS
cells stressed with sodium arsenite following previous treatment with either
siUNR or a control siRNA
The changes in protein levels were explored in turn for each of the four groups stated in previous
sections.
1) t-test p-value less than 0.1, higher in siUNR samples
In total, there were 13 proteins that had p-values under 0.05 and higher abundances in the
siUNR-treated samples. As this was a very low number compared to the equivalent value for
HeLa, it was decided to extend the p-value cut-off to p<0.1. That gave an additional 6 hits, giving
19 in total. The top ten hits that were higher in the siUNR-treated samples, by t-test p-value, are
presented in Table 6.28.
Table 6.28: Top ten proteins whose expression is higher in arsenite stressed siUNR-treated
U2OS cells than in arsenite stressed control siRNA-treated U2OS cells, by t-test
p-value
Protein p-value
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (Fragment)
GN=NGLY1 0.000493
Carbohydrate sulfotransferase 2 GN=CHST2 0.003760
Uncharacterized protein (Fragment) 0.006895
Isoform 2 of CD166 antigen GN=ALCAM 0.008512
Peroxiredoxin-6 GN=PRDX6 0.010145
Isoform 5 of PDZ and LIM domain protein 2 GN=PDLIM2 0.015700
Protein ELFN1 GN=ELFN1 0.018046
Trinucleotide repeat-containing gene 18 protein GN=TNRC18 0.019842
Paralemmin-1 GN=PALM 0.036128
Caskin-2 GN=CASKIN2 0.037437
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2) t-test p-value less than 0.1, higher in control siRNA samples
In total, there were 68 proteins that had p-values under 0.1 and higher abundances in the control
siRNA-treated samples. The top ten hits that were higher in the control siRNA-treated samples,
by t-test p-value, are presented in Table 6.29. This shows that, unlike the situation with
unstressed HeLa and U2OS cells, there were more proteins down-regulated rather than up-
regulated following UNR knockdown in U2OS cells.
Table 6.29: Top ten proteins whose expression is higher in arsenite stressed control siRNA-
treated U2OS cells than in arsenite stressed siUNR-treated U2OS cells, by t-test
p-value
Description p-value
Caprin-1 GN=CAPRIN1 0.002978
Inorganic pyrophosphatase GN=PPA1 0.006884
Cold shock domain-containing protein E1 GN=CSDE1 0.007902
Syntaxin-12 GN=STX12 0.008339
Signal recognition particle 14 kDa protein GN=SRP14 0.009660
Glutathione S-transferase omega-1 (Fragment) GN=GSTO1 0.010657
Isoform 2 of Protein enabled homolog GN=ENAH 0.011367
Pumilio homolog 2 GN=PUM2 0.013507
PDZ and LIM domain protein 5 GN=PDLIM5 0.014547
DNA fragmentation factor subunit alpha GN=DFFA 0.014795
3) siUNR/control siRNA ratio greater than 10
No proteins were considered significant on the grounds of having siUNR/control siRNA
abundance ratios above 10:1. The highest ratio was 1.8:1 for Trinucleotide repeat-containing
gene 18 protein (GN=TNRC18).
4) control siRNA/siUNR ratio greater than 10
18 proteins were considered significant on the grounds of having control siRNA/siUNR
abundance ratios above 10:1. These were largely ribosomal proteins. The top ten by ratio are
presented in Table 6.30. It was noted that proteins that are down-regulated following siUNR
treatment are down-regulated by a greater degree than those that are up-regulated.
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Table 6.30: Top ten proteins whose expression is higher in arsenite stressed control siRNA-
treated U2OS cells than in arsenite stressed siUNR-treated U2OS cells, by fold
enrichment
Description p-value control siRNA/siUNR
40S ribosomal protein S29 GN=RPS29 0.2968 4690811
Alanine--tRNA ligase, cytoplasmic GN=AARS 0.3304 62.99
60S ribosomal protein L27 GN=RPL27 0.3440 57.62
40S ribosomal protein S13 GN=RPS13 0.3146 31.05
60S ribosomal protein L10 GN=RPL10 0.3560 28.20
60S ribosomal protein L27a GN=RPL27A 0.3450 25.02
60S ribosomal protein L34 GN=RPL34 0.3478 23.33
60S ribosomal protein L8 GN=RPL8 0.3354 21.00
40S ribosomal protein S17 GN=RPS17 0.3180 19.45
60S ribosomal protein L18a GN=RPL18A 0.3568 19.06
6.8 GO-term overrepresentation analyses using proteins differentially expressed in
sodium arsenite-treated U2OS cells that had previously been treated with either
siUNR or control siRNA
In order to carry out GO term analyses on the arsenite stressed U2OS knockdown data, the
proteins that were statistically up-regulated by siUNR treatment were used alone whereas the
down-regulated proteins were merged with those that had were present in the control siRNA
sample at a level at least ten times greater than that in the siUNR samples.
6.8.1 GO-term overrepresentation analysis on proteins that were more abundant in
siUNR-treated U2OS cells, that were subsequently treated with sodium
arsenite, than in equivalent control siRNA-treated U2OS cells
The 19 proteins that were significantly more abundant in the siUNR-treated samples were fed
into the GO tool at http://amigo.geneontology.org/rte which recognised all of them. The list, as
used, is presented in Table 6.31.
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Table 6.31: Gene names of proteins higher in abundance in arsenite stressed siUNR-treated
U2OS cells than in arsenite stressed control siRNA-treated U2OS cells
ALCAM CHST2 H7C0S8 PALM RAPGEF3
BBX CNN1 KNSTRN PDLIM2 TM4SF1
CALD1 DNMT1 NGLY1 PRDX6 TNRC18
CASKIN2 ELFN1 NLRP10 PTK2B
There were no enriched Biological Process or Molecular Function GO terms using proteins up-
regulated following siUNR treatment in arsenite stressed U2OS cells. There were four
significantly enriched cellular component GO terms (Table 6.32).
Table 6.32: Overrepresented cellular component GO terms associated with proteins that
were higher in abundance in arsenite stressed siUNR-treated U2OS cells than in
arsenite stressed control siRNA-treated U2OS cells, by p-value
GO cellular component complete Ref Obs Exp FE p-value
adherens junction (GO:0005912) 684 6 0.62 9.68 2.92E-02
anchoring junction (GO:0070161) 702 6 0.64 9.43 3.38E-02
cortical actin cytoskeleton (GO:0030864) 65 3 0.06 50.94 3.59E-02
somatodendritic compartment (GO:0036477) 720 6 0.65 9.2 3.90E-02
6.8.2 Consideration of GO term analysis on proteins that were more abundant in
siUNR-treated U2OS cells, that were subsequently treated with sodium
arsenite, than in equivalent control siRNA-treated U2OS cells
The low number of proteins that significantly increased in abundance following siUNR treatment
was presumably responsible for the lack of Bonferroni-corrected significant biological process
or molecular function GO terms. It was interesting that ‘adherens junction’ was the top cellular
component hit. It would appear that UNR is strongly associated with the expression levels of
proteins found at adherens junctions.
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6.8.3 GO-term overrepresentation analysis on proteins that were less abundant in
siUNR-treated U2OS cells, that were subsequently treated with sodium
arsenite, than in equivalent control siRNA-treated U2OS cells
The proteins considered significantly down-regulated by p-value and fold change following
siUNR treatment were listed by gene name and any duplicate values were removed. These were
then initially fed into the GO tool at http://amigo.geneontology.org/rte. That returned two
genes with multiple entries. Acceptable Uniprot identifiers were obtained for those genes and
were used to replace them. The gene/protein list was re-entered into the GO tool. One protein
retained multiple entries, this time for two genes. As the two genes encoded the same protein,
the protein was retained in the list. That 86 entry list, as used, is presented in Table 6.33.
Table 6.33: Gene/protein list corresponding to proteins down-regulated on siUNR
treatment
AARS CLIC1 KPNA2 PPP1R13L RPL36AL TJP2
ACTR2 CSDE1 LAP3 PRRC2A RPL8 TK1
AIMP1 CYR61 LETM2 PTPN12 RPP30 TLK1
ANXA5 DFFA LIMD1 PUM2 RPS13 TUBA1B
ARF4 DHRS2 LRRFIP1 Q13748 RPS17 TUBA1C
ARPC1B DYNLL2 MCCC2 Q99575 RPS27 TUBB2A
ATP6V1G1 EEF1D MED15 RAB29 RPS29 TUBB4B
BOD1L1 EFTUD2 NAP1L1 RPL10 RPS4X TUBB6
C11orf98 EIF2S2 NCOA3 RPL13A RPSA UBE2A
C1orf122 ENAH NLRP8 RPL18A SEPHS2 YWHAB
CAPRIN1 ERH NOP56 RPL27 SRP14 YWHAZ
CAPZB FAM103A1 NPM3 RPL27A STX12
CDK14 GOLM1 NUMB RPL32 SUPT5H
CDKN2AIPNL GSTO1 PDLIM5 RPL34 TAF7
CKAP2L IARS2 PPA1 RPL36A TCERG1
1) Enriched Biological Process GO terms using proteins down-regulated following siUNR
treatment in U2OS cells that were subsequently treated with sodium arsenite
There were 85 significantly overrepresented biological process GO terms among the proteins
down-regulated by siUNR treatment. The top ten over-represented GO terms by p-value are
presented in Table 6.34 and the top ten by fold enrichment in Table 6.35.
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Table 6.34: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by p-value
GO biological process complete Ref Obs Exp FE p-value
SRP-dependent cotranslational protein
targeting to membrane (GO:0006614) 95 16 0.39 40.6 2.28E-17
protein targeting to ER (GO:0045047) 101 16 0.42 38.19 5.96E-17
cotranslational protein targeting to
membrane (GO:0006613) 103 16 0.43 37.45 8.11E-17
establishment of protein localization to
endoplasmic reticulum (GO:0072599) 105 16 0.44 36.73 1.10E-16
translation (GO:0006412) 455 24 1.89 12.72 4.47E-16
multi-organism metabolic process
(GO:0044033) 145 17 0.6 28.26 4.89E-16
peptide biosynthetic process (GO:0043043) 479 24 1.99 12.08 1.43E-15
protein localization to endoplasmic
reticulum (GO:0070972) 125 16 0.52 30.86 1.67E-15
peptide metabolic process (GO:0006518) 625 26 2.59 10.03 3.10E-15
viral transcription (GO:0019083) 115 15 0.48 31.44 1.84E-14
Table 6.35: Top ten overrepresented biological process GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by fold enrichment
GO biological process complete Ref Obs Exp FE p-value
SRP-dependent cotranslational protein
targeting to membrane (GO:0006614) 95 16 0.39 40.6 2.28E-17
protein targeting to ER (GO:0045047) 101 16 0.42 38.19 5.96E-17
cotranslational protein targeting to membrane
(GO:0006613) 103 16 0.43 37.45 8.11E-17
establishment of protein localization to
endoplasmic reticulum (GO:0072599) 105 16 0.44 36.73 1.10E-16
viral transcription (GO:0019083) 115 15 0.48 31.44 1.84E-14
protein localization to endoplasmic reticulum
(GO:0070972) 125 16 0.52 30.86 1.67E-15
nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay (GO:0000184) 119 15 0.49 30.39 3.03E-14
viral gene expression (GO:0019080) 126 15 0.52 28.7 6.98E-14
multi-organism metabolic process
(GO:0044033) 145 17 0.6 28.26 4.89E-16
translational initiation (GO:0006413) 154 16 0.64 25.04 4.29E-14
protein targeting to membrane (GO:0006612) 164 16 0.68 23.52 1.14E-13
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2) Enriched Molecular Function GO terms using proteins down-regulated following
siUNR treatment in U2OS cells that were subsequently treated with sodium
arsenite
There were 16 significantly overrepresented molecular function GO terms among the proteins
down-regulated by siUNR treatment. The top ten over-represented GO terms by p-value are
presented in Table 6.36 and the top ten by fold enrichment in Table 6.37.
Table 6.36: Top ten overrepresented molecular function GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by p-value
GO molecular function complete Ref Obs Exp FE p-value
RNA binding (GO:0003723) 1631 39 6.77 5.76 2.79E-17
poly(A) RNA binding (GO:0044822) 1168 31 4.85 6.4 5.69E-14
structural constituent of ribosome (GO:0003735) 226 16 0.94 17.07 5.06E-12
structural molecule activity (GO:0005198) 784 24 3.25 7.38 2.54E-11
heterocyclic compound binding (GO:1901363) 5953 55 24.7 2.23 4.12E-08
organic cyclic compound binding (GO:0097159) 6037 55 25.04 2.2 7.49E-08
cadherin binding involved in cell-cell adhesion
(GO:0098641) 277 12 1.15 10.44 5.32E-06
protein binding involved in cell-cell adhesion
(GO:0098632) 287 12 1.19 10.08 7.87E-06
protein binding involved in cell adhesion
(GO:0098631) 292 12 1.21 9.91 9.53E-06
cadherin binding (GO:0045296) 295 12 1.22 9.81 1.07E-05
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Table 6.37: Top ten overrepresented molecular function GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by fold enrichment
GO molecular function complete Ref Obs Exp FE p-value
structural constituent of cytoskeleton
(GO:0005200) 109 8 0.45 17.69 5.75E-05
structural constituent of ribosome (GO:0003735) 226 16 0.94 17.07 5.06E-12
cadherin binding involved in cell-cell adhesion
(GO:0098641) 277 12 1.15 10.44 5.32E-06
protein binding involved in cell-cell adhesion
(GO:0098632) 287 12 1.19 10.08 7.87E-06
protein binding involved in cell adhesion
(GO:0098631) 292 12 1.21 9.91 9.53E-06
cadherin binding (GO:0045296) 295 12 1.22 9.81 1.07E-05
GTPase activity (GO:0003924) 233 9 0.97 9.31 1.61E-03
structural molecule activity (GO:0005198) 784 24 3.25 7.38 2.54E-11
cell adhesion molecule binding (GO:0050839) 456 13 1.89 6.87 1.47E-04
poly(A) RNA binding (GO:0044822) 1168 31 4.85 6.4 5.69E-14
3) Enriched Cellular component GO terms using proteins down-regulated following siUNR
treatment in U2OS cells that were subsequently treated with sodium arsenite
There were 46 significantly overrepresented cellular component GO terms among the proteins
down-regulated by siUNR treatment. The top ten over-represented GO terms by p-value are
presented in Table 6.38 and the top ten by fold enrichment in Table 6.39.
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Table 6.38: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by p-value
GO cellular component complete Ref Obs Exp FE p-value
cytosolic ribosome (GO:0022626) 122 16 0.51 31.61 1.78E-16
adherens junction (GO:0005912) 684 26 2.84 9.16 4.25E-15
anchoring junction (GO:0070161) 702 26 2.91 8.93 7.93E-15
ribosomal subunit (GO:0044391) 174 16 0.72 22.17 4.42E-14
cytosolic part (GO:0044445) 243 17 1.01 16.86 3.62E-13
cytosol (GO:0005829) 3487 48 14.47 3.32 4.21E-13
intracellular ribonucleoprotein complex
(GO:0030529) 775 24 3.22 7.47 9.60E-12
ribonucleoprotein complex (GO:1990904) 776 24 3.22 7.46 9.87E-12
ribosome (GO:0005840) 252 16 1.05 15.31 1.29E-11
intracellular non-membrane-bounded organelle
(GO:0043232) 3990 47 16.55 2.84 4.64E-10
Table 6.39: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells, by fold enrichment
GO cellular component complete Ref Obs Exp FE p-value
cytosolic large ribosomal subunit (GO:0022625) 68 10 0.28 35.45 5.29E-10
cytosolic small ribosomal subunit (GO:0022627) 45 6 0.19 32.14 5.48E-05
cytosolic ribosome (GO:0022626) 122 16 0.51 31.61 1.78E-16
large ribosomal subunit (GO:0015934) 104 10 0.43 23.18 3.28E-08
ribosomal subunit (GO:0044391) 174 16 0.72 22.17 4.42E-14
small ribosomal subunit (GO:0015935) 70 6 0.29 20.66 7.15E-04
cytosolic part (GO:0044445) 243 17 1.01 16.86 3.62E-13
ribosome (GO:0005840) 252 16 1.05 15.31 1.29E-11
focal adhesion (GO:0005925) 393 17 1.63 10.43 7.95E-10
cell-substrate adherens junction (GO:0005924) 396 17 1.64 10.35 8.96E-10
6.8.4 Consideration of GO term analysis on proteins that were less abundant in
siUNR-treated U2OS cells, that were subsequently treated with sodium
arsenite, than in equivalent control siRNA-treated U2OS cells
The first observation regarding the overrepresented GO terms was that, whilst the number of
significant GO terms in each group was quite different (biological process = 85, molecular
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function = 16, cellular component = 46), the strongest p-value from each group was quite similar
(biological process = 2.28x10-17, molecular function = 2.79x10-17 with cellular component being
slightly higher = 1.78x10-16).
In terms of the most significantly overrepresented biological process GO terms, an initial
observation was that one of the top ten by p-value (Table 6.34) and two of the top ten by fold
enrichment (Table 6.35) were to do with viral gene expression. This is in contrast to the
unstressed HeLa samples that had significant virus-related GO terms located using proteins that
were more abundant in siUNR-treated samples. A group of proteins generated four closely
related significant biological process GO terms that implied that UNR knockdown resulted in a
reduction of expression of proteins involved in signal recognition particle (SRP)-dependent
cotranslational protein targeting to the endoplasmic reticulum. This would imply that UNR
would normally increase or maintain the expression of those proteins in the presence of arsenite
stress. Whilst the composition changes between eukaryotes, eubacteria and archaea, the
general ribonucleoprotein SRP complex is ubiquitous in nature (Luirink & Sinning 2004). Given
the conserved nature of the SRP complex, it would be interesting to see if this observation could
be repeated in other animals, such as Drosophila melanogaster. The next most significantly
overrepresented GO term by p-value was ‘translation’. The reduction of proteins involved in
translation on arsenite treatment of siUNR-treated cells relative to arsenite treated control
siRNA-treated cells suggests that UNR could increase or maintain translation under arsenite
stress. This would offer a mechanism by which UNR could mediate the cellular response to
oxidative stress. The top two overrepresented molecular function GO terms by p-value among
proteins up-regulated by siUNR treatment in unstressed U2OS cells were ‘poly(A) RNA binding’
and ‘RNA binding’ (section 6.6.6). This was not observed when the cells were stressed prior to
harvesting (section 6.8.1). Interestingly, the same two GO terms were the top two among
proteins down-regulated in siUNR-treated U2OS cells that were stressed prior to harvesting
(Table 6.36). Indeed, the p-values were even stronger. Another top hit by p-value (Table 6.36)
and fold enrichment (Table 6.35) was ‘structural component of the ribosome’. Ribosome-related
GO terms were among the most significant overrepresented cellular component GO terms, both
by p-value (Table 6.38) and fold enrichment (Table 6.39). Indeed, the strongest p-value was for
‘cytosolic ribosome’. The second strongest p-value (p = 4.25x10-15) was for ‘adherens junction’,
reinforcing the idea that UNR is intimately involved in regulation of protein levels at adherens
junctions (Table 6.38).
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6.9 Cellular Component GO-term overrepresentation analysis revisited for proteins that
were less abundant in siUNR-treated U2OS cells, that were subsequently treated with
sodium arsenite, than in equivalent control siRNA-treated U2OS cells
It seemed clear that the list of proteins down-regulated on siUNR treatment was likely to contain
a lot of true positives. This assumption was based on the GO term analysis; if the proteins had
largely been random false positives, it would be extremely unlikely that they would generate
such strong p-values. This point was particularly important as the analysis as a whole was based
upon the GO term analysis being a safety net against the acceptance of a large number of false
positives as multiple testing correction was not possible at the earlier significance-detection
stage of the analysis.
As a test of the assumption that the significance detection level was adequately stringent,
accepting more hits by loosening the stringency should strengthen the overrepresented GO-
term p-values. Should the overrepresented GO-term p-values weaken upon the addition of the
additional proteins, it would imply that the p-value cut-offs had been too liberal and that would
be less positive in terms of confidence in the overall analysis.
To do this, the protein universe that was used to detect significant proteins based on their t-test
p-values and abundance ratios was expanded to include proteins with any ANOVA value. If this
method produced more putative significant proteins and also stronger p-values for specific
overrepresented GO terms, with particular reference to the recurrent ‘adherens junction’
cellular component GO term, that would strongly imply that most hits were likely to be true
positives and that more true positives were excluded by the original detection criteria.
To avoid repeating the entire analysis, the new protein list is presented below (Table 6.40) and
then used exclusively for cellular component overrepresentation GO term analysis (Table 6.41).
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Table 6.40: Gene list corresponding to proteins that are higher in arsenite stressed control
siRNA-treated U2OS cells over arsenite stressed siUNR-treated U2OS cells
AARS CDK14 FUS NCOA3 PTK2B RPL9 SPECC1L ZDHHC5
ACTN2 CDKN2AIPNL GNG5 NEB PTPN12 RPP30 SRP14 ZFYVE27
ACTR2 CHAMP1 GOLM1 NGLY1 PUF60 RPS11 STX12
ACTR3 CHST2 GPBP1 NLRP10 PUM2 RPS13 SULF2
ADD1 CKAP2L GSPT1 NLRP8 RAB29 RPS14 SUPT5H
AGFG1 CLIC1 GSTO1 NOL8 RAPGEF3 RPS15 SZRD1
AIF1L CLSPN H7C0S8 NOP56 RFC1 RPS15A TAF7
AIMP1 CNN1 HBA1 NPM1 RFX1 RPS17 TCERG1
AKAP2 CSDE1 HBD NPM3 RNMT RPS18 TJP2
ALCAM CYR61 HDAC6 NR3C1 RPL10 RPS2 TK1
ALDH3A2 DDX17 HINT2 NUDT1 RPL10A RPS23 TLK1
ANXA5 DDX3X IARS2 NUMB RPL11 RPS24 TM4SF1
ANXA6 DFFA IL17RA NUMBL RPL12 RPS26 TMEM154
APEX1 DHRS2 IMMT NUSAP1 RPL13A RPS27 TNRC18
APOE DNMT1 KAT7 PA2G4 RPL15 RPS29 TNRC6B
ARF4 DPY30 KHSRP PALM RPL18A RPS3 TOMM34
ARID1A DYNLL2 KNSTRN PALM3 RPL21 RPS3A TPD52L2
ARPC1B ECHDC1 KPNA2 PDLIM2 RPL22 RPS4X TSPAN31
ATP6V1G1 EEF1D LAP3 PDLIM5 RPL27 RPS8 TSPAN4
BBX EEF2 LEPRE1 PHGDH RPL27A RPS9 TUBA1B
BOD1L1 EFTUD2 LETM2 POLR2G RPL28 RPSA TUBA1C
C11orf98 EIF1AD LIMD1 POP1 RPL30 RSRC2 TUBA3C
C1orf122 EIF2S2 LRRFIP1 PPA1 RPL32 RTCB TUBB2A
C8orf88 EIF4A1 M6PR PPA2 RPL34 S100A11 TUBB4B
CALD1 EIF4EBP1 MBOAT7 PPP1R13L RPL36 SACM1L TUBB6
CAP1 ELFN1 MCCC2 PPP1R14B RPL36A SEC11A UBE2A
CAPRIN1 ENAH MCM3 PQBP1 RPL36AL SEPHS2 USO1
CAPZA1 ERBB2IP MED15 PRDX6 RPL37A SGOL2 WBP11
CAPZB ERH MEF2D PRMT5 RPL6 SLC4A1 WDR5
CASKIN2 ERLIN2 MTCH1 PRRC2A RPL7 SMARCAL1 XRN2
CD3EAP EXTL2 MYADM PSMD4 RPL7A SNW1 YWHAB
CD81 FAM103A1 NAP1L1 PTGES3 RPL8 SPATA20 YWHAZ
It was considered useful here to make one brief technical observation concerning nucleolar
protein 8 (NOL8). There is a well-publicised and on-going problem with Microsoft Excel
converting gene names into dates (Zeeberg et al. 2004; Ziemann et al. 2016). Whilst it is hoped
that no errors survived proof-reading, this issue was a problem for the author in processing RNA
data for chapter 5 whilst using an English language MacBook Pro. This current chapter was
written on a Windows computer that is set up in the author’s first national language, Gae ilg e
(Irish). It was noted that Microsoft Excel converted NOL8 into a date (Nollaig being the Irish
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word for Christmas and mí na Nollag being the month of Christmas [i.e. December]). It is
therefore likely to be the case that the problem with Excel is universal and that papers, whilst
they may be written in English, may have different errors in them based on the language of
choice of the authors. As was the case in chapter 5, it is hoped that any Microsoft Excel-induced
errors were located and rectified prior to the use of the GO tool. This was, in fact, a main reason
why it was decided to include every gene name exactly how it was entered into the GO tool in
this chapter.
Table 6.41: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells without exclusions
based on ANOVA p-value, by p-value
GO cellular component complete Ref Obs Exp FE p-value
cytosolic ribosome (GO:0022626) 122 45 1.36 33.2 3.43E-50
ribosomal subunit (GO:0044391) 174 45 1.93 23.28 1.88E-43
adherens junction (GO:0005912) 684 68 7.6 8.95 3.48E-41
anchoring junction (GO:0070161) 702 68 7.8 8.72 1.76E-40
cytosolic part (GO:0044445) 243 47 2.7 17.41 7.67E-40
ribosome (GO:0005840) 252 47 2.8 16.79 3.92E-39
intracellular ribonucleoprotein complex
(GO:0030529) 775 66 8.61 7.67 9.17E-36
ribonucleoprotein complex (GO:1990904) 776 66 8.62 7.66 9.91E-36
cell-substrate junction (GO:0030055) 400 50 4.44 11.25 1.13E-33
focal adhesion (GO:0005925) 393 49 4.37 11.22 7.08E-33
Whilst this was reassuring and implied that the analysis was sound, it was decided to undertake
an additional analysis using the addition of extra proteins that were not considered significant
to the 86 original hits (Table 6.33). It was hypothesised that the p-values for the overrepresented
GO terms should become weaker as a result of the addition of non-significant proteins. It was
decided to add the same number of additional proteins as was added following the widening of
the selection universe (140). These were selected as the 140 least significant proteins by t-test
p-value (either higher or lower in the arsenite-stressed siUNR-treated U2OS samples) when
duplicated gene names were removed. Those 140 proteins (Table 6.42) were added to the 86
proteins previously accepted as being significantly down-regulated in arsenite-stressed siUNR-
treated U2OS cells over arsenite-stressed control siRNA-treated U2OS cells (Table 6.33) and
were fed into the GO tool to look for overrepresented cellular component GO-terms, the top
ten of which by Bonferroni-adjusted p-value are presented in Table 6.43.
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Table 6.42: List of non-significant genes/proteins added as a negative control to proteins
that were significantly less abundant in arsenite-stressed siUNR-treated U2OS
cells than in arsenite-stressed control siRNA-treated U2OS cells
ACBD5 CNN3 FKBP2 LAMC1 NUPL1 PUM2 SUOX
ACP2 COPS3 FTH1 LAMP1 ORC2 Q9UK23 TERF2
AHCY COPS8 FXN LDHA P20290 Q9UPQ9 TGOLN2
AIMP1 CT45A9 GIGYF2 LGALS3 P28062 RAB10 TIPIN
AJUBA CTTN GNG2 LMAN2 P29692 RAB1B TMEM106B
ALDOC CYB5A GOLIM4 LSM4 P40855 RAB7A TMEM263
APOA1BP DAD1 GPHN LZIC PCM1 RAD23B TNFRSF12A
ARID2 DDA1 GPRIN1 MMTAG2 PCNP RDX TPM1
ARPC4-TTLL3 DIDO1 GPX1 MSN PDLIM4 RLTPR TPM3
BOLA3 DLST HLA-A MT-ATP8 PHB RPS28 TSSC4
BPTF DNASE2 HLA-B MYL12B PHF3 RRM2B UBQLN4
C14orf119 DYNLL1 HMGB1 NACC1 PITHD1 SCAMP3 UBXN1
C9orf78 DYNLL2 HMGB3 NAPG PKN2 SCPEP1 UQCRFS1
CCDC43 EIF2B4 HSPE1 NDUFV2 PPIF SFPQ VAPA
CD81 EMC6 HYPK NFIC PPP2CA SGTB VBP1
CFL1 ENG ICT1 NME1 PPP4R2 SLC1A5 VKORC1L1
CFL2 ENO2 INIP NME2 PRDX4 SMIM12 VTI1A
CHMP2B ENSA ITGA6 NUMA1 PRRC2A SNAPIN WARS
CNDP2 FAM192A ITGB1 NUP50 PSMB7 SPTBN4 WNK1
CNN1 FBN2 KTN1 NUP62 PSMD9 STOML2 YWHAZ
Table 6.43: Top ten overrepresented cellular component GO terms associated with proteins
that were higher in abundance in arsenite stressed control siRNA-treated U2OS
cells than in arsenite stressed siUNR-treated U2OS cells with 140 non-significant
proteins added as a negative control
GO cellular component complete REF OBS EXP FE p value
adherens junction (GO:0005912) 684 48 7.37 6.51 6.52E-22
anchoring junction (GO:0070161) 702 48 7.56 6.35 1.94E-21
extracellular exosome (GO:0070062) 2735 88 29.47 2.99 2.21E-19
extracellular vesicle (GO:1903561) 2749 88 29.62 2.97 3.12E-19
extracellular organelle (GO:0043230) 2750 88 29.63 2.97 3.20E-19
intracellular organelle (GO:0043229) 11822 192 127.4 1.51 4.08E-17
cytoplasm (GO:0005737) 10799 182 116.37 1.56 1.44E-16
macromolecular complex (GO:0032991) 4876 114 52.55 2.17 8.25E-16
extracellular region part (GO:0044421) 3825 99 41.22 2.4 9.81E-16
focal adhesion (GO:0005925) 393 32 4.24 7.56 1.61E-15
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As expected, the p-values were lower than those that had been observed with the addition of
proteins that were presumed to be significantly higher in abundance in arsenite-stressed control
siRNA-treated U2OS cells than in unstressed siUNR-treated U2OS cells (Tables 6.41, 6.43). To
compare the effect of widening the protein universe to accept additional significant proteins or
adding additional non-significant proteins, it was decided to look at the top ten overrepresented
cellular component GO-terms listed in Table 6.38. The fold enrichment values and p-values for
each of the ten GO terms was then listed alongside the equivalent values where additional
significant or non-significant proteins had been added (Table 6.44).
Table 6.44: Fold enrichment and p-value data for the top ten overrepresented cellular
component GO terms associated with proteins that were higher in abundance
in arsenite stressed control siRNA-treated U2OS cells than in arsenite stressed
siUNR-treated U2OS cells, by p-value, with the addition of additional significant
proteins (green), additional non-significant proteins (orange) or without any
additional proteins (yellow)
Original + significant + non-significant
GO cellular component complete FE p-value FE p-value FE p-value
cytosolic ribosome (GO:0022626) 31.61 1.78E-16 33.2 3.43E-50 12.93 6.50E-11
adherens junction (GO:0005912) 9.16 4.25E-15 8.95 3.48E-41 6.51 6.52E-22
anchoring junction (GO:0070161) 8.93 7.93E-15 8.72 1.76E-40 6.35 1.94E-21
ribosomal subunit (GO:0044391) 22.17 4.42E-14 23.28 1.88E-43 9.60 1.61E-09
cytosolic part (GO:0044445) 16.86 3.62E-13 17.41 7.67E-40 8.44 6.01E-11
cytosol (GO:0005829) 3.32 4.21E-13 2.74 1.13E-21 2.47 3.20E-15
intracellular ribonucleoprotein
complex (GO:0030529) 7.47 9.60E-12 7.67 9.17E-36 3.83 1.33E-07
ribonucleoprotein complex
(GO:1990904) 7.46 9.87E-12 7.66 9.91E-36 3.83 1.37E-07
ribosome (GO:0005840) 15.31 1.29E-11 16.79 3.92E-39 6.63 6.06E-07
intracellular non-membrane-
bounded organelle (GO:0043232) 2.84 4.64E-10 2.80 3.21E-28 2.07 1.53E-09
This showed that, for every GO term presented, the addition of the additional significant genes
led to similar fold enrichments and p-values that were much stronger, by more than ten orders
of magnitude for nine of the ten GO terms and by more than 20 orders of magnitude for eight
of the ten (Table 6.44). These observations strongly support the suggestion that the significance
detection criteria were stringent and that the observed hits are likely to be heavily populated
with true positives. They also lend support to the idea that UNR may selectively modulate the
expression of groups of proteins that are annotated to the GO terms that have been shown to
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be overrepresented throughout this chapter. The addition of non-significant proteins, however,
led to lower fold enrichments for all of the ten GO terms and weaker p-values for seven of the
ten. This strongly supports the idea that the additional putative significant proteins were
independently rich in true positives and that the putative non-significant proteins were indeed
rich in false positives.
6.9.1 Consideration of GO term analysis with additional proteins
The observation that the p-values got better when more significant proteins were included was
extremely reassuring as to the validity of the analysis. It should be noted that removal of proteins
with high ANOVA p-values greatly improved the PCA analysis. It should also be noted, however,
that ANOVA over two groups is similar to a t-test and, whilst paired t-tests ask a different
question of groups of data to standard t-tests, it would nevertheless be expected that the paired
t-tests alone would have led to a great improvement in the PCA analysis should that method
have been offered by the Progenesis software.
6.10 Chapter summary
The chapter set out to explore the effect of knocking down UNR on protein expression under
different conditions. The decision was made to use Progenesis or Scaffold to quantify mass
spectrometry data and calculate an ANOVA p-value for each protein. Proteins with ANOVA p-
values over 0.1 were excluded and paired t-tests were then carried out on the remaining
proteins. Unfortunately, no individual proteins were particularly significant and none would
have passed a multiple testing correction in which the total number of possible proteins (for
example, 20000) was multiplied by the t-test p-value. The strongest p-value across all conditions
was for prohibitin which was lower in siUNR treated HeLa cells than in control siRNA treated
HeLa cells (p-value = 5.8x10-6). Multiplying that p-value by 20,000 would just miss the p=0.1 cut
off (adjusted p = 0.116). It was decided to add in proteins that either increased or decreased at
least ten-fold on siUNR treatment, irrespective of their t-test p-value.
As the individual significant proteins were dubious as they would not pass a multiple testing
correction, it was decided to use the Bonferroni multiple testing correction in GO term
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overrepresentation analysis. It was assumed that, if the proteins were generally true hits, there
may be some strong and reproducible overrepresented GO terms. If they were mainly random
false positives, they would be unlikely to generate reproducible overrepresented GO terms with
strong p-values. Many significantly overrepresented GO terms were found, including a number
with very strong p-values. Some of these GO terms were reproducible between HeLa and U2OS
and between arsenite stressed U2OS and unstressed U2OS. These observations led to the
assumption that the methodology, as used, was sound.
One of the strongest and most reproducible GO terms was the molecular function GO term
‘poly(A) RNA binding’ which was a significant hit for the proteins that either increased or
decreased on siUNR treatment of HeLa cells, as well as those that increased on siUNR treatment
in unstressed U2OS cells or those that decreased on siUNR treatment in arsenite stressed U2OS
cells. Possible the most reproducible of all the overrepresented GO terms was the cellular
component GO term ‘adherens junction’. This was significant in proteins that increased or
decreased in both arsenite stressed and unstressed U2OS cells. It was also significant among
proteins that increased following siUNR treatment in HeLa cells.
Having been satisfied that the methodology was adequate to locate differentially expressed
proteins, it was then decided to see if it would be possible to find as many significant GO terms
using extra proteins obtained by carrying out t-tests on all proteins, including those with ANOVA
p-values greater than 0.1. This was tested using proteins that decreased in arsenite stressed
siUNR-treated U2OS cells compared to arsenite stressed control siRNA-treated U2OS cells and
looking at cellular component GO terms. This greatly improved the strength of the p-values (e.g.
‘adherens junction’ went from a Bonferroni-adjusted p-value of 4.25x10-15 to a Bonferroni-
adjusted p-value of 3.48x10-41). This observation provided even greater confidence in the results
already obtained having excluded all proteins with ANOVA p-values over 0.1.
These results, as a minimum, support the claim that UNR modulates the expression of proteins
involved in poly(A) binding and proteins that are localised to adherens junctions.
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7 Summary and conclusions
The idea that there are two UNR genes in humans was suggested by Jeffers et al. (1990). No
subsequent evidence was forthcoming to substantiate that claim. It was shown here that a
region on Chromosome 10 had a similar degree of identity to Jeffers’ probe as did the equivalent
region on chromosome 1 that overlapped the human UNR gene. It is suggested here that Jeffers
had mistakenly inferred that the region on chromosome 10 was a second UNR gene (section
1.1.5). A search of the human genome failed to locate a second UNR gene but did locate a
previously discovered partial processed pseudogene of UNR on chromosome 5 (over 600 base
pairs) and a stretch of over 300 base pairs on chromosome 7 that was almost 90% identical to
part of the UNR gene that encodes a single exon (section 1.1.5).
It was noted that a disproportionately high number of arginine residues from the UNR protein
are recorded as having at least one non-silent mutation in the COSMIC database (section 1.6.1).
Whilst it is not a novel finding, per se, the homemade ECL solution recipes stated in section 2.2.7
offer other labs the potential to save money compared to buying commercial ECL solutions.
Whilst some optimisation was carried out within the lab, most credit is due to Dr Andrew Turnell
for the suggestion and to Haan & Behrmann (2007) for the original research.
It was shown that UNR levels fall in cultured HeLa cells as they become more confluent (section
3.1.3) but this relationship is reversed in cultured U2OS cells (section 3.3.2).
It was shown that UNR and TP53 colocalise within stress granules in HeLa cells at one or two
hours post-treatment with 1 mM sodium arsenite (section 3.1.6).
UNR levels were shown to be lower in 50%- or 70%-confluent U2OS cells that had been treated
with 1 mM sodium arsenite for one hour compared to similar cells that were mock-treated with
sterile PBS. This mirrored a similar reduction in TP53 levels (section 3.3.2).
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Among the most reproducible novel UNR-interacting proteins discovered by RIP-mass
spectrometry were the ubiquitin E3 ligase, HUWE1; the nucleolar protein, NARR; the
multifunctional protein, SQSTM1; and the erythropoiesis-related protein, LDB1. Of these,
HUWE1 was validated by Western blot and immunofluorescence microscopy and SQSTM1 was
validated by Western blot. Each of these proteins would be interesting topics of future research.
HUWE1 targets proteins involved in many processes, including cellular proliferation (e.g. MYC,
which represses UNR transcription and has its own translation promoted by UNR) and promotes
restart at stalled replication forks (Choe et al. 2016). Whilst the functional purpose of an
interaction between UNR and HUWE1 is currently unknown, it is possible that UNR modulates
HUWE1 function. Among other things, this would add an additional layer of complexity to the
UNR-MYC relationship. As discussed below, UNR appears to regulate protein expression on
multiple levels. It is further possible that interaction between UNR and a ubiquitin E3 ligase, such
as HUWE1, could implicate UNR in protein turnover. Little work has been published on the NARR
protein, which is the product of an alternative reading frame of an alternatively spliced RAB34
transcript. It has been shown to be a nucleolar protein that is heavily phosphorylated during M
phase (Zougman et al. 2011). UNR levels spike during M phase and this has been linked to the
control of the cell cycle. It would be interesting to see if NARR and UNR play a joint role in the
regulation of mitosis. SQSTM1 was shown to be involved in a number of interesting physiological
pathways and pathologies, including autophagy (Katsuragi et al. 2015), tumour metastasis
(Qiang et al. 2014) and Alzheimer’s disease (Salminen et al. 2012). As UNR has also been
reported to influence many of the same pathways as SQSTM1, it would be interesting to
investigate whether or not the UNR-SQSTM1 interaction is important in respect to these
processes. LDB1 has been shown to be involved in insulin expression (Hunter et al. 2013) and
erythropoiesis (Li et al. 2010). UNR was shown to be differentially expressed in patients with
uncontrolled diabetes (Xavier et al. 2014) and work by the von Lindern group in Holland has
discovered links between UNR and Diamond Blackfan anaemia (Horos et al. 2012). As LDB1
influences transcription by LIM domain-containing transcription factors, an interaction between
UNR and LDB1 could lead to UNR affecting pathways such as erythropoiesis and pathologies
such as diabetes at the transcriptional level.
Groups of statistically significant putative UNR-interacting proteins from each cell type, either
arsenite stressed or unstressed, were subjected to gene ontology overrepresentation analysis.
The most overrepresented biological process GO term for all conditions was ‘mRNA metabolic
process’ and the top two most overrepresented molecular function GO terms were ‘RNA
binding’ and ‘poly(A) RNA binding’ (section 4.13). It was noted that ‘ribonucleoprotein complex’
3Chapter 7
was a recurring highly overrepresented cellular component GO term (section 4.13). It is also
suggested that UNR may be involved in selenium metabolism which was considered interesting
in light of the findings of Xavier et al. (2014) (sections 4.13 and 1.7). Some evidence was found
that UNR may bind to a number of proteins that are located at adherens junctions (e.g. section
4.10.5). This was interesting, given that some immunofluorescence microscopy evidence
suggested that UNR can be found concentrated at cell-cell junctions under certain conditions
(section 4.12.1). The adherens junction cellular component GO term was also significantly
overrepresented among proteins that were upregulated in siUNR-treated HeLa cells or either
unstressed or arsenite-stressed siUNR-treated U2OS cells (sections 6.4.1, 6.6.5 and 6.8.1). It was
also overrepresented among proteins that were downregulated in either unstressed or arsenite-
stressed siUNR-treated U2OS cells (sections 6.6.7 and 6.8.3). These findings suggested that UNR
can both interact with proteins at adherens junctions and also modulate the expression levels
of proteins at adherens junctions, making UNR a potential key player in the control of the
adherens junction. This is suggested as a potential avenue of future research.
RNA was then extracted from a portion of the RIP samples and sequenced in an attempt to
identify and quantify UNR-interacting transcripts. PCA was used to validate samples and remove
outliers. DESeq2 was then used to find significant UNR-interacting transcripts. The significant
hits were then entered into a GO term overrepresentation analysis tool to explore whether or
not UNR interacts with specific groups of transcripts.
Multiple novel UNR-interacting transcripts are suggested in chapter 5, although there was little
identity between the transcripts flagged up as binding to UNR in each of the three cell types.
Notwithstanding that observation, some highly overrepresented GO terms were generated
using DESeq2-suggested UNR-interacting transcripts merged from arsenite-stressed and
unstressed SaOS-2 cells and from merged arsenite-stressed and unstressed cells from all three
cell lines.
Among the top hits for SaOS-2 were ‘RNA processing’, ‘RNA binding’ and ‘poly(A) RNA binding’
(adjusted p-values ranging from 6.52x10-11 to 3.12x10-10). The cellular component GO term
‘nuclear part’ had an adjusted p-value of 6.79x10-21 (section 5.6.2). Among all cell types, the
most overrepresented biological process GO term was ‘nucleobase-containing compound
metabolic process’ (adjusted p-value = 1.97x10-11). Other top hits included ‘chromosome
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organization’ and ‘chromatin modification’ (adjusted p-values = 6.52x10-9 and 1.07x10-7,
respectively). Among the most overrepresented molecular function GO terms were ‘RNA
binding’ (adjusted p-value = 2.51x10-9) and ‘poly (A) RNA binding’ with an adjusted p-value of
1.08x10-6. The most overrepresented cellular component GO term was ‘nuclear part’ with an
adjusted p-value of 4.51x10-23 (section 5.7.3). This evidence suggests that UNR interacts with
transcripts that encode proteins that are involved in RNA- and nuclear-related processes. It is
interesting to consider that UNR interacts with both proteins and transcripts that encode
proteins involved in processes such as poly (A) RNA binding. This implies a potential fundamental
role for UNR in the control of protein expression, potentially at the transcriptional, translational
and post-translational levels.
A large number of proteins that are differentially regulated following siUnr-treatment in HeLa
and U2OS cells (the latter with or without arsenite stress prior to harvesting) are presented in
chapter 6. Akin to the analysis carried out with data from chapters 4 and 5, GO term
overrepresentation analysis was carried out using these proteins.
Among the most overrepresented biological process GO terms generated using proteins
upregulated in siUNR-treated HeLa cells were ‘posttranscriptional regulation of gene expression’
and terms related to viral processes. 26 proteins were observed that were annotated with ‘poly
(A) RNA binding’, whereas only 7.07 were expected (adjusted p-value = 2.03x10-5). ‘Extracellular
exosome’ and, as stated above, ‘adherens junction’, were among the most overrepresented
cellular component GO terms (section 6.4.1). Among those proteins downregulated by siUNR
treatment in HeLa cells, the most overrepresented biological process GO term was ‘oxidative
phosphorylation’. The top molecular function GO term was ‘protein binding involved in cell-cell
adhesion’ and others included ‘RNA binding’ and ‘poly (A) RNA binding’. Mitochondrion-
associated GO terms were among the most overrepresented cellular component GO terms
(section 6.4.3). These findings further corroborate the hypothesis that UNR has a fundamental
role to play in the overall control of protein synthesis. They also suggest that UNR may play a
role in cellular respiration.
The two most overrepresented biological process GO terms generated using proteins
upregulated in unstressed siUNR-treated U2OS cells were ‘mRNA processing’ and ‘RNA splicing’.
‘Poly (A) RNA binding’ was the top molecular function GO term with an adjusted p-value of
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5.11x10-12. ‘Adherens junction’ was among the most overrepresented cellular component GO
terms, with 19 proteins observed with 3.26 expected (section 6.6.5).
Among the proteins downregulated by siUNR treatment in unstressed U2OS cells, there were
no overrepresented biological process GO terms with adjusted p-values <0.01 and only two very
general overrepresented molecular function GO terms. ‘Anchoring junction’ and ‘extracellular
exosome’ were the most overrepresented cellular component GO terms (section 6.6.7).
There were neither any significantly overrepresented biological process nor molecular function
GO terms obtained using proteins upregulated in siUNR-treated U2OS cells that were arsenite-
stressed prior to being harvested. There were four significant cellular component GO terms, all
of which had adjusted p-values >0.01, of which the most significant was ‘adherens junction’
(section 6.8.1).
A large number of proteins were significantly downregulated on siUNR treatment in U2OS cells
that were stressed with arsenite prior to harvesting; 86 were entered into the GO tool (section
6.8.3). These yielded a large number of significantly overrepresented GO terms. The most
significant biological process GO terms included terms related to translation and protein
targeting. Another top ten hit by adjusted p-value was ‘viral transcription’. ‘RNA binding’
(adjusted p-value = 2.79x10-17) and ‘poly (A) RNA binding’ (adjusted p-value = 5.69x10-14) were
the most overrepresented molecular function GO terms by p-value. ‘Cytosolic ribosome’
(adjusted p-value = 1.78x10-16) and ‘adherens junction’ (adjusted p-value = 4.25x10-15) were the
most overrepresented cellular component GO terms by p-value (section 6.8.3).
It was found that the method used to detect significant proteins among those discovered by
mass spectrometry had been quite stringent as, when the criteria were relaxed, the p-values
associated with significantly overrepresented GO terms became much stronger. The same was
not true when putatively non-significant genes were added (section 6.9).
This work has produced evidence that supports a role for UNR as a potential master regulator
of protein expression. The exact cellular function(s) of UNR remain(s) to be discovered but it is
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hoped that this work will both widen the current knowledge of UNR and, potentially, help guide
future researchers both in the UNR field and beyond.
7.1 Caveats
It is considered useful to conclude with a number of caveats. Firstly, mass spectrometry data can
be biased in terms of differential detectability of processed tryptic digest peptides (Fricker
2015). The peptides that were detected here were fed into software that utilises databases, both
of which are constantly changing and, thereby, changing the probabilities associated with
protein detection. For example, the Scaffold report from section 4.3.1 mentions the use of
version 4.5.3 that used Mascot version 2.5.0 and the human Uniprot database from 18th June
2015. As of 17th May 2017, Scaffold is on version 4.7.5, Mascot is on 2.6 and Uniprot had last
updated its human proteome data on 25th March 2017. Ultimately, a parsimony-based
approach was used to assign peptides to proteins and this is another potential source of error
(Cottrell 2011). Likewise, RNA-Seq has many limitations from the sequencing depth to similar
issues surrounding databases. Finally, gene ontology databases also change over time, both with
respect to the number of terms and the group of terms annotated to each individual protein
(Khatri & Draghici 2005). Possible errors are therefore magnified as false positive are likely to be
present in the input data and some false negatives will have been rejected. This could potentially
hide true associations or cause false relationships to be suggested. This is expected to have been
particularly pronounced with the RNA-Seq data as it was not known whether a putative
interaction with UNR would lead to a transcript being expressed at a greater rate or
translationally repressed. Furthermore, the putative UNR-interacting transcripts were fed into a
database that ultimately looked at protein attributes (biological process, molecular function and
cellular component). It is hoped that a deeper exploration of the knockdown data provided in
Chapter 6 could be used to strengthen future analysis of the RNA-Seq data from Chapter 5.
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1Supplementary Tables
Table S1: Putative Unr-interacting proteins in arsenite-stressed SaOS-2 cells, by t-test p-value
(using Progenesis data – see section 4.11)
p-value Protein
0.00025 PFKAL_HUMAN Isoform 2 of ATP-dependent 6-phosphofructokinase, liver type OS=Homosapiens GN=PFKL
0.00052 SETMR_HUMAN Histone-lysine N-methyltransferase SETMAR OS=Homo sapiens GN=SETMARPE=1 SV=2
0.00139 F5H2T0_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=1
0.00170 A0A087WZL3_HUMAN Tyrosine-protein kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=1
0.00241 WDR1_HUMAN WD repeat-containing protein 1 OS=Homo sapiens GN=WDR1 PE=1 SV=4
0.00272 PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sapiens GN=PCBP1 PE=1 SV=2
0.00312 CCD50_HUMAN Coiled-coil domain-containing protein 50 OS=Homo sapiens GN=CCDC50 PE=1SV=1
0.00320 HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2
0.00385 RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2
0.00432 X6RK96_HUMAN TRMT1-like protein (Fragment) OS=Homo sapiens GN=TRMT1L PE=1 SV=1
0.00468 LDB1_HUMAN LIM domain-binding protein 1 OS=Homo sapiens GN=LDB1 PE=1 SV=2
0.00500 A0A075B6S5_HUMAN Protein IGKV1-27 (Fragment) OS=Homo sapiens GN=IGKV1-27 PE=1 SV=1
0.00531 ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5
0.00606 EF2_HUMAN Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=4
0.00700 J3KR97_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=1
0.00731 A0A0A0MRH2_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=1
0.00731 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=2
0.00834 RS27A_HUMAN
0.00917 B4DXZ6_HUMAN Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiensGN=FXR1 PE=1 SV=1
0.00986 A0A075B6K4_HUMAN HCG2043238 (Fragment) OS=Homo sapiens GN=IGLV3-10 PE=1 SV=1
0.01058 A0A0A0MTE2_HUMAN LIM domain only protein 7 OS=Homo sapiens GN=LMO7 PE=1 SV=1
0.01078 HS71A_HUMAN Heat shock 70 kDa protein 1A OS=Homo sapiens GN=HSPA1A PE=1 SV=1
0.01082 G5E9Q6_HUMAN Profilin OS=Homo sapiens GN=PFN2 PE=1 SV=1
0.01117 H0Y2W2_HUMAN ATPase family AAA domain-containing protein 3A (Fragment) OS=Homosapiens GN=ATAD3A PE=1 SV=1
0.01130 SPG20_HUMAN Spartin OS=Homo sapiens GN=SPG20 PE=1 SV=1
0.01140 NARR_HUMAN Ras-related protein Rab-34, isoform NARR OS=Homo sapiens GN=RAB34 PE=1SV=1
0.01197 ATD3A_HUMAN Isoform 2 of ATPase family AAA domain-containing protein 3A OS=Homosapiens GN=ATAD3A
0.01248 P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1
0.01249 TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein OS=Homo sapiensGN=TNRC6C PE=1 SV=3
0.01266 STRAP_HUMAN Serine-threonine kinase receptor-associated protein OS=Homo sapiensGN=STRAP PE=1 SV=1
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0.01305 BAG2_HUMAN BAG family molecular chaperone regulator 2 OS=Homo sapiens GN=BAG2 PE=1SV=1
0.01332 SSBP3_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3 PE=1 SV=1
0.01381 RS26L_HUMAN Putative 40S ribosomal protein S26-like 1 OS=Homo sapiens GN=RPS26P11 PE=5SV=1
0.01408 H3BND4_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homosapiens GN=PDXDC1 PE=1 SV=1
0.01420 RBBP6_HUMAN E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens GN=RBBP6 PE=1 SV=1
0.01425 A0A087WY61_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1PE=1 SV=1
0.01436 E9PN89_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
0.01491 ATD3B_HUMAN ATPase family AAA domain-containing protein 3B OS=Homo sapiensGN=ATAD3B PE=1 SV=1
0.01494 CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1 OS=Homo sapiensGN=CSDE1
0.01495 E9PLT0_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 PE=1SV=1
0.01529 H3BRU6_HUMAN Poly(rC)-binding protein 2 (Fragment) OS=Homo sapiens GN=PCBP2 PE=1SV=1
0.01530 H3BN98_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=2
0.01552 E9PKE3_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
0.01558 E9PM36_HUMAN 40S ribosomal protein S2 OS=Homo sapiens GN=RPS2 PE=1 SV=1
0.01567 LMO4_HUMAN LIM domain transcription factor LMO4 OS=Homo sapiens GN=LMO4 PE=1 SV=1
0.01631 ATPG_HUMAN ATP synthase subunit gamma, mitochondrial OS=Homo sapiens GN=ATP5C1PE=1 SV=1
0.01660 A0A0D9SFS2_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=4SV=1
0.01670 M0QXS5_HUMAN Heterogeneous nuclear ribonucleoprotein L (Fragment) OS=Homo sapiensGN=HNRNPL PE=1 SV=1
0.01680 E9PQU5_HUMAN RNA-binding protein 25 (Fragment) OS=Homo sapiens GN=RBM25 PE=1 SV=1
0.01729 RS4X_HUMAN 40S ribosomal protein S4, X isoform OS=Homo sapiens GN=RPS4X PE=1 SV=2
0.01853 E9PLD4_HUMAN Cold shock domain-containing protein E1 (Fragment) OS=Homo sapiensGN=CSDE1 PE=1 SV=5
0.01854 CSDE1_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 PE=1SV=2
0.01856 V9GYM8_HUMAN Rho guanine nucleotide exchange factor 2 OS=Homo sapiens GN=ARHGEF2PE=1 SV=1
0.01867 E7EMW7_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens GN=UBR5 PE=1 SV=1
0.01892 E9PI65_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
0.01901 FND3B_HUMAN Fibronectin type III domain-containing protein 3B OS=Homo sapiensGN=FNDC3B PE=1 SV=2
0.01907 I3L404_HUMAN 40S ribosomal protein S2 (Fragment) OS=Homo sapiens GN=RPS2 PE=1 SV=1
0.01927 A0A0D9SF25_HUMAN F-box-like/WD repeat-containing protein TBL1XR1 (Fragment) OS=Homosapiens GN=TBL1XR1 PE=4 SV=1
0.01929 F5H018_HUMAN GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens GN=RAN PE=1SV=5
0.01958 G3V0J0_HUMAN Fragile X mental retardation 1, isoform CRA_e OS=Homo sapiens GN=FMR1PE=1 SV=1
0.01991 TRIP6_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=1 SV=3
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0.02029 H0YEN5_HUMAN 40S ribosomal protein S2 (Fragment) OS=Homo sapiens GN=RPS2 PE=1 SV=1
0.02045 J3KQE5_HUMAN GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens GN=RAN PE=1SV=1
0.02048 TB10C_HUMAN Carabin OS=Homo sapiens GN=TBC1D10C PE=1 SV=1
0.02184 A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3PE=1 SV=1
0.02200 Q5TFJ7_HUMAN Importin subunit alpha-7 (Fragment) OS=Homo sapiens GN=KPNA6 PE=1 SV=1
0.02317 HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
0.02352 J3KTE4_HUMAN Ribosomal protein L19 OS=Homo sapiens GN=RPL19 PE=1 SV=1
0.02444 E5RIM3_HUMAN Phospholipase A-2-activating protein OS=Homo sapiens GN=PLAA PE=1 SV=1
0.02474 E9PQD7_HUMAN 40S ribosomal protein S2 OS=Homo sapiens GN=RPS2 PE=1 SV=1
0.02498 C9JZR2_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=2
0.02647 DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=Homo sapiens GN=DYNLL2 PE=1 SV=1
0.02685 E7EMC7_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
0.02701 D6R9I7_HUMAN 40S ribosomal protein S23 OS=Homo sapiens GN=RPS23 PE=1 SV=1
0.02820 EFTU_HUMAN Elongation factor Tu, mitochondrial OS=Homo sapiens GN=TUFM PE=1 SV=2
0.03016 C9J2C0_HUMAN Tubulin alpha-8 chain (Fragment) OS=Homo sapiens GN=TUBA8 PE=1 SV=1
0.03092 TBB5_HUMAN Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=2
0.03092 TBB4B_HUMAN Tubulin beta-4B chain OS=Homo sapiens GN=TUBB4B PE=1 SV=1
0.03238 XPOT_HUMAN Exportin-T OS=Homo sapiens GN=XPOT PE=1 SV=2
0.03248 SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
0.03259 TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1
0.03271 SYC2L_HUMAN Synaptonemal complex protein 2-like OS=Homo sapiens GN=SYCP2L PE=1 SV=2
0.03299 TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens GN=TUBB2A PE=1 SV=1
0.03317 RS27_HUMAN 40S ribosomal protein S27 OS=Homo sapiens GN=RPS27 PE=1 SV=3
0.03326 TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2
0.03535 F5H5D3_HUMAN Tubulin alpha-1C chain OS=Homo sapiens GN=TUBA1C PE=1 SV=1
0.03536 TBA4A_HUMAN Tubulin alpha-4A chain OS=Homo sapiens GN=TUBA4A PE=1 SV=1
0.03563 F8VQQ4_HUMAN Tubulin alpha-1A chain (Fragment) OS=Homo sapiens GN=TUBA1A PE=1 SV=1
0.03595 H3BLZ8_HUMAN Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens GN=DDX17PE=1 SV=1
0.03653 TBA3C_HUMAN Tubulin alpha-3C/D chain OS=Homo sapiens GN=TUBA3C PE=1 SV=3
0.03696 Q5QNZ2_HUMAN ATP synthase F(0) complex subunit B1, mitochondrial OS=Homo sapiensGN=ATP5F1 PE=1 SV=1
0.03746 MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1SV=4
0.03797 TBA1B_HUMAN Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1
0.03885 E7ET15_HUMAN U2 snRNP-associated SURP motif-containing protein OS=Homo sapiensGN=U2SURP PE=1 SV=1
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0.03914 H0YBW4_HUMAN Phospholipase A-2-activating protein (Fragment) OS=Homo sapiens GN=PLAAPE=1 SV=1
0.03931 A0A0A0MS74_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homosapiens GN=PCK2 PE=1 SV=1
0.04050 F8WAE5_HUMAN Eukaryotic translation initiation factor 2A OS=Homo sapiens GN=EIF2A PE=1SV=1
0.04057 PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiensGN=PCK2 PE=1 SV=3
0.04149 A0A075B736_HUMAN Tubulin beta-8 chain OS=Homo sapiens GN=TUBB8 PE=1 SV=1
0.04167 A0A087WX29_HUMAN TAR DNA-binding protein 43 (Fragment) OS=Homo sapiens GN=TARDBPPE=1 SV=1
0.04224 SYYC_HUMAN Tyrosine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4
0.04263 FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3
0.04314 RBM25_HUMAN RNA-binding protein 25 OS=Homo sapiens GN=RBM25 PE=1 SV=3
0.04322 G3V1A4_HUMAN Cofilin 1 (Non-muscle), isoform CRA_a OS=Homo sapiens GN=CFL1 PE=1 SV=1
0.04324 J3KTJ3_HUMAN 60S ribosomal protein L23 OS=Homo sapiens GN=RPL23 PE=1 SV=1
0.04339 H0Y368_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 (Fragment) OS=Homosapiens GN=DPM1 PE=1 SV=1
0.04472 H0YDD4_HUMAN Acetyltransferase component of pyruvate dehydrogenase complex(Fragment) OS=Homo sapiens GN=DLAT PE=1 SV=1
0.04491 M0QXL5_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
0.04515 E3W990_HUMAN Sequestosome-1 (Fragment) OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
0.04526 B4DEB1_HUMAN Histone H3 OS=Homo sapiens GN=H3F3A PE=1 SV=1
0.04557 SIR1_HUMAN NAD-dependent protein deacetylase sirtuin-1 OS=Homo sapiens GN=SIRT1 PE=1SV=2
0.04732 J3KTM9_HUMAN Importin subunit beta-1 (Fragment) OS=Homo sapiens GN=KPNB1 PE=1 SV=1
0.04782 LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16APE=1 SV=1
0.04785 B0YJC4_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=1 SV=1
0.04962 H0Y3Z3_HUMAN Protein disulfide-isomerase (Fragment) OS=Homo sapiens GN=P4HB PE=1SV=1
0.05048 X6RLN4_HUMAN La-related protein 4 (Fragment) OS=Homo sapiens GN=LARP4 PE=1 SV=1
0.05188 COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2
0.05202 J3KT29_HUMAN 60S ribosomal protein L23 OS=Homo sapiens GN=RPL23 PE=1 SV=1
0.05246 IMB1_HUMAN Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2
0.05275 GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 SV=2
0.05414 H0YMR4_HUMAN Importin-4 (Fragment) OS=Homo sapiens GN=IPO4 PE=1 SV=1
0.05424 FBSP1_HUMAN F-box/SPRY domain-containing protein 1 OS=Homo sapiens GN=FBXO45 PE=1SV=1
0.05424 NU107_HUMAN Nuclear pore complex protein Nup107 OS=Homo sapiens GN=NUP107 PE=1SV=1
0.05479 SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=AARS PE=1 SV=2
0.05534 G3V196_HUMAN Ras-related protein Rab-15 OS=Homo sapiens GN=RAB15 PE=1 SV=1
0.05640 DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=3
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0.05690 HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3
0.05730 P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens GN=P4HA2 PE=1 SV=1
0.05801 XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3
0.05913 H0YN14_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=1
0.06011 IF2A_HUMAN Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens GN=EIF2S1PE=1 SV=3
0.06481 K7ENJ4_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
0.06544 I3L3H2_HUMAN Eukaryotic initiation factor 4A-III (Fragment) OS=Homo sapiens GN=EIF4A3PE=1 SV=1
0.06572 E9PEJ4_HUMAN Acetyltransferase component of pyruvate dehydrogenase complex OS=Homosapiens GN=DLAT PE=1 SV=1
0.06577 EDC4_HUMAN Enhancer of mRNA-decapping protein 4 OS=Homo sapiens GN=EDC4 PE=1 SV=1
0.06745 A0A0A0MSP3_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1SV=1
0.06879 RS25_HUMAN 40S ribosomal protein S25 OS=Homo sapiens GN=RPS25 PE=1 SV=1
0.06886 IPO4_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=2
0.06910 X1WI28_HUMAN 60S ribosomal protein L10 (Fragment) OS=Homo sapiens GN=RPL10 PE=1SV=4
0.07024 E7END7_HUMAN Ras-related protein Rab-1A OS=Homo sapiens GN=RAB1A PE=1 SV=1
0.07066 E5RH77_HUMAN 40S ribosomal protein S14 OS=Homo sapiens GN=RPS14 PE=1 SV=1
0.07073 Q5T6W2_HUMAN Heterogeneous nuclear ribonucleoprotein K (Fragment) OS=Homo sapiensGN=HNRNPK PE=1 SV=1
0.07149 K7EK77_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
0.07193 M0QX76_HUMAN 40S ribosomal protein S16 (Fragment) OS=Homo sapiens GN=RPS16 PE=1SV=1
0.07256 RS14_HUMAN 40S ribosomal protein S14 OS=Homo sapiens GN=RPS14 PE=1 SV=3
0.07311 P4HA1_HUMAN Prolyl 4-hydroxylase subunit alpha-1 OS=Homo sapiens GN=P4HA1 PE=1 SV=2
0.07338 CY1_HUMAN Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens GN=CYC1 PE=1SV=3
0.07367 I3L397_HUMAN Eukaryotic translation initiation factor 5A (Fragment) OS=Homo sapiensGN=EIF5A PE=1 SV=5
0.07385 I3L1U9_HUMAN Actin, cytoplasmic 2 (Fragment) OS=Homo sapiens GN=ACTG1 PE=1 SV=1
0.07418 F8VPD4_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=1
0.07444 F5H423_HUMAN Uncharacterized protein OS=Homo sapiens PE=3 SV=1
0.07446 J3KMX5_HUMAN 40S ribosomal protein S13 OS=Homo sapiens GN=RPS13 PE=1 SV=1
0.07506 H7BY10_HUMAN 60S ribosomal protein L23a (Fragment) OS=Homo sapiens GN=RPL23A PE=1SV=1
0.07558 F6RFD5_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=1
0.07624 J3JS69_HUMAN 40S ribosomal protein S18 OS=Homo sapiens GN=RPS18 PE=1 SV=1
0.07776 K7EM90_HUMAN Enolase (Fragment) OS=Homo sapiens GN=ENO1 PE=1 SV=1
0.07794 A2A3R7_HUMAN 40S ribosomal protein S6 OS=Homo sapiens GN=RPS6 PE=1 SV=1
0.07797 G5E9Y7_HUMAN LIM domain binding 2, isoform CRA_b OS=Homo sapiens GN=LDB2 PE=1 SV=1
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0.07807 M0R0P1_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
0.07865 A0A087WZ27_HUMAN Zinc finger protein 90 OS=Homo sapiens GN=ZNF90 PE=4 SV=2
0.07936 ATPA_HUMAN Isoform 3 of ATP synthase subunit alpha, mitochondrial OS=Homo sapiensGN=ATP5A1
0.07999 SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4
0.08021 HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPKPE=1 SV=1
0.08302 I3L0K7_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens GN=TRAP1 PE=1SV=1
0.08349 A0A0D9SFL3_HUMAN RNA-binding protein EWS OS=Homo sapiens GN=EWSR1 PE=4 SV=1
0.08479 RS18_HUMAN 40S ribosomal protein S18 OS=Homo sapiens GN=RPS18 PE=1 SV=3
0.08523 Q5T4U5_HUMAN Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain, isoform CRA_aOS=Homo sapiens GN=ACADM PE=1 SV=1
0.08630 ATPA_HUMAN ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1SV=1
0.08700 RS11_HUMAN 40S ribosomal protein S11 OS=Homo sapiens GN=RPS11 PE=1 SV=3
0.08985 Q5SZU1_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1SV=1
0.09013 E9PLL6_HUMAN 60S ribosomal protein L27a OS=Homo sapiens GN=RPL27A PE=1 SV=1
0.09076 C9JJQ8_HUMAN Tubulin alpha-4A chain (Fragment) OS=Homo sapiens GN=TUBA4A PE=1 SV=1
0.09142 ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1SV=3
0.09255 ACTB_HUMAN Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1
0.09400 ARMC6_HUMAN Armadillo repeat-containing protein 6 OS=Homo sapiens GN=ARMC6 PE=1SV=2
0.09452 KHDR2_HUMAN KH domain-containing, RNA-binding, signal transduction-associated protein 2OS=Homo sapiens GN=KHDRBS2 PE=1 SV=1
0.09587 J3KNN5_HUMAN Probable ATP-dependent RNA helicase DDX41 (Fragment) OS=Homo sapiensGN=DDX41 PE=1 SV=1
0.09663 MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens GN=MYCBP2 PE=1 SV=3
0.09696 POTEE_HUMAN POTE ankyrin domain family member E OS=Homo sapiens GN=POTEE PE=1SV=3
0.09733 SND1_HUMAN Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiensGN=SND1 PE=1 SV=1
N.B. the t-test p-values are for a two-tailed paired t-test without multiple testing correction
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Table S2: Putative Unr-interacting proteins in unstressed SaOS-2 cells, by Unr/IgG ratio (using
Progenesis data – see section 4.11)
Unr/IgG
ratio Protein
∞ 
H3BLZ8_HUMAN Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens GN=DDX17
PE=1 SV=1
∞ 
TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein OS=Homo sapiens
GN=TNRC6C PE=1 SV=3
∞ TRA2B_HUMAN Transformer-2 protein homolog beta OS=Homo sapiens GN=TRA2B PE=1 SV=1 
∞ G5E9Y7_HUMAN LIM domain binding 2, isoform CRA_b OS=Homo sapiens GN=LDB2 PE=1 SV=1 
∞ 
A0A087WY61_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1
PE=1 SV=1
∞ C9JJQ8_HUMAN Tubulin alpha-4A chain (Fragment) OS=Homo sapiens GN=TUBA4A PE=1 SV=1 
∞ 
H0Y3Z3_HUMAN Protein disulfide-isomerase (Fragment) OS=Homo sapiens GN=P4HB PE=1
SV=1
∞ 
H0Y9Y4_HUMAN 40S ribosomal protein S3a (Fragment) OS=Homo sapiens GN=RPS3A PE=1
SV=1
∞ BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 
∞ E9PKU4_HUMAN 60S ribosomal protein L8 (Fragment) OS=Homo sapiens GN=RPL8 PE=1 SV=1 
∞ 
X6RAL5_HUMAN Histone deacetylase complex subunit SAP18 OS=Homo sapiens GN=SAP18
PE=1 SV=1
∞ 
AN32E_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo
sapiens GN=ANP32E PE=1 SV=1
19575 AP2A2_HUMAN AP-2 complex subunit alpha-2 OS=Homo sapiens GN=AP2A2 PE=1 SV=2
3524 F8VVM2_HUMAN Phosphate carrier protein, mitochondrial OS=Homo sapiens GN=SLC25A3PE=1 SV=1
2587 M0QXS5_HUMAN Heterogeneous nuclear ribonucleoprotein L (Fragment) OS=Homo sapiensGN=HNRNPL PE=1 SV=1
1662 D6R9I9_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens GN=ABCE1PE=1 SV=1
1299 H3BPE7_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1
652 FBSP1_HUMAN F-box/SPRY domain-containing protein 1 OS=Homo sapiens GN=FBXO45 PE=1SV=1
652 NU107_HUMAN Nuclear pore complex protein Nup107 OS=Homo sapiens GN=NUP107 PE=1SV=1
511 V9GYZ6_HUMAN Bifunctional glutamate/proline--tRNA ligase (Fragment) OS=Homo sapiensGN=EPRS PE=1 SV=1
349 A0A0D9SF25_HUMAN F-box-like/WD repeat-containing protein TBL1XR1 (Fragment) OS=Homosapiens GN=TBL1XR1 PE=4 SV=1
336 SSBP3_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3 PE=1 SV=1
336 A0A0D9SFL3_HUMAN RNA-binding protein EWS OS=Homo sapiens GN=EWSR1 PE=4 SV=1
298 E3W990_HUMAN Sequestosome-1 (Fragment) OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
279 H0Y8N0_HUMAN Transmembrane protein 33 (Fragment) OS=Homo sapiens GN=TMEM33 PE=1SV=1
204 HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPKPE=1 SV=1
200 B4DLN1_HUMAN Uncharacterized protein OS=Homo sapiens PE=2 SV=1
199 B2R5W2_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiensGN=HNRNPC PE=1 SV=1
190 A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3PE=1 SV=1
183 PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiensGN=PSMD2 PE=1 SV=3
173 E7ERJ7_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1 SV=1
168 B4DY09_HUMAN Interleukin enhancer-binding factor 2 OS=Homo sapiens GN=ILF2 PE=1 SV=1
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165 LMO4_HUMAN LIM domain transcription factor LMO4 OS=Homo sapiens GN=LMO4 PE=1 SV=1
161 SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
160 H7C086_HUMAN ATP synthase subunit O, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5O PE=4 SV=1
149 E7EMC7_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
138 EDC4_HUMAN Enhancer of mRNA-decapping protein 4 OS=Homo sapiens GN=EDC4 PE=1 SV=1
137 Q5T6W2_HUMAN Heterogeneous nuclear ribonucleoprotein K (Fragment) OS=Homo sapiensGN=HNRNPK PE=1 SV=1
137 TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1SV=2
119 MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1SV=4
112 J3KTE4_HUMAN Ribosomal protein L19 OS=Homo sapiens GN=RPL19 PE=1 SV=1
112 PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1SV=3
107 IMB1_HUMAN Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2
98 MPCP_HUMAN Phosphate carrier protein, mitochondrial OS=Homo sapiens GN=SLC25A3 PE=1SV=2
90 LDB1_HUMAN LIM domain-binding protein 1 OS=Homo sapiens GN=LDB1 PE=1 SV=2
89 SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens GN=SRSF6 PE=1 SV=2
85 B4DR61_HUMAN Protein transport protein Sec61 subunit alpha isoform 1 OS=Homo sapiensGN=SEC61A1 PE=1 SV=1
83 COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2
80 CAND1_HUMAN Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1PE=1 SV=2
77 I3L3H2_HUMAN Eukaryotic initiation factor 4A-III (Fragment) OS=Homo sapiens GN=EIF4A3PE=1 SV=1
76 A0A087WTT1_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1SV=1
73 NARR_HUMAN Ras-related protein Rab-34, isoform NARR OS=Homo sapiens GN=RAB34 PE=1SV=1
68 J3KTM9_HUMAN Importin subunit beta-1 (Fragment) OS=Homo sapiens GN=KPNB1 PE=1 SV=1
64 LPPRC_HUMAN Leucine-rich PPR motif-containing protein, mitochondrial OS=Homo sapiensGN=LRPPRC PE=1 SV=3
61 ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiensGN=HADHA PE=1 SV=2
57 RPN1_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1OS=Homo sapiens GN=RPN1 PE=1 SV=1
53 E7EMW7_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens GN=UBR5 PE=1 SV=1
52 E9PN89_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
51 AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiensGN=ATP2A2 PE=1 SV=1
50 J3KQL8_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=2
48 E7EQU1_HUMAN High mobility group protein B3 (Fragment) OS=Homo sapiens GN=HMGB3PE=1 SV=1
48 SYLC_HUMAN Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=LARS PE=1 SV=2
44 A0A075B736_HUMAN Tubulin beta-8 chain OS=Homo sapiens GN=TUBB8 PE=1 SV=1
44 Q5QNZ2_HUMAN ATP synthase F(0) complex subunit B1, mitochondrial OS=Homo sapiensGN=ATP5F1 PE=1 SV=1
43 CCD50_HUMAN Coiled-coil domain-containing protein 50 OS=Homo sapiens GN=CCDC50 PE=1SV=1
41 A2A3R7_HUMAN 40S ribosomal protein S6 OS=Homo sapiens GN=RPS6 PE=1 SV=1
40 E9PLD4_HUMAN Cold shock domain-containing protein E1 (Fragment) OS=Homo sapiensGN=CSDE1 PE=1 SV=5
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40 H7BZ35_HUMAN Aspartate--tRNA ligase, cytoplasmic (Fragment) OS=Homo sapiens GN=DARSPE=1 SV=1
40 P4HA1_HUMAN Prolyl 4-hydroxylase subunit alpha-1 OS=Homo sapiens GN=P4HA1 PE=1 SV=2
38 M0R0P1_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
38 F5H423_HUMAN Uncharacterized protein OS=Homo sapiens PE=3 SV=1
38 C9JZR2_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=2
38 A0A0A0MSP3_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1SV=1
37 A0A087WX29_HUMAN TAR DNA-binding protein 43 (Fragment) OS=Homo sapiens GN=TARDBPPE=1 SV=1
36 IF4A3_HUMAN Eukaryotic initiation factor 4A-III OS=Homo sapiens GN=EIF4A3 PE=1 SV=4
35 J3KMX5_HUMAN 40S ribosomal protein S13 OS=Homo sapiens GN=RPS13 PE=1 SV=1
35 H0YDD4_HUMAN Acetyltransferase component of pyruvate dehydrogenase complex(Fragment) OS=Homo sapiens GN=DLAT PE=1 SV=1
34 A6NLM8_HUMAN Translocon-associated protein subunit delta OS=Homo sapiens GN=SSR4PE=1 SV=1
34 HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2
33 PFKAL_HUMAN Isoform 2 of ATP-dependent 6-phosphofructokinase, liver type OS=Homosapiens GN=PFKL
31 CNN3_HUMAN Calponin-3 OS=Homo sapiens GN=CNN3 PE=1 SV=1
31 CY1_HUMAN Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens GN=CYC1 PE=1SV=3
30 DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=Homo sapiens GN=DYNLL2 PE=1 SV=1
30 F8VPD4_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=1
29 SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens GN=SRRM2 PE=1SV=2
29 ATD3A_HUMAN Isoform 2 of ATPase family AAA domain-containing protein 3A OS=Homosapiens GN=ATAD3A
28 Q5T4U5_HUMAN Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain, isoform CRA_aOS=Homo sapiens GN=ACADM PE=1 SV=1
28 E7EQV9_HUMAN Ribosomal protein L15 (Fragment) OS=Homo sapiens GN=RPL15 PE=1 SV=1
27 GNAL_HUMAN Guanine nucleotide-binding protein G(olf) subunit alpha OS=Homo sapiensGN=GNAL PE=1 SV=1
26 P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1
26 CH60_HUMAN 60 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPD1 PE=1SV=2
26 RAP1B_HUMAN Isoform 4 of Ras-related protein Rap-1b OS=Homo sapiens GN=RAP1B
26 A0A087X0X3_HUMAN Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiensGN=HNRNPM PE=1 SV=1
25 P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens GN=P4HA2 PE=1 SV=1
24 ADT2_HUMAN ADP/ATP translocase 2 OS=Homo sapiens GN=SLC25A5 PE=1 SV=7
24 M0QXL5_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
23 DNJA1_HUMAN DnaJ homolog subfamily A member 1 OS=Homo sapiens GN=DNAJA1 PE=1SV=2
23 X1WI28_HUMAN 60S ribosomal protein L10 (Fragment) OS=Homo sapiens GN=RPL10 PE=1SV=4
22 E9PKE3_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
21 SRRM1_HUMAN Serine/arginine repetitive matrix protein 1 OS=Homo sapiens GN=SRRM1 PE=1SV=2
21 PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sapiens GN=PCBP1 PE=1 SV=2
21 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=2
20 A0A0D9SEM4_HUMAN Serine/arginine-rich-splicing factor 4 (Fragment) OS=Homo sapiensGN=SRSF4 PE=4 SV=1
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20 H0Y2W2_HUMAN ATPase family AAA domain-containing protein 3A (Fragment) OS=Homosapiens GN=ATAD3A PE=1 SV=1
20 PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiensGN=PCK2 PE=1 SV=3
19 A0A0A0MS74_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homosapiens GN=PCK2 PE=1 SV=1
18 I3L0K7_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens GN=TRAP1 PE=1SV=1
18 TIF1B_HUMAN Transcription intermediary factor 1-beta OS=Homo sapiens GN=TRIM28 PE=1SV=5
18 LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16APE=1 SV=1
18 HS90B_HUMAN Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 SV=4
18 J3KP15_HUMAN Serine/arginine-rich-splicing factor 2 (Fragment) OS=Homo sapiens GN=SRSF2PE=1 SV=5
17 ATPA_HUMAN ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1SV=1
17 ATPB_HUMAN ATP synthase subunit beta, mitochondrial OS=Homo sapiens GN=ATP5B PE=1SV=3
17 HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3
17 GRP75_HUMAN Stress-70 protein, mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2
16 ATPA_HUMAN Isoform 3 of ATP synthase subunit alpha, mitochondrial OS=Homo sapiensGN=ATP5A1
16 KHDR1_HUMAN KH domain-containing, RNA-binding, signal transduction-associated protein 1OS=Homo sapiens GN=KHDRBS1 PE=1 SV=1
16 SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4
16 RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens GN=RANGAP1 PE=1 SV=1
16 J3KR97_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=1
16 K7ENJ4_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
16 XPOT_HUMAN Exportin-T OS=Homo sapiens GN=XPOT PE=1 SV=2
15 V9GYM8_HUMAN Rho guanine nucleotide exchange factor 2 OS=Homo sapiens GN=ARHGEF2PE=1 SV=1
15 V9GYG0_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=1
15 K7EK77_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
15 MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens GN=MYCBP2 PE=1 SV=3
15 NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens GN=WHSC1 PE=1SV=1
15 TBB5_HUMAN Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=2
15 F8VQQ4_HUMAN Tubulin alpha-1A chain (Fragment) OS=Homo sapiens GN=TUBA1A PE=1 SV=1
14 EFTU_HUMAN Elongation factor Tu, mitochondrial OS=Homo sapiens GN=TUFM PE=1 SV=2
14 F8W026_HUMAN Endoplasmin (Fragment) OS=Homo sapiens GN=HSP90B1 PE=1 SV=5
14 ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1SV=3
14 HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
14 ATD3B_HUMAN ATPase family AAA domain-containing protein 3B OS=Homo sapiensGN=ATAD3B PE=1 SV=1
14 E9PI65_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
14 HS90A_HUMAN Heat shock protein HSP 90-alpha OS=Homo sapiens GN=HSP90AA1 PE=1 SV=5
13 CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1 OS=Homo sapiensGN=CSDE1
13 GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 SV=2
13 POTEE_HUMAN POTE ankyrin domain family member E OS=Homo sapiens GN=POTEE PE=1SV=3
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13 G8JLB6_HUMAN Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens GN=HNRNPH1PE=1 SV=1
13 ADT3_HUMAN ADP/ATP translocase 3 OS=Homo sapiens GN=SLC25A6 PE=1 SV=4
13 H2AZ_HUMAN Histone H2A.Z OS=Homo sapiens GN=H2AFZ PE=1 SV=2
13 TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens GN=TUBB2A PE=1 SV=1
13 H3BN98_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=2
13 RS27_HUMAN 40S ribosomal protein S27 OS=Homo sapiens GN=RPS27 PE=1 SV=3
13 H0Y368_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 (Fragment) OS=Homosapiens GN=DPM1 PE=1 SV=1
12 COPB_HUMAN Coatomer subunit beta OS=Homo sapiens GN=COPB1 PE=1 SV=3
12 TBB4B_HUMAN Tubulin beta-4B chain OS=Homo sapiens GN=TUBB4B PE=1 SV=1
12 DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=3
12 J3KT29_HUMAN 60S ribosomal protein L23 OS=Homo sapiens GN=RPL23 PE=1 SV=1
12 H3BRG4_HUMAN Cytochrome b-c1 complex subunit 2, mitochondrial OS=Homo sapiensGN=UQCRC2 PE=1 SV=1
12 EF1A3_HUMAN Putative elongation factor 1-alpha-like 3 OS=Homo sapiens GN=EEF1A1P5 PE=5SV=1
11 E9PLT0_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 PE=1SV=1
11 RL27_HUMAN 60S ribosomal protein L27 OS=Homo sapiens GN=RPL27 PE=1 SV=2
11 DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1SV=5
11 BAG2_HUMAN BAG family molecular chaperone regulator 2 OS=Homo sapiens GN=BAG2 PE=1SV=1
11 E9PLL6_HUMAN 60S ribosomal protein L27a OS=Homo sapiens GN=RPL27A PE=1 SV=1
11 TBA1B_HUMAN Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1
11 A0A0A0MSG2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens GN=FHL2PE=1 SV=1
11 EF1A2_HUMAN Elongation factor 1-alpha 2 OS=Homo sapiens GN=EEF1A2 PE=1 SV=1
10 E7END7_HUMAN Ras-related protein Rab-1A OS=Homo sapiens GN=RAB1A PE=1 SV=1
N.B. Ratios are mean(Unr)/mean(IgG) and all infinities were ignored unless every Unr value was greater
than zero. The yellow shading highlights a protein absent in every IgG sample but present in every Unr
sample. Finite ratios were rounded to the nearest whole number.
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Table S3: Putative Unr-interacting proteins in arsenite-stressed SaOS-2 cells, by Unr/IgG ratio
(using Progenesis data – see section 4.11)
Unr/IgG
ratio Protein
∞ G5E9Q6_HUMAN Profilin OS=Homo sapiens GN=PFN2 PE=1 SV=1 
∞ 
A0A087WY61_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1
PE=1 SV=1
∞ TBR1_HUMAN T-box brain protein 1 OS=Homo sapiens GN=TBR1 PE=2 SV=1 
∞ 
H3BLZ8_HUMAN Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens GN=DDX17
PE=1 SV=1
∞ 
AN32E_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo
sapiens GN=ANP32E PE=1 SV=1
∞ TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2 
∞ 
A0A0D9SF25_HUMAN F-box-like/WD repeat-containing protein TBL1XR1 (Fragment) OS=Homo
sapiens GN=TBL1XR1 PE=4 SV=1
∞ 
FND3B_HUMAN Fibronectin type III domain-containing protein 3B OS=Homo sapiens
GN=FNDC3B PE=1 SV=2
∞ 
FBSP1_HUMAN F-box/SPRY domain-containing protein 1 OS=Homo sapiens GN=FBXO45 PE=1
SV=1
∞ 
NU107_HUMAN Nuclear pore complex protein Nup107 OS=Homo sapiens GN=NUP107 PE=1
SV=1
∞ 
TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein OS=Homo sapiens
GN=TNRC6C PE=1 SV=3
∞ SYLC_HUMAN Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=LARS PE=1 SV=2 
∞ MAGD1_HUMAN Melanoma-associated antigen D1 OS=Homo sapiens GN=MAGED1 PE=1 SV=3 
∞ 
USMG5_HUMAN Up-regulated during skeletal muscle growth protein 5 OS=Homo sapiens
GN=USMG5 PE=1 SV=1
∞ SUMO1_HUMAN 
∞ F8WE65_HUMAN Peptidyl-prolyl cis-trans isomerase OS=Homo sapiens GN=PPIA PE=1 SV=1 
∞ 
D6R9I9_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens GN=ABCE1
PE=1 SV=1
∞ BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 
∞ U3KQF2_HUMAN ADP-ribosylation factor 4 OS=Homo sapiens GN=ARF4 PE=1 SV=1 
∞ 
H0Y8R5_HUMAN Guanine nucleotide-binding protein subunit beta-2-like 1 (Fragment)
OS=Homo sapiens GN=GNB2L1 PE=1 SV=1
∞ 
H0Y9Y4_HUMAN 40S ribosomal protein S3a (Fragment) OS=Homo sapiens GN=RPS3A PE=1
SV=1
∞ 
J3KP15_HUMAN Serine/arginine-rich-splicing factor 2 (Fragment) OS=Homo sapiens GN=SRSF2
PE=1 SV=5
∞ B5MCT8_HUMAN 40S ribosomal protein S9 OS=Homo sapiens GN=RPS9 PE=1 SV=1 
∞ G5E9Y7_HUMAN LIM domain binding 2, isoform CRA_b OS=Homo sapiens GN=LDB2 PE=1 SV=1 
16177 X6RLN4_HUMAN La-related protein 4 (Fragment) OS=Homo sapiens GN=LARP4 PE=1 SV=1
15686 SSBP3_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3 PE=1 SV=1
2605 Q5T6W2_HUMAN Heterogeneous nuclear ribonucleoprotein K (Fragment) OS=Homo sapiensGN=HNRNPK PE=1 SV=1
1805 A0A0A0MSP3_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1SV=1
1779 SYYC_HUMAN Tyrosine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4
1401 H3BM89_HUMAN 60S ribosomal protein L4 OS=Homo sapiens GN=RPL4 PE=1 SV=1
1354 B4DY09_HUMAN Interleukin enhancer-binding factor 2 OS=Homo sapiens GN=ILF2 PE=1 SV=1
1317 F8VVM2_HUMAN Phosphate carrier protein, mitochondrial OS=Homo sapiens GN=SLC25A3PE=1 SV=1
637 E7EQU1_HUMAN High mobility group protein B3 (Fragment) OS=Homo sapiens GN=HMGB3PE=1 SV=1
553 SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
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550 DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=3
512 E9PLD4_HUMAN Cold shock domain-containing protein E1 (Fragment) OS=Homo sapiensGN=CSDE1 PE=1 SV=5
465 EDC4_HUMAN Enhancer of mRNA-decapping protein 4 OS=Homo sapiens GN=EDC4 PE=1 SV=1
456 M0R0P1_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
447 E3W990_HUMAN Sequestosome-1 (Fragment) OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
366 E7ERJ7_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1 SV=1
339 F8VPD4_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=1
286 A0A087WX29_HUMAN TAR DNA-binding protein 43 (Fragment) OS=Homo sapiens GN=TARDBPPE=1 SV=1
278 E7EMC7_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1
278 F8WAE5_HUMAN Eukaryotic translation initiation factor 2A OS=Homo sapiens GN=EIF2A PE=1SV=1
273 C9JJQ8_HUMAN Tubulin alpha-4A chain (Fragment) OS=Homo sapiens GN=TUBA4A PE=1 SV=1
261 A0A087WTT1_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1SV=1
249 C9J7E5_HUMAN Transportin-3 OS=Homo sapiens GN=TNPO3 PE=1 SV=1
248 HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPKPE=1 SV=1
244 IMB1_HUMAN Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2
233 H0YN14_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=1
233 M0QXS5_HUMAN Heterogeneous nuclear ribonucleoprotein L (Fragment) OS=Homo sapiensGN=HNRNPL PE=1 SV=1
220 SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens GN=SRSF6 PE=1 SV=2
196 I3L3H2_HUMAN Eukaryotic initiation factor 4A-III (Fragment) OS=Homo sapiens GN=EIF4A3PE=1 SV=1
158 XPOT_HUMAN Exportin-T OS=Homo sapiens GN=XPOT PE=1 SV=2
157 HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2
157 A0A087WVT6_HUMAN Single-stranded DNA-binding protein 3 OS=Homo sapiens GN=SSBP3PE=1 SV=1
153 BAG2_HUMAN BAG family molecular chaperone regulator 2 OS=Homo sapiens GN=BAG2 PE=1SV=1
143 A0A075B736_HUMAN Tubulin beta-8 chain OS=Homo sapiens GN=TUBB8 PE=1 SV=1
137 RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens GN=RANGAP1 PE=1 SV=1
126 B1AKQ8_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Fragment)OS=Homo sapiens GN=GNB1 PE=1 SV=5
123 J3KTM9_HUMAN Importin subunit beta-1 (Fragment) OS=Homo sapiens GN=KPNB1 PE=1 SV=1
123 H3BRU6_HUMAN Poly(rC)-binding protein 2 (Fragment) OS=Homo sapiens GN=PCBP2 PE=1SV=1
122 H0Y3Z3_HUMAN Protein disulfide-isomerase (Fragment) OS=Homo sapiens GN=P4HB PE=1SV=1
122 ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1SV=3
121 J3KQL8_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=2
121 H7BY10_HUMAN 60S ribosomal protein L23a (Fragment) OS=Homo sapiens GN=RPL23A PE=1SV=1
117 PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiensGN=PSMD2 PE=1 SV=3
113 PFKAL_HUMAN Isoform 2 of ATP-dependent 6-phosphofructokinase, liver type OS=Homosapiens GN=PFKL
111 LMO4_HUMAN LIM domain transcription factor LMO4 OS=Homo sapiens GN=LMO4 PE=1 SV=1
110 SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=AARS PE=1 SV=2
108 C9JZR2_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=2
106 PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sapiens GN=PCBP1 PE=1 SV=2
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102 MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1SV=4
102 E9PKU4_HUMAN 60S ribosomal protein L8 (Fragment) OS=Homo sapiens GN=RPL8 PE=1 SV=1
101 TRIP6_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=1 SV=3
95 H0YMR4_HUMAN Importin-4 (Fragment) OS=Homo sapiens GN=IPO4 PE=1 SV=1
94 V9GYZ6_HUMAN Bifunctional glutamate/proline--tRNA ligase (Fragment) OS=Homo sapiensGN=EPRS PE=1 SV=1
94 IPO4_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=2
91 E9PN89_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
89 DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=Homo sapiens GN=DYNLL2 PE=1 SV=1
86 IF2A_HUMAN Eukaryotic translation initiation factor 2 subunit 1 OS=Homo sapiens GN=EIF2S1PE=1 SV=3
81 LDB1_HUMAN LIM domain-binding protein 1 OS=Homo sapiens GN=LDB1 PE=1 SV=2
79 I3L397_HUMAN Eukaryotic translation initiation factor 5A (Fragment) OS=Homo sapiensGN=EIF5A PE=1 SV=5
78 NARR_HUMAN Ras-related protein Rab-34, isoform NARR OS=Homo sapiens GN=RAB34 PE=1SV=1
75 ATD3A_HUMAN Isoform 2 of ATPase family AAA domain-containing protein 3A OS=Homosapiens GN=ATAD3A
73 HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
73 AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiensGN=ATP2A2 PE=1 SV=1
68 E9PKE3_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1
66 RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2
65 P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1
64 H7BZ35_HUMAN Aspartate--tRNA ligase, cytoplasmic (Fragment) OS=Homo sapiens GN=DARSPE=1 SV=1
63 COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2
59 H7C086_HUMAN ATP synthase subunit O, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5O PE=4 SV=1
59 P4HA1_HUMAN Prolyl 4-hydroxylase subunit alpha-1 OS=Homo sapiens GN=P4HA1 PE=1 SV=2
58 E9PLT0_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 PE=1SV=1
58 A0A0A0MSG2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens GN=FHL2 PE=1SV=1
58 B2R5W2_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiensGN=HNRNPC PE=1 SV=1
57 CSDE1_HUMAN Isoform 3 of Cold shock domain-containing protein E1 OS=Homo sapiensGN=CSDE1
56 A0A0A0MS74_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homosapiens GN=PCK2 PE=1 SV=1
55 J3KT29_HUMAN 60S ribosomal protein L23 OS=Homo sapiens GN=RPL23 PE=1 SV=1
52 CAND1_HUMAN Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1PE=1 SV=2
52 NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens GN=WHSC1 PE=1SV=1
52 CCD50_HUMAN Coiled-coil domain-containing protein 50 OS=Homo sapiens GN=CCDC50 PE=1SV=1
51 Q5QNZ2_HUMAN ATP synthase F(0) complex subunit B1, mitochondrial OS=Homo sapiensGN=ATP5F1 PE=1 SV=1
51 H3BPE7_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1
49 A6NLM8_HUMAN Translocon-associated protein subunit delta OS=Homo sapiens GN=SSR4PE=1 SV=1
48 ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiensGN=HADHA PE=1 SV=2
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48 F8VQQ4_HUMAN Tubulin alpha-1A chain (Fragment) OS=Homo sapiens GN=TUBA1A PE=1 SV=1
47 TBB5_HUMAN Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=2
45 TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens GN=TUBB2A PE=1 SV=1
45 F6RFD5_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=1
44 CSDE1_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens GN=CSDE1 PE=1SV=2
43 RS27_HUMAN 40S ribosomal protein S27 OS=Homo sapiens GN=RPS27 PE=1 SV=3
43 MPCP_HUMAN Phosphate carrier protein, mitochondrial OS=Homo sapiens GN=SLC25A3 PE=1SV=2
43 J3KR97_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=1
43 TBB4B_HUMAN Tubulin beta-4B chain OS=Homo sapiens GN=TUBB4B PE=1 SV=1
42 J3KMX5_HUMAN 40S ribosomal protein S13 OS=Homo sapiens GN=RPS13 PE=1 SV=1
42 A0A0D9SFL3_HUMAN RNA-binding protein EWS OS=Homo sapiens GN=EWSR1 PE=4 SV=1
42 H0Y2W2_HUMAN ATPase family AAA domain-containing protein 3A (Fragment) OS=Homosapiens GN=ATAD3A PE=1 SV=1
40 DNJA1_HUMAN DnaJ homolog subfamily A member 1 OS=Homo sapiens GN=DNAJA1 PE=1SV=2
40 H0YDD4_HUMAN Acetyltransferase component of pyruvate dehydrogenase complex(Fragment) OS=Homo sapiens GN=DLAT PE=1 SV=1
40 STRAP_HUMAN Serine-threonine kinase receptor-associated protein OS=Homo sapiensGN=STRAP PE=1 SV=1
39 CY1_HUMAN Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens GN=CYC1 PE=1SV=3
39 H0Y8N0_HUMAN Transmembrane protein 33 (Fragment) OS=Homo sapiens GN=TMEM33 PE=1SV=1
39 TBA1B_HUMAN Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1
38 IF4A3_HUMAN Eukaryotic initiation factor 4A-III OS=Homo sapiens GN=EIF4A3 PE=1 SV=4
38 Q5JR08_HUMAN Rho-related GTP-binding protein RhoC (Fragment) OS=Homo sapiensGN=RHOC PE=1 SV=5
38 F5H5D3_HUMAN Tubulin alpha-1C chain OS=Homo sapiens GN=TUBA1C PE=1 SV=1
38 P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens GN=P4HA2 PE=1 SV=1
37 SND1_HUMAN Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiensGN=SND1 PE=1 SV=1
36 TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1
36 I3L404_HUMAN 40S ribosomal protein S2 (Fragment) OS=Homo sapiens GN=RPS2 PE=1 SV=1
34 V9GYM8_HUMAN Rho guanine nucleotide exchange factor 2 OS=Homo sapiens GN=ARHGEF2PE=1 SV=1
34 RAP1B_HUMAN Isoform 4 of Ras-related protein Rap-1b OS=Homo sapiens GN=RAP1B
34 ATD3B_HUMAN ATPase family AAA domain-containing protein 3B OS=Homo sapiensGN=ATAD3B PE=1 SV=1
33 TBA4A_HUMAN Tubulin alpha-4A chain OS=Homo sapiens GN=TUBA4A PE=1 SV=1
33 E9PI65_HUMAN Heat shock cognate 71 kDa protein (Fragment) OS=Homo sapiens GN=HSPA8PE=1 SV=1
32 CNN3_HUMAN Calponin-3 OS=Homo sapiens GN=CNN3 PE=1 SV=1
30 J3KTJ3_HUMAN 60S ribosomal protein L23 OS=Homo sapiens GN=RPL23 PE=1 SV=1
30 TBA3C_HUMAN Tubulin alpha-3C/D chain OS=Homo sapiens GN=TUBA3C PE=1 SV=3
30 PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiensGN=PCK2 PE=1 SV=3
29 AP2A2_HUMAN AP-2 complex subunit alpha-2 OS=Homo sapiens GN=AP2A2 PE=1 SV=2
29 Q5T4U5_HUMAN Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain, isoform CRA_aOS=Homo sapiens GN=ACADM PE=1 SV=1
27 A0A0A0MSX9_HUMAN Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=IARS PE=1SV=1
27 E5RIM3_HUMAN Phospholipase A-2-activating protein OS=Homo sapiens GN=PLAA PE=1 SV=1
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27 C9J2C0_HUMAN Tubulin alpha-8 chain (Fragment) OS=Homo sapiens GN=TUBA8 PE=1 SV=1
27 A2A3R7_HUMAN 40S ribosomal protein S6 OS=Homo sapiens GN=RPS6 PE=1 SV=1
26 F5H2T0_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=1
26 LPPRC_HUMAN Leucine-rich PPR motif-containing protein, mitochondrial OS=Homo sapiensGN=LRPPRC PE=1 SV=3
25 X1WI28_HUMAN 60S ribosomal protein L10 (Fragment) OS=Homo sapiens GN=RPL10 PE=1SV=4
24 RPN1_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1OS=Homo sapiens GN=RPN1 PE=1 SV=1
23 KHDR1_HUMAN KH domain-containing, RNA-binding, signal transduction-associated protein 1OS=Homo sapiens GN=KHDRBS1 PE=1 SV=1
23 J3KQE5_HUMAN GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens GN=RAN PE=1SV=1
22 B4DR61_HUMAN Protein transport protein Sec61 subunit alpha isoform 1 OS=Homo sapiensGN=SEC61A1 PE=1 SV=1
21 SPG20_HUMAN Spartin OS=Homo sapiens GN=SPG20 PE=1 SV=1
21 GSH0_HUMAN Glutamate--cysteine ligase regulatory subunit OS=Homo sapiens GN=GCLM PE=1SV=1
21 HS90B_HUMAN Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 SV=4
21 EFTU_HUMAN Elongation factor Tu, mitochondrial OS=Homo sapiens GN=TUFM PE=1 SV=2
20 M0QXL5_HUMAN rRNA 2'-O-methyltransferase fibrillarin (Fragment) OS=Homo sapiens GN=FBLPE=1 SV=1
20 K7EK77_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
20 HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3
20 ADT2_HUMAN ADP/ATP translocase 2 OS=Homo sapiens GN=SLC25A5 PE=1 SV=7
19 ATPA_HUMAN ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1SV=1
19 RS14_HUMAN 40S ribosomal protein S14 OS=Homo sapiens GN=RPS14 PE=1 SV=3
19 GRP75_HUMAN Stress-70 protein, mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2
19 GNAL_HUMAN Guanine nucleotide-binding protein G(olf) subunit alpha OS=Homo sapiensGN=GNAL PE=1 SV=1
19 A0A0D9SEM4_HUMAN Serine/arginine-rich-splicing factor 4 (Fragment) OS=Homo sapiensGN=SRSF4 PE=4 SV=1
19 RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2
19 HS90A_HUMAN Heat shock protein HSP 90-alpha OS=Homo sapiens GN=HSP90AA1 PE=1 SV=5
18 ATPA_HUMAN Isoform 3 of ATP synthase subunit alpha, mitochondrial OS=Homo sapiensGN=ATP5A1
18 H2AZ_HUMAN Histone H2A.Z OS=Homo sapiens GN=H2AFZ PE=1 SV=2
17 F8W026_HUMAN Endoplasmin (Fragment) OS=Homo sapiens GN=HSP90B1 PE=1 SV=5
17 K7ENJ4_HUMAN ATP synthase subunit alpha, mitochondrial (Fragment) OS=Homo sapiensGN=ATP5A1 PE=1 SV=1
17 H0YBW4_HUMAN Phospholipase A-2-activating protein (Fragment) OS=Homo sapiens GN=PLAAPE=1 SV=1
16 B4DXZ6_HUMAN Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiensGN=FXR1 PE=1 SV=1
16 SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens GN=SRRM2 PE=1SV=2
16 I3L0K7_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens GN=TRAP1 PE=1SV=1
16 CH60_HUMAN 60 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPD1 PE=1SV=2
16 E9PEJ4_HUMAN Acetyltransferase component of pyruvate dehydrogenase complex OS=Homosapiens GN=DLAT PE=1 SV=1
16 B0YJC4_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=1 SV=1
15 GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 SV=2
17Supplementary Tables
15 EF2_HUMAN Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=4
15 COPB_HUMAN Coatomer subunit beta OS=Homo sapiens GN=COPB1 PE=1 SV=3
14 A0A087WVQ9_HUMAN Elongation factor 1-alpha 1 OS=Homo sapiens GN=EEF1A1 PE=1 SV=1
14 TIF1B_HUMAN Transcription intermediary factor 1-beta OS=Homo sapiens GN=TRIM28 PE=1SV=5
14 G3V1A4_HUMAN Cofilin 1 (Non-muscle), isoform CRA_a OS=Homo sapiens GN=CFL1 PE=1 SV=1
14 G8JLB6_HUMAN Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens GN=HNRNPH1PE=1 SV=1
14 E7EMW7_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens GN=UBR5 PE=1 SV=1
14 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=2
14 FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3
14 J3JS69_HUMAN 40S ribosomal protein S18 OS=Homo sapiens GN=RPS18 PE=1 SV=1
13 RS18_HUMAN 40S ribosomal protein S18 OS=Homo sapiens GN=RPS18 PE=1 SV=3
13 H3BRG4_HUMAN Cytochrome b-c1 complex subunit 2, mitochondrial OS=Homo sapiensGN=UQCRC2 PE=1 SV=1
13 H0Y368_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 (Fragment) OS=Homosapiens GN=DPM1 PE=1 SV=1
13 POTEE_HUMAN POTE ankyrin domain family member E OS=Homo sapiens GN=POTEE PE=1SV=3
13 F5H018_HUMAN GTP-binding nuclear protein Ran (Fragment) OS=Homo sapiens GN=RAN PE=1SV=5
13 ACTC_HUMAN Actin, alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1
12 DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1SV=5
12 B4DEB1_HUMAN Histone H3 OS=Homo sapiens GN=H3F3A PE=1 SV=1
12 LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16APE=1 SV=1
12 RL27_HUMAN 60S ribosomal protein L27 OS=Homo sapiens GN=RPL27 PE=1 SV=2
12 ATPG_HUMAN ATP synthase subunit gamma, mitochondrial OS=Homo sapiens GN=ATP5C1PE=1 SV=1
12 WDR1_HUMAN WD repeat-containing protein 1 OS=Homo sapiens GN=WDR1 PE=1 SV=4
12 ATPB_HUMAN ATP synthase subunit beta, mitochondrial OS=Homo sapiens GN=ATP5B PE=1SV=3
12 EF1A3_HUMAN Putative elongation factor 1-alpha-like 3 OS=Homo sapiens GN=EEF1A1P5 PE=5SV=1
12 A0A087WV01_HUMAN Elongation factor 1-alpha OS=Homo sapiens GN=EEF1A1 PE=1 SV=1
11 A0A087X0X3_HUMAN Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiensGN=HNRNPM PE=1 SV=1
11 E7EQV9_HUMAN Ribosomal protein L15 (Fragment) OS=Homo sapiens GN=RPL15 PE=1 SV=1
11 A0A087WZ27_HUMAN Zinc finger protein 90 OS=Homo sapiens GN=ZNF90 PE=4 SV=2
11 SRSF7_HUMAN Isoform 2 of Serine/arginine-rich splicing factor 7 OS=Homo sapiens GN=SRSF7
10 SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4
N.B. Ratios are mean(Unr)/mean(IgG) and all infinities were ignored unless every Unr value was greater
than zero. The yellow shading highlights a protein absent in every IgG sample but present in every Unr
sample. Finite ratios were rounded to the nearest whole number.
